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A B S T R A C T
Background
Antibiotic resistance is a major public health problem. Infections caused by multidrug-resistant bacteria are associated with prolonged
hospital stay and death compared with infections caused by susceptible bacteria. Appropriate antibiotic use in hospitals should ensure
effective treatment of patients with infection and reduce unnecessary prescriptions. We updated this systematic review to evaluate the
impact of interventions to improve antibiotic prescribing to hospital inpatients.
Objectives
To estimate the effectiveness and safety of interventions to improve antibiotic prescribing to hospital inpatients and to investigate the
effect of two intervention functions: restriction and enablement.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library), MEDLINE, and Embase. We
searched for additional studies using the bibliographies of included articles and personal files. The last search from which records were
evaluated and any studies identified incorporated into the review was January 2015.
Selection criteria
We included randomised controlled trials (RCTs) and non-randomised studies (NRS).We included three non-randomised study designs
to measure behavioural and clinical outcomes and analyse variation in the effects: non- randomised trials (NRT), controlled before-
after (CBA) studies and interrupted time series (ITS) studies. For this update we also included three additional NRS designs (case
control, cohort, and qualitative studies) to identify unintended consequences. Interventions included any professional or structural
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interventions as defined by the Cochrane Effective Practice and Organisation of Care Group. We defined restriction as ’using rules
to reduce the opportunity to engage in the target behaviour (or increase the target behaviour by reducing the opportunity to engage
in competing behaviours)’. We defined enablement as ’increasing means/reducing barriers to increase capability or opportunity’. The
main comparison was between intervention and no intervention.
Data collection and analysis
Two review authors extracted data and assessed study risk of bias. We performed meta-analysis and meta-regression of RCTs and meta-
regression of ITS studies. We classified behaviour change functions for all interventions in the review, including those studies in the
previously published versions. We analysed dichotomous data with a risk difference (RD). We assessed certainty of evidence with
GRADE criteria.
Main results
This review includes 221 studies (58 RCTs, and 163 NRS). Most studies were fromNorth America (96) or Europe (87). The remaining
studies were from Asia (19), South America (8), Australia (8), and the East Asia (3). Although 62% of RCTs were at a high risk of bias,
the results for the main review outcomes were similar when we restricted the analysis to studies at low risk of bias.
More hospital inpatients were treated according to antibiotic prescribing policy with the intervention compared with no intervention
based on 29 RCTs of predominantly enablement interventions (RD 15%, 95% confidence interval (CI) 14% to 16%; 23,394 partic-
ipants; high-certainty evidence). This represents an increase from 43% to 58% .There were high levels of heterogeneity of effect size
but the direction consistently favoured intervention.
The duration of antibiotic treatment decreased by 1.95 days (95%CI 2.22 to 1.67; 14 RCTs; 3318 participants; high-certainty evidence)
from 11.0 days. Information from non-randomised studies showed interventions to be associated with improvement in prescribing
according to antibiotic policy in routine clinical practice, with 70% of interventions being hospital-wide compared with 31% for RCTs.
The risk of death was similar between intervention and control groups (11% in both arms), indicating that antibiotic use can likely
be reduced without adversely affecting mortality (RD 0%, 95% CI -1% to 0%; 28 RCTs; 15,827 participants; moderate-certainty
evidence). Antibiotic stewardship interventions probably reduce length of stay by 1.12 days (95% CI 0.7 to 1.54 days; 15 RCTs; 3834
participants; moderate-certainty evidence). One RCT and six NRS raised concerns that restrictive interventions may lead to delay in
treatment and negative professional culture because of breakdown in communication and trust between infection specialists and clinical
teams (low-certainty evidence).
Both enablement and restriction were independently associated with increased compliance with antibiotic policies, and enablement
enhanced the effect of restrictive interventions (high-certainty evidence). Enabling interventions that included feedback were probably
more effective than those that did not (moderate-certainty evidence).
There was very low-certainty evidence about the effect of the interventions on reducing Clostridium difficile infections (median -
48.6%, interquartile range -80.7% to -19.2%; 7 studies). This was also the case for resistant gram-negative bacteria (median -12.9%,
interquartile range -35.3% to 25.2%; 11 studies) and resistant gram-positive bacteria (median -19.3%, interquartile range -50.1% to
+23.1%; 9 studies). There was too much variance in microbial outcomes to reliably assess the effect of change in antibiotic use.
Heterogeneity of intervention effect on prescribing outcomes
We analysed effect modifiers in 29 RCTs and 91 ITS studies. Enablement and restriction were independently associated with a larger
effect size (high-certainty evidence). Feedback was included in 4 (17%) of 23 RCTs and 20 (47%) of 43 ITS studies of enabling
interventions andwas associated with greater intervention effect. Enablementwas included in 13 (45%) of 29 ITS studies with restrictive
interventions and enhanced intervention effect.
Authors’ conclusions
We found high-certainty evidence that interventions are effective in increasing compliance with antibiotic policy and reducing duration
of antibiotic treatment. Lower use of antibiotics probably does not increase mortality and likely reduces length of stay. Additional trials
comparing antibiotic stewardship with no intervention are unlikely to change our conclusions. Enablement consistently increased the
effect of interventions, including those with a restrictive component. Although feedback further increased intervention effect, it was
used in only aminority of enabling interventions. Interventions were successful in safely reducing unnecessary antibiotic use in hospitals,
despite the fact that the majority did not use the most effective behaviour change techniques. Consequently, effective dissemination
of our findings could have considerable health service and policy impact. Future research should instead focus on targeting treatment
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and assessing other measures of patient safety, assess different stewardship interventions, and explore the barriers and facilitators to
implementation. More research is required on unintended consequences of restrictive interventions.
P L A I N L A N G U A G E S U M M A R Y
Improving how physicians working in hospital settings prescribe antibiotics
Review aim
The aim of this Cochrane review was to learn of ways to improve how physicians working in hospital settings prescribe antibiotics. We
collected and analysed all relevant studies to answer this question and found 221 studies.
Key messages
The use of an antibiotic policy leads to improved prescribing practices and decreases in the duration of antibiotic treatment.
Interventions that are directed to physicians to improve their antibiotic prescribing practices reduced participant length of stay in
hospitals by 1.12 days (based on findings from 15 studies) and did not increase the risk of death (based on findings from 29 studies).
Interventions providing advice or feedback to physicians were more effective in improving prescribing practices than those interventions
that did not provide this information to physicians. Evidence from seven studies raised concerns that with interventions applying rules
to make to make physicians prescribe properly there were delays in treatment and a breakdown in trust between infection specialists
and clinical teams.
What was studied in the review?
Antibiotics are used to treat bacterial infections such as pneumonia. Many bacteria have become resistant to antibiotics over time.
Antibiotic resistance is a serious problem for patients and healthcare systems because infections caused by antibiotic-resistant bacteria
can lead to higher rates of death and longer hospital stays. Bacterial resistance often occurs because antibiotics are used when they are
not needed. Studies have shown that in about half of cases physicians in hospital are not prescribing antibiotics properly.
We investigated the effectiveness and safety of interventions to help physicians prescribe antibiotics properly and what techniques of
behaviour change could influence the success of the interventions.
Key results
We found 221 relevant studies. Ninety-six studies were from North America. The remaining 125 studies were from Europe (87), Asia
(19), South America (8), Australia (8), and East Asia (3). The studies tested interventions that fell broadly into two categories: restrictive
techniques, which apply rules to make physicians prescribe properly, and enablement techniques, which provide advice or feedback to
help physicians prescribe properly.
We found high-certainty evidence that interventions lead to more hospital inpatients receiving the appropriate treatment for their
condition according to antibiotic prescribing policies. We found moderate-certainty evidence that interventions reduce the length of
hospital stay without increasing patient deaths. Both restriction and enabling techniques were successful in achieving effectiveness of
the intervention. We do not need more studies to answer the question of whether these interventions reduce unnecessary antibiotic
use, but we do need more research to understand the unintended consequences of the use of restrictive interventions.
Interventions were successful in safely reducing unnecessary antibiotic use in hospitals, despite the fact that the majority did not use a
widely adopted behaviour change technique, which is to audit and provide feedback on performance. Effective communication of the
review results could have considerable health service and policy impact.
How up-to-date is the review?
We searched for studies published up to January 2015.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Patient or population: adults or children undergoing inpat ient ant ibiot ic prophylaxis or treatment
Settings: mainly high-income countries (North America or Western Europe)
Intervention: any intervent ion target ing healthcare professionals that aimed to improve ant ibiot ic prescribing to hospital inpat ients
Comparison: usual care (varied across studies)
Effectiveness: prescribing outcomes from RCTs
Outcomes Absolute effect* No of participants
(No of studies)
Certainty of the evidence
(GRADE)
Comments
Without intervention With intervention
Proport ion of part icipants
who were treated accord-
ing to ant ibiot ic prescribing
guidelines
Follow-up to end of study
43 per 100 58 per 100 23,394 part icipants
(29 RCTs)
⊕⊕⊕⊕
High
We have graded the certainty of
evidence as high because het-
erogeneity was explained by pre-
specif ied ef fect modif iers (see
below). The intervent ion ef fect
varied between the studies, but
the direct ion of ef fect was con-
sistent. Restrict ing the analysis
to studies at low risk of bias gave
a sim ilar result (RD 11%, 95% CI
10% to 12%)
Dif ference: 19 more part icipants per 100
(95% CI 15 to 23) received appropriate
treatment following intervent ion
Durat ion of all ant ibiot ic
treatment
11.0 days 9.1 days 3318 part icipants
(14 RCTs)
⊕⊕⊕⊕
High
Dif ference: 1.95 fewer days per part ici-
pant (95% CI 2.22 to 1.67)
Mortality
Follow-up to end of study
11 per 100 11 per 100 15,827 part icipants
28 (RCTs)
⊕⊕⊕©1
Moderate
Mortality and length of stay were
measured to determ ine the im-
pact of reduced ant ibiot ic use
on clinical outcomes. The results
were sim ilar for studies that tar-
geted ant ibiot ic choice or expo-
sure
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Only 1 of the intervent ions in the
RCTs with mortality or length-of -
stay outcomes had a restrict ive
component (Singh 2000). This
evidence is therefore at high risk
of indirectness because 7 stud-
ies in the next sect ion of the table
(see below) raise concerns about
the safety of restrict ive interven-
t ions. Moreover, the ITS studies
showed that restrict ive compo-
nents were included in 42 (34%)
of 123 hospital intervent ions
Dif ference: 0 more deaths per 100 part ic-
ipants (95% CI 1 to 0 fewer)
Mean length of hospital stay
per part icipant
12.9 days 11.8 days 3834 part icipants
15 (RCTs)
⊕⊕⊕©1
Moderate
Dif ference: 1.1 fewer days per part icipant
(95% CI 1.5 to 0.7 fewer)
Delay in treatment Restrict ive intervent ions increased the
risk of delay in all 3 studies. The risk
to pat ients resulted in term inat ion of the
RCT by the Trial Monitoring Committee
1 RCT, 2 cohort ⊕⊕©©2
Low
The evidence f rom these 7 stud-
ies of unintended consequences
raises concerns about the direct-
ness of the evidence of safety
f rom the 29 RCTs in the previous
sect ion of the table (see above)
Negative professional cul-
ture
Loss of trust in infect ion specialists be-
cause of failure to record approvals for
restricted drugs or provide warning about
stopping treatment
Misleading or inaccurate information
f rom prescribers in order to meet criteria
for restricted drugs. In 1 hospital, m is-
diagnosis of hospital-acquired infect ion
was large enough to trigger an outbreak
invest igat ion
1 case control, 2 cohort , 1 quali-
tat ive
⊕⊕ 3
Low
Effect modifiers (heterogeneity) for immediate effect of intervention on prescribing outcomes:
impact of behaviour change functions (enablementor restriction) and additional impact of feedback, RCTs and ITS studies. A positive value for Beta means the modifier is
associated with increased effect
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Effect modifier Adjusted effect in meta- regression
Beta
(95% CI)
Number of studies Certainty of the evidence
(GRADE)
Comments
Enablement 15.12
(8.45 to 21.8)
29 RCTs ⊕⊕⊕⊕
High
The ef fect of enablement and re-
strict ion is sim ilar in the RCTs
and ITS studies. Of the 29 RCTs,
only 8 (31%) of intervent ions
were hospital-wide, the majority
being in single units. In contrast,
64 (70%) of the intervent ions in
ITS studies were hospital-wide
12.86
(4.11 to 21.6)
91 ITS
Restrict ion 34.91
(13.52 to 56.29)
29 RCTs ⊕⊕⊕⊕
High
24.69
(13.74 to 35.64)
91 ITS
Addit ion of feedback to en-
ablement
10.88
(7.16 to 19.32)
23 RCTs ⊕⊕⊕©2
Moderate
Feedback was included in 4 (17%)
of 23 RCTs and 20 (47%) of
43 ITS studies with intervent ions
that included enablement. There
were not enough intervent ions
with goal sett ing and act ion plan-
ning to analyse as ef fect modi-
f iers
15.63
(0.56 to 30.70)
43 ITS
Addit ion of enablement to
restrict ion
38.36
(18.94 to 57.78)
29 ITS ⊕⊕ 3
Low
Enablement was included in 13
(45%) of 29 ITS studies with re-
strict ive intervent ions
* The risk WITHOUT the intervent ion is based on the median control group risk across studies. The corresponding risk WITH the intervent ion (and the 95% conf idence interval
for the dif ference) is based on the overall relat ive ef fect (and its 95% conf idence interval).
CI: conf idence interval; ITS: interrupted t ime series; RCT: randomised controlled trial; RD: risk dif f erence
GRADE Working Group grades of evidence
High certainty: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate certainty: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low certainty: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
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Very low certainty: We are very uncertain about the est imate.
Details of f ive GRADE criteria for all outcomes f rom RCTs are in Appendix 2.
1We downgraded the evidence to moderate because of indirectness.
2We downgraded the evidence because most studies are non-randomised studies.
3We graded the evidence as low because it is all f rom non-randomised studies.
4We graded the evidence as very low because it is all f rom non-randomised studies and there was too much heterogeneity for
reliable evidence synthesis.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Description of the condition
Antibiotic resistance is a major public health problem. In compar-
ison with infections caused by susceptible bacteria, those caused
by multidrug-resistant bacteria are associated with higher inci-
dences of mortality and prolonged hospital stay (de Kraker 2011).
Clostridium difficile infection (CDI) is another manifestation of
the collateral damage caused by antimicrobial prescribing (Davey
2010). Such infections are also associated with increased costs re-
sulting from the need to use more expensive antibiotics, prolonged
hospital stay (the principal contributor), and expenses related to
screening and surveillance, eradication regimens, and consumables
(the gloves, gowns, and aprons used to prevent cross-infection) (de
Kraker 2011). The UK 5 Year Antimicrobial Resistance Strategy
2013 to 2018 recognises the importance of reducing inappropri-
ate antibiotic prescribing (Department of Health 2013), the im-
plication being that antibiotic resistance is largely a consequence
of the selective pressures of antibiotic usage, and that reducing
these pressures by the judicious administration of antibiotics will
facilitate a return of susceptible bacteria or, at least, will prevent
or slow the pace of the emergence of resistant strains.
At the same time, sepsis is a major cause of avoidable mortality
in hospitals, with an estimated 100,000 cases per year in the UK
alone (NCEPOD 2015).
Description of the intervention
We included any intervention to improve antibiotic prescribing
to hospital inpatients. Antibiotic stewardship has two aims: first,
to ensure effective treatment of patients with infection, and sec-
ond, tominimise collateral damage from antimicrobial use (Davey
2010). Hence the UK Department of Health’s Guidance on An-
timicrobial Stewardship emphasises the need for urgent treatment
of serious infections in addition to minimising unnecessary use
of antibiotics (Department of Health 2013). We compared inter-
ventions to change professional behaviour with standard practice
(no intervention). We classified interventions by their interven-
tion function (Michie 2011). The previous version of this review
suggested that restrictive interventions had greater immediate ef-
fect on prescribing than interventions that used education or per-
suasion (Davey 2013). For this update, we identified interventions
that were designed to increase enablement, defined as ’increas-
ing means/reducing barriers to increase capability or opportunity’
(Michie 2011).
How the intervention might work
In this update of the review we used new data extraction sheets to
classify the intervention functions and to identify the behaviour
change functions that are used in antimicrobial stewardship in-
terventions (Michie 2013). In particular, we assessed the relative
effectiveness of interventions according to how they used enable-
ment and restriction to change behaviour (Michie 2011). We di-
vided the interventions into four groups: enablement without re-
striction; restriction without enablement; both enablement and
restriction; and neither enablement nor restriction.
Why it is important to do this review
This review is an update of Davey 2005 and Davey 2013. It com-
plements a review of interventions to improve prescribing of an-
tibiotics to patients in ambulatory care (Arnold 2005).
O B J E C T I V E S
To estimate the effectiveness and safety of interventions to improve
antibiotic prescribing to hospital inpatients and investigate the
effect of two intervention functions: restriction and enablement.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) and non-ran-
domised studies (NRS). We included three NRS study designs to
measure behavioural and clinical outcomes and analyse variation in
the effects: non-randomised trials (NRT), controlled before-after
(CBA) studies and interrupted time series (ITS) studies. We used
Cochrane Effective Practice and Organisation of Care (EPOC)
Group eligibility guidance for CBAs and NRTs (EPOC 2016).
In addition, for the assessment of unintended consequences, we
included three additional NRS designs (case control, cohort, and
qualitative studies) to identify additional evidence about long-
term effects and harms of interventions in order to enhance the
directness of evidence from RCTs (Schünemann 2013).
Types of participants
Healthcare professionals who prescribe antibiotics to hospital in-
patients receiving acute care (including elective inpatient surgery).
We excluded interventions targeted at residents in nursing homes
or other long-term healthcare settings.
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Types of interventions
We included interventions relevant to improving antibiotic pre-
scribing as outlined in the EPOC taxonomy (EPOC 2015).
1. Audit and feedback defined as any summary of clinical
performance of health care over a specified period of time.
2. Education through meetings or distribution of educational
materials.
3. Educational outreach through academic detailing or review
of individual patients with recommendation for change.
4. Reminders provided verbally, on paper, in the workplace
environment (e.g. posters or messages printed on equipment) or
on computer.
5. Structural: the influence on antibiotic prescribing of
changing from paper to computerised records and of the
introduction of new technology for rapid microbiology testing or
measurement of inflammatory markers.
In addition, we included the following restrictive interventions:
selective reporting of laboratory susceptibilities; formulary restric-
tion; requiring prior authorisation (expert approval) therapeutic
substitution; and automatic stop orders.
Enabling interventions were: audit and feedback; educational out-
reach through review of individual patients with recommendation
for change; and circumstantial reminders that were targeted at doc-
tors who were managing specific patients (Table 1). We classified
reminders in the form of posters or pocket cards summarising an-
tibiotic policies as environmental restructuring but not as enabling
(Table 1). Terms used to describe interventions are described in
more detail in the Data extraction and management section.
We did not consider studies that compared the effectiveness of
antibiotic treatments (e.g. intravenous versus oral administration
of antibiotics) as eligible for this review.
Types of outcome measures
Primary outcomes
The effect of interventions on antibiotic prescribing measured
as either compliance with antibiotic guidelines or policies, the
durationof antibiotic treatment, decision to treat, or total duration
of treatment. We included studies without reliable or adequate
information addressing the primary outcome measure, but we did
not use these studies in data synthesis.
Secondary outcomes
Mortality, length of stay, or other clinical outcomes (e.g. surgical-
site infection or acute kidney injury), microbial outcomes (CDI,
colonisation or infection with antimicrobial-resistant bacteria),
unintended-consequences measures (e.g. a delay in start of antibi-
otic treatment, a change in threshold for diagnosis of hospital-ac-
quired infection to justify existing prescribing practice). Note that
clinical outcomes could be indicators of improved clinical out-
comes associated with interventions to increase effective antibiotic
treatment, or unintended consequences (e.g. to provide evidence
about the safety of interventions to reduce unnecessary antibiotic
treatment).
Search methods for identification of studies
Electronic searches
We searched the Cochrane Database of Systematic Reviews
(CDSR) and the Database of Abstracts of Reviews of Effects
(DARE) for related systematic reviews and the following databases
for primary studies without language, publication year, or publi-
cation status restrictions in January 2015.
Databases
• Cochrane Central Register of Controlled Trials
(CENTRAL; 2015, Issue 1) in the Cochrane Library (searched
22 January 2015)
• MEDLINE (1946 to 19 January 2015) (OvidSP)
• Embase (1947 to 22 January 2015) (OvidSP)
The MEDLINE search strategy was developed by the Cochrane
EPOC Group Information Specialist in consultation with the re-
view authors and translated for use in other databases employ-
ing appropriate syntax and vocabulary. Results were limited by
two methodological filters: the Cochrane Highly Sensitive Search
Strategy (sensitivity- and precision-maximising version, 2008 revi-
sion) to identify randomised trials (Higgins 2011), and aCochrane
EPOC Group study design filter to identify NRS. Full search
strategies are provided in Appendix 1.
Searching other resources
We searched for additional studies using the bibliographies of in-
cluded articles, personal files, and by contacting experts in the field
regarding any unpublished work.
Data collection and analysis
Selection of studies
Two review authors (EB andPD) independently reviewed citations
and abstracts retrieved in the search to identify all reports that
included original data about interventions to change antibiotic
prescribing. If either review author had doubts about eligibility,
then both review authors reviewed the full papers. The review
authors were not blinded to study author or location. We resolved
disagreements by discussion and consensus.
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We excluded studies that had no relevant and interpretable data
presented or obtainable. We defined ’relevant data’ as an interven-
tion that included a change in antibiotic treatment for hospital
inpatients and where at least one of the study’s reported outcomes
was directly attributable to change in antibiotic treatment. We de-
fined ’interpretable data’ as follows: CBA, NRT, or RCT designs
had to include sufficient data to estimate effect size as change in
at least one relevant outcome after the intervention. Interrupted
time series studies had to include a clearly defined intervention
point.
We did not exclude studies due to high risk of bias.
Data extraction and management
Working in pairs, five review authors (PD, CM, CS, EC, KM)
independently performed data abstraction using data extraction
sheets including informationon: study design, type of intervention
(intervention components and functions), presence of controls,
type of targeted behaviour, participants, setting, methods (unit of
allocation, unit of analysis, study power, methodological risk of
bias, consumer involvement), outcomes, and results.
Explanation of terms used to describe interventions
Restriction
We defined restriction as ’using rules to reduce the opportunity to
engage in the target behaviour (or increase the target behaviour by
reducing the opportunity to engage in competing behaviours)’.
Enablement
We defined enablement as ’increasing means/reducing barriers to
increase capability or opportunity’.
Goal setting
We documented the specific prescribing behaviour that was tar-
geted by the intervention (e.g. switch participants from parenteral
to oral antibiotics) and how this was incorporated into an aim
for the intervention. Was the aim simply a directional change of
the target behaviour (e.g. increase or decrease behaviour?), or did
the intervention include a specific threshold to be reached (e.g.
target behaviour performed more than 95% of the time) or the
duration within which the target had to be achieved (e.g. more
than 95% reliability within six months)? If the study reported a
power calculation, we did not accept this as evidence of a specific
threshold unless it was clearly communicated to the professionals
who were the targets of the intervention. For example, a power
calculation showing that the study could detect a 10% improve-
ment in the targeted behaviour would have to be accompanied by
some explicit statement about the intervention aim being at least
10% improvement.
Feedback
We classified interventions as including feedback only if they pro-
vided a “summary of clinical performance of healthcare over a
specified period of time” (EPOC2015).We found that some stud-
ies did not meet this definition, even though they described their
intervention as including feedback in the title (e.g. Elligsen 2012
and Newland 2012) or in the methods (e.g. Palmay 2014). The
intervention in these studies was educational outreach by review
and recommended change, so the feedback was limited to the in-
dividual participants who were reviewed with no feedback about
the treatment of other participants over time. In contrast, Buising
2008a is an example of an intervention in which “a formal feed-
back was provided to units regarding their compliance with the
approval system over time” in addition to review and recommend
change for individual participants. For studies that met our defini-
tion of feedback, we recorded frequency, format (verbal, written,
or both) and whether it was delivered by a colleague, supervisor,
or somebody external to the clinical team.
Action planning
We documented whether there was a reward for meeting a target,
which could bematerial or social reward (either from self or others)
and the use of action plans if the target was notmet.Our definition
of an action plan was: prompt, detailed planning of performance
of the behaviour, which had to include at least one of context,
frequency, duration, or intensity. If there was evidence of action
planning, we recorded to whom the action plan was tailored (e.g.
individual participant or group) and whether participants were
involved in developing the action plan.
Intervention components and functions
In the Characteristics of included studies we have listed the inter-
vention components (Types of interventions) and the intervention
functions (Michie 2011; Michie 2013). Note that each interven-
tion component may have more than one intervention function.
We have presented definitions of intervention functions and their
relationship to intervention components in Table 1.
Assessment of the impact of interventions
We have used meta-analysis to assess the impact of RCTs of in-
terventions and meta-regression to understand variation in effect
estimates for RCTs and ITS studies.
Assessment of risk of bias in included studies
We applied the 2013 EPOC ’Risk of bias’ criteria to all papers in
the review, including articles in the 2003 review (EPOC 2013).We
scored each study for risk of bias as ’low’ if all criteria were scored
as ’low’, ’medium’ if one or two criteria were scored as ’unclear’ or
’high’, and ’high’ if more than two criteria were scored as ’unclear’
or ’high’.
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We applied three additional criteria to studies with microbial out-
comes, based on the ORION statement: Guidelines for transpar-
ent reporting of outbreak reports and intervention studies of noso-
comial infection (Orion Statement; Stone 2007).
1. Case definition: score as ’low’ if there is a clear definition
either of infection or of colonisation and there were no major
changes in laboratory diagnostic methods during the study
period.
2. Planned intervention: score as ’low’ if the intervention was
planned to reduce endemic rates of colonisation or infection and
was not implemented in response to an outbreak. Regression to
the mean following an outbreak is an important risk of bias for
estimates of the effect of interventions in ITS studies of infection
(Davey-Smith 2001; Stone 2007).
3. Other infection control measures: score as ’low’ if infection
control practices (hand hygiene, gowning, or other personal
protection) and isolation or cohorting policies are described and
there were no changes coincident with the intervention to
change antibiotic prescribing.
We have presented microbial ’Risk of bias’ results in the Notes
section of the Characteristics of included studies. We have not in-
cluded them in the ’Risk of bias’ tables unless there might also be
a risk to prescribing outcomes (e.g. appointment of additional in-
fection control practitioners who might have influenced prescrib-
ing).
We assessed risk of bias in case control or cohort studies of unin-
tended consequences with ROBINS-I: a tool for assessing Risk of
Bias in Non-randomised Studies of Interventions (Sterne 2016).
We have reported these ’Risk of bias’ assessments in the Notes
section of the Characteristics of included studies.
Measures of treatment effect
We assessed the impact of interventions on clinical outcome for
studies that provided reliable data about mortality, length of hos-
pital stay, or other clinical outcomes such as acute kidney injury.
We did not include clinical outcomes for studies that estimated the
impact of their intervention based on modelling (Barlow 2007).
We analysed dichotomous data (such as increase in desired practice
and mortality) as risk differences and analysed continuous data
(such as length of hospital stay) as mean differences.
We critically examined the methods of analysis of ITS data. The
preferred method is a statistical comparison of time trends before
and after the intervention. If the original paper did not include
an analysis of this type, we extracted the data presented in tables
or graphs in the original paper and used them to perform new
analyses where possible. We used segmented time series regression
analysis to estimate the effect of the intervention whilst taking ac-
count of time trend and autocorrelation among the observations.
We obtained estimates for regression coefficients corresponding
to two standardised effect sizes for each study: a change in level
and a change in trend before and after the intervention. A change
in level was defined as the difference between the observed level
at the first intervention time point and that predicted by the pre-
intervention time trend. A change in trend was defined as the dif-
ference between post- and pre-intervention slopes (Ramsay 2003).
We evaluated the direct effect of the intervention using results
reported one month after the start of the intervention. We also
reported the level effects at six months, and yearly thereafter when
possible. We standardised the results of some ITS studies so that
they were on the same scale (per cent change in outcome), thereby
facilitating comparisons of different interventions. To do this, we
used the change in level and change in slope to estimate the effect
size with increasing time after the intervention (one month, six
months, one year, etc.) as the per cent change in level at each time
point.We did not extrapolate beyond the end of data collection af-
ter the intervention. We anticipated that the eligible studies would
exhibit significant heterogeneity, due to variations in target clini-
cal behaviours, patient and provider populations, methodological
features, characteristics of the interventions, and the contexts in
which the interventions were delivered. To address the source of
variation in results due to the use of enabling or restrictive inter-
ventions, we undertook a random-effects meta-regression analysis
on study-level summary effect size at each time point.
We assessed the impact of interventions on microbial outcomes
if the study provided reliable data about colonisation or infection
with Clostridium difficile or with antibiotic-resistant bacteria. We
did not include microbial outcomes for studies that estimated
the future impact of their intervention based on modelling (Paul
2006), or that used clinical definitions of infection that did not
distinguish between resistant and sensitive bacteria (Micek 2004;
Singh 2000).
Unit of analysis issues
If an RCT did not take into account the effect of clustering in
the analysis, we stated this in the ’Risk of bias’ assessment. We
incorporated consideration of unit of analysis issues as part of the
sensitivity analyses.
We estimated intracluster correlation (ICC) for each outcome.
The ICCs used reflect that process measures usually have higher
ICC than outcome measures and were obtained from the database
of ICCs held by the Health Services Research Unit, University of
Aberdeen (Health Services Research Unit 2016).
• Prescribing 0.2
• Mortality 0.01
• Length of stay 0.2
Average cluster size (m) = (total number of participants (interven-
tion + control)) (total number of clusters). Inflation factor = 1 +
(m-1) x ICC. For dichotomous outcomes, we divided events and
participants by the inflation factor for intervention and control
groups. For continuous outcomes, wemultiplied intervention and
control standard deviation by the inflation factor.
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Dealing with missing data
We have not attempted to account for missing data in the meta-
analysis of RCTsormeta-regression of ITS studies. For ITS studies,
we only analysed effects at a specified time point when data were
available, we have not carried forward regression lines beyond the
last observation or used regression lines to estimate missing data..
Assessment of heterogeneity
We quantified heterogeneity among studies using the I2 statistic
and Cochran’s Q test (Cochran 1954). The I2 statistic quantifies
the percentage of the total variation across studies that is due to
heterogeneity rather than chance (Higgins 2003); smaller percent-
ages suggest less observed heterogeneity.
Assessment of reporting biases
We assessed publication and selective reporting bias.
Data synthesis
Wehave analysed the results for RCTs, CBAs, NRT, and ITS stud-
ies separately. For the RCT data, we employed a standard meta-
analysis approach using ReviewManager 5 for binary (e.g. compli-
ance with guidelines) and continuous (e.g. duration of treatment)
outcomes. We analysed the data with a fixed-effect model (Review
Manager 5).
We used Stata 14 for all statistical re-analyses and meta-regressions
(Stata 2015), and ReviewManager 5 for all data synthesis (Review
Manager 5).
Subgroup analysis and investigation of heterogeneity
We used meta-regression to investigate potential effect modifiers.
In meta-regression, the outcome variable is the effect estimate (e.g.
a mean difference or a risk difference). The explanatory variables
are characteristics of studies that might influence the size of inter-
vention effect (Higgins 2011).
We prespecified four subgroups as explanatory variables for the
meta-regression (Davey 2014):
1. interventions that included enablement versus those that
did not;
2. interventions that included restriction versus those that did
not;
3. enabling interventions that included feedback versus those
that did not;
4. feedback interventions that included goal setting or action
planning versus those that did not.
Definitions of these terms can be found in Data extraction and
management and Table 1. We expected restriction, enablement,
feedback goal setting and action planning to be associated with
increased effectiveness of interventions (Ivers 2012).
We included the following three additional variables in the meta-
regression because they might influence the size of intervention
effect and explain heterogeneity.
1. Target: choice of antibiotic regimen versus time to first
antibiotic dose or exposure to antibiotics, effects possibly greater
for interventions targeting choice.
2. Setting: single unit versus multiple wards, effects possibly
greater in single unit.
3. Intent: increase effective versus decrease excessive, effects
possibly greater with increase effective.
The meta-regression was performed using standard weighted (by
standard error of estimate) linear regression (Higgins 2011).
Sensitivity analysis
We conducted sensitivity analyses by re-analysing data to investi-
gate the effect of two risks of bias.
1. Lack of adjustment for the effect of clustering in cluster
RCTs. We repeated all analyses that included cluster RCTs with
adjusted numbers of events and total participants for
dichotomous variables and adjusted standard deviation for
continuous variables (Analysis 1.2; Analysis 1.5; Analysis 2.2;
Analysis 2.5).
2. Overall high risk of bias. We analysed all studies at medium
and low risk of bias separately in sensitivity analyses (Analysis
1.3; Analysis 1.6; Analysis 2.3; Analysis 2.6).
Summary of findings
We summarised the findings of themain intervention comparison
for the most important outcomes in Summary of findings for the
main comparison. Two review authors independently assessed the
certainty of the evidence for each key outcome (high, moderate,
low, and very low) using the five GRADE considerations (study
limitations, consistency of effect, imprecision, indirectness, and
publication bias) (Guyatt 2011). We assessed the following out-
comes:
1. compliance with desired practice;
2. duration of antibiotic treatment;
3. mortality;
4. length of hospital stay;
5. delay in treatment;
6. negative professional culture.
We also assessed the evidence from the meta-regression in terms
of the extent to which we believed it helped explain variation of
effect. We included the following effect modifiers in our analysis.
1. Enablement (Yes/No)
2. Restriction (Yes/No)
3. Addition of feedback to enablement (Yes/No)
4. Addition of enablement to restriction (Yes/No)
We used the methods and recommendations described in Section
8.5 and Chapter 12 of the Cochrane Handbook for Systematic Re-
views of Interventions, Higgins 2011, and the EPOC worksheets
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(EPOC 2013a). Disagreements on certainty ratings were resolved
by discussion, and justification for decisions to down- or upgrade
the ratings are provided in footnotes in the table and comments
made to aid readers’ understanding of the review where necessary.
We used plain language statements to report these findings in the
review. Further details about each of the five GRADE criteria are
in Appendix 2.
Evidence from randomised studies started at high certainty and
was downgraded according to the five considerations described
above. Evidence from non-randomised studies started at low cer-
tainty and was assessed against the same five criteria. We only con-
sidered upgrading for non-randomised evidence in the presence
of a large treatment effect, dose response, or where plausible con-
founding would have reduced the observed effect.
R E S U L T S
Description of studies
Results of the search
The combined results of all literature searches are described in the
study flow diagram (Figure 1).
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Figure 1. Figure 1 Study flow diagram.
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Included studies
The Characteristics of included studies table lists 221 studies, of
which 211 used the following designs to evaluate the intended ef-
fect of interventions: 138 ITS studies, 58 RCTs (14 cluster RCTs),
6 CBAs, and 8 NRTs. The remaining 11 studies were designed
to identify unintended consequences of interventions and used
the following designs: 8 cohort (Connor 2007; Duvoisin 2014;
Friedberg 2009;Kanwar 2007; LaRosa 2007; Linkin 2007;Welker
2008; Winters 2010), 1 case control (Calfee 2003), and 1 quali-
tative (semi-structured interviews) (Baysari 2013) and 1 ITS (Bell
2014).
Geographical location of study
Ninety-six studies were from North America. The remaining 125
were from Europe (87, includes Israel), Asia (19), South America
(8), Australia (8), and East Asia (3). The number of studies by
country (including the countries in four multinational studies)
is: Argentina, 1; Australia, 9; Austria, 2; Belgium, 4; Brazil, 4;
Canada, 8;China, 6;Colombia, 2;Croatia, 1;Denmark, 3; France,
11; Germany, 12; Greece, 1; Hong Kong, 1; Hungary, 1; India,
1; Indonesia, 1; Israel, 1; Italy, 3; Japan, 1; Korea, 3; Lebanon,
1; Mexico, 1; Netherlands, 11; Norway, 1; Serbia, 1; Singapore,
1; Spain, 5; Sweden, 2; Switzerland, 11; Taiwan, 3; Thailand, 4;
Turkey, 1; UK, 22; USA, 89.
Number of hospitals
A total of 178 (79%) studies were conducted in one hospital, 9
studies in 2 hospitals, 18 studies in 3 to 9 hospitals, and 16 studies
in 10 or more hospitals.
Deliverer of intervention
Of the 221 interventions, 112 (51%) were designed and delivered
by a multidisciplinary team, 54 (24%) by specialist physicians
(infectious diseases or microbiology), 35 (16%) by department
physicians (e.g. emergency department or critical care), and 20
(9%) by pharmacists.
Funding
Five studies received some funding from manufacturers of drugs
or laboratory tests. The remaining 216 studies were funded by
government agencies or the participating hospitals. Details are
provided in the Characteristics of included studies table.
Power calculations
Details of power calculations are provided in Appendix 3
Excluded studies
We excluded 32 unique studies from the review because they did
not contain relevant or interpretable data (Selection of studies).
For details of each study, see Characteristics of excluded studies.
Risk of bias in included studies
All 14 CBAs and NRTs were at high risk of bias (Figure 2). High
risk of bias was more common in RCTs (36/58, 62%) than in ITS
studies (20/138, 14%) (Figure 2). All 51 studies at low risk of bias
were ITS studies (Figure 2). Among RCTs, high risk of bias was
much more likely in studies with two or fewer hospitals (31/36,
86%) versus three ormore hospitals (11/22, 50%).Of the 11RCTs
with two or fewer hospitals with medium risk of bias, nine inter-
ventions were circumstantial reminders targeted at doctors who
were managing specific patients (Christ-Crain 2004; Christ-Crain
2006; Esposito 2011; Kerremans 2009; Lacroix 2014; Lesprit
2013; Long 2014; Senn 2004; Stocker 2010; Strom 2010), so the
risks of allocation or contamination bias were relatively low com-
pared with the other RCTs of interventions in one or two hospi-
tals. However, the remaining two RCTs at low risk of bias show
that these risks can be minimised for RCTs of review and rec-
ommend change interventions in single hospitals (Lesprit 2013;
Palmay 2014).
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.Blank sections in this graph are due to use of different ROB criteria for
CBA, NRT and RCT versus ITS studies
We have presented ’Risk of bias’ criteria for the case control and
cohort studies of unintended consequences in the Notes section
in Characteristics of included studies.. For the nine studies, we
assessed the risk of bias as high in two (Calfee 2003; Friedberg
2009), medium in two (Linkin 2007; Welker 2008), and low in
five (Connor 2007; Duvoisin 2014; Kanwar 2007; LaRosa 2007;
Winters 2010).
Allocation
Most of the RCTs had high risk of selection bias because of prob-
lems with concealment of allocation (Figure 2). The RCTs with
low risk of selection bias were either cluster RCTs or interventions
with circumstantial reminders, for which concealment of alloca-
tion is relatively straightforward.
Blinding
Most of the RCTs also had high risk of performance and detection
bias because RCTs in single hospitals were often single-blind and
it was difficult to conceal the allocation of participants in these
trials (Figure 2).
Incomplete outcome data
The RCTs used data collected specifically for the trial, and all
provided convincing evidence about lack of attrition bias. Most
of the ITS studies used data from routine systems for prescribing
(pharmacy) and microbial (microbiology) outcomes; we assessed
these sources as having low risk of attrition bias (Figure 2). Ex-
amples of high risk of attrition bias in routine data are changes
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in the number of participants who did not have serum creatinine
measure preoperatively during the study period, which may have
biased ascertainment of postoperative kidney injury (Bell 2014),
and use of surveillance data about surgical-site infection that did
not include information about infections arising after discharge
from hospital (Dua 2014).
Selective reporting
We also assessed routine data systems as being at low risk of re-
porting bias (Figure 2).Most of the ITS studies used computerised
pharmacy systems to measure drug consumption.
Other potential sources of bias
Less than 25% of RCTs provided clear information about baseline
outcome; most of these were cluster RCTs (Figure 2). The most
common single risk of bias for ITS studieswas that the intervention
was not independent of other changes (Figure 2). For ITS studies,
the main risks of bias were that there were insufficient data to
account for seasonal variation or that one or more of the microbial
’Risk of bias’ criteria were present (Figure 2).
Effects of interventions
See: Summary of findings for the main comparison Effects of
interventions to improve use of antibiotics on prescribing, clinical
outcomes, adverse events, and effect modifiers (heterogeneity)
Studies included in evidence synthesis and ’Summary
of findings’ tables
Outcomes from 49 (84%) of the 58 RCTs and110 (80%) of the
138 ITS studies were used in at least one meta-analysis or meta-
regression or are summarised in text or Additional tables. The
contribution that each RCT made can be found in Appendix 4.
One ITS study contributed data about unintended consequences (
Bell 2014). The contributionof 109 ITS studies tometa-regression
of prescribing outcomes is summarised in Appendix 5. Reasons for
exclusion of 10 RCTs and 28 ITS studies from evidence synthesis
can be found in Appendix 6.
The 10 case control, cohort, or qualitative studies of unintended
consequences all contributed evidence about adverse effects.
None of the 6 CBAs or 8 NRTs included evidence about adverse
effects of interventions, and there were not enough studies for
evidence synthesis.
Intended prescribing outcomes for RCTs and ITS
studies included in evidence synthesis
Interventions were targeted at antibiotic treatment for 46 (94%)
of 49 RCTs and 101 (92%) of 110 ITS studies. The remaining 11
studies targeted surgical antibiotic prophylaxis (Bell 2014; Dull
2008; Gulmezoglu 2007; Kritchevsky 2008; Meyer 2010; Perez
2003; Schwann 2011; Sun 2011; Van Kasteren 2005; Wax 2007;
Weinberg 2001).
For the 148 interventions targeted at antibiotic treatment, the in-
tended outcome of 137 (93%) interventions was to decrease ex-
cessive use of antibiotics: 45/46 (98%) RCTs and 93/102 (91%)
ITS studies. The only RCT that was primarily intended to in-
crease effective treatment targeted dosing of gentamicin (Burton
1991). Two RCTs with antibiotic choice as the primary outcome
did include time to first antibiotic dose for participants with com-
munity-acquired pneumonia as a secondary outcome (Schouten
2007; Yealy 2005). The only other evidence about increasing ef-
fective treatment of sepsis came from six ITS studies that aimed
to reduce time to first antibiotic dose (Barlow 2007; Hitti 2012;
Jobson 2015; Marwick 2013; Volpe 2012; Weiner 2009).
In contrast, reduction in excessive use of antibiotics was the in-
tended outcome of only 3 (25%) of the 12 interventions targeted at
surgical antibiotic prophylaxis (Bell 2014; Sun 2011; VanKasteren
2005). The remaining nine interventions were all intended to in-
crease effective use of antibiotics by increasing the number of par-
ticipants who received prophylaxis or reducing the time to first
antibiotic dose.
Effectiveness and adverse effects of interventions
Effectiveness of interventions in RCTs
Interventions were associated with an increase in compliance with
desired practice by 19% (95% confidence interval (CI) 15% to
23%) in 29 RCTs (Analysis 1.1; Figure 3). We obtained similar
results in sensitivity analyses for unit of analysis errors (Analysis
1.2) or risk of bias (Analysis 1.3). Interventions were associated
with a reduction in duration of total antibiotic treatment by -1.95
days (95% CI -2.22 to -1.67) in 14 RCTs (Analysis 1.4; Figure
4). We obtained similar results in sensitivity analyses for unit of
analysis errors (Analysis 1.5) or risk of bias (Analysis 1.6).
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Figure 3. Forest plot of comparison: 1 Prescribing: RCTs of all interventions to reduce unnecessary
prescribing, outcome: 1.1 Dichotomous outcomes, increase in desired practice.
Figure 4. Forest plot of comparison: 1 Effectiveness: Prescribing outcomes from RCTs of interventions to
reduce unnecessary antibiotic use, outcome: 1.4 Continuous outcomes, duration of all antibiotic treatment
(days).
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In four RCTs the prescribing outcome was the consumption of
targeted antibiotics measured in different units (cost, days, or de-
fined daily dose), so results were expressed as standardised mean
reduction (Analysis 1.7.).
Adverse effects of interventions
Evidence from RCTs
Interventions were not associated with any increase in mortality
(95% CI 1 to 0 fewer deaths per 100 participants) in 28 RCTs
(Analysis 2.1; Figure 5). We obtained similar results in sensitivity
analyses for unit of analysis errors (Analysis 2.2) or risk of bias
(Analysis 2.3). Interventions were associated with reduction in
length of stay by -1.12 days (95% CI -1.54 to -0.70) in 15 RCTs
Analysis 2.4; Figure 6). We obtained similar results in sensitivity
analyses for unit of analysis errors (Analysis 2.5) or risk of bias
(Analysis 2.6). We found no evidence of a difference in results for
interventions that targeted antibiotic exposure (decision to treat or
duration of all antibiotic treatment) versus the choice of antibiotic
prescribed (Analysis 3.1; Analysis 3.2; Analysis 4.1; Analysis 4.2).
Figure 5. Forest plot of comparison: 2 Adverse effects: Clinical outcomes from RCTs of interventions to
reduce unnecessary antibiotic use, outcome: 2.1 Mortality, all RCTs.
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Figure 6. Forest plot of comparison: 2 Adverse effects: Clinical outcomes from RCTs of interventions to
reduce unnecessary antibiotic use, outcome: 2.4 Length of stay, all RCTs.
One RCTmeasured clinical outcome as potentially harmful delay
in essential treatment (Strom 2010). The outcome was ascertained
by the Trial Monitoring Committee, who stopped the trial pre-
maturely when four participants were found to have potentially
harmful delay in treatment with trimethoprim-sulphamethoxa-
zole or warfarin. This was a restrictive intervention intended to
prevent interactions between these drugs.
Evidence from NRS
ITS studies
Clinical outcome data were measured as mortality in four ITS
studies (Table 2) and length of stay in one ITS study (Table 3).
However, we could only calculate 95%CI for three of these studies
(Lee 2014; Popovski 2015; Skaer 1993), and the outcome data
came from all participants in the hospital rather than just the
participants who were the targets of the interventions.
Three ITS studies reported other clinical outcomes that provided
more direct evidence about unintended consequences of the in-
terventions (Table 4). An intervention to promote gentamicin for
prophylaxis was intended to reduce risk of CDI but was associ-
ated with a large increase in acute kidney injury in the partici-
pants undergoing target operations, and as a consequence the an-
tibiotic policy change was reversed (Bell 2014). An intervention
designed to shorten time to first antibiotic dose for people with
sepsis was not associated with any increase in the time left without
being seen for all other participants in the emergency department
(Volpe 2012). An intervention to reduce the duration of surgical
antibiotic prophylaxis was not associated with increased surgical-
site infection (Van Kasteren 2005).
Case control, cohort and qualitative studies
Ten studies investigated unintended consequences of interventions
to change antibiotic choice with cohort (n = 8), case control (n =
1), or qualitative case study (n = 1) designs (Table 5).
There was a restrictive component to the intervention in seven
studies. One study showed that restriction of laboratory tests of
inflammation (C-reactive protein and white blood cell count) was
not associated with an increase in time to first antibiotic dose (
Duvoisin 2014). The remaining six studies all revealed unintended
consequences of interventions that restricted antibiotic choice by
requiring prior approval, as follows.
• Negative professional culture through breakdown in trust
and communication (Baysari 2013; Calfee 2003; Connor 2007;
Linkin 2007).
• Delay in time to first antibiotic dose (LaRosa 2007;
Winters 2010). Evidence of delay in essential treatment was also
seen in one RCT (Strom 2010).
In three studies (Friedberg 2009; Kanwar 2007; Welker 2008),
the intervention was a national financial incentive in the USA that
was intended to reduce time to first antibiotic dose for people ad-
mitted to hospital with community-acquired pneumonia (CAP).
In all three studies, the unintended consequence was misdiagno-
sis of pneumonia, which could lead to an increase in unnecessary
antibiotic treatment. In two single-centre studies, there was a de-
crease in the percentage of participants with correct diagnosis of
CAP based on prespecified criteria (Kanwar 2007; Welker 2008).
In contrast, a large, multicentre study reported no evidence of an
overall increase in the diagnosis of CAP (Friedberg 2009); how-
ever, this study was at high risk of bias.
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Explaining heterogeneity in the intended effect of
interventions
Meta-regresson of RCTs
We performed meta-regression on 29 RCTs with dichotomous
prescribing outcomes (Analysis 1.1; Figure 3). Outcomes for all
of these trials could be expressed as number of participants where
treatment was compliant with policy divided by total participants.
We did not performmeta-regression on 15 RCTs with continuous
prescribing outcomes because the outcomes were heterogeneous
(Analysis 1.4; Analysis 1.7) and because none of the interventions
included restriction or feedback, and only two did not include
enablement (Danaher 2009; Kerremans 2008).
Meta-regression results for 29 RCTs with dichotomous
outcomes
In the meta-regression, enablement, restriction, targeting antibi-
otic choice versus exposure and high risk of bias were significantly
associated with greater intervention effect in univariate analysis,
and they all remained significant in multivariate analysis (Figure
7).
Figure 7. Meta-regression by effect modifier for 29 RCTs. A positive value for Beta indicates enhanced
intervention effect. One RCT had both enabling and restrictive components in the intervention (Strom 2010).
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Of the 23 RCTs of enabling interventions, four also included
feedback (Camins 2009; Schnoor 2010; Schouten 2007; Yealy
2005). All four of these RCTs targeted antibiotic choice, sowe have
compared their effects with seven RCTs of enabling interventions
without feedback that also targeted antibiotic choice. The mean
risk difference for interventions with feedback was 19% (95% CI
16% to 22%) (Figure 8) compared with 13% (95% CI 9% to
17%) (Figure 9) for interventions with no feedback. Only two of
the feedback RCTs also included action planning (Schouten 2007;
Yealy 2005).
Figure 8. Forest plot of comparison 5: RCTs of enablement with and without feedback, outcome: 5.1
Enablement plus feedback.
Figure 9. Forest plot of comparison 5: RCTs of enablement with and without feedback, outcome: 5.2
Enablement without feedback.
Meta-regression of ITS studies
Do interventions that involve enablement have greater initial
effect?
There were 107 ITS studies with data that could be used for
meta-regression of prescribing outcomes at one, six, or 12 months’
postintervention. We used multivariable meta-regression to iden-
tify effect modifiers in 91 ITS studies including data about pre-
22Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
scribing at six months’ postintervention. As with the RCTs (Figure
7), both enablement and restriction were independently associated
with increased effect in ITS studies (Figure 10). Of 29 ITS stud-
ies with restrictive interventions, 13 (45%) also had enablement,
and this independently enhanced intervention effect (Figure 11).
In comparison with interventions targeting antibiotic exposure,
those targeting choice were associated with greater effect in RCTs
(Figure 7), but not in ITS studies (Figure 10). The number of stud-
ies in each category only allowed analysis of the effects of setting
in ITS studies (Figure 10), and intention could only be included
in meta-regression of ITS studies of enabling intervention (Figure
12). The limited evidence suggests that intention and setting were
not effect modifiers (Figure 7; Figure 10).
Figure 10. Meta-regression by effect modifiers of intervention for 91 ITS studies. Outcome is effect on
prescribing six months’ postintervention. There are 16 studies with both enabling and restricting intervention
components ().
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Figure 11. Meta-regression of prescribing outcome by effect modifiers for 29 ITS studies of interventions
that included restriction.
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Figure 12. Meta-regression by effect modifier for 43 ITS studies of interventions that included enablement
but not restriction. Outcome is effect on prescribing six months’ postintervention. Note that four studies with
feedback were not included in this analysis because they also included restriction.
Are interventions that include feedback more effective than
those that do not?
Feedback was included in 4 (17%) of 23 RCTs (Figure 8) and
20 (47%) of 43 ITS studies (Figure 12) of enabling interventions
that did not include restriction. The intervention was audit and
feedback alone in three RCTs and 10 ITS studies. In one RCT
and 11 ITS studies, audit and feedback was combined with re-
view and recommend change or circumstantial reminders. Inter-
ventions that included feedback were more effective than those
that did not. However, there were too few studies with goal setting
or action planning to assess their effect in addition to feedback.
There were only two ITS studies with enough data to analyse the
effect of adding an additional component to an effective inter-
vention. However, the second intervention component did not
include goal setting, feedback, or action planning in either study
(Mol 2005; Po 2012)
Summary of interventions for the studies included in meta-
regression
In comparisonwith RCTs, the ITS studies weremore likely to have
multiple intervention components: 35 (38%) of 91 ITS studies
versus 5 (17%) of 29 RCTs, odds ratio 3.00 (95%CI 1.05 to 8.59)
(Table 6). There were also differences in the components for en-
abling interventions (review and recommend change was included
in 53% of ITS studies versus 25% of RCTs) and restrictive inter-
ventions (removal of target drugs from clinical areas was included
in 34% of ITS studies but in no RCTs) (Table 6). Educational
meetings or distribution of educational materials was the most
common intervention in studies that did include enablement or
restriction (75% of RCTs and 89% of ITS studies) (Table 6).
Sustainability of intervention effect
Sustainability was assessed in 64 of 91 ITS studies, with prescrib-
ing outcome data at both 6 and 12 months’ postintervention. In-
tervention effect was sustained at 12 months’ postintervention in
55 (86%) of these studies (95% CI 77% to 94%). There were 13
interventions with neither enablement nor restriction; interven-
tion effect was sustained in 11 (85%) (95% CI 65% to 100%).
Consequently, it was unlikely that either enablement or restriction
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would be associated with greater sustainability. However, the re-
sults suggest that restrictive interventions were less likely to have
sustained effect if they did not include enablement: 5/8 (62%)
versus 12/13 (92%) with enablement, risk difference 30% (95%
CI -7% to 66%).
Five ITS studies with data about removal of interventions provided
additional information about sustainability of interventions (Table
7). Three of these studies also provided data about the effect of the
intervention. The intended effect of all interventions was decrease
in the use of target antibiotics. Removal of the intervention was
associated with increase in the use of target antibiotics in all five
studies and, with one exception (Kim 2008), the 95%CI for effect
size did not include decrease in use of target antibiotics. Kim 2008
was the only one of these five interventions including enablement
by audit and feedback.
Microbial outcomes (antibiotic resistance and CDI)
There were 1 CBA and 5 RCTs with microbial outcome data, and
these were too heterogeneous for data synthesis (Table 8).
We performed meta-regression on 26 ITS studies including re-
liable data about prescribing outcomes at 6 months and micro-
bial outcomes at 12 months after the intervention (Table 9). Six
unplanned interventions (in response to outbreaks) were associ-
ated with markedly greater effect on microbial outcomes (Figure
13). When studies were ranked in descending order of effect size
for microbial outcome at 12 months, the top five studies were all
unplanned interventions (Kim 2008; May 2000; McNulty 1997;
Tangdén 2011; Valiquette 2007), with the remaining unplanned
intervention ranking 9th (Lautenbach 2003).
Figure 13. Meta-regression by effect modifiers for 34 microbial outcomes 12 months’ postintervention from
26 ITS studies. The bars show the results for unadjusted versus adjusted analyses, the comparison for
unplanned interventions is with planned interventions in both the unadjusted and adjusted analysis.CDI:
Clostridium difficile infectionGPC: infection with antibiotic-resistant gram-positive cocciGNB: infection with
antibiotic-resistant gram-negative bacteriaOther infection control: ’Yes’ means there were changes to
infection control processes during the study period.
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In the 20 studies of planned intervention, there were six stud-
ies with unclear information about other infection control inter-
ventions or changes during the study period (Chan 2011; Grohs
2014; Jump 2012; Liebowitz 2008;Meyer 2009; Petrikkos 2007).
We performed meta-regression on the remaining 14 studies from
Table 9 (Figure 14). In contrast with the meta-regression of all 27
studies (Figure 13), the effects of setting, other infection control
interventions, and microbial outcome type were all reversed so
that each of these variables was associated with increase in effect
size in the 14 studies with planned interventions and details of
other infection control interventions (Figure 14).
Figure 14. Meta-regression by effect modifiers for 20 microbial outcomes 12 months’ postintervention from
14 ITS studies of planned interventions that provided details about other infection control changes or
interventions.CDI: Clostridium difficile infectionGPC: infection with antibiotic-resistant gram-positive
cocciGNB: infection with antibiotic-resistant gram-negative bacteriaOther infection control: ’Yes’ means there
were changes to infection control processes during the study period.
The antibiotic targets for the 20 studies of planned interventions
were single antibiotic classes in nine studies (Cook 2011b; Grohs
2014; Knudsen 2014; Lafaurie 2012; Lee 2007; Meyer 2009;
Petrikkos 2007; Willemsen 2010; Yoon 2014), high-risk antibi-
otics in nine studies (Aldeyab 2012; Aldeyab 2014; Ananda-Rajah
2010; Buising 2008a; Chan 2011; Dancer 2013; Fowler 2007;
Liebowitz 2008; Talpaert 2011), and all antibiotics in the remain-
ing two studies (Cook 2011a; Jump 2012). High-risk antibiotics
were a combination of drugs from more than one class of antibi-
otic, which were all considered to be high risk for the microbial
outcome. The prescribing outcome data reported in these nine
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studies varied from just one of the high-risk antibiotics, in Dancer
2013, through individual results for all of the high-risk antibiotics,
in Buising 2008a, Chan 2011, Fowler 2007, and Talpaert 2011,
to combined results for all of the high-risk antibiotics (Aldeyab
2012; Aldeyab 2014; Ananda-Rajah 2010; Liebowitz 2008).
One study can be used to demonstrate the technical challenges of
estimation of intervention effect on microbial outcomes (Dancer
2013). The intervention was addition of complete restriction of
ceftriaxone and ciprofloxacin to a pre-existing multifaceted inter-
vention introduced seven months before restriction and remain-
ing in place throughout the restrictive period (Dancer 2013). We
could not analyse the effect of the initial multifaceted intervention
because there were no pre-intervention data about prescribing or
microbial outcomes. However, the available data showed CDI was
lower by -0.143 cases per 1000 occupied bed days permonth in the
nine months prior to the addition of the restrictive intervention.
At the start of the restrictive intervention, CDI rates were already
low (1.5 cases per 1000 occupied bed days). After the introduction
of restriction, CDI rates continued to decline for five months, and
then stabilised at around 0.5 cases per 1000 occupied bed days.
These data suggest that the restrictive intervention had no addi-
tional effect on the rate of CDI. However, the segmented regres-
sion analysis estimated that there was a relative increase of 35.8%
in CDI rate 12 months after the restrictive intervention with very
wide confidence intervals (from 81.0% decrease to 152.7% in-
crease).
Our review did include onemulticentre controlled ITS study com-
paring CDI rates in six hospitals with antimicrobial stewardship
programmes versus four control hospitals (Ostrowsky 2014). We
did not include this study in evidence synthesis because neither
the interventions nor the prescribing outcomes were standardised
across the six hospitals with stewardship programmes. Baseline
rates of CDI were only 0.8 cases per 1000 occupied bed days in
the intervention and control hospitals before the intervention, and
the authors did not report a decrease in aggregate CDI rates either
between intervention and non-intervention groups or within the
intervention groups over time (Ostrowsky 2014).
We have not attempted to synthesise microbial outcome data be-
cause of the small number of studies, the heterogeneity of in-
tervention targets and prescribing outcomes, and the wide confi-
dence intervals for estimated relative effect. We have focused on
the 20 ITS studies of planned interventions and separated the
results by microbial outcome type. Interventions were associated
with consistent reduction in CDI (median -48.6%, interquartile
range -80.7% to -19.2%) but inconsistent effect on resistant gram-
negative bacteria (median -12.9%, interquartile range -35.3% to
25.2%) and resistant gram-positive bacteria (median -19.3%, in-
terquartile range -50.1% to 23.1%). There were too few studies
with too much variance in microbial outcomes to reliably assess
the relationship between change in antibiotic use and each of the
microbial outcomes.
D I S C U S S I O N
Summary of main results
The RCTs provide high-certainty evidence that interventions are
effective in increasing compliance with antibiotic policies and in
reducing duration of antibiotic treatment safely, without an in-
crease in mortality. Furthermore, interventions were associated
with a reduction in length of stay. The mechanism is not clear,
and further investigation is required. However, reducing length
of stay is a key organisational objective for most hospitals, so this
evidence should be used to prioritise antimicrobial stewardship in
hospitals.
Analysis of effect modifiers in RCTs and ITS studies consistently
supported the theory that involving enablement increases inter-
vention effect, including those with restrictive components. How-
ever, feedback was only used in a minority of enablement inter-
ventions, and very few included goal setting or action planning.
Overall completeness and applicability of
evidence
The RCTs show that interventions increase compliance with poli-
cies or guidelines by 15%, which is a clinically important effect
size. However, the result is less impressive when one considers that
health professionals’ adherence to prescribing recommendations
increased from 43% to 58%, because 58% compliance is probably
still far too low. Three studies did achieve 90% compliance with
guidelines by making this an explicit goal for the intervention and
using action planning to revise interventions until the goal was
achieved (Jobson 2015; Volpe 2012; Weinberg 2001).
The ITS studies provided important additional evidence that the
results of RCTs regarding effectiveness of interventions can be
reproduced in routine practice: 70% of ITS studies reported on
hospital-wide interventions compared with only 31% of RCTs.
Only two ITS studies included data that enabled assessment of the
effect of adding an intervention component to an existing inter-
vention (Mol 2005; Po 2012). This is a strong study design that
should be more widely used to evaluate these types of interven-
tions.
Safety and unintended consequences of interventions
The main limitation of the RCT evidence regarding safety of re-
ducing unnecessary use was that only two interventions included
restriction, and one was stopped early because of delay in the start
of treatment (Strom 2010). Two NRS also raised concerns about
delay in time to first antibiotic dose associated with restrictive
interventions (LaRosa 2007; Winters 2010). Furthermore, four
NRS described negative effects of restrictive interventions on pro-
fessional culture through breakdown in trust and communication
(Baysari 2013; Calfee 2003; Connor 2007; Linkin 2007). These
NRS used either case control, cohort, or qualitative designs be-
cause they required collection of data that were not available in
routine clinical systems (Table 5).
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The ITS studies provided very little evidence about the safety of
interventions because they rely on routine clinical systems for out-
come measures, which are currently largely incapable of provid-
ing information about specific patients, for example those with
infection. Moreover, the range of clinical measures should be ex-
tended beyond infection outcomes to include safety indicators
such as acute kidney injury (AKI). (Bell 2014). Scotland’s Infec-
tion Intelligence Platform was established to improve linkage and
availability of routine data (ISD 2016), but research is required
to improve timeliness, quality, and relevance of clinical outcome
measures and to provide a richer understanding of the unintended
consequences of improvement interventions (SISCC 2016). We
found only one example of a qualitative study of unintended con-
sequences (Baysari 2013). This is an important study design for
investigation of unanticipated consequences of interventions and
should be more widely used (Rogers 1995).
Studying the effect of removal of an intervention can be used to
provide additional evidence about the outcomes of the original
intervention (Walker 2016). This study was from the same group
that reported that an intervention that was intended to reduce risk
of CDI in people undergoing orthopaedic surgery was associated
with an increased risk of postoperative AKI (Bell 2014) (Table 4).
The increase in AKI was attributed to change in antibiotic surgical
prophylaxis policy from cefuroxime to flucloxacillin and gentam-
icin. This second study showed reduction in postoperative AKI
associated with a change away from flucloxacillin and gentamicin,
which provides persuasive additional evidence that gentamicinwas
responsible for the original increase in postoperative AKI (Walker
2016).
Interventions were consistently associated with reduced length of
stay (Analysis 2.4), and the results were similar when analysis was
restricted to RCTs at low or medium risk of bias (Analysis 2.6).
Measurement of length of stay was intended to provide reassurance
about safety of the intervention so that reduction in length of
stay is an example of an unanticipated beneficial outcome (Ash
2007; Rogers 1995). We found similar results for interventions
that targeted antibiotic choice (Analysis 3.2) or antibiotic exposure
(Analysis 4.2). One possible mechanism for reduction in length
of stay is that interventions reduced the duration of intravenous
antibiotic therapy (Carratala 2012). However, further research is
required.
Microbial outcomes
Interventions were consistently associated with reduction in CDI,
but less consistently associated with reduction in infection by re-
sistant bacteria. However, intervention effects on microbial out-
comes could only be analysed reliably in planned interventions
(Figure 13), and our meta-analysis was limited by four technical
challenges.
1. Each study had considerable variance because of the small
number of microbial events in each time point.
2. Studies rarely had stable pre-intervention data, so that
extrapolation of the pre-intervention trend throughout the
postintervention phase was probably unreliable.
3. We analysed a single prescribing outcome for each study
(even if more were reported). The criteria for selection of the
prescribing outcome were determined by the analysis plan for the
effect of interventions on prescribing behaviour. However, these
criteria may not have been correct for analysis of the relationship
between changes in prescribing and microbial outcomes.
4. We could only analyse the relationship between prescribing
and microbial outcomes at fixed time points. We chose six and
12 months, respectively, imposing a six-month time lag for all
interventions. However, the time lag will likely vary by
prescribing and microbial outcomes, and by intervention context
(Vernaz 2008).
Quality of the evidence
We found high-certainty evidence that interventions increase ap-
propriate use of antibiotics, reduce duration of antibiotic treat-
ment, and shorten hospital stay without increasing the risk of
mortality. There was low-certainty evidence that these interven-
tions can delay treatment and create a negative professional cul-
ture (Summary of findings for the main comparison). High risk
of bias was associated with greater intervention effect in RCTs
(Figure 7) for the outcome of compliance with desired practice.
However, we have presented separate analysis of effects for RCTs
at low or medium risk of bias (Analysis 1.3; Analysis 1.6; Analysis
2.3; Analysis 2.6). These analyses provide evidence supporting our
decision not to downgrade for risk of bias, since excluding studies
at high risk of bias did not substantively change the direction of
effect.We did not downgrade for inconsistency since the direction
of effect across the studies was consistent, and our meta-regression
provides some explanation for the high levels of statistical hetero-
geneity between the results of the studies. The certainty of evidence
about adverse effects was more variable, with particular concerns
about the unintended consequences of restrictive interventions,
namely delays in treatment and negative professional culture, for
which we have low-certainty evidence.
The quality of reporting of interventions was poor, which makes it
difficult for professionals and clinical teams to reliably implement
interventions that have been shown to be useful and for other
researchers to replicate or build on research findings (Hoffmann
2014). We found high-certainty evidence that enablement and re-
striction both enhanced the effectiveness of interventions. How-
ever, we found only moderate-certainty evidence for the effective-
ness of feedback, and there were too few studies with action plan-
ning and goal setting to provide any reliable information about
the combined effects of these behaviour change techniques.
In the analysis of risk of bias equal weight is given to all criteria
(Figure 2). Our results for microbial outcomes clearly showed that
the risk of bias from unplanned interventions is much greater than
29Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
the risk from other infection control interventions (Figure 13;
Figure 14).
We found that some NRS study designs provided important ad-
ditional evidence about intervention effects and sustainability in
routine clinical practice (ITS studies) and about unintended con-
sequences (case control, cohort, and qualitative studies). However,
we found no useful evidence from CBAs or NRTs and suggest
that these study designs should not be included in updates to this
review.
Heterogeneity of intervention effect
We found that two intervention functions, enablement and re-
striction, explained some of the variation in targeted prescrib-
ing behaviour. However, we found little evidence that behaviour
change theory had been used to design interventions (Charani
2011). There were too few interventions with explicit goals or ac-
tion planning to include these variables in meta-regression.
Therewas no consistent evidence that intervention setting or target
explained variation in the effect of interventions (Figure 7; Figure
10)
Potential biases in the review process
Our decision not to use adjusted data for cluster RCTs for the pri-
mary analysis could be contested. The consequences of using un-
adjusted data would be to assign too much weight to cluster stud-
ies in the analysis, potentially biasing the effect from our analyses
to their results (Higgins 2011). We believe that taking clustering
into account is unlikely to impact on the strength of the results in
such a way as to change the conclusions of the review. Our sensi-
tivity analyses provide some indirect support for the approach we
have undertaken. In comparison to unadjusted results, analyses
based on the effective sample sizes calculated from assumed ICCs
consistently gave a larger average intervention effect (Analysis 1.1
versus Analysis 1.2; Analysis 2.1 versus Analysis 2.2; Analysis 2.4
versus Analysis 2.5).The increased effect size could be explained
by the lower weight assigned to the cluster studies, which tended
to have smaller effects than the individually randomised studies.
The electronic literature search did not identify 42 (19%) of the
221 included studies, highlighting some of the challenges in con-
structing sensitive search terms for reviews of behavioural inter-
ventions and the identification of non-randomised studies. It is
possible that additional eligible studies have not been retrieved by
the search process we undertook for this review.
We did not find evidence of publication bias in the RCTs, how-
ever publication bias is more likely in the ITS studies because the
decision to publish may have been made after the analysis of in-
tervention effect.
Agreements and disagreements with other
studies or reviews
Agreements
Ivers 2012 included and analysed 140 RCTs that compared any in-
tervention in which audit and feedback was a core, essential com-
ponent to usual care and evaluated effects on professional prac-
tice. The review concluded that interventions were more effective
if they also included goal setting and action planning. We were
unable to reproduce their analysis because only four of our RCTs
included feedback (Figure 8). Although 20 ITS studies included
feedback (Figure 12), there were not enough studies with goal set-
ting or action planning for reliable analysis.
Our findings are similar to a previous review that found that be-
havioural determinants and social norms were not given due con-
sideration in the design and evaluation of interventions to change
antibiotic prescribing (Charani 2011).
Sustainability of intervention effect
We found evidence that removal of restriction, in Himmelberg
1991, Kallen 2009, Kim 2008, and Skrlin 2011, or of review and
recommend change (enablement, Standiford 2012) was associated
with reversal of intervention effect (Table 7). Three previous stud-
ies have shown that removal of financial incentives is associated
with reversal of intervention effects in primary care (Avery 2012;
Dreischulte 2016; Lester 2010). This is an important issue because
the attractiveness of interventions will be reduced if improvement
resources cannot be moved on to new priorities. Restriction is a
relatively low-cost intervention, but it is worrying that an enabling
intervention (review and recommend change) apparently had no
sustained effect on clinical teams after being in place for seven
years (Standiford 2012). Review and recommend change is a time-
intensive process that was included in 36 (54%) of 67 of the en-
abling interventions in ITS studies.
Disagreements
A systematic review on current evidence about antimicrobial stew-
ardship objectives reported that “guideline-adherent empirical
therapy was associated with a reduction for mortality (odds ratio
0.65, 95% CI 0.54-0.80)” (Schuts 2016). Only two of the 39
studies in this review reported an intervention: one was invalid
because it was an uncontrolled before-after study (Garcia 2007),
and the other was a CBA (Dean 2006). The remaining 27 stud-
ies used case control study or cohort designs to compare the out-
comes of participants with and without guideline-adherent antibi-
otic treatment, and did not include an intervention to change pro-
fessional practice. The results of this review are in marked contrast
to our analysis of mortality in 11 RCTs targeting antibiotic choice
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(Analysis 3.1). Themost likely explanation for the discrepancy be-
tween our results and Schuts 2016 is confounding by indication.
It is likely that participants with less complex or severe illness were
more likely to receive guideline-adherent antibiotic treatment and
that there was residual confounding after adjustment for available
clinical information.
A systematic review on the effect of antibiotic stewardship pro-
grammes on CDI reported that interventions were associated with
a consistent, significant protective effect (pooled risk ratio for CDI
0.48, 95% CI 0.38 to 0.62) (Feazel 2014). Of the 16 studies in-
cluded in this systematic review, four were ITS studies that were
also included in our review (Elligsen 2012; Fowler 2007; Price
2010; Talpaert 2011), and the remaining 12 studies were either
uncontrolled before-after or inadequate ITS studies. The statisti-
cal analysis in this review was not appropriate (Feazel 2014). Cal-
culation of risk ratios for the post- versus pre-intervention periods
is an uncontrolled before-after analysis, which does not provide a
reliable estimate of intervention effect.
Additional details about the disagreements with Feazel 2014 and
Schuts 2016 can be found in Appendix 7.
Limitations
There are five weaknesses in the current evidence.
1. Evidence of intended effects is unbalanced towards
reducing unnecessary treatment (compliance with guidelines that
are intended to reduce use of broad-spectrum antibiotics or
shorten duration of treatment). More evidence is required about
finessing effective treatment of sepsis without also causing
excessive use of antibiotics.
2. The limited evidence regarding adverse effects of restrictive
interventions suggests that they can be associated with delay in
essential treatment. There is a need for better patient safety
outcome measures that can be used in studies of interventions in
clinical practice.
3. The majority of the interventions do not use effective
behaviour change techniques such as action planning or
feedback.
4. Given the critical role of junior doctors in antimicrobial
stewardship in hospitals, it is surprising that there is only a single
example of an intervention that involved junior doctors in self
monitoring and reflection on feedback about their prescribing
(Price 2010).
5. Analysis of the impact of interventions on microbial
outcomes requires large, multihospital RCTs.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Reducing antimicrobial resistance and hospital-associated infec-
tion is a public health priority. Our review shows that antimicro-
bial stewardship interventions can safely reduce unnecessary an-
tibiotic use in hospitals, despite the fact that the majority of in-
terventions did not use the most effective behaviour change tech-
niques. Consequently, effective dissemination of the review results
could have considerable health service and policy impact through
greater use of interventions that enhance enablement.
The randomised controlled trials provided high-certainty evidence
that the interventions we have assessed are effective in increas-
ing compliance with guidelines to reduce unnecessary treatment
without increasing the risk of mortality. Furthermore, the inter-
ventions were associated with reduction in length of stay. The ev-
idence from this review should inform implementation decisions
regarding antimicrobial stewardship interventions in hospitals.
In randomised controlled trials and interrupted time series studies,
enablement consistently increased the effectiveness of interven-
tions, including restrictive interventions; however, feedback was
used in only a minority of enablement interventions, and very few
included goal setting or action planning. Antimicrobial manage-
ment teams might consider using evidence about effective feed-
back from other clinical settings (Ivers 2012). Training in the de-
sign and reporting of behaviour change interventions should be a
priority for antimicrobial management teams.
Implications for research
Given the high certainty of evidence for our primary outcome,
we believe that additional trials comparing antibiotic stewardship
with no intervention are unlikely to change our conclusions or
build on our understanding of the current evidence. Future re-
search should instead focus on measuring clinical outcomes and
assessing other measures of patient safety and different steward-
ship interventions and explore the barriers and facilitators to im-
plementation.
We included 163NRS but only 11 of these were about unintended
consequences. Moreover only one NRS used qualitative methods,
which are likely to be required in addition to survey methods for
the investigation of unanticipated consequences (Rogers 1995).
Future research should make greater use of qualitative methods
for investigation of consequences of interventions, for example in
process evaluation alongside clinical trials (Grant 2013). Antici-
pated, undesirable consequences should be regarded as trade-offs
whichmay need to be accepted in exchange for a greater good (Ash
2007). Future research should examine how decisions are made
about the acceptability of trade-offs (SISCC 2016). The purpose,
design, and use of balancing measures in quality and safety im-
provement has been identified as a priority for research on meth-
ods in improvement science (SISCC 2016). Antimicrobial stew-
ardship is an important topic for further research because of the
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clear competing risks of excessive use of antibiotics and delayed or
ineffective treatment of life threatening infection.
Antibiotic stewardship requires clinicians to change their infec-
tion control behaviours. Given that the extent to which current
antibiotic stewardship programs have incorporated insights and
approaches from behavioural science is limited, there is an urgent
need to bring together key stakeholders in the design and delivery
of stewardship programmes and research experts in improvement
and social sciences to develop more impactful stewardship pro-
grammes. We propose three key questions, which a Transnational
Working Group within the Joint Programming Initiative in An-
timicrobial Resistance will address in 2017 (JPIAMR 2016):
1. What behaviour change approaches can be recommended
now to optimise hospital stewardship programmes?
2. How can hospital stewardship programmes be designed to
maximise implementation across countries?
3. What is the research agenda to optimise efficient
implementation of antibiotic stewardship programmes
worldwide?
We were unable to perform reliable evidence synthesis on the re-
lationship between prescribing and microbial outcomes with seg-
mented regression analysis of interrupted time series studies from
single hospitals. There is an urgent need for co-ordinated, multi-
centre research studies.
We found consistent evidence of reduced length of stay as an unan-
ticipated beneficial consequence of interventions that targeted ei-
ther choice of antibiotic or duration of antibiotic treatment. Fur-
ther research is required to understand the mechanism for this
effect.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Abramowitz 1982
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: all adult patients in the hospital
CLINICAL PROBLEM: receiving treatment with target antibiotics
SETTING: single university hospital in the USA
Interventions FORMAT, Interventions: educational meetings with dissemination of materials; audit
and feedback; educational outreach by review and recommend change
Intervention Functions: education; enablement; persuasion
DELIVERER: pharmacist
COMPARISON: 9 months’ pre-intervention. Usual care
DESIRED CHANGE: reduce inappropriate
Outcomes PRESCRIBING: Choice: decrease in use of cefoxitin and cefamandole
COST: total cost of 6 target antibiotics (calculated from data in Tables 1 and 2)
Notes FINANCIAL SUPPORT: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk Not stated.
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper
(comparison of means, uncontrolled be-
fore-after)
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
50Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Abramowitz 1982 (Continued)
Free of selected reporting (ITS) ? Low risk Done, data were from routine pharmacy
systems database.
Free of other bias (ITS) ? Low risk Price of target antibiotics constant over the
study period.
Adachi 1997
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients requiring antibiotic treatment
SETTING: single hospital in the USA
Interventions FORMAT, Interventions: dissemination of educational materials; educational outreach
by review and recommend change; reminders (physical - newsletter)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: pharmacist
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: reduce vancomycin prescribing and increase appropriate use
of vancomycin
COST: valid financial savings
Notes FINANCIAL SUPPORT: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk > 1 year data pre- and postintervention
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper
(comparison ofmeans, uncontrolled before
and after)
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
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Adachi 1997 (Continued)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Unclear risk Not clear, no information about changes in
price of vancomycin over the study period
Akenroye 2014
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all paediatricians and nurses in the ED
PARTICIPANTS: all children with bronchiolitis
CLINICAL PROBLEM: acute bronchiolitis presenting to a paediatric ED
SETTING: 1 university hospital in the USA
Interventions FORMAT, Interventions: audit and feedback; dissemination of educational materials;
educational outreach by review and recommend change; reminders (physical - posters
and email)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: departmental physicians, nurses, and managers
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: exposure, % children treated with antibiotics
CLINICAL: balancing, % admission rate, % return ED visit rate, ED length of stay
(minutes)
FINANCIAL: total cost per patient. No data about the intervention cost
Notes FINANCIAL SUPPORT: Funding: Boston Children’s Hospital Department of
Medicine Quality Improvement Publication (QIPub) grant. Competing Interest: none
declared
ADDITIONAL INFORMATION: care pathway is in a supplementary online file
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
52Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Akenroye 2014 (Continued)
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Electronic outcome data
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Electronic outcome data
Incomplete outcome data addressed (ITS)
?
Low risk Electronic outcome data
Free of selected reporting (ITS) ? Low risk Electronic outcome data
Free of other bias (ITS) ? Low risk > 1 year of data pre- and postintervention
Aldeyab 2012
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all adult patients in the hospital
CLINICAL PROBLEM: patients requiring therapeutic or prophylactic antibiotics
SETTING: 1 university hospital in the UK
Interventions FORMAT, Interventions: audit and feedback; restrictive - expert approval
Intervention Functions: enablement, restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of target antibiotics in DDD/100 OBD
MICROBIAL: Clostridium difficile infections/100 OBD
Notes FINANCIAL SUPPORT: Funding: Deanship of Scientific Research (DSR), King Ab-
dulaziz University, Jeddah grant no. 7-968-D1432. Competing interest: none declared
ADDITIONAL DATA: restriction policy is described in detail in an additional online
file for this paper and in Conlon 2011.
Microbial Risk of Bias: LOW, case definition Low, planned intervention Low, other
infection control Low
Risk of bias
Bias Authors’ judgement Support for judgement
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Aldeyab 2012 (Continued)
Intervention independent (ITS) ? High risk Changes in CDI screening policy and
cleaning policy occurred between Phases 1
and 2 (Figure 1)
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Electronic data from pharmacy and micro-
biology
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Electronic data from pharmacy and micro-
biology
Incomplete outcome data addressed (ITS)
?
Low risk Electronic data from pharmacy and micro-
biology
Free of selected reporting (ITS) ? Low risk Electronic data from pharmacy and micro-
biology
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
Aldeyab 2014
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all adult patients in the hospital
CLINICAL PROBLEM: patients requiring therapeutic or prophylactic antibiotics
SETTING: 1 university hospital in the UK
Interventions FORMAT: same as in Aldeyab 2012; this article provides additional microbial outcome
data for impact on MRSA infections
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: same as in Aldeyab 2012
MICROBIAL: MRSA infections/100 OBD
Notes FINANCIAL SUPPORT: same as in Aldeyab 2012
ADDITIONAL DATA: restriction policy is described in detail in an additional online
file for Aldeyab 2012 and in Conlon 2011 (additional studies)
Microbial Risk of Bias: LOW, case definition Low, planned intervention Low, other
infection control Low
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Aldeyab 2014 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Data and segmented regression model of
alcohol-based hand rub included as a proxy
measure for infection control practices
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Electronic data from microbiology
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Electronic data from microbiology
Incomplete outcome data addressed (ITS)
?
Low risk Electronic data from microbiology
Free of selected reporting (ITS) ? Low risk Electronic data from microbiology
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
Ananda-Rajah 2010
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the medical-surgical ICU
PARTICIPANTS: all patients in the ICU
CLINICAL PROBLEM: reduction in use of broad-spectrum antibiotics considered high
risk for selection of MRSA
SETTING: 1 university hospital in Australia
Interventions FORMAT, Interventions: educational outreach by review and recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of broad-spectrum antibiotics in DDD/1000 OBD
MICROBIAL: MRSA bacteraemia rate
Notes FINANCIAL SUPPORT: none declared. Competing Interest: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: HIGH, case definition Low, planned intervention Low, other
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Ananda-Rajah 2010 (Continued)
infection control High. Infection control interventions close to antibiotic stewardship
interventions clearly documented in Figure 1
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Other changes are clearly documented in
Figure 1. This includes an outbreak of
Acinetobacter infection co-incidentwith the
stewardship intervention, which resulted in
appointment of 2 infection control prac-
titioners and associated interventions. The
additional staff could have influenced pre-
scribing outcome
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention is point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Pharmacy and microbiology routine data
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Pharmacy and microbiology routine data
Incomplete outcome data addressed (ITS)
?
Low risk Pharmacy and microbiology routine data
Free of selected reporting (ITS) ? Low risk Pharmacy and microbiology routine data
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
Annane 2013
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in participating ICUs
PARTICIPANTS: all patients in the ICUs with sepsis. Over a 3-year period, 62/1250
screened patients were eligible for the study, of whom 31 were randomised to each arm
CLINICAL PROBLEM: sepsis
SETTING: 8 hospitals in France
Interventions FORMAT, Interventions: structural - rapid testing of PCT with decision support algo-
rithm
Intervention Functions: enablement, environmental restructuring
DELIVERER: departmental physician
COMPARISON: usual care
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Annane 2013 (Continued)
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 140 participants in total (70 in each arm) would be
needed (details in Appendix 3)
Outcomes PRESCRIBING: exposure, % receiving antibiotics at day 5
CLINICAL: mortality, length of ICU stay, length of hospital stay
MICROBIAL: colonisation with MRSA (nasal swab) and GNRB (rectal swabs)
Notes FINANCIAL SUPPORT: Funding: commercial, Thermo Fisher B.R.A.H.M.S. France,
a subsidiary of the maker of the PCT assay used in this study. Competing interests:
none declared
ADDITIONAL INFORMATION: supplementary online file has PCT algorithm, au-
thors provided full study protocol (in French)
Microbial Risk of Bias: MEDIUM (no data about infection control)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Central allocation
Blinding (performance bias and detection
bias)
All outcomes
High risk PCT levels not reported on control partic-
ipants.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants lost to follow-up.
Selective reporting (reporting bias) Low risk No participants lost to follow-up.
Other bias High risk Study stopped prematurely because of low
recruitment.
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk PCT levels not reported on control partic-
ipants.
Baseline characteristics similar? Low risk Table 1
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Ansari 2003
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: antibiotics dispensed to hospital wards for administration for
therapy or prophylaxis
SETTING: 1 university hospital in the UK
Interventions FORMAT, Interventions: educationalmeetings; dissemination of educationalmaterials;
educational outreach by review and recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: total use of Alert Antibiotics in DDD/1000 OBD
FINANCIAL: cost of antibiotics adjusted for changes in price over the 4-year study
period. Cost of the Alert AntibioticMonitoring intervention and of the setup and analysis
of the ward antimicrobial supply database (Table 3)
Notes FINANCIAL SUPPORT: no financial support. Competing Interests: none declared
ADDITIONAL DATA: email response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk “In 2000, the Antibiotic Subcommittee of
Tayside University Hospitals Trust devised
an Alert Antibiotic Policy to reduce inap-
propriate use of key antibiotics, targeted
because they should be reserved for infec-
tions caused by organisms that are resistant
to first line antimicrobials.” There were no
other changes in local or national policy
likely to influence use of Alert Antibiotics
Analysed appropriately (ITS) ? Low risk Done in original paper: segmented regres-
sion analysis with adjustment for autocor-
relation and seasonality
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk “The aim of this study was to use rou-
tine data from the pharmacy stock con-
trol computer to evaluate this interven-
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Ansari 2003 (Continued)
tion”. Sources and methods of data collec-
tion were the same before and after the in-
tervention
Knowledge of the allocation adequately
prevented(ITS)?
Low risk “After evaluation of the intervention ac-
cording to patient records and its short-
comings, we decided to use the pharmacy
stock data. During the 4 year period of
analysis no restriction policy for dispensing
the Alert Antibiotics was implemented by
the hospital pharmacy, therefore the phar-
macy data about dispensed Alert Antibi-
otics would provide us with the best avail-
able independent indicator for evaluation
of the intervention.”
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk “Correcting for autocorrelation avoids un-
derestimating standard errors
and overestimated significance of the ef-
fects of an intervention. For
estimating seasonal autocorrelation, the au-
toregression model needs to
evaluate correlations between error terms
separated by multiples of
12 months. Accounting for seasonally cor-
related errors usually requires
at least 24 monthly data points.”
Data about cost of antibiotics adjusted for
price changes during study period
Avorn 1988
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians at 1 teaching hospital
PARTICIPANTS: all patients with clinical problem
CLINICAL PROBLEM: patients receiving therapy with cefazolin, clindamycin, or
metronidazole
SETTING: a 460-bed teaching hospital in the USA
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Avorn 1988 (Continued)
Interventions FORMAT, Interventions: educational meetings; dissemination of educational materi-
als; reminders - circumstantial (order form triggered by receiving target antibiotic) and
physical (posters)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: inappropriate dosing intervals of cefazolin, clindamycin, and
metronidazole
FINANCIAL: estimated annual expenditure on the 3 drugs
Notes FINANCIAL SUPPORT: Fund for Cooperative Innovation of Blue Cross of Mas-
sachusetts and the Massachusetts Hospital Association. Competing interests: none de-
clared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk No price changes in the target antibiotics
during the study period
Analysed appropriately (ITS) ? Low risk Done in original paper: segmented regres-
sion analysis.
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk No other apparent biases found.
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Bailey 1997
Methods STUDY DESIGN: RCT stratified by type of infection
Risk of Bias: HIGH
Participants PROVIDERS: all physicians at 2 teaching hospitals, excluding ICUs
PARTICIPANTS: a total of 102 inpatients, 51 intervention and 51 control
CLINICAL PROBLEM: patients receiving IV ABs for at least 3 days, but excluded if in
ICU or with uncontrolled infection or close to discharge
SETTING: 2 tertiary-care teaching hospitals in USA
Interventions FORMAT, Interventions: educational outreach by review and recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: pharmacist
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: none reported
Outcomes PRESCRIBING: patients switched fromparenteral to oral antibiotics or discontinuation
of 1 or more antibiotics and mean IV antibiotic days
COST: mean antibiotic costs
CLINICAL: 30-day re-admission (total and infection-related) and in-hospital mortality
Notes FINANCIAL SUPPORT: Funding: Department of Pharmacy. Competing Interests:
none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Physicians of patients considered candi-
dates for intervention were randomised to
be either contacted by the clinical pharma-
cist ... or to be observed”
Allocation concealment (selection bias) Unclear risk Not stated
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not stated
Incomplete outcome data (attrition bias)
All outcomes
Low risk No problems found.
Selective reporting (reporting bias) Low risk No problems found.
Other bias High risk No power calculation. Prices of antibiotics
unlikely to change over the 6-month study
period
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Bailey 1997 (Continued)
Baseline Outcomes similar? Unclear risk Not stated
Free of contamination? Unclear risk Not stated
Baseline characteristics similar? Low risk See Table 1 in study.
Bantar 2006
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: IV antibiotics, restriction applied to carbapenems
SETTING: a single university hospital in Argentina. Total use was compared for > 2
years before and after the intervention
Interventions FORMAT, Intervention 1: educational outreach by review and recommend change;
restrictive - compulsory order form
Intervention Functions: education, enablement, persuasion, restriction
Intervention 2: unavailability of antibiotics during a national financial crisis
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive (choice)
Outcomes PRESCRIBING: use of all IV antibiotics and carbapenems in DDD/1000 OBD
CLINICAL: all-cause inpatient mortality
Notes FUNDING: none. Competing Interests: 2 authors declared conflicts of interest for
speaker and advisory board fees
ADDITIONAL INFORMATION: no response from authors
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Intervention 1 was independent of other
changes. The “crisis” (following the inter-
vention) was a national economic crisis and
will be reported separately in the review
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data were obtained from pharmacy sys-
tems.
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Bantar 2006 (Continued)
Knowledge of the allocation adequately
prevented(ITS)?
High risk Prescribing data were processed by the in-
vestigators to convert grams to DDD and
identify only IV antibiotics
Incomplete outcome data addressed (ITS)
?
Low risk Routine pharmacy data
Free of selected reporting (ITS) ? Unclear risk Processing of data has potential for selective
outcome reporting
Free of other bias (ITS) ? Low risk 3 years’ data pre- and 2 years’ data postin-
tervention
Barlow 2007
Methods STUDY DESIGN: Controlled ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: all patients presenting with pneumonia were recruited prospectively
CLINICAL PROBLEM: adults with community-acquired pneumonia
SETTING: 2 acute university hospitals in Scotland
Interventions FORMAT, Interventions: audit and feedback; educational meetings; dissemination of
educational materials; reminders - physical by posters and email
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: AMT
COMPARISON: control hospital with no intervention
DESIRED CHANGE: increase effective
Outcomes PRESCRIBING: Choice:% appropriate antibiotics within 4 h of admission
COST: cost-effectiveness, intervention cost, and estimated impact on mortality
Notes FINANCIAL SUPPORT: Funding: NHS Education Scotland and Chief Scientist Of-
fice, Scotland. Competing Interests: none declared
ADDITIONALDATA: email response from authors with additional information about
intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk
Shape of effect pre-specified (ITS) ? Low risk
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Barlow 2007 (Continued)
Unlikely to affect data collection (ITS) ? Low risk
Knowledge of the allocation adequately
prevented(ITS)?
High risk
Incomplete outcome data addressed (ITS)
?
Low risk
Free of selected reporting (ITS) ? Low risk
Free of other bias (ITS) ? High risk
Bassetti 2009
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the ICU (mixed medical/surgical)
PARTICIPANTS: all patients in the ICU
CLINICAL PROBLEM: requiring empirical antibiotic therapy
SETTING: 1 university hospital in Italy
Interventions FORMAT, Interventions: educational outreach by review and recommend change; re-
strictive - compulsory order form
Intervention Functions: education, enablement, persuasion, restriction
DELIVERER: specialist physicians (ID)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of cephalosporins in DDD/1000 OBD
MICROBIAL: MRSA
Notes FINANCIAL SUPPORT: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: LOW
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk
Unlikely to affect data collection (ITS) ? Low risk Routine pharmacy data
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Bassetti 2009 (Continued)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Routine pharmacy data
Incomplete outcome data addressed (ITS)
?
Low risk Routine pharmacy data
Free of selected reporting (ITS) ? Low risk Routine pharmacy data
Free of other bias (ITS) ? Low risk >1 year data pre- andpostintervention.Mi-
crobial Risk of Bias: case defintion done,
planned intervention done, other infection
control measures done
Baysari 2013
Methods STUDY DESIGN: unintended consequences, qualitative
Risk of Bias: not assessed (qualitative study)
Participants PROVIDERS: 36 physicians
PARTICIPANTS: patients receiving antibiotic treatment
CLINICAL PROBLEM: patients receiving antibiotics that the hospital policy designated as requiring approval
SETTING: 1 hospital in Australia
Interventions FORMAT, Intervention: audit and feedback; restriction by prior approval
Intervention Functions: enablement, persuasion, restriction
DELIVERER: AMT
DESIRED CHANGE: decrease excessive
Outcomes UNINTENDED CONSEQUENCES: problems with antibiotic policy and approval process identified through
semi-structured interviews with prescribers who had received feedback letters
Notes FINANCIAL SUPPORT: Funding: St Vincent’s Clinic Foundation Research Grant, annual Grant #3 and National
Health and Medical Research Council program grant #568612. Competing Interests: none declared
ADDITIONAL DATA: email from authors with additional data about the antibiotic policy and feedback
Bell 2014
Methods STUDY DESIGN: unintended consequences, ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in general, gynaecological, orthopaedic, urological, and
vascular surgery wards
PARTICIPANTS: 12,883 patients undergoing elective surgery
CLINICAL PROBLEM: risk of postoperative AKI following policy change to gentam-
icin for prophylaxis
SETTING: 1 hospital in the UK
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Bell 2014 (Continued)
Interventions FORMAT: Interventions: audit and feedback; educational meetings; dissemination of
antibiotic policy; reminders (physical - posters in operating theatres)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: AMT
COMPARISON: usual care
DESIREDCHANGE: decrease excessive, the policy was intended to reduceClostridium
difficile infection
Outcomes UNINTENDEDCONSEQUENCES:% postoperative AKI before and after antibiotic
policy change
Notes FINANCIAL SUPPORT: Funding: Scottish Government Healthcare Associated Infec-
tion Task Force. Competing Interests: none declared
ADDITIONAL DATA: email response from authors but no additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of analysis was point of intervention.
Unlikely to affect data collection (ITS) ? Low risk Data from laboratory computer system
(serum creatinine)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from laboratory computer system
Incomplete outcome data addressed (ITS)
?
High risk Completeness of pre- and postoperative
creatinine data presented in full for all ser-
vices (Table 2). There was a significant in-
crease in testing after policy change in gy-
naecology
Free of selected reporting (ITS) ? Low risk Data from laboratory computer system
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
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Belliveau 1996
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: all patients in hospital
CLINICAL PROBLEM: patients receiving vancomycin therapy
SETTING: 1 university hospital in the USA
Interventions FORMAT, Interventions: educationalmeetings; dissemination of educationalmaterials;
educational outreach by academic detailing; reminders (physical - posters and newsletter)
; restrictive - expert approval
Intervention Functions: education, environmental restructuring, persuasion, restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: vancomycin doses/1000 OBD
Notes FINANCIAL SUPPORT: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk > 12 months’ pre- and postrestriction data
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper
(comparison of means with t-test, uncon-
trolled before-after)
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention. Outcome data were
collected from all participants
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
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Belliveau 1996 (Continued)
Free of other bias (ITS) ? Low risk No other apparent biases found.
Benson 2014
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients receiving therapeutic antibiotics
SETTING: 1 university hospital in the USA
Interventions FORMAT, Interventions: audit and feedback; educational outreach by academic de-
tailing
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: antibiotic cost per patient day
Notes FINANCIAL SUPPORT: none. Competing Interests; none declared
ADDITIONAL INFORMATION: no response from author
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Electronic data from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Electronic data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Electronic data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Electronic data from pharmacy computer
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
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Berild 2002
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: physicians (paediatricians) in the hospital
PARTICIPANTS: all paediatric patients in the hospital
CLINICAL PROBLEM: children with infections requiring antibiotic therapy
SETTING: 1 paediatric university hospital in Norway
Interventions FORMAT, Interventions: audit and feedback; educational meetings; dissemination of
educational materials
Intervention Functions: education, enablement
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: total antibiotic usage and usage of 5 specific groups of antibi-
otics in DDD/100 OBD
Notes FINANCIAL SUPPORT: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Done, 3 years’ pre-intervention and 2 years’
postintervention data
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper
(run charts, Figure 1, with no statistical
analysis)
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
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Berild 2002 (Continued)
Free of other bias (ITS) ? Low risk Changes in antibiotic price were docu-
mented with their contribution to reduc-
tion in cost over the study period (Table 1
in study)
Borde 2014a
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians and pharmacists in the Medical Service
PARTICIPANTS: all adult patients in the Medical Service
CLINICAL PROBLEM: patients receiving antibiotics
SETTING: 1 university hospital in Germany
Interventions FORMAT, Interventions: audit and feedback; educational meetings; dissemination of
educationalmaterials; educational outreach by review and recommend change; reminders
- circumstantial, on rounds
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive, aim was to reduce use of 3rd-generation
cephalosporins and fluoroquinolones by 30% in 12 months
Outcomes PRESCRIBING: Choice: drug use measured in RDD/100 OBD
FINANCIAL: cost of intervention and impact on prescribing cost
Notes FINANCIAL SUPPORT: Funding: internal funds from the Department of Medicine
and Federal Ministry of Health (BMG grant IIA5-2011-2511FSB340). Competing
Interests: none declared
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Prescribing data from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Prescribing data from pharmacy computer
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Borde 2014a (Continued)
Incomplete outcome data addressed (ITS)
?
Low risk Prescribing data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Prescribing data from pharmacy computer
Free of other bias (ITS) ? Low risk > 24 months’ data pre- and postinterven-
tion
Borde 2014b
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients with Staphylococcus aureus bacteraemia
CLINICAL PROBLEM: compliance with a bundle of indicators of effective treatment
and investigation
SETTING: 1 community hospital in Southern Germany
Interventions FORMAT, Interventions: dissemination of educational materials; reminders - circum-
stantial, on microbiology reports for positive blood cultures
Intervention Functions: education, enablement, environmental restructuring
DELIVERER: ID physician
COMPARISON: usual care
DESIRED CHANGE: increase effective
Outcomes PRESCRIBING: Choice: average score per participant, with 0.5 points for each of 4
prescribing indicators, maximum score 2.0 per participant
CLINICAL: not valid (mean mortality in pre- and postintervention phases)
Notes FINANCIAL SUPPORT: Funding: internal funds from the Department of Medicine
and Federal Ministry of Health (BMG grant IIA5-2011-2511FSB340). Competing
Interests: none declared
ADDITIONAL DATA: the original paper reports average scores per participant for
compliance, with 5 bundle elements of which only 2 were about antibiotic prescribing
(Figure 2). The authors provided uswith additional data about scores for the 2 prescribing
elements in the bundle
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
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Borde 2014b (Continued)
Unlikely to affect data collection (ITS) ? High risk Prescribing outcomes were collected by the
investigators.
Knowledge of the allocation adequately
prevented(ITS)?
High risk Prescribing outcomes were collected by the
investigators.
Incomplete outcome data addressed (ITS)
?
Unclear risk Data are presented as % compliance per
quarter, but it is not clear whether complete
data were collected from all participants
Free of selected reporting (ITS) ? Unclear risk Data are presented as % compliance per
quarter, but it is not clear whether complete
data were collected from all participants
Free of other bias (ITS) ? High risk Only 9 months’ data postintervention
Borde 2015a
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians caring for medical emergency patients
PARTICIPANTS: all medical patients in the ED
CLINICAL PROBLEM: patients requiring antibiotic treatment
SETTING: 1 university hospital in Germany
Interventions FORMAT, Interventions: audit and feedback; educational meetings; dissemination of
educationalmaterials; educational outreach by review and recommend change; reminders
- circumstantial, on rounds
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive, aim was to reduce use of 3rd-generation
cephalosporins by 20% in 12 to 24 months
Outcomes PRESCRIBING: Choice: drug use measured in RDD/100 OBD
Notes FINANCIAL SUPPORT: Funding: internal funds from the Department of Medicine
and Federal Ministry of Health (BMG grant IIA5-2011-2511FSB340). Competing
Interests: none declared
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
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Borde 2015a (Continued)
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Data from pharmacy computer
Free of other bias (ITS) ? Low risk > 24 months’ data pre- and postinterven-
tion
Borde 2015b
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians and pharmacists in the Medical Service
PARTICIPANTS: all adult patients in the Medical Service
CLINICAL PROBLEM: patients receiving antibiotics
SETTING: 1 200-bed community hospital
Interventions FORMAT, Interventions: educationalmeetings; dissemination of educationalmaterials;
educational outreach by review and recommend change in ICU and for bacteraemic
patients in other wards; reminders - circumstantial, on rounds
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive, aim was to reduce use of 3rd-generation
cephalosporins and fluoroquinolones by 30% in 12 months
Outcomes PRESCRIBING: Choice: target drug use measured in RDD/100 OBD. Exposure:
impact on total anti-infective use was measured
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
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Borde 2015b (Continued)
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Data from pharmacy computer
Free of other bias (ITS) ? Low risk > 12 months’ data pre- and postinterven-
tion
Bouadma 2010
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the ICU
PARTICIPANTS: all patients in the ICU, 311 randomised to intervention and 319 to
control
CLINICAL PROBLEM: patients requiring antibiotic treatment
SETTING: 5 hospitals in France, 4 university and 1 general
Interventions FORMAT, Interventions: reminders - circumstantial; structural - procalcitonin testing
with decision support by treatment algorithm
Intervention Functions: enablement, environmental restructuring
DELIVERER: departmental physicians (Anaesthesiology and Intensive Care)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 133 participants per study group (details in Appendix
3)
Outcomes PRESCRIBING: Exposure: days of antibiotic exposure per 1000 patient days
CLINICAL: primary outcome measure 28-day mortality, also 60-day mortality,
length of ICU stay, and length of hospital stay
Notes FINANCIAL SUPPORT: Funding: Assistance Publique-Hopitaux de Paris, France and
B.R.A.H.M.S, Germany. Competing Interests: 4 authors declared conflicts of interest
from several pharmaceutical companies
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
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Bouadma 2010 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation se-
quence
Allocation concealment (selection bias) Low risk Assignment concealed before allocation.
Blinding (performance bias and detection
bias)
All outcomes
High risk Assignment not concealed postallocation.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data reported on 98% of partic-
ipants in control and intervention groups
Selective reporting (reporting bias) Low risk Outcome data reported fully on all in-
cluded participants.
Other bias High risk Patients assigned to the trial were < 50%
of all patients receiving antibiotics (630/
1315)
Baseline Outcomes similar? High risk No data
Free of contamination? Low risk Procalcitonin only reported on interven-
tion participants.
Baseline characteristics similar? Low risk ITS
Bouza 2004
Methods STUDY DESIGN: RCT
Risk of bias: HIGH
Participants PROVIDERS: ICU staff
PARTICIPANTS: 297 patients with bloodstream infection in hospital, 109 control and
188 intervention
CLINICAL PROBLEM: bacteraemia/fungaemia (bloodstream infection)
SETTING: 1 university hospital in Spain
Interventions FORMAT, Interventions: educational outreach by review and recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: microbiologists (specialist physicians)
COMPARISON: usual care
DESIRED CHANGE: reduce inappropriate
POWER CALCULATION: no information about sample size
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Bouza 2004 (Continued)
Outcomes PRESCRIBING: Choice: proportion of days on which adequate treatment received
CLINICAL: Intended: length of stay, mortality
Notes FINANCIAL SUPPORT: Funding: Red Española de Investigación de Patología Infec-
ciosa (REIPI C03-14) and Fondo de Investigaciones Sanitarias of Spain (FIS 02-1049).
Competing Interest: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “We randomly classified the patients ... into
3 different group by means of a computer
assisted random list”
Allocation concealment (selection bias) Unclear risk No information
Blinding (performance bias and detection
bias)
All outcomes
High risk Not possible with this study design
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not stated
Selective reporting (reporting bias) Unclear risk Not stated
Other bias High risk Not done, adequate prescription was de-
fined by 7 criteria, some of which required
clinical judgement. The reliability of the
primary outcome measure was not assessed
Baseline Outcomes similar? Unclear risk Not stated
Free of contamination? High risk All doctors in the hospital were distributed
across all 3 study groups
Baseline characteristics similar? Unclear risk Not stated
Bouza 2007
Methods STUDY DESIGN: RCT
Risk of bias: HIGH
Participants PROVIDERS: ICU staff
PARTICIPANTS: 250 patients in the adult ICU, 167 intervention and 83 control
CLINICAL PROBLEM: ventilator-associated pneumonia with bacteria identified on
gram stain of first tracheal aspirate
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Bouza 2007 (Continued)
SETTING: single general, teaching, and referral hospital in Spain
Interventions FORMAT, Interventions: educational outreach by review and recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: microbiologists (specialist physicians)
COMPARISON: usual care
DESIRED CHANGE: reduce inappropriate
POWER CALCULATION: no information about sample size
Outcomes PRESCRIBING: Exposure: mean days of therapy
MICROBIAL: Clostridium difficile infection
CLINICAL:Balancing: median days of fever and mechanical ventilation
FINANCIAL: cost of antibiotics
Notes Microbial Risk of Bias HIGH: no case definition, no details of other infection control
measures
ADDITIONAL DATA: no response from authors to request for additional data
FINANCIAL SUPPORT: Red Española de Investigación de Patología Infecciosas
(REIPI) and Fondo de Investigación Sanitaria (FIS). The Spanish Ministry of Health
(BEFI BF03/00237, to M.V.T.). Competing Interest: none declared
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Computer generated
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on all participants.
Selective reporting (reporting bias) Unclear risk No primary outcome measure identified.
Defined daily dose of antibiotic therapy
free from selective reporting, but other out-
comes (e.g. % adequate days of antibiotic
therapy) were not
Other bias High risk High microbial risk of bias
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk ETEST results only available for interven-
tion group.
77Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Bouza 2007 (Continued)
Baseline characteristics similar? Low risk Table 1
Bradley 1999
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: physicians in an adult haematology unit
PARTICIPANTS: all patients with clinical problem
CLINICAL PROBLEM: adult patients receiving treatment for haematological malig-
nancy
SETTING: adult haematology unit in a university hospital in the UK
Interventions FORMAT, Interventions: restrictive
Intervention Functions: restriction by removal
DELIVERER: specialist physician (microbiologist)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of 4 principal IV antibiotics in patient days per month
MICROBIAL: probability of remaining free of colonisationbyGREbyweeks of exposure
on the ward from date of first admission
Notes FINANCIAL SUPPORT: Funding: commercial, Wyeth Pharmaceuticals. Competing
Interest: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Only 4 months’ pre-intervention data, so
secular changes possible
Analysed appropriately (ITS) ? Low risk Done in original paper: Kaplan-Meier plot
and log rank test.
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, screening protocol was the same
throughout the study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, screening protocol was the same
throughout the study period
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Bradley 1999 (Continued)
Incomplete outcome data addressed (ITS)
?
Low risk Done, screening protocol was the same
throughout the study period
Free of selected reporting (ITS) ? Low risk Done, screening protocol was the same
throughout the study period
Free of other bias (ITS) ? Low risk Microbiology Risk of Bias Criteria: Case
definition: DONE, colonisation by screen-
ing; Planned intervention: DONE; Other
infection control, isolation, and IC prac-
tices: DONE, same throughout study
Bruins 2005
Methods STUDY DESIGN: NRT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: 1833 patients with bacterial infection in hospital in 3 study periods.
Period 1: 294 intervention, 320 control; Period 2: 303 intervention, 317 control; Period
3: 308 intervention, 328 control
CLINICAL PROBLEM: inappropriate antibiotic therapy
SETTING: 1 university hospital in the Netherlands
Interventions FORMAT, Interventions: structural - rapid microbiology laboratory testing
Intervention Functions: environmental restructuring
DELIVERER: specialist physician (microbiologist)
COMPARISON: usual care
DESIRED CHANGE: reduce inappropriate
POWERCALCULATION: yes, 296 participants in each study arm (details in Appendix
3)
Outcomes PRESCRIBING: % of participants who receive appropriate treatment in first 48 h.
Turnaround times for microbiology tests and results
CLINICAL: intended clinical outcomes, total hospital mortality rate and length of
hospital stay
COST: valid financial savings
Notes FINANCIAL SUPPORT: Funding: commercial, bioMerieux and Stichting Zorg op
Regionale ´ Grondslag (ZORG). Competing Interest: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
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Bruins 2005 (Continued)
Random sequence generation (selection
bias)
High risk Quasi-randomised. “Patients were ran-
domised on the basis of the sum of the day
and month of their date of birth ... even
numbers assigned to the control group ...
odd number to the intervention group”
Allocation concealment (selection bias) High risk Allocation not concealed.
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk
Selective reporting (reporting bias) Low risk
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk Rapid reports only received by intervention
group.
Baseline characteristics similar? Low risk Table 1
Buising 2008a
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: use of restricted antibiotics: cephalosporins, carbapenems,
quinolones, glycopeptides, and aminoglycosides
SETTING: 1 university hospital in Australia
Interventions FORMAT, Interventions: audit and feedback; educational outreach by review and rec-
ommend change; restrictive - expert approval and removal
Intervention Functions: education, enablement, environmental, persuasion, restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of restricted antibiotics in DDD/1000 OBD
MICROBIAL: ARGNB (Escherichia coli,Pseudomonas aeruginosa); ARGPB (MRSA)
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Buising 2008a (Continued)
Notes FINANCIAL SUPPORT: Funding: National Health and Medical Research Council
of Australia; Biotechnology Innovation Fund from the Commonwealth Government of
Australia; Melbourne Health. Competing Interest: none declared
Microbial Risk of Bias: LOW (case definition, planned intervention, andother infection
control measures all low risk)
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of analysis is point of intervention.
Unlikely to affect data collection (ITS) ? Low risk Data frompharmacy andmicrobiology sys-
tems
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data frompharmacy andmicrobiology sys-
tems
Incomplete outcome data addressed (ITS)
?
Low risk Data frompharmacy andmicrobiology sys-
tems
Free of selected reporting (ITS) ? Low risk Data frompharmacy andmicrobiology sys-
tems
Free of other bias (ITS) ? Low risk 5 years’ pre- and 2 years’ postintervention
data
Buising 2008b
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the ED
PARTICIPANTS: all patients with community-acquired pneumonia in the ED
CLINICAL PROBLEM: rate of empiric antibiotic prescribing that was concordant with
recommendations
SETTING: 1 university hospital in Australia
Interventions FORMAT, Interventions 1: educational outreach by academic detailing; reminders -
physical, posters
Intervention Functions: education, environmental restructuring, persuasion
Intervention 2: structural - computerised decision support
Intervention Functions: enablement, environmental restructuring
DELIVERER: AMT
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Buising 2008b (Continued)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice:% prescribing concordant with recommendation
Notes FINANCIAL SUPPORT: Funding: National Health and Medical Research Council of
Australia. Competing Interest: none declared
ADDITIONAL DATA: email response from authors with further details about inter-
vention
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Junior staff who were targets of the inter-
vention rotated every 3 months
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data collectionwas identical in all 3 phases.
Knowledge of the allocation adequately
prevented(ITS)?
High risk The nurse and physicians who collected
data were not blinded to allocation
Incomplete outcome data addressed (ITS)
?
Low risk Data were collected from all eligible partic-
ipants.
Free of selected reporting (ITS) ? Low risk Data were collected from all eligible partic-
ipants. The accuracy of data collection was
checked in a 5% sample of participants
Free of other bias (ITS) ? High risk 1 year of data in pre- and Intervention 1
time series, but only 6 months’ data for In-
tervention 2
Bunz 1990
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: all patients in hospital
CLINICAL PROBLEM: receiving metronidazole
SETTING: single university hospital in Canada
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Bunz 1990 (Continued)
Interventions FORMAT, Interventions: educationalmeetings; dissemination of educationalmaterials;
reminders - circumstantial, on rounds; restrictive - review and make change
Intervention Functions: education, enablement, restriction
DELIVERER: pharmacist
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice:% doses of metronidazole prescribed 12-hourly
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Although the pre- and postintervention
phases were only a 6-month period, data
from 1 year prior to the intervention were
used to control for any seasonal variation
in prescribing patterns
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
run charts with no statistical analysis
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, the analysis included all prescrip-
tions for metronidazole
Free of other bias (ITS) ? Low risk No other apparent biases found.
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Burton 1991
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: 147 receiving aminoglycosides
CLINICAL PROBLEM: patients receiving IV aminoglycosides
SETTING: 1 hospital in the USA
Interventions FORMAT, Interventions: educational outreach by review and recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: pharmacist
COMPARISON: usual care
DESIRED CHANGE: reduce inappropriate
POWER CALCULATION: no information about sample size
Outcomes PRESCRIBING: Choice: aminoglycoside dosing and serum concentration
CLINICAL: Intended: length of stay
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Random numbers table used to assign 9
of 17 house staff teams to the intervention
group. Patients allocated to intervention or
control groups based on house staff team
to which they were admitted. The other 8
teams were assigned as control groups”
Allocation concealment (selection bias) Unclear risk Not stated but unlikely: 9 house staff teams
were in the intervention group, 8 control,
groups swapped over after 4 months
Blinding (performance bias and detection
bias)
All outcomes
High risk “Blinding as to patient status was not per-
formed”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No problems found.
Selective reporting (reporting bias) Low risk No problems found.
Other bias High risk Unit of analysis error for length of stay. This
was a cluster RCT, but length of stay was
analysed at participant level
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Burton 1991 (Continued)
Baseline Outcomes similar? Unclear risk Not measured before interventions.
Free of contamination? High risk Not done, 9 house staff teams were in
the intervention group, 8 control, groups
swapped over after 4 months
Baseline characteristics similar? Low risk See Table 2 in paper.
Buyle 2010
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: all patients receiving IV fluoroquinolones
CLINICAL PROBLEM: switch from IV fluoroquinolones to oral
SETTING: 1 hospital in Belgium
Interventions FORMAT, Interventions: educational meetings; dissemination of guideline; reminders
- circumstantial and physical (pre-printed note placed in patient notes when the patient
fulfilled criteria for IV to oral switch). NB: the circumstantial reminder was only imple-
mented on some wards (abdominal surgery, gastro-enterology, and plastic surgery) over
2 months, and there are no reliable data to estimate the effect of this component
Intervention Functions: education, enablement (only for the circumstantial reminder)
, environmental restructuring (only for the circumstantial reminder)
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: reduce inappropriate
Outcomes PRESCRIBING: Choice:% IV/(IV + oral) fluoroquinolone usage
Notes FINANCIAL SUPPORT: Funding: none. Competing Interest: none declared
ADDITIONAL DATA: email from authors with further information about the inter-
vention
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data for ITS from pharmacy computer
(Figure 1). Other data in Tables 2 and 3
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Buyle 2010 (Continued)
not valid, UBA
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data for ITS from pharmacy computer
(Figure 1). Other data in Tables 2 and 3
not valid, UBA
Incomplete outcome data addressed (ITS)
?
Low risk Data for ITS from pharmacy computer
(Figure 1). Other data in Tables 2 and 3
not valid, UBA
Free of selected reporting (ITS) ? Low risk Data for ITS from pharmacy computer
(Figure 1). Other data in Tables 2 and 3
not valid, UBA
Free of other bias (ITS) ? Low risk 21 months’ pre- and 24 months’ postinter-
vention
Calfee 2003
Methods STUDY DESIGN: unintended consequences, case control
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in adult medical and surgical units
PARTICIPANTS: all patients in the units
CLINICAL PROBLEM: use of targeted antibiotics (3rd-generation cephalosporins, piperacillin/tazobactam, aztre-
onam, carbapenems, parenteral clindamycin, oral and parenteral vancomycin, parenteral fluoroquinolones and
macrolides, and fluconazole)
SETTING: 1 hospital in the USA
Interventions FORMAT, Interventions: restrictive by review and make change, automatic stop order for prescriptions not meeting
policy indications
Intervention Functions: restriction
DELIVERER: AMT
COMPARISON: case control study
DESIRED CHANGE: decrease excessive use of targeted drugs
Outcomes UNINTENDEDCONSEQUENCES: proportion of nosocomial infections reported solely on the basis of a treating
physician’s diagnosis during the endemic and epidemic periods (Table 1)
Notes ROBINS-I RISK OF BIAS CRITERIA:
1. Confounding: Low, confounding unlikely
2. Selection of participants into the study: Unclear, insufficient detail about selection of cases for the endemic and
epidemic period
3. Measurement classification of interventions: Low, intervention status well defined, recorded at the time of inter-
vention, and unaffected by knowledge of the outcome or risk of the outcome
4. Deviation from intended interventions: Low, no switches to other interventions or evidence of intervention failure
5. Missing data: Unclear, outcomes are reported as % with no numerator or denominator data
6. Measurement of outcome: High, outcome measure objective, but outcome assessors were aware of the intervention
status, and the study does not report the actual number of cases
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Calfee 2003 (Continued)
7. Selection of the reported result: High, reported effect selected from multiple measurements within the outcome
domain
FINANCIAL SUPPORT:Funding: no information. Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Calil 2001
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: staff in a neonatal unit
PARTICIPANTS: all patients in the neonatal care unit
CLINICAL PROBLEM: requiring neonatal care
SETTING: 1 neonatal care unit in a university hospital in Brazil
Interventions FORMAT: no valid prescribing data. Restrictive
DELIVERER: specialist physician
COMPARISON: usual carer
DESIRED CHANGE: decrease exessive
Outcomes MICROBIAL: monthly incidence of Enterobacter cloacae infections
Notes FINANCIAL SUPPORT: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk More than 1 year of data before and after
intervention
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after) with logistic regression analysis of re-
lationship between antibiotic prescribing
and resistance
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
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Calil 2001 (Continued)
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Unclear risk Not clear, no information about changes
in sampling or testing protocol over study
period
Free of other bias (ITS) ? High risk Not done.
Microbial Risk of Bias Criteria:Case def-
inition: infection, monthly infections with
E cloacae; Unplanned intervention: other
infection control measures: barrier precau-
tions, isolation of participants, and per-
sonal IC procedures fully described and
same in both phases
Camins 2009
Methods STUDY DESIGN: cluster RCT, service level
Risk of Bias: HIGH
Participants PROVIDERS: all internal medicine teams in the hospital
PARTICIPANTS: 784 patients prescribed antibiotics in the hospital (390 intervention,
394 control), 12 clusters (internal medicine teams)
CLINICAL PROBLEM: patients receiving therapeutic piperacillin-tazobactam, lev-
ofloxacin, or vancomycin
SETTING: 1 hospital in the USA
Interventions Interventions: audit and feedback; dissemination of guidelines; educational outreach by
review and recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease in excessive treatment
POWER CALCULATION: assuming a baseline proportion of inappropriate use for
target antimicrobials of 35% (with inappropriate-use data based on preliminary-usage
data from Grady Memorial Hospital), review of at least 330 antimicrobial prescriptions
in each armwould allow for detection of a 10% reduction in inappropriate antimicrobial
use
Outcomes PRESCRIBING: Choice:% appropriate
Notes FINANCIAL SUPPORT: Emory Medical Care Foundation; National Institutes of
Health (UL1RR024992 to BCC, K12 RR017643 to MDK and HMB, K23 AI054371
to MDK, and UL1 RR025008 to HMB). Competing Interests: BCC reports was on
the speakers’ bureau for Wyeth Pharmaceuticals. All other authors report no conflicts of
interest
ADDITIONAL DATA: no additional data requested
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Camins 2009 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Each month, 6 internal medicine teams
were randomly assigned to the intervention
arm, and 6 teams were randomly assigned
to the control group by means of a random
number list
Allocation concealment (selection bias) High risk Not concealed
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on all participants.
Selective reporting (reporting bias) Low risk Outcomes reported on all participants.
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? High risk Doctors randomised to intervention were
in the same hospital as control doctors
Baseline characteristics similar? Low risk
Carling 2003
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: NOT CLEAR
SETTING: 1 community teaching hospital in the USA
Interventions FORMAT: no valid prescribing data. Educational outreach - review and recommend
change; educational meetings with dissemination of educational materials
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
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Carling 2003 (Continued)
Outcomes MICROBIAL: prevalence of Clostridium difficile, ceftazidime-resistant Enterobacteri-
aceae, and MRSA
FINANCIAL: cost of intervention
Notes FINANCIAL SUPPORT: Funding: institutional support. Competing Interests: none
declared
ADDITIONAL DATA: no additional data requested
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk 3 years’ pre-intervention data
Analysed appropriately (ITS) ? Low risk Done in original paper: regression analysis
with adjustment for autocorrelation. Anal-
ysis repeated by review team because of in-
complete reporting of results
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Unclear risk Not clear, no information about changes
in sampling or testing protocol over study
period
Free of other bias (ITS) ? Low risk VRE isolation unlikely to have influenced
C difficile or resistant gram-negative bac-
teria. Microbial Risk of Bias Criteria:
Planned intervention: DONE Implemen-
tation of antimicrobial management team
in response to increase in use of target
drugs. Case definition: DONE for C diffi-
cile infection (diarrhoea and toxin positive)
or infection with clinical isolates of gram-
negative bacteria resistant to ceftazidime, or
MRSA (CDC definition of nosocomial in-
fection). Other infection control measures:
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Carling 2003 (Continued)
DONE For C difficile contact precautions
and procedures for cleansing equipment
andpatient care areas remainedunchanged.
Other infection control processes are not
described in detail but may have changed
during the study period (e.g. VRE isolation
introduced after intervention).Data about
VRE infections NOT RELIABLE: There
were no cases in the pre-intervention phase
and none in the first 3 years postinterven-
tion, but there was an outbreak in the 4th
and 5th postintervention years caused by
admission of patients from other hospitals
who were colonised with VRE
Chan 2011
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients
CLINICAL PROBLEM: use of restricted antibiotics (amikacin, 3rd- and 4th-gener-
ation cephalosporins, carbapenems, fluoroquinolones, glycopeptides, and piperacillin/
tazobactam)
SETTING: 1 university hospital in Taiwan
Interventions FORMAT, Interventions: educational outreach by review and recommend change; re-
strictive - expert approval required plus review and make change
Intervention Functions: education, enablement, persuasion, restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: DDD/1000 OBD of restricted antibiotics
MICROBIAL: isolation ratesClostridium difficile,MRSA, andmultidrug-resistant gram-
negative bacteria
Notes ADDITIONAL DATA: no response from authors to request for additional data
FINANCIAL SUPPORT: Funding: Chang Gung Memorial Hospital (Taoyuan, Tai-
wan) (grant CMRPG340236). Competing Interests: none declared
Microbial Risk of Bias: HIGH (case definition clear, planned intervention but no data
about infection control)
Risk of bias
Bias Authors’ judgement Support for judgement
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Chan 2011 (Continued)
Intervention independent (ITS) ? Low risk States in discussion that biggest limitation
was lack of external controls, but that is
common to all ITS studies
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of analysis was point of intervention.
Unlikely to affect data collection (ITS) ? Unclear risk DDD data from pharmacy computer, the
same pre- and postintervention
Knowledge of the allocation adequately
prevented(ITS)?
Low risk DDD data from pharmacy computer, the
same pre- and postintervention
Incomplete outcome data addressed (ITS)
?
Low risk DDD data from pharmacy computer, the
same pre- and postintervention
Free of selected reporting (ITS) ? Low risk DDD data from pharmacy computer, the
same pre- and postintervention
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
Chan 2015
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients requring vancomycin
CLINICAL PROBLEM: patients requiring more than 2 doses of vancomycin treatment
SETTING: 1 university hospital in the USA
Interventions FORMAT Interventions: restrictive - expert approval
Intervention Functions: restriction
DELIVERER: AMT
COMPARISON: pre-existing antimicrobial stewardship programme with audit and
feedback. No valid data about impact of this programme (UBA).
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of vancomycin in DDD/1000 OBD
Notes FINANCIAL SUPPORT: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
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Chan 2015 (Continued)
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk
Unlikely to affect data collection (ITS) ? Low risk Routine data from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Routine data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Routine data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Routine data from pharmacy computer
Free of other bias (ITS) ? Low risk 21 months’ pre- and 51 months’ postinter-
vention data
Chandy 2014
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients receiving antibiotics
CLINICAL PROBLEM: total antibiotic use in the hospital
SETTING: 1 university hospital in India
Interventions FORMAT Interventions: dissemination of educational materials (guidelines)
Intervention Functions: education
DELIVERER: AMT
COMPARISON: pre-dissemination
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure: total antibiotic use in DDD/100 OBD
Notes FINANCIAL SUPPORT: none. Competing Interests: none declared
ADDITIONAL INFORMATION: authors provided additional detail about the antibi-
otic policy and confirmed that feedback was not used in this intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
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Chandy 2014 (Continued)
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk
Unlikely to affect data collection (ITS) ? Low risk Routine data from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Routine data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Routine data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Routine data from pharmacy computer
Free of other bias (ITS) ? Low risk > 18 months’ data pre- and postinterven-
tion
Charbonneau 2006
Methods STUDY DESIGN: Controlled ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: all patients who qualified for fluoroquinolone therapy
CLINICAL PROBLEM: infection with MRSA
SETTING: 1 university hospital in France
Interventions FORMAT: no valid prescribing data. Restriction, educational meetings, and dissemina-
tion of educational materials
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes MICROBIAL: reduction of MRSA infections
Notes FINANCIAL SUPPORT: Funding: Programme Hospitalier de Recherche Clinique.
Competing Interests: none declared
ADDITIONAL DATA: no request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk 1 year post- and 2 years’ pre-intervention
data, so secular changes unlikely. Infection
control protocols were unchanged pre- and
postintervention
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Charbonneau 2006 (Continued)
Analysed appropriately (ITS) ? Low risk Done in original paper: the study is anal-
ysed as a CBA adjusting for confounders
and slope and level. The ITS analyses are
correct, but the results are not well reported
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Unclear risk Not clear, no information about changes
in sampling or testing protocol over study
period
Free of other bias (ITS) ? Low risk Microbial Risk of Bias Criteria: Planned
intervention: DONE Case definition:
DONE clear case definition of clinical in-
fection: “A new case was defined as a case in
a patient with no previous history ofMRSA
or ESBL-EB colonization or infection who
was infected with MRSA or ESBL-EB no
less than 48 h after hospital admission.”
Other infection control measures: DONE
“The measures recommended by French
national guidelines for the prevention of
nosocomial infections were implemented
in the 4 study hospitals several years before
the study began”
Cheng 2009
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients receiving IV antibiotics
CLINICAL PROBLEM: reduce inappropriate prescribing of broad-spectrum IV antibi-
otics in hospital inpatients
SETTING: 1 university hospital in China
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Cheng 2009 (Continued)
Interventions FORMAT, Interventions: educational meetings with dissemination of guidelines; edu-
cational outreach by review and recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of targeted antibiotics in DDD/1000 OBD
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk Does not mention other changes apart
from preceding Antimicrobial Stewardship
Programme
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Routine pharmacy data used for outcome,
so assume complete.
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Routine pharmacy data used for outcome,
so assume complete.
Incomplete outcome data addressed (ITS)
?
Low risk Routine pharmacy data used for outcome,
so assume complete.
Free of selected reporting (ITS) ? Low risk
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
Christ-Crain 2004
Methods STUDY DESIGN: cluster RCT
Risk of bias: MEDIUM
Participants PROVIDERS: physicians in hospital
PARTICIPANTS: 234 patients (124 intervention, 119 control), 16 clusters (weeks ran-
domly assigned to either standard or procalcitonin)
CLINICAL PROBLEM: suspected lower respiratory tract infection
SETTING: 1 university hospital in Switzerland
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Christ-Crain 2004 (Continued)
Interventions FORMAT, Interventions: dissemination of educational materials; reminders - circum-
stantial and physical (procalcitonin algorithm) triggered by prescribing antibiotics; struc-
tural
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: department physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 105 participants in each group
Outcomes PRESCRIBING: Choice: relative risk of antibiotic exposure measured in percentage
and patient-days
CLINICAL: Balancing: length of stay; mortality
Notes FINANCIAL SUPPORT: Funding: B.R.A.H.M.S (Hennigsdorf, Germany) and Orge-
nium Laboratories (Turku, Finland) provided assay material and partial support of this
investigator-initiated project. Freiwillige Akademische Gesellschaft Basel, Switzerland;
internal from the Department of Internal Medicine and the Divisions of Endocrinology
and Pneumology.Competing Interests: BM served as consultant and received payments
fromB.R.A.H.M.S (themanufacturer of procalcitonin assays) to attendmeetings related
to the trial and for travel expenses, speaking engagements, or research
ADDITIONAL DATA: email response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “We randomly assigned eligible patients ..
. according to a computer generated week
wise randomisation scheme”
Allocation concealment (selection bias) Unclear risk “We randomly assigned eligible pa-
tients either standard antimicrobial ther-
apy (standard group) or procalcitonin-
guided antimicrobial treatment (procalci-
tonin group) according to a computer-gen-
erated week wise randomisation scheme”.
No information about concealment of al-
location
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Single blinded intervention trial”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Antibiotic data from all treated participants
Selective reporting (reporting bias) Low risk Objective outcome measure in all partici-
pants
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Christ-Crain 2004 (Continued)
Other bias Low risk No other apparent biases found.
Baseline Outcomes similar? Unclear risk Not stated
Free of contamination? Low risk Although same doctors treated participants
in non-intervention weeks, they did not
have data about procalcitonin results
Baseline characteristics similar? Low risk Done, Tables 1 and 2 in the original paper
Christ-Crain 2006
Methods STUDY DESIGN: RCT
Risk of bias: MEDIUM
Participants PROVIDERS: physicians in hospital
PARTICIPANTS: 302 patients (151 intervention, 151 control)
CLINICAL PROBLEM: suspected community-acquired pneumonia
SETTING: 1 university hospital in Switzerland
Interventions FORMAT, Interventions: dissemination of educational materials; reminders - circum-
stantial and physical (procalcitonin algorithm) triggered by prescribing antibiotics; struc-
tural
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: department physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 150 participants in each group
Outcomes PRESCRIBING: Choice: relative risk of antibiotic exposure, total antibiotic use. Du-
ration of antibiotic course
CLINICAL: Balancing: mortality and length of hospital stay
FINANCIAL: total antibiotic cost and cost per patient
Notes FINANCIAL SUPPORT: Funding: B.R.A.H.M.S (Hennigsdorf, Germany), Pfizer
(Schweiz AG), and Mepha (Schweiz AG) was used for assay material and salaries of
technical personnel; internal from Departments of Internal Medicine and Emergency
Medicine, the Stiftung Forschung Infektionskrankheiten (SFI), and Departments of En-
docrinology and PulmonaryMedicine, University Hospital Basel, Switzerland.Compet-
ing Interests: 2 authors received payments from B.R.A.H.M.S AG, the manufacturer
of the procalcitonin assay
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
98Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Christ-Crain 2006 (Continued)
Random sequence generation (selection
bias)
Unclear risk “Patients were randomly assigned to one
of the two groups by sealed opaque en-
velopes”, no information about generation
of randomisation sequence
Allocation concealment (selection bias) Low risk “Sealed opaque envelopes”
Blinding (performance bias and detection
bias)
All outcomes
Low risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk
Selective reporting (reporting bias) Low risk
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk Same doctors in the intervention and con-
trol weeks, but they did not have access to
procalcitonin results in the control weeks
Baseline characteristics similar? Low risk Done, Table 1 in the original paper
Chu 2003
Methods STUDY DESIGN: CBA
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: patients with clinical problem
CLINICAL PROBLEM: community-acquired pneumonia
SETTING: a total of 36 (20 intervention, 16 control), non-university community hos-
pitals in USA
Interventions FORMAT, Interventions: audit and feedback; educational meetings; dissemination of
educational materials - pack including guideline and literature review
Intervention Functions: education, enablement
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: increase effective
Outcomes PRESCRIBING: Choice: process measures sputum and blood cultures within 4 hours,
antibiotics within 4 hours, first antibiotic in emergency room
CLINICAL: Intended: mortality and LOS
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Chu 2003 (Continued)
Notes FINANCIAL SUPPORT: Funding: contract 500-99-P619 “Utilization and Quality
Control Peer Review Organization for the State of Oklahoma” from the Centers for
Medicare and Medicaid Services. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Control cohort study (CBA)
Allocation concealment (selection bias) High risk Control cohort study (CBA)
Blinding (performance bias and detection
bias)
All outcomes
High risk Control cohort study (CBA)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Objective primary outcome collected on all
participants.
Selective reporting (reporting bias) Low risk Objective primary outcome collected on all
participants.
Other bias Low risk No other apparent biases found.
Baseline Outcomes similar? Low risk Tables 1 and 2
Free of contamination? Low risk Intervention and control were at different
sites.
Baseline characteristics similar? Low risk Tables 3 and 4
Clerc 2014
Methods STUDY DESIGN: NRT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: “We planned to include around 100 patients in the intervention
group”. No power calculation provided. Recruited 106 intervention and 91 control
participants.
CLINICAL PROBLEM: first episode of Staphylococcus aureus bacteraemia
SETTING: 1 university hospital in Switzerland
Interventions FORMAT, Interventions: structural - rapid laboratory testing for meticillin resistance
Intervention Functions: environmental restructuring
DELIVERER: specialist physician (ID and Microbiology)
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Clerc 2014 (Continued)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: % compliance with guideline recommended use of van-
comycin
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL INFORMATION: the authors confirmed that this intervention did
not include feedback to participants
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Odd versus even hospital number
Allocation concealment (selection bias) Unclear risk “Mode of allocation was concealed from
the clinicians”, but unclear how this was
achieved
Blinding (performance bias and detection
bias)
All outcomes
High risk Open study
Incomplete outcome data (attrition bias)
All outcomes
Low risk Primary outcome reported on all partici-
pants.
Selective reporting (reporting bias) Unclear risk Primary outcome reported on all partici-
pants. Authors did a secondary analysis ex-
cluding participants with penicillin allergy,
but this was not prespecified
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Unclear risk Clinicians received results verbally and
electronically, so it is likely that they were
aware of the intervention, which may have
influenced their management of other par-
ticipants
Baseline characteristics similar? Low risk Table 1
101Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Climo 1998
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: all patients in the hospital
SETTING: a 703-bed tertiary-care university hospital in the USA
Interventions FORMAT: no reliable prescribing data. Restriction by expert approval
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes MICROBIAL: cases of Clostridium difficile-associated diarrhoea per quarter (ITS data).
Prevalence of clindamycin-resistant C difficile
Notes FINANCIAL SUPPORT: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Done, infection control measures fully de-
scribed and same in both phases
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after) with t-test
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Unclear risk Not clear, no information about changes
in sampling or testing protocol over study
period
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Climo 1998 (Continued)
Free of other bias (ITS) ? High risk NOTDONEMicrobial Risk of Bias Cri-
teria:Planned intervention:NOTDONE;
Case definition: DONE infection, diar-
rhoea, and toxin positive Other infection
control measures: DONE barrier precau-
tions, isolation of participants with C dif-
ficile-associated diarrhoea, and personal IC
procedures fully described and same in
both phases
Connor 2007
Methods STUDY DESIGN: unintended consequences, cohort study
Risk of Bias: LOW
Participants PROVIDERS: all physicians prescribing vancomycin
PARTICIPANTS: 120 patients with vancomycin prescription approved for only 72 hours
CLINICAL PROBLEM: interruption of vancomycin treatment
SETTING: 1 hospital in the USA
Interventions FORMAT, Interventions: reminders (circumstantial and physical) stickers in medical records on day 3 warning of
impending stop order; restrictive: stop order if approval not obtained
Intervention Functions: enablement, environmental restructuring, restriction
DELIVERER: AMT
COMPARISON: participants with and without sticker
DESIRED CHANGE: decrease excessive
Outcomes UNINTENDED CONSEQUENCES: interruption of vancomycin treatment
Notes ROBINS-I RISK OF BIAS CRITERIA:
1. Confounding: Low, confounding unlikely
2. Selection of participants into the study: Low, selection into the study unrelated to intervention (sticker in notes)
or outcome
3. Measurement classification of interventions: Low, intervention status well defined, recorded at the time of inter-
vention and unaffected by knowledge of the outcome
4. Deviations from intended interventions: Low, the study was designed to detect intervention failure (no warning
sticker)
5. Missing data: Low, outcome data and intervention status complete on all 120 participants
6. Measurement of outcome: Low, outcome measure objective and unaffected by intervention status
7. Selection of the reported result: Low, reported effect predefined
FINANCIAL SUPPORT: Funding: none. Competing Interests: EL received research support from Merck Phar-
maceuticals and Ortho-McNeil Pharmaceuticals. All other authors reported no conflicts of interest
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Cook 2011a
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients receiving antibiotics
CLINICAL PROBLEM: use of all prophylactic and therapeutic antibiotics
SETTING: 1 university hospital in the USA
Interventions FORMAT, Interventions: educational outreach by review and recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure: total use of all antibiotics in DDD/1000 OBD
MICROBIAL: Clostridium difficile and MRSA infections/1000 OBD
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: PPC is a member of
the speakers’ bureau of Pfizer, Astellas, and Merck. PPC has received research funding
from GlaxoSmithKline, Merck, Gilead, Pfizer, and Bristol-Myers Squibb. All other au-
thors have none to declare
ADDITIONAL DATA: email response from authors with additional data about inter-
vention
Microbial Risk of Bias HIGH: case definition low; planned intervention, other in-
fection control high - new policy for screening and isolation of MRSA introduced just
before prescribing intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Routine data from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Routine data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Routine data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Routine data from pharmacy computer
Free of other bias (ITS) ? Low risk 2 years’ pre- and postintervention data
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Cook 2011b
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients receiving antibiotics
CLINICAL PROBLEM: patients receiving ciprofloxacin for treatment of any infection
SETTING: 1 university hospital in the USA
Interventions FORMAT, Intervention 1 component: educational outreach by review and recommend
change
Intervention 1 functions: education, enablement, persuasion
Intervention 2 component: restrictive by expert approval
Intervention 2 function: restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of ciprofloxacin in DDD/1000 OBD
MICROBIAL: infections with ARGNB - % carbapenem resistant Pseudomonas aerugi-
nosa
Notes FINANCIAL SUPPORT: Funding: commercial, grant from Merck & Co., Inc. Com-
peting Interests: PC is a member of the speakers’ bureau of Merck and Astellas. He has
received research support from Merck, Gilead, and Pfizer
ADDITIONAL DATA: email response from authors with additional data about inter-
vention
Microbial Risk of BiasHIGH case definition low; planned intervention, other infection
control high - change in screening and isolation for MRSA just before prescribing
intervention may have impacted on transmission of P aeruginosa
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Routine data from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Routine data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Routine data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Routine data from pharmacy computer
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Cook 2011b (Continued)
Free of other bias (ITS) ? Low risk 5 years’ pre- and 4 years’ postintervention
data
Cortoos 2011
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all adult patients with community-acquired pneumonia
CLINICAL PROBLEM: compliance with guideline for community-acquired pneumo-
nia
SETTING: 1 university hospital in the Netherlands
Interventions FORMAT: Intervention 1: dissemination of educational materials
Intervention 1 function: education
Intervention 2: reminders - physical, questionnaire about guideline compliance, dis-
tributed once
Intervention 2 functions: environmental restructuring, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice:% guideline compliance
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL INFORMATION: no response from authors to request for additional
data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk This and all other ROB criteria are for in-
terventions 1 and 2 only. Intervention 3
and 4 could not be evaluated because they
are too close together and also coincided
with an influenza epidemic. Neither in-
tervention 3 nor intervention 4 meets the
EPOC minimum criteria for ITS. There
are insufficient data to adjust for seasonal
effects, and the target condition (pneumo-
nia) has large seasonal variation
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
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Cortoos 2011 (Continued)
Unlikely to affect data collection (ITS) ? High risk Data collection was different in the postin-
tervention phase (see below)
Knowledge of the allocation adequately
prevented(ITS)?
Unclear risk Compliance to therapy was assessed with
a “computerised algorithm”. However, the
criteria for guideline adherence presented
in the supplementary materials (Table S2)
would require chart review, unless the hos-
pitals had very sophisticated electronic pa-
tient records, which is not stated. The fact
that patients were excluded because of “in-
complete files” suggests that chart review
was required, so knowledge of the allocated
interventions could not be adequately pre-
vented
Incomplete outcome data addressed (ITS)
?
Unclear risk The 477 included participants had com-
plete data for assessment of outcomes. 5 pa-
tients were excluded because of incomplete
patient records
Free of selected reporting (ITS) ? Low risk
Free of other bias (ITS) ? Unclear risk Insufficient data to account for seasonal ef-
fects. Although information about guide-
line compliance is reported for 2 hospitals,
the ITS in Figure 1 only has data from 1
hospital (UZL). The data for the second
hospital (ZOL) are actually aUBAandhave
been excluded
Danaher 2009
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: 52 patients (14 intervention, 38 control)
CLINICAL PROBLEM: excessive prescribing of antibiotics
SETTING: 1 military teaching hospital in USA
Interventions FORMAT, Interventions: educational outreach by review and recommend change
Intervention Functions: education, enablement, persuasion
FORMAT: Persuasive: educational outreach - review and recommend change
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: “Since this was an explanatory study, no a priori estimates
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Danaher 2009 (Continued)
of effect size were available to perform power and sample size calculations.” The goal
was to have 180 participants in the trial
Outcomes PRESCRIBING: Choice: antibiotic use (DDDs and days of treatment)
CLINICAL: Balancing: clinical outcomes, mortality, and re-admission
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Unclear risk 21 of 73 patients considered for enrolment
were excluded, but it is not clear if this was
pre- or postrandomisation. The number of
participants in the study group was 14, ver-
sus 38 in the control group, with no justi-
fication for the unequal numbers
Blinding (performance bias and detection
bias)
All outcomes
Low risk Primary outcome data from pharmacy
computer
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on all participants.
Selective reporting (reporting bias) Low risk Outcomes reported on all participants.
Other bias High risk Aim was to enrol 180 patients, but only
72 patients were identified, and 21 of them
were excluded
Baseline Outcomes similar? Unclear risk No data
Free of contamination? High risk Education intervention with study and
control in same hospital
Baseline characteristics similar? Low risk
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Dancer 2013
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: requiring antibiotic prophylaxis or treatment
SETTING: 1 district general hospital in the UK
Interventions FORMAT: Interventions: restrictive
Intervention Functions: restriction by removal from all wards except for ED and ICU
and by therapeutic substitution (“empirical prescription of ceftriaxone and ciprofloxacin
for systemic sepsis and surgical prophylaxis was changed to amoxicillin, gentamicin and
metronidazole”)
DELIVERER: AMT
COMPARISON:multifaceted intervention introduced 7 months before restriction and
remaining in place throughout restrictive period. Components: audit and feedback; ed-
ucational outreach by review and recommend change; educational meetings and re-
minders on microbiology reports. There is only 2 months’ data before the multifaceted
intervention, so it is not possible to estimate its effect.
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of cephalosporins and ciprofloxacin in DDD/1000 OBD
MICROBIAL: CDI, MRSA, and resistant gram-negative bacteria
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: SD received financial
support for attending conferences by Janssen-Cilag, Pfizer, and Novartis
ADDITIONAL DATA: authors provided additional details about the intervention, in-
cluding information about regular feedback to participants that was not in the original
paper
Microbial Risk of Bias LOW case definition Low, planned intervention Low, other
infection control practices Low
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk 9 months’ data pre-restriction includes
an additional persuasive intervention 7
months’ pre-restriction; effect cannot be as-
sessed because of insufficient pre-interven-
tion data
Analysed appropriately (ITS) ? Low risk Analysed by correlation and time-lag mod-
elling, but re-analysed as segmented regres-
sion analysis
Shape of effect pre-specified (ITS) ? Low risk
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Dancer 2013 (Continued)
Unlikely to affect data collection (ITS) ? Low risk Routine data from microbiology and phar-
macy computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Routine data from microbiology and phar-
macy computers
Incomplete outcome data addressed (ITS)
?
Low risk Routine data from microbiology and phar-
macy computers
Free of selected reporting (ITS) ? Low risk Routine data from microbiology and phar-
macy computers
Free of other bias (ITS) ? High risk Only 9 months’ pre-intervention data
de Champs 1994
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: physicians on a paediatric ICU
PARTICIPANTS: all patients on paediatric ICU
CLINICALPROBLEM:neonates requiring intensive care including empirical antibiotic
treatment
SETTING: paediatric ICU in a university hospital in France
Interventions FORMAT: No valid prescribing data. Restrictive: change in antibiotic policy from gen-
tamicin to amikacin
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes MICROBIAL: monthly incidence of infection with multiresistant Enterobacter cloacae
Notes FINANCIAL SUPPORT: Funding: grant from D.R.E.D. (Direction de la Recherche
et des Etudes Doctorales). Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Only 7 months’ pre-intervention data,
so secular/seasonal changes possible. Very
complex case definition with no informa-
tion about how this was applied reliably
across the pre- and postintervention peri-
ods
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de Champs 1994 (Continued)
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after) with t-test
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Unclear risk Case definition included clinical interpre-
tation.
Knowledge of the allocation adequately
prevented(ITS)?
Unclear risk NOT CLEAR because of case definition
Incomplete outcome data addressed (ITS)
?
Unclear risk Availability of all data required for the case
definition not documented
Free of selected reporting (ITS) ? Unclear risk Not clear, no information about changes
in sampling or testing protocol over study
period
Free of other bias (ITS) ? High risk Microbial outcome risk of bias: Un-
planned intervention: implementation of
change in response to emergence of gen-
tamicin-resistantE cloacae; Case definition:
infection from clinical or screening isolates
combined with 7 clinical criteria and 5 ad-
ditional laboratory criteria assessed by a res-
ident paediatrician and a consultant micro-
biologist and verified by a consultant pae-
diatrician. Reliability of this outcome mea-
sure not clear.Other infection controlmea-
sures: well documented, no changes during
the study period
Dean 2001
Methods STUDY DESIGN: CBA
Risk of Bias: HIGH
Participants PROVIDERS: all inpatient and outpatient services in the state of Utah
PARTICIPANTS: 22,985 Medicare beneficiaries aged 65 or older with 28,661 episodes
of community-acquired pneumonia, of which 7719 were hospitalised
CLINICAL PROBLEM: community-acquired pneumonia
SETTING: 23 hospitals (and 60 outpatient clinics), all in Utah, USA
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Dean 2001 (Continued)
Interventions FORMAT: no valid prescribing data. Reminder; educational outreach - academic detail-
ing; and educational meetings or dissemination of educational material
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: increase effective
Outcomes CLINICAL: Intended: 30-day mortality and length of stay
Notes FINANCIAL SUPPORT: supported by HealthInsight and Intermountain Healthcare.
The analyses upon which this publication is based were performed under contract num-
ber 500 -96-P604, entitled “Utilization and Quality Control Peer Review Organization
for the State of Utah”, sponsored by the Health Care Financing Administration (HCFA)
, Department of Health and Human Services. This article is a direct result of the Health
Care Quality Improvement Program initiated by HCFA, which has encouraged identi-
fication of quality improvement projects derived from analysis of patterns of care, and
therefore required no special funding on the part of the contractor. Conflict of interest:
no information
ADDITIONAL DATA: authors provided additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk CBA
Allocation concealment (selection bias) High risk CBA
Blinding (performance bias and detection
bias)
All outcomes
High risk CBA
Incomplete outcome data (attrition bias)
All outcomes
Low risk Objective outcomemeasure collected on all
participants.
Selective reporting (reporting bias) Low risk Objective outcomemeasure collected on all
participants.
Other bias Low risk No other apparent biases found.
Baseline Outcomes similar? Low risk Table 1
Free of contamination? Unclear risk NOT CLEAR, some hospitals had both
intervention and control physicians. Inter-
mountain Healthcare provides 50% of re-
gional health care delivery in Utah. In ru-
ral IHC hospitals, 90% of pneumonia ad-
missions were cared for by IHC-affiliated
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Dean 2001 (Continued)
physicians, whereas in urban IHC hospi-
tals only 44% of pneumonia admissions
were cared for by IHC-affiliated physi-
cians. Non-affiliated physicians caring for
patients at IHC hospitals may have been
influenced by guideline implementation at
these hospitals
Baseline characteristics similar? Low risk Table 1
Dean 2006
Methods STUDY DESIGN: CBA
Risk of bias: HIGH
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: a total of 17,728 patients aged 66 years or older
CLINICAL PROBLEM: admitted with community-acquired pneumonia
SETTING: 35 hospitals in Utah, USA (16 from Intermountain Healthcare and 19 from
other systems)
Interventions FORMAT: no valid prescribing data. Reminder; educational outreach by academic de-
tailing; and educational meetings with dissemination of educational materials
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: increase effective
Outcomes CLINICAL: Intended: 30-day mortality, LOS, and 30-day re-admission
Notes FINANCIAL SUPPORT: this study was funded by theDeseret Foundation and Health-
Insight, Salt Lake City. The authors have no relevant conflicts of interest to report
ADDITIONAL DATA: authors provided additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk CBA
Allocation concealment (selection bias) High risk CBA
Blinding (performance bias and detection
bias)
All outcomes
High risk CBA
Incomplete outcome data (attrition bias)
All outcomes
Low risk Electronic record linkage used.
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Dean 2006 (Continued)
Selective reporting (reporting bias) Low risk 30-day mortality was primary outcome.
Other bias Low risk Objective primary outcome measure
Baseline Outcomes similar? Low risk Table 3
Free of contamination? Low risk NOT CLEAR, some hospitals had both
intervention and control physicians. The
100,000 annual inpatient admissions of In-
termountain Healthcare represent almost
one-half of Utah hospital admissions. In-
termountain Healthcare has an employed
physician group and several non-Medicare
healthmaintenance organisation insurance
plans, but many non-employed physicians
and non-health maintenance organisation
patients also utilise its facilities. Non-affili-
ated physicians caring for patients at Inter-
mountain Healthcare hospitals may have
been influenced by guideline implementa-
tion at these hospitals
Baseline characteristics similar? Unclear risk Not stated
Dempsey 1995
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients with clinical problem
CLINICAL PROBLEM: patients with nursing home-acquired pneumonia
SETTING: 1 hospital in the USA
Interventions FORMAT: no valid prescribing data. Audit and feedback; reminders; and educational
meetings with dissemination of educational materials
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: increase effective
Outcomes CLINICAL: Intended: length of stay
FINANCIAL: charge per case of nursing home-acquired pneumonia
Notes FINANCIAL SUPPORT: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
114Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Dempsey 1995 (Continued)
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk < 1 year data pre- and postintervention, so
seasonal trends cannot be excluded
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Patient administration system
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Patient administration system
Incomplete outcome data addressed (ITS)
?
Unclear risk No explicit statement about complete fol-
low-up
Free of selected reporting (ITS) ? Low risk
Free of other bias (ITS) ? Low risk
Ding 2013
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians
PARTICIPANTS: 78 patients with acute exacerbations of idiopathic pulmonary fibrosis
(39 intervention, 39 control)
CLINICAL PROBLEM: management of acute exacerbations
SETTING: 1 hospital in China
Interventions FORMAT, Interventions: structural - introductionof procalcitonin testingwith decision
support algorithm
Intervention Functions: enablement, environmental restructuring
DELIVERER: respiratory physicians
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: no information
Outcomes PRESCRIBING: Exposure:%participants treated and duration of antibiotic treatment
CLINICAL: Balancing: mortality, length of stay, duration of mechanical ventilation
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response to request from authors
Risk of bias
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Ding 2013 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated numbers
Allocation concealment (selection bias) Low risk Computer-generated numbers
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on all participants.
Selective reporting (reporting bias) Low risk Outcomes reported on all participants.
Other bias High risk No power calculation
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk Procalcitonin results only available for in-
tervention participants
Baseline characteristics similar? Low risk Table 1
Dranitsaris 2001
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: physicians assigned to the 7 services
PARTICIPANTS: 309 patients with clinical problem (162 intervention, 147 control)
CLINICAL PROBLEM: adult patients with infections requiring IV cefotaxime
SETTING: 2 hospitals in Canada
Interventions FORMAT: Interventions: educational outreach - review and recommend change
Intervention Functions: enablement, persuasion
DELIVERER: pharmacist
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 330 participants, 165 in each group. Details in
Appendix 3
Outcomes PRESCRIBING: Choice: percentage of cefotaxime prescriptions that were consistent
with guideline for both indication and dosage
SECONDARY: mean duration of therapy and cost per treatment course
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Dranitsaris 2001 (Continued)
Notes FINANCIAL SUPPORT: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomised on a one to one basis via a
computer generated list”
Allocation concealment (selection bias) Low risk Randomisations carried out in central
pharmacy and “telephone on a consecutive
basis”
Blinding (performance bias and detection
bias)
All outcomes
High risk Not done, acknowledged as a limitation by
authors on page 179
Incomplete outcome data (attrition bias)
All outcomes
Low risk See Table 3; all participants included
Selective reporting (reporting bias) Low risk See Table 3; all participants included
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? High risk Control participants were managed by the
same physicians as intervention partici-
pants
Baseline characteristics similar? Low risk Table 1
Dua 2014
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all physicians involved in vascular surgery
PARTICIPANTS: all patients undergoing vascular surgery
CLINICAL PROBLEM: surgical-site infection following vascular surgery
SETTING:USA,multiple hospitals (stratified, random sample of 20% of all non-federal
inpatient hospital admissions throughout the USA)
Interventions FORMAT: no valid prescribing data. Surgical Care Improvement Project core measures
with financial incentives implemented in 2006
DELIVERER: specialist phsicians
COMPARISON: usual care
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Dua 2014 (Continued)
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: no data
CLINICAL: inpatient surgical-site infection
Notes FINANCIAL SUPPORT: no funding. Competing Interests: none declared
ADDIDIONAL DATA: authors responded to request but had no additional relevant
data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk No data about antibiotic prescribing
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Unclear risk Outcome relied on ICD discharge coding
to identify surgical-site infection, may have
been influenced by financial incentives to
meet SCIP targets
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Electronic outcome data
Incomplete outcome data addressed (ITS)
?
High risk Outcome data were restricted to inpatient
coding, but most surgical-site infections
likely to present postdischarge
Free of selected reporting (ITS) ? Low risk Electronic outcome data
Free of other bias (ITS) ? Low risk > 1 year of pre- and postintervention data
Dull 2008
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians, pharmacists, and nurses in surgical department
PARTICIPANTS: all patients undergoing elective surgery
CLINICAL PROBLEM: choice, timing, and duration of antibiotic prophylaxis
SETTING: 7 hospitals in the USA
Interventions FORMAT: Interventions: audit and feedback; educational meetings with dissemination
of educational materials; educational outreach by academic detailing; reminders (physi-
cal, posters, intranet, and faxes to physicians)
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Dull 2008 (Continued)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure:% participants with prophylaxis discontinued within 24 h
of surgery
Notes FINANCIAL SUPPORT: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Electronic outcome data
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Electronic outcome data
Incomplete outcome data addressed (ITS)
?
Low risk Electronic outcome data
Free of selected reporting (ITS) ? Low risk Electronic outcome data
Free of other bias (ITS) ? High risk 10 months’ pre- and 12 months’ postinter-
vention data
Duvoisin 2014
Methods STUDY DESIGN: unintended consequences, cohort study
Risk of Bias: LOW
Participants PROVIDERS: all physicians
PARTICIPANTS: 222 infants with early-onset neonatal sepsis
CLINICAL PROBLEM: early onset sepsis
SETTING: 1 hospital in Switzerland
Interventions FORMAT, Interventions: restrictive by review and make change targeted at ordering of CBC and CRP tests
Intervention Functions: restriction
DELIVERER: specialist physician (ID)
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Duvoisin 2014 (Continued)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive use of diagnostic tests
Outcomes UNINTENDED CONSEQUENCES: time to first antibiotic dose and complications (requirement for cate-
cholamine treatment and/or mechanical ventilation, meningitis, or death)
Notes ROBINS-I RISK OF BIAS CRITERIA:
1. Confounding: Low, confounding unlikely
2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome
3. Measurement classification of interventions: Low, intervention status well defined, recorded at the time of inter-
vention and unaffected by knowledge of the outcome
4. Deviations from intended interventions: Low, the study demonstrated large reduction in CBC (30%) and CRP
(91%)
5. Missing data: Low, outcome data and intervention status complete on all 222 participants
6. Measurement of outcome: Low, outcome measure objective and unaffected by intervention status
7. Selection of the reported result: Low, reported outcomes predefined and measured from routine data
FINANCIAL SUPPORT: Funding: SICPA Foundation and the Société Académique Vaudoise. Competing Inter-
ests: none declared
ADDITIONAL DATA: email from authors with additional data about intervention
Elligsen 2012
Methods STUDY DESIGN: CITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the critical care team
PARTICIPANTS: all critical care patients in the hospital
CLINICAL PROBLEM: decrease use of broad-spectrum antibiotics in critical care pa-
tients
SETTING: 1 tertiary-care centre in Ontario, Canada
Interventions FORMAT: Interventions: educational outreach by review and recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of targeted broad-spectrum antibiotics (days of therapy/
1000 OBD)
Notes FINANCIAL SUPPORT: Funding: Canadian Institutes of Health Research, Ontario
Ministry of Health, and Long Term Care Academic Health Services Centre Innovation
Award. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
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Elligsen 2012 (Continued)
Intervention independent (ITS) ? Low risk Done. October to August both pre- and
postintervention
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Done, point of analysis was point of inter-
vention.
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
High risk No, the intervention was open to all partic-
ipants and prescribers, difficult to conceal
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, Figures 1 and 2
Free of other bias (ITS) ? Low risk Done, no other apparent biases
Esposito 2011
Methods STUDY DESIGN: RCT
Risk of Bias: MEDIUM
Participants PROVIDERS: all paediatric physicians
PARTICIPANTS: 319 children with pneumonia were enrolled and randomly assigned
1:1 to the treatment groups, but, as consent was withdrawn during the study in 9
cases (5 intervention and 4 control), the final analysis was based on 310 children (155
intervention and control)
CLINICAL PROBLEM: children hospitalised with community-acquired pneumonia
SETTING: 1 university hospital in Italy
Interventions FORMAT: Interventions: structural - rapid testing for procalcitonin and decision sup-
port algorithm
Intervention Functions: enablement, environmental restructuring
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 76 participants in each group. Details in Appendix 3
Outcomes PRESCRIBING: Exposure: % started on antibiotics and % children treated for > 10
days
CLINICAL: length of stay, duration of fever, antibiotic adverse effects
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Esposito 2011 (Continued)
Notes FINANCIAL SUPPORT: Funding: Italian Ministry of Health (Bando Giovani Ricer-
catori 2007). Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
Low risk PCT levels only reported on intervention
participants.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 319 randomised, consent was withdrawn
during the study in 9 cases (3% partici-
pants, 5 in the PCT group and 4 in the
control group). Outcomes reported on all
participants (Tables 2-3). All 310 children
came to the planned follow-up visits
Selective reporting (reporting bias) Low risk Outcomes reported on all 310 participants
(Tables 2-3). All 310 children came to the
planned follow-up visits
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk PCT levels only reported on intervention
participants.
Baseline characteristics similar? Low risk Table 1
Everitt 1990
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: physicians in Obstetrics & Gynaecology
PARTICIPANTS: patients (women) with clinical problem
CLINICAL PROBLEM: Caesarean section
SETTING: 1 university hospital in the USA
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Everitt 1990 (Continued)
Interventions FORMAT: Interventions: educational meetings with dissemination of guidelines; re-
minders (circumstantial, on the structured order form for intravenous antibiotics, which
was triggered for every order for IV antibiotics); restriction by expert approval and by
removal
Intervention Functions: education, enablement, environmental restructuring, restric-
tion
DELIVERER: department physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: relative use of cefazolin or cefoxitin in Caesarean sections that received
< 5 g of either drug perioperatively
FINANCIAL: estimated financial savings
Notes FINANCIAL SUPPORT: Funding: Beth Israel Hospital, Boston, Massachusetts and
Fund for Cooperative Innovation of Blue Cross of Massachusetts and the Massachusetts
Hospital Association. Competing Interests: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Only 9 months pre-intervention data, so
secular/seasonal changes possible
Analysed appropriately (ITS) ? Low risk Done in original paper, segmented regres-
sion analysis
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk Antibiotic costs adjusted to 1986 prices
over the whole study period
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Farinas 2012
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: 1185 patients receiving at least 3 days of IV antibiotics (571 inter-
vention, 614 control)
CLINICAL PROBLEM: adherence to recommendations for change of therapy
SETTING: 1 university hospital in Spain
Interventions FORMAT: no valid prescribing outcome data. Educational outreach (review and rec-
ommend change)
DELIVERER: specialist (ID) physicians
COMPARISON: usual care
DESIRED CHANGE: increase appropriate antibiotic treatment
SAMPLE SIZE: 571 intervention, 614 control
POWER CALCULATION: no power calculation. No adjustment for intracluster cor-
relation
Outcomes PRESCRIBING: Choice but no valid outcome data (% adherence with recommenda-
tions, but no data about antibiotic use in terms of choice, route, or duration of treatment)
CLINICAL: Balancing: length of stay and % treatment failure
Notes FINANCIAL SUPPORT: Funding: Fondo de Investigaciones Sanitarias (FIS PI06/
90094), and Instituto de Formación e Investigación Marqués de Valdecilla (IFIMAV)
(API 06/03). Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer
Allocation concealment (selection bias) High risk Randomisation stratified by clinical units,
not blinded. Participants were randomised
by groups (stratified randomisation by clin-
ical units) to intervention or non-interven-
tion using the EPIDAT 3.1 programme
(Dirección Xeral de Saúde Pública, Xunta
de Galicia & Organización Panamericana
de la Salud. Santiago de Compostela,
Coruña, Spain, 2003)
Blinding (performance bias and detection
bias)
All outcomes
High risk Randomisation not blinded
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Farinas 2012 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on all participants.
Selective reporting (reporting bias) Unclear risk The primary outcome (clinical failure) was
complex and not entirely objective
Other bias High risk Unit of analysis error, no adjustment for
intracluster correlation
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk 19 participants in the control group were
excluded because they had ID consultation
Baseline characteristics similar? Low risk Table 1
Fine 2003
Methods STUDY DESIGN: cluster RCT, service level
Risk of bias: HIGH
Participants PROVIDERS: all physicians in hospitals
PARTICIPANTS: 608 patients with community-acquired pneumonia (263 interven-
tion, 325 control), 7 clusters (sites)
CLINICAL PROBLEM: duration of IV antibiotic therapy and LOS
SETTING: 7 nonprofit hospitals in Pittsburgh, Pennsylvania, USA
Interventions FORMAT: Interventions: dissemination of educational materials, educational outreach
by review and recommend change; reminders (circumstantial, physical, detail sheets in
physician notes for patients with community-acquired pneumonia and verbal, telephone
calls); restrictive; structural
Intervention Functions: education, enablement, environmental restructuring, persua-
sion, restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 600 participants in total. Details in Appendix 3
Outcomes PRESCRIBING: Choice: duration of IV antibiotic therapy
CLINICAL: intended clinical outcomes, mortality, re-admission
Notes FINANCIAL SUPPORT: Funding: Agency for Healthcare Research and Quality and
the National Institute of Allergy and Infectious Diseases (HS08282), Robert Wood
Johnson Foundation. Competing Interests: no statement
ADDITIONAL DATA: authors provided additional data
Risk of bias
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Fine 2003 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Physician groups were randomly assigned
after stratification for practice type, group
size, and patient volume, but details not
clear
Allocation concealment (selection bias) High risk
Blinding (performance bias and detection
bias)
All outcomes
Low risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk
Selective reporting (reporting bias) Low risk
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data about LOS prior to intervention
Free of contamination? Low risk
Baseline characteristics similar? Low risk
Fitzpatrick 2008
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: prescribing of cefuroxime and quinolones
SETTING: 1 hospital in the UK
Interventions FORMAT: Interventions: dissemination of guideline
Intervention Functions: education
DELIVERER: pharmacist
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of cefuroxime and ciprofloxacin (DDD/Finished Consul-
tant Episode ratio)
Notes FINANCIAL SUPPORT: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
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Fitzpatrick 2008 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk Nomentionof any other changes, although
little information given
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Done. Intervention point was clear.
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done. Outcomes are objective.
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done. Figures 1 and 2
Free of other bias (ITS) ? Low risk Done. No other bias apparent.
Fowler 2007
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: physicians in the hospital
PARTICIPANTS: patients 80 years and older
CLINICAL PROBLEM: Clostridium difficile infection in the elderly
SETTING: 3 acute medical wards for the elderly in 1 university hospital in the UK
Interventions FORMAT: Interventions: audit and feedback, dissemination of guideline; reminders
(physical, laminated pocket version of guideline)
Intervention Functions: education, enablement, environmental restructuring
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: reduce inappropriate
Outcomes PRESCRIBING: Choice: monthly use of target antibiotics
MICROBIAL: monthly count of cases of CDI
Notes FINANCIAL SUPPORT: no funding. Competing Interests: none declared
ADDITIONAL DATA: email response from authors but no additional data
Microbial Risk of Bias LOW: Planned intervention: Low Case definition: Low, Na-
127Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fowler 2007 (Continued)
tional definition. Other infection control measures: Low
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Ongoing audit and feedback
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Done. Point of analysis is point of the in-
tervention.
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
High risk No, not possible
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems so
unlikely to be incomplete
Free of selected reporting (ITS) ? Low risk Done, Figures 3 and 4
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
Franz 2004
Methods STUDY DESIGN: RCT
Risk of Bias: MEDIUM
Participants PROVIDERS: physicians in neonatal units
PARTICIPANTS: 1291 neonates < 72 hours of age were randomised (656 intervention,
635 control)
CLINICAL PROBLEM: suspected bacterial infection
SETTING: 8 centres in 5 countries (Australia, Austria, Belgium, Germany, Sweden)
Interventions FORMAT, Interventions: dissemination of guideline; structural, introduction of testing
for C-reactive protein and interleukin-8 with decision support algorithm
Intervention Functions: education, enablement, environmental restructuring
DELIVERER: department physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, total of 1150 participants. Details in Appendix 3
Outcomes PRESCRIBING: Exposure: number of newborn infants who received antibiotic therapy
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Franz 2004 (Continued)
Notes FINANCIAL SUPPORT: Funding: grant P.575 from the Center for Applied Clinical
Studies of theUniversity of Ulm and Swedish Research Council. DPC (Los Angeles, CA)
provided the Immulite automated analysers and the kits for determination of IL-8 and
sponsored the initial meeting of the investigators. Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomly assigned to 1 or 2 diagnostic
algorithms using sealed opaque envelopes”
Allocation concealment (selection bias) Low risk
Blinding (performance bias and detection
bias)
All outcomes
Low risk Done, IL-8 results were only provided to
physicians in the intervention group
Incomplete outcome data (attrition bias)
All outcomes
Low risk
Selective reporting (reporting bias) Low risk
Other bias Low risk
Baseline Outcomes similar? High risk No data
Free of contamination? Low risk
Baseline characteristics similar? Low risk
Fraser 1997
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: medical, surgery, intensive care, haematology, and oncology
PARTICIPANTS: patients with the clinical problem
CLINICALPROBLEM: adult inpatients receiving 1 ormore of 10 designated parenteral
antibiotics for 3 or more consecutive days
SETTING: single teaching hospital in the USA
Interventions FORMAT: Interventions: educational outreach by review and recommend change; re-
minders (circumstantial, physical, written suggestions placed in the notes of participants
receiving IV antibiotics)
Intervention Functions: enablement, environmental restructuring, persuasion
DELIVERER: AMT
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Fraser 1997 (Continued)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
SAMPLE SIZE CALCULATION: no information
Outcomes PRESCRIBING: Choice: days receiving IV antibiotic therapy per participant, DDDs
of IV antibiotics per participant. Antibiotic charges (USD) per participant
CLINICAL: Balancing: clinical response at 3 days after completion of antibiotics; re-
treatment with antibiotics within 7 days; inpatient mortality; re-admission within 30
days of discharge
FINANCIAL: savings on drug costs in USD
Notes FINANCIALSUPPORT:Funding: commercial (Bayer Pharmaceuticals) and theMaine
Medical Center Research Committee. Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients randomised ... using an un-
blocked computer generated randomnum-
ber table”
Allocation concealment (selection bias) High risk Not possible; “The patient population was
assigned to 1 of 4 medical service groups
based on where they were treated at ran-
domizations”
Blinding (performance bias and detection
bias)
All outcomes
High risk Not possible
Incomplete outcome data (attrition bias)
All outcomes
Low risk For primary outcomes, not secondary
Selective reporting (reporting bias) Low risk Based onmicrobial response andother clin-
ical parameters
Other bias Low risk No problems noted.
Baseline Outcomes similar? Unclear risk No information about baseline outcomes
pretrial in the allocated groups
Free of contamination? High risk Doctors likely to have cared for participants
in all groups.
Baseline characteristics similar? Low risk Table 1
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Fridkin 2002
Methods STUDY DESIGN: CBA
Risk of Bias: HIGH
Participants PROVIDERS: a total of 50 ICUs located in 20 hospitals
PARTICIPANTS: patients in the ICU
CLINICAL PROBLEM: vancomycin use, prevalence of VRE
SETTING: hospitals in the USA participating in the ICU surveillance component of
National Nosocomial Infection Surveillance
Interventions FORMAT: 5 interventions were used by 3 to 19 hospitals (some hospitals used more
than 1). 3 interventions were hospital-wide and 2 were unit-specific
Hospital-wide interventions (22 ICUs)
Intervention 1: educational meetings with dissemination of educational materials, 9
ICUs. Intervention function: education.
Intervention 2: audit and feedback, 19 ICUs. Intervention function: enablement.
Intervention 3: restriction, 3 ICUs. Intervention function: restriction.
Unit-specific interventions (11 ICUs)
Intervention 4: educational meetings with dissemination of educational materials. In-
tervention function: education.
Intervention 5: restriction, 3 ICUs. Intervention function: restriction.
DELIVERER: AMT
COMPARISON: national benchmark data
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: DDDs of vancomycin
MICROBIAL: percentages of VRE and MRSA
Notes FINANCIAL SUPPORT: Funding: CDC Emerging Infections Program. Competing
Interests: no information
ADDITIONAL DATA: email response from authors but no additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk CBA - not randomised
Allocation concealment (selection bias) High risk CBA - not randomised
Blinding (performance bias and detection
bias)
All outcomes
High risk CBA, allocation not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Not clear: “Susceptibility reports from iso-
lates obtained as part of infection-control
surveillance were excluded.”Criteria for ex-
clusion of isolates are not described and
may not have been consistent across all hos-
pitals
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Fridkin 2002 (Continued)
Selective reporting (reporting bias) Low risk Not clear: “Susceptibility reports from iso-
lates obtained as part of infection-control
surveillance were excluded.”Criteria for ex-
clusion of isolates are not described and
could have led to reporting bias
Other bias Unclear risk NOT CLEAR Microbial Risk of Bias
Criteria: Case definition: percentage VRE
or percentage MRSA in clinical isolates;
Planned intervention: DONE; Other in-
fection control isolation: NOT CLEAR;
IC practices: NOT CLEARData were col-
lected about infection control changes in
response to feedback of data, but the paper
does not report any results
Baseline Outcomes similar? Unclear risk Not stated
Free of contamination? Low risk Interventions were at different hospitals
from control sites
Baseline characteristics similar? Unclear risk Not stated
Friedberg 2009
Methods STUDY DESIGN: unintended consequences, cohort study
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in EDs
PARTICIPANTS: 13,042 adult patients
CLINICAL PROBLEM: presenting with respiratory symptoms
SETTING: 385 hospitals in the USA
Interventions FORMAT, Interventions: audit and feedback, public reporting of antibiotic timing measure as 1 of 10 national
quality indicators; financial, institution incentive
Intervention Functions: enablement, incentive
DELIVERER: Hospital Quality Alliance
COMPARISON: usual care
DESIRED CHANGE: increase effective
Outcomes UNINTENDED CONSEQUENCES: rates of pneumonia diagnosis, antibiotic use, and waiting times to see a
physician
Notes ROBINS-I RISK OF BIAS CRITERIA:
1. Confounding: Unclear, analysis says it was adjusted for confounding of the effect of intervention but insufficient
detail
2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome
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Friedberg 2009 (Continued)
3. Measurement classification of interventions: Low, intervention status well defined, recorded at the time of inter-
vention and unaffected by knowledge of the outcome or risk of the outcome
4. Deviations from intended interventions: Low, no switches to other interventions or evidence of intervention failure
5. Missing data: Unclear, outcome data reported as % with no numerator/denominator (Table 2)
6. Measurement of outcome: High, the effect estimate is based on regression analysis of annual data for 3 years pre-
and 2 years postintervention (i.e. only 2 postintervention time points). The authors say that “based on the NHAMCS
sample, there were an estimated 40 million (95% confidence interval, 39 to 42 million) ED visits to hospitals by
adults with respiratory symptoms between 2001 and 2005.” In Table 1, around 10% of these patients had a diagnosis
of CAP, so they were not short of data! They should surely have split their data into more time points
7. Selection of the reported result: Low, single analysis of the intervention-outcome relationship
FINANCIAL SUPPORT:Funding: Primary Care Teaching and Education Fund (internal), Health Resources and
Services Administration, and Agency for Healthcare Research and Quality. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Fukuda 2014
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all adult inpatients receiving target antibiotics for 14 days or more
CLINICAL PROBLEM: de-escalation of treatment in patients who received carbapen-
ems, cephalosporins, or quinolones for at least 14 days
SETTING: 1 community hospital in Japan
Interventions FORMAT: Interventions: educational outreach by review and recommend change
Intervention Functions: enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive and decrease cost
Outcomes PRESCRIBING: Choice: cost of target antibiotics (USD/1000 OBD)
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcome data from pharmacy computer
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Fukuda 2014 (Continued)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Outcome data from pharmacy computer
Free of other bias (ITS) ? High risk Only 6 month pre-intervention data, so
cannot adjust for seasonal effects
Gerding 1985
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all prescribers in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: requiring aminoglycoside treatment
SETTING: 1 Veterans Administration hospital in the USA. UBA data about resistance
from 14 other similar hospitals
Interventions FORMAT: no valid prescribing data. Restrictive.
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes MICROBIAL: resistance to gentamicin and aminoglycoside use
Notes FINANCIAL SUPPORT: Funding: commercial, Bristol Laboratories and the Veterans
Administration. Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: MEDIUM, case definition Low, planned intervention Low,
other infection control Unclear, no information
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk Only 4 months’ pre-intervention data, so
secular/seasonal changes possible. No in-
formation about infection control mea-
sures
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of analyses was point of intervention.
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Gerding 1985 (Continued)
Unlikely to affect data collection (ITS) ? Low risk Routine data
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Routine data
Incomplete outcome data addressed (ITS)
?
Low risk Routine data
Free of selected reporting (ITS) ? Low risk Routine data
Free of other bias (ITS) ? Unclear risk NOT CLEARMicrobial Outcome Risk
of Bias: Planned intervention: DONE Im-
plementation in response to emergence of
gentamicin resistance over the previous 5
years; Case definition: DONE Infection
from clinical isolates; Other infection con-
trol measures: NOT CLEAR, no informa-
tion provided
Goldstein 2009
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians
PARTICIPANTS: all adult patients in the hospital
CLINICAL PROBLEM: patients requiring IV antibiotics
SETTING: 1 university hospital in the USA
Interventions FORMAT: Interventions: dissemination of formulary
Intervention Function: education
After 9 months there was an additional restrictive intervention (autosubstitution of
ampicillin sulbactam by ertapenem), but this was not targeted at imipenem use, and no
data are provided about prescribing or microbial outcomes for ampicillin sulbactam.
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: imipenem use in DDD
MICROBIAL: % susceptibility to imipenem in clinical isolates of Pseudomonas aerugi-
nosa
Notes FINANCIAL SUPPORT: Funding: commercial Merck (manufacturers of ertapenem).
Competing Interests: Ellie JC Goldstein is on the advisory boards of Merck, is in the
speakers’ bureau of Merck, and received research support from Merck; Shuang Lu is
employed byMerck Research Laboratories and may own stock or stock options. Anne R
Meibohm was formerly employed by Merck Research Laboratories and may own stock
or stock options
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Goldstein 2009 (Continued)
ADDITIONAL DATA: email response from authors to request for additional data
Microbial Risk of Bias LOW: case definition low risk, planned intervention low risk,
other infection control measures low risk, no change
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy and microbiology
computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy and microbiology
computers
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy and microbiology
computers
Free of selected reporting (ITS) ? Low risk Data from pharmacy and microbiology
computers
Free of other bias (ITS) ? High risk Only 6 months’ pre-intervention data for
intervention 1 and 9 months’ for interven-
tion 2
Grohs 2014
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians
PARTICIPANTS: all adult patients
CLINICAL PROBLEM: requiring treatment with IV 3rd-generation cephalosporin
SETTING: 1 university hospital in France
Interventions FORMAT: Intervention: distribution of antibiotic policy
Intervention Function: education
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: ceftriaxone use in DDD/1000 OBD
MICROBIAL: number of participants carrying high level AmpC beta-lactamase
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Grohs 2014 (Continued)
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: HIGH case definition low, planned intervention low, other
infection control measures unclear (no data)
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcome data from microbiology and
pharmacy computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome data from microbiology and
pharmacy computers
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data from microbiology and
pharmacy computers
Free of selected reporting (ITS) ? Low risk Outcome data from microbiology and
pharmacy computers
Free of other bias (ITS) ? High risk Short time series, annual data with only 5
pre- and 7 postintervention data points
Gulmezoglu 2007
Methods STUDY DESIGN: cluster RCT, hospital level
Risk of Bias: HIGH
Participants PROVIDERS: obstetric teams
PARTICIPANTS: 1000 consecutively delivered women in obstetric units, 40 clusters
(hospitals)
CLINICAL PROBLEM: women undergoing Caesarean section
SETTING: 22 hospitals in Mexico City and 18 in Thailand
Interventions FORMAT: Interventions: educational meetings and dissemination of brochures; re-
minders (physical, posters and brochures)
Intervention Functions: education, environmental restructuring, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: increase effective
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Gulmezoglu 2007 (Continued)
POWER CALCULATION: yes, 40 hospitals. Details in Appendix 3
Outcomes PRESCRIBING: Exposure: % women receiving antibiotic prophylaxis for Caesarean
section
Notes FINANCIAL SUPPORT: Funding: UNDP/UNFPA/WHO/World Bank Special Pro-
gramme of Research, Development and Research Training in Human Reproduction
(HRP).Competing Interests: 4 authors were editors of TheWHOReproductiveHealth
Library since its inception in 1997 to date of publication
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number generator used (detailed
in other article).
Allocation concealment (selection bias) Low risk Allocation by hospital
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No mention of this
Incomplete outcome data (attrition bias)
All outcomes
Low risk Field workers collected from hospital data
and were able to consult mothers for any
missing data
Selective reporting (reporting bias) Low risk Field workers collected from hospital data
and were able to consult mothers for any
missing data
Other bias High risk End of study in Thai control hospital was
conducted at a later stage due to other
healthcare-related activities going on
Baseline Outcomes similar? Unclear risk Appear to be different but unclear
Free of contamination? Low risk Allocation by hospital
Baseline characteristics similar? Unclear risk No data
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Gums 1999
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: a total of 272 patients
CLINICAL PROBLEM: patients receiving inappropriate antibiotic therapy judged on
culture results, risk of toxicity or drug interaction, drug cost, and duration of treatment
SETTING: single 275-bed community hospital in the USA
Interventions FORMAT: Interventions: educational outreach by review and recommend change; re-
minders (circumstantial and physical, placed in notes of patients who were receiving
antibiotics)
Intervention Functions: enablement, environmental restructuring, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: no justification provided for the sample size
Outcomes PRESCRIBING: Choice: cost of antibiotic therapy
CLINICAL: Balancing: length of stay
FINANCIAL: charges for antibiotics, laboratory and radiology services, total patient
charges. Implementation cost based on days per week required for Pharmacy and Infec-
tious Diseases staff
Notes FINANCIAL SUPPORT: no information
ADDITIONAL INFORMATION: no response from authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of sequence generation not clear;
“eligible patients were blindly randomised
to the intervention or control group”
Allocation concealment (selection bias) High risk Not possible to conceal allocation because
all intervention participants had a consul-
tation, whereas no control participants did
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear, despite objective primary out-
comemeasure (LOS), it is not clearly stated
that record linkage was without knowledge
of allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk No problems found, data were analysed
from 93% of randomised participants
Selective reporting (reporting bias) Low risk No problems found.
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Gums 1999 (Continued)
Other bias Low risk No other apparent biases found.
Baseline Outcomes similar? Low risk Done for primary outcome
Free of contamination? Low risk Participants were randomised to receive a
consultation from an ID specialist (inter-
vention) or no consultation (control), so no
contamination likely
Baseline characteristics similar? Low risk Done, Table 1 of the original paper
Gupta 1989
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: patients with clinical problem
CLINICAL PROBLEM: patients receiving cefazolin
SETTING: 1 university hospital in Canada
Interventions FORMAT: Interventions: dissemination of memo; reminders (physical, newsletter);
restrictive by review and make change
Intervention Functions: education, environmental restructuring, persuasion, restriction
DELIVERER: pharmacist
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice:% of cefazolin doses prescribed at < 8-hour intervals
Notes FINANCIAL SUPPORT: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Only 3 months’ pre-intervention data, so
secular/seasonal changes possible
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper,
2 test on mean before-after.
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
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Gupta 1989 (Continued)
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk No other apparent biases found.
Hadi 2008
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: residents in internal medicine department
PARTICIPANTS: patients with clinical problem
CLINICAL PROBLEM: antibiotics use in patients with a fever
SETTING: 5 wards in internal medicine department of teaching hospital in Indonesia
Interventions FORMAT: Interventions: educational meetings with dissemination of guidelines; ed-
ucational outreach by academic detailing; reminders (physical, pocket book version of
guideline)
Intervention Functions: education, environmental restructuring, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: reduce inappropriate
Outcomes PRESCRIBING:Exposure:%patients treated and total antibiotic consumption (DDD/
100 patient days)
Notes FINANCIAL SUPPORT: Funding: Royal Netherlands Academy of Arts and Sciences,
Scientific Programme Indonesia-Netherlands (SPIN). Competing Interests: no infor-
mation
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk No, seasonal variation
Analysed appropriately (ITS) ? Low risk Re-analysed
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Hadi 2008 (Continued)
Shape of effect pre-specified (ITS) ? Low risk Done, point of analysis is point of inter-
vention.
Unlikely to affect data collection (ITS) ? Low risk Done, data was collected by trained data
collectors.
Knowledge of the allocation adequately
prevented(ITS)?
High risk No, blinding was not possible.
Incomplete outcome data addressed (ITS)
?
Low risk Done, states they assured completeness of
data by collecting while patients were still
in the department
Free of selected reporting (ITS) ? Low risk Done, Figure 2
Free of other bias (ITS) ? Low risk Done, all biases addressed.
Halm 2004
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospitals
PARTICIPANTS: all patients with clinical problem
CLINICAL PROBLEM: adults with community-acquired pneumonia
SETTING: 4 university hospitals, New York, USA
Interventions FORMAT: Interventions: educational meetings with dissemination of guidelines; re-
minders (circumstantial and physical, on computer order system for antibiotics and
pocket version of guideline)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: percentage of patients treated with guideline-recommended
antibiotics
Notes FINANCIAL SUPPORT: Funding:Mount Sinai-New York University Health System,
the North Shore-Long Island Jewish Health System, and the Robert Wood Johnson
Foundation Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
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Halm 2004 (Continued)
Intervention independent (ITS) ? High risk NOT DONE, subjective outcome mea-
sure, not blinded
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after) with χ2 test.
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data collection same pre- andpostin-
tervention.
Knowledge of the allocation adequately
prevented(ITS)?
High risk NOT DONE, subjective outcome mea-
sure, not blinded
Incomplete outcome data addressed (ITS)
?
Unclear risk Not stated whether outcome data collected
on all participants
Free of selected reporting (ITS) ? Unclear risk Not stated whether outcome data collected
on all participants
Free of other bias (ITS) ? High risk NOT DONE, the only reliable data for
analysis are about compliance with the an-
tibiotic policy, which was 80% at baseline.
Serious risk of ceiling effect
Hess 1990
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: receiving cefazolin therapy
SETTING: a 719-bed tertiary-care medical centre in the USA
Interventions FORMAT: Interventions: dissemination of guideline; educational outreach by review
and recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: pharmacist
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: cefazolin expenditure per patient day
FINANCIAL: savings in drug costs
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Hess 1990 (Continued)
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk 12 months’ data pre- and postintervention
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper,
no statistical analysis, and only comparison
was between mean (uncontrolled) before
and after
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Unclear risk On page 588 the authors state that “a pro-
portion of these savings can be attributed
to a decrease in acquisition cost”, but they
do not say how much
Himmelberg 1991
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: physicians in the hospital
PARTICIPANTS: patients in the hospital
CLINICAL PROBLEM: patients receiving restricted antibiotics
SETTING: a tertiary-care teaching hospital in the USA
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Himmelberg 1991 (Continued)
Interventions FORMAT: Interventions: restrictive, removal of restriction
Intervention Functions: restriction
DELIVERER: specialist physician
COMPARISON: 6 months in the restriction period were compared with 6 months after
restriction was lifted.
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: number of courses and cost of restricted drugs
FINANCIAL: cost of drugs
Notes FINANCIAL SUPPORT:Funding: commercial, Pfizer Roerig and the Upjohn compa-
nies. Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Data collected in same months in 2 con-
secutive years.
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after) with t-test
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk No other apparent biases found.
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Hitti 2012
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the ED
PARTICIPANTS: all patients with sepsis in the ED
CLINICAL PROBLEM: sepsis
SETTING: 1 hospital in Beirut, Lebanon
Interventions FORMAT, Interventions: structural
Intervention Functions: environmental restructuring, antibiotics required for sepsis
treatment were stored in an Automated Dispensing Cabinet in the ED instead of having
to be ordered from pharmacy
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: time to first antibiotic dose in minutes measured both from
arrival in the ED and from ordering the antibiotic
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention is point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Retrospective data collection using the
same methods throughout
Knowledge of the allocation adequately
prevented(ITS)?
High risk Data were collected from case records, and
allocation was not concealed
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data reported on all 110 included
participants.
Free of selected reporting (ITS) ? Low risk Exclusion rates similar pre- (13/69) and
post- (11/65) intervention
Free of other bias (ITS) ? High risk Data only collected for 7months pre- and 8
months postintervention, so secular trends
possible
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Hochreiter 2009
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in ICU
PARTICIPANTS: all patients with the clinical problem
CLINICAL PROBLEM: duration of antibiotic therapy in 110 patients with suspected
bacterial infections (57 intervention, 53 control)
SETTING: surgical intensive care ward in 1 hospital in Germany
Interventions FORMAT, Interventions: reminders (circumstantial and physical, procalcitonin-based
decision support algorithm); structural (introduction of procalcitonin testing)
Intervention Functions: enablement, environmental restructuring, persuasion
DELIVERER: department (ICU) physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: no information provided
Outcomes PRESCRIBING: Exposure: duration of all antibiotic therapy in days
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: SS has served as con-
sultant and received payments from B.R.A.H.M.S AG for speaking engagements. All
other authors declare no conflicts of interest
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No explanation of randomisation process
Allocation concealment (selection bias) Unclear risk Details of allocation process not provided.
Blinding (performance bias and detection
bias)
All outcomes
High risk Open trial
Incomplete outcome data (attrition bias)
All outcomes
Low risk Done, Table 1 and text regarding excluded
patients
Selective reporting (reporting bias) Unclear risk No explicit statement, so selective outcome
reporting is possible
Other bias Low risk Done, all biases addressed.
Baseline Outcomes similar? Unclear risk No baseline outcome measurement
Free of contamination? Low risk Done, procalcitonin results not available
for controls.
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Hochreiter 2009 (Continued)
Baseline characteristics similar? Low risk Done, mainly similar (IC days slightly dif-
ferent)
Huber 1982
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in hospital
CLINICAL PROBLEM: appropriateness of inpatient prescribing of cephalexin
SETTING: 1 university hospital in the USA
Interventions FORMAT, Interventions: restrictive by expert approval and removal
Intervention Functions: restriction
DELIVERER: pharmacists
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: cephalexin dosing units
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk > 2 years’ data pre- and postintervention
Analysed appropriately (ITS) ? Low risk Re-analysed.Not done in original paper: no
statistical analysis of time series, presented
as chart
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
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Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk No other apparent biases found.
Hulgan 2004
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: physicians in the hospital
PATIENTS: all patients with clinical problem
CLINICAL PROBLEM: use of IV and oral quinolones
SETTING: university hospital in the USA
Interventions FORMAT, Interventions: reminders (circumstantial and physical, computerised deci-
sion support system integrated into an existing provider order entry system)
Intervention Functions: enablement, environmental restructuring, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive use of IV quinolones
Outcomes PRESCRIBING: Choice: number of orders for oral quinolone
FINANCIAL: savings on drug costs in USD
Notes FINANCIAL SUPPORT: Funding: NIH Training Grant T32 AI 07474-08 and Van-
derbilt Clinical Research Scholar Award K12 RR17697 (TH). Competing Interests:
DAT and RAM receive authorship royalties through Vanderbilt University from the
commercial distribution of WizOrder. STR has received consulting fees fromMcKesson
Information Solutions, which has licensedWizOrder for commercial distribution. None
of the other authors has related disclosures or potential conflicts of interest
ADDITIONAL DATA: email response from authors with additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Objective outcome measure
Analysed appropriately (ITS) ? Low risk Done in original paper: segmented regres-
sion analysis
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was increase in pri-
mary outcome, and point of analysis was
point of intervention
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Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk 1 year of data pre- and postintervention
Free of other bias (ITS) ? Low risk Objective primary outcome, cost analysis
adjusted to 2003 prices
Inaraja 1986
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients receiving antibiotics
CLINICAL PROBLEM: patients receiving antibiotics
SETTING: 1 447-bed university hospital in Spain
Interventions Interventions: educational outreach by review and recommend change; restrictive an-
tibiotic policy but mode of restriction not clear
Intervention Functions: enablement, persuasion, restriction
DELIVERER: pharmacist
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: cephalosporin use measured with costs as a percentage of
cephalosporins plus penicillins plus aminoglycosides
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk Only 12 months’ data (9 months’ pre-
and 3months’ postintervention), so cannot
control for seasonal effects
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
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after)
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk No other apparent biases found.
Jensen 2011
Methods STUDY DESIGN: RCT
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in ICUs
PARTICIPANTS: All adult patients in ICUs for > 24 hrs
CLINICAL PROBLEM: suspected sepsis
SETTING: 9 multidisciplinary ICUs across Denmark
Interventions FORMAT:Interventions: reminders (circumstantial and physical, drug-escalation algo-
rithm and intensified diagnostics based on daily procalcitonin measurements); structural
(rapid procalcitonin testing)
Intervention Functions: enablement, environmental restructuring, persuasion
DELIVERER: deparmental physicians (ICU)
COMPARISON: usual care
DESIRED CHANGE: increase effective
SAMPLE SIZE: yes, total 1200 participants. Details in Appendix 3
1200 participants were randomised and included in the analysis
Outcomes PRESCRIBING:Choice: time to first antibiotic dose; number (%) ICU days spent with
at least 3 antibiotics
CLINICAL: intended 28-day mortality; unintended (balancing) days in ICU; relative
risk of renal impairment
Notes FINANCIAL SUPPORT: Funding: Danish State, the Lundbeck Foundation, the Toy-
ota Foundation, the A.P. Møller Foundation, the Horboe Foundation, and the Capitol
Region of Denmark. Competing Interests: Dr. Jensen received speaker fee and travel
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reimbursement from B.R.A.H.M.S Diagnostica and an unrestricted grant from the or-
ganisation for sample transport and analysis. The remaining authors have not disclosed
any potential conflicts of interest
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation was performed 1:1 using
a computerised algorithm created by the
database manager
Allocation concealment (selection bias) Low risk Investigators were masked to assignment
before randomisation. Concealed block
size, pre-stratified for site of recruitment,
initial Acute Physiology and Chronic
Health Evaluation, and age (entered in an
encrypted screening form in a password-
protected website)
Blinding (performance bias and detection
bias)
All outcomes
Low risk Investigators, treating physicians, and the
co-ordinator were unaware of outcomes
during the study
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on all randomised par-
ticipants.
Selective reporting (reporting bias) Low risk Outcomes reported on all randomised par-
ticipants.
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk PCT measures only reported for interven-
tion participants.
Baseline characteristics similar? Low risk Table 1
Jobson 2015
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians and nurses in the paediatric ED
PARTICIPANTS: all children with central lines
CLINICAL PROBLEM: time to first antibiotic dose in children with fever
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SETTING: 1 university hospital in the USA
Interventions FORMAT: Interventions: audit and feedback at individual and group level; educational
meetings, dissemination of educational materials; educational outreach by academic
detailing at individual and group level; reminders (circumstantial (on electronic health
record), physical (cards attached to computers, weekly email newsletter), and verbal);
structural (placing antibiotics in front-line Pyxis stock)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: departmental physicians
COMPARISON: usual care
DESIRED CHANGE: increase effective
Outcomes PRESCRIBING: Choice: % of participants receiving first antibiotic dose within 60
minutes
Notes FINANCIAL SUPPORT: Funding: no external. Competing Interests: none declared
ADDITIONAL DATA: authors provided additional data about intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Statistical process control chart
Shape of effect pre-specified (ITS) ? Low risk Point of analysis was point of intervention.
Unlikely to affect data collection (ITS) ? Low risk Primary outcome was time to first antibi-
otic dose from patient administration sys-
tem
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Primary outcome was time to first antibi-
otic dose from patient administration sys-
tem
Incomplete outcome data addressed (ITS)
?
Low risk Primary outcome was time to first antibi-
otic dose from patient administration sys-
tem
Free of selected reporting (ITS) ? Low risk Primary outcome was time to first antibi-
otic dose from patient administration sys-
tem
Free of other bias (ITS) ? High risk Only 8 months’ pre-intervention data, so
seasonal effects cannot be excluded
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Jump 2012
Methods STUDY DESIGN: CITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians and nurses in the hospitals
PARTICIPANTS: all patients in the hospitals
CLINICAL PROBLEM: patients requiring antibiotics or with suspected Clostridium
difficile infection
SETTING: 1 long-term care facility (intervention) and 1 hospital (control) in the USA
Interventions FORMAT: Interventions: audit and feedback; educational outreach by review and rec-
ommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure: days of therapy with all antibiotics/1000 OBD
MICROBIAL: +ve C difficile tests per 1000 OBD
Notes FINANCIAL SUPPORT: Funding: National Institutes of Health (grants R03-
AG040722 to RLPJ, K23-DK087919 to PED, and R01-AI063517 to RAB), Veterans
Affairs Merit Review Program, Veterans Integrated Service Network 10 Geriatric Re-
search Education and Clinical Center (VISN 10 GRECC). Competing Interests: RLPJ
reports that she has consulted for GOJO and Pfizer and has received grant support Vi-
roPharma. RAB reports that he has consulted for AstraZeneca and has received grant
support from AstraZeneca, Ribx, Pfizer, and Steris. CJD reports that he has consulted for
BioK, Optimer, and GOJO and has received grant support from ViroPharma, Merck,
and Pfizer. All other authors report no conflicts of interest
ADDITIONAL DATA: email with additional data; further information about the in-
tervention is given in Jump 2013.
Microbial Risk of Bias: HIGH. Case definition low; Planned intervention low; Other
infection control high, no data about infection control other than that the intervention
also increased isolation of participants with C difficile infection. Moreover, the interven-
tion discouraged repeat testing of participants with known C difficile infection, which
may have biased the microbial outcome.
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcome data from pharmacy and micro-
biology computers
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Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome data from pharmacy and micro-
biology computers
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data from pharmacy and micro-
biology computers
Free of selected reporting (ITS) ? Low risk Outcome data from pharmacy and micro-
biology computers
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
Kallen 2009
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients requiring therapeutic antibiotics
SETTING: 1 community hospital in the USA
Interventions FORMAT: Intervention: restrictive by removal from all wards
Intervention Function: restriction
DELIVERER: AMT
COMPARISON: usual care
DESIREDCHANGE: decrease use of fluoroquinolones in order to contain an outbreak
of Clostridium difficile infection
Outcomes PRESCRIBING: Choice: use of fluoroquinolones, DDD/100 OBD
MICROBIAL: C difficile infections
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
Microbial Risk of Bias: HIGH, case definition yes, planned intervention no (part of
response to outbreak), other infection control measures no (several important changes
made at the same time as prescribing intervention)
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk No, as this was during an outbreak
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of analysis was point of intervention.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy computer
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Kallen 2009 (Continued)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Data from pharmacy computer
Free of other bias (ITS) ? High risk < 1 year data postintervention, fluoro-
quinolones reintroduced
Kanwar 2007
Methods STUDY DESIGN: unintended consequences, cohort study
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the ED
PARTICIPANTS: 518 adult patients
CLINICAL PROBLEM: hospital admission diagnosis of CAP
SETTING: 1 hospital in the USA
Interventions FORMAT, Interventions: audit and feedback; financial, institution incentive
Intervention Functions: enablement, incentive
DELIVERER: Blue Cross-Blue Shield of Michigan incentive program
COMPARISON: usual care
DESIRED CHANGE: increase effective
Outcomes UNINTENDED CONSEQUENCES: confirmation of admission diagnosis by chest X-ray, mean antibiotic admin-
istration per patient admitted with CAP
Notes NRSI RISK OF BIAS CRITERIA:
1. Confounding: Low, confounding of the effect of intervention unlikely in this study
2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome
3. Measurement class of interventions: Low, intervention status well defined, recorded at the time of intervention
and unaffected by knowledge of the outcome or risk of the outcome
4. Departures from intended interventions: Low, no switches to other interventions or evidence of intervention failure
5. Missing data: Low, outcome data and intervention status reported on all 518 patients
6. Measurement of outcome: Low, outcome measure objective and measured from patient administration system
7. Selection of the reported result: Low, single, prespecified analysis of the intervention-outcome relationship
FINANCIAL SUPPORT: Funding, none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
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Kerremans 2008
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: 1498 patients with bacterial infections (746 intervention, 752 con-
trol)
CLINICAL PROBLEM: antibiotic use in adult patients with bacterial infections
SETTING: 1 university hospital in the Netherlands
Interventions FORMAT: Intervention: structural (rapid microbiology laboratory testing)
Intervention Functions: environmental restructuring
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 1500 participants in total. Details in Appendix 3
Outcomes PRESCRIBING: Exposure: total antibiotic use (average DDDs per patient)
CLINICAL: Intended: mortality
Notes FINANCIAL SUPPORT: Funding: Dutch Association of University Hospitals (‘VAZ-
Doelmatigheidproject’ no. 99207). bioMerieux provided additional funding through an
unrestricted grant. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Done, computer-generated randomisation
Allocation concealment (selection bias) High risk No, states concealment was impossible.
Blinding (performance bias and detection
bias)
All outcomes
High risk No formal blinding attempted.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Done, Figure 1
Selective reporting (reporting bias) Low risk Done, all outcomes reported.
Other bias Low risk No other apparent issues
Baseline Outcomes similar? Unclear risk No baseline measurement of outcome
Free of contamination? Low risk Done
Baseline characteristics similar? Low risk Done, Table 1
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Kerremans 2009
Methods STUDY DESIGN: RCT
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: 211 patients with positive blood cultures (93 intervention, 108 con-
trol)
CLINICAL PROBLEM: antibiotic use in adult patients with bacterial infections
SETTING: 1 tertiary-care university medical centre in the Netherlands
Interventions FORMAT: Intervention: structural - other (out-of-hours blood culture incubator in-
tended to reduce laboratory turnaround time)
Intervention Function: environmental restructuring
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: increase effective
POWER CALCULATION: no information. In the Discussion, the authors say “our
sample size was too small to study the impacts of time to positivity (Gram stain), iden-
tification, and susceptibility testing separately on outcome”
Outcomes PRESCRIBING: Choice: time to first antibiotic regimen change
CLINICAL: Intended: mortality and length of stay
Notes FINANCIAL SUPPORT: Funding: Becton Dickinson provided the outside BACTEC
incubator used in this study. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated list by independent
epidemiologist
Allocation concealment (selection bias) High risk Allocation not concealed
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 episode of missing data in each arm of
study
Selective reporting (reporting bias) Low risk Complete outcomes reported.
Other bias Low risk
Baseline Outcomes similar? Low risk States no significant differences at baseline.
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Free of contamination? Low risk Rapid reporting only occurred for interven-
tion participants.
Baseline characteristics similar? Low risk States no significant differences at baseline.
Khan 2003
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: all patients in hospital
CLINICAL PROBLEM: Clostridium difficile-associated diarrhoea
SETTING: an 800-bed non-teaching hospital in the UK
Interventions FORMAT: no valid prescribing data. Restriction with educational meetings and dissem-
ination of guideline
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes MICROBIAL: incidence of C difficile-associated diarrhoea
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk > 1 year data in each of the 3 phases
Analysed appropriately (ITS) ? Low risk Re-analysed.Not done in original paper: no
statistical analysis, mean cases per quarter
compared between periods
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
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Khan 2003 (Continued)
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done: “The standard operating procedure
for selection and processing stool speci-
mens did not change over the study period.
All stool specimens from inpatients with
liquid or bloody diarrhoea and those receiv-
ing antibiotic therapywere tested forC. dif-
ficile toxin. C. difficile toxin was detected
by cytotoxic activity on afibroblast cell line,
with specific neutralization by Clostridium
sordelli antiserum”
Free of other bias (ITS) ? High risk NOTDONE for the intervention that was
intended to reduce C difficile infection in
Phase 3Microbial Outcome Risk of Bias:
Planned intervention: NOT DONE for
unplanned intervention Phase 3 Case defi-
nition:DONECdifficile infection; all stool
specimens from inpatients with liquid or
bloody diarrhoea and those receiving an-
tibiotic therapy were tested for C difficile
toxin. Other infection control measures:
DONE, well described and same in all 3
phases
Kim 2008
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients receiving therapeutic antibiotics
CLINICAL PROBLEM: outbreak of ESBL infections
SETTING: 1 hospital in Korea
Interventions FORMAT: Interventions: audit and feedback; restrictive by expert approval
Intervention Functions: enablement, restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive, use of cephalosporins to contain outbreak of
ESBL
Outcomes PRESCRIBING: use of cephalosporins (DDD/1000 OBD)
MICROBIAL: isolates of ESBL and new patients with ESBL infection
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Kim 2008 (Continued)
Notes FINANCIAL SUPPORT: Funding: City of Seoul grant #10920 and KICOS project
grant (Battelle Institute, Korea University). Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias HIGH. Case definition Low, planned intervention High (re-
sponse to outbreak of ESBL), other infection control Unclear (no detail, and authors
state that they did not take this into account in their analysis)
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Not in original paper but re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of analysis was point of intervention.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy and microbiology
computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy and microbiology
computers
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy and microbiology
computers
Free of selected reporting (ITS) ? Low risk Data from pharmacy and microbiology
computers
Free of other bias (ITS) ? Low risk
Knudsen 2014
Methods STUDY DESIGN: CITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians, nurses, and pharmacists in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: the intervention was intended to reduce infections caused by
ESBL- and AmpC-producing gram-negative bacteria
SETTING: 1 university hospital (intervention) and 4 additional hospitals (control) in
Denmark
Interventions FORMAT: Interventions: audit and feedback; educational meetings; dissemination of
guidelines; educational outreach by review and recommend change; reminders (physi-
cal, intranet and pocket guidelines; circumstantial, verbal by pharmacy technicians and
infection control nurses)
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Knudsen 2014 (Continued)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
The intervention also included the same components targeted at infection control mea-
sures (hand hygiene and isolation).
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: cefuroxime use in DDD/1000 OBD
MICROBIAL: cases per 1000 OBD per month
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: the authors provided multiple additional files of information
about the intervention, including examples of the feedback newsletters (in Danish)
Microbial Risk of Bias: LOW, case definition low, planned intervention low, other
infection control measures low
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk The antimicrobial stewardship interven-
tion was simultaneous with an intervention
to improve infection control practice (per-
sonal protection and isolation)
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcome data from pharmacy and micro-
biology computuers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome data from pharmacy and micro-
biology computuers
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data from pharmacy and micro-
biology computuers
Free of selected reporting (ITS) ? Low risk Outcome data from pharmacy and micro-
biology computuers
Free of other bias (ITS) ? Low risk > 1 year of data pre- and postintervention.
Microbial risk of bias low
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Kristoffersen 2009
Methods STUDY DESIGN: RCT
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: 210 patients with suspected lower respiratory tract infection (103
intervention, 107 control)
CLINICAL PROBLEM: antibiotic consumption and length of stay in patients with
suspected lower respiratory tract infections
SETTING: 3 hospitals in Denmark
Interventions FORMAT: Interventions: dissemination of guideline; reminders (circumstantial and
physical, decision support algorithm triggered by PCT test result); structural, introduc-
tion of PCT testing
Intervention Functions: education, enablement, environmental restructuring
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 107 participants in each group. Details in Appendix 3
Outcomes PRESCRIBING:Choice and exposure: antibiotics prescribed andduration of antibiotic
treatment
CLINICAL: Balancing: length of stay and mortality
Notes FINANCIAL SUPPORT: Funding: Danish Medical Research Council and the Danish
Lung Association Study ID: NCT00415753, 271-05-0765. Competing Interests: none
declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Concealed until PCT test results available
Blinding (performance bias and detection
bias)
All outcomes
Low risk Objective outcome measure: length of stay
from routine data system
Incomplete outcome data (attrition bias)
All outcomes
Low risk States that 3 patients died, 2 in PCT and 1
in control
Selective reporting (reporting bias) Low risk Objective outcome measure: length of stay
from routine data system
Other bias Low risk Adequately powered
163Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kristoffersen 2009 (Continued)
Baseline Outcomes similar? Unclear risk No beseline outcome measures
Free of contamination? Low risk PCT results only available for intervention
participants.
Baseline characteristics similar? Low risk Mostly similar apart from those with cancer
(7 in PCT and 0 in control), although this
was adjusted for using sensitivity analysis
Kritchevsky 2008
Methods STUDY DESIGN: cluster RCT, hospital level
Risk of Bias: MEDIUM
Participants PROVIDERS: physicians responsible for antimicrobial prophylaxis
PARTICIPANTS: patients undergoing cardiac surgery, hip and knee replacements, and
hysterectomy, 44 clusters (hospitals)
CLINICAL PROBLEM: Preoperative antimicrobial prophylaxis
SETTING: 44 acute care hospitals in the USA
Interventions FORMAT: Interventions: educational meetings with dissemination of guideline; edu-
cational outreach by academic detailing
Intervention Functions: education, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: increase effective
POWER CALCULATION: yes, 40 hospitals sampling 100 cases per measurement pe-
riod. Details in Appendix 3
Outcomes PRESCRIBING: Choice and exposure: 5 performance measures of antimicrobial pro-
phylaxis (timing, receipt, duration, selection, and single preoperative dose)
Notes FINANCIAL SUPPORT: Funding: grant R01 HS11331-01A1 from the Agency for
Healthcare Research andQuality and Centers for Disease Control and Prevention.Com-
peting Interests: none declared
ADDITIONAL DATA: authors provided additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised random number generator
Allocation concealment (selection bias) Low risk By institution
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Kritchevsky 2008 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Does not say if it was blinded or not
Incomplete outcome data (attrition bias)
All outcomes
Low risk Trained data collectors, completeness as-
sured by project staff
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias High risk High risk of selection bias, as hospitals
nominated themselves to be included into
the study
Baseline Outcomes similar? Low risk See Table 3
Free of contamination? Low risk By institution
Baseline characteristics similar? Low risk See Table 2
Kumana 2001
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PATIENTS: all patients in the hospital
CLINICAL PROBLEM: patients receiving glycopeptides (teicoplanin or vancomycin)
SETTING: 1 hospital in Hong Kong
Interventions FORMAT: Interventions: audit and feedback; educational meetings with dissemination
of guidelines
Intervention Functions: education, enablement
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: DDD per month of glycopeptides
CLINICAL: Balancing: cohort study of patients who died following Staphylococcus
aureus bacteraemia
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
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Kumana 2001 (Continued)
Intervention independent (ITS) ? Low risk Done, 32 months’ pre- and 11 months’
postintervention, so secular or seasonal ef-
fects unlikely
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparison of means (uncontrolled before
and after) with χ2 test.
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk 11 months’ postintervention data, 32
months’ pre-intervention data
Free of other bias (ITS) ? Low risk Reliable primary outcome
Lacroix 2014
Methods STUDY DESIGN: RCT
Risk of Bias: MEDIUM
Participants PROVIDERS: 30 physicians
PARTICIPANTS: 271 children with fever (131 intervention, 140 control)
CLINICAL PROBLEM: fever without source
SETTING: 1 university hospital in Switzerland
Interventions FORMAT: Interventions: reminders (circumstantial and physical, decision support lab
score derived from PCT, C-reactive protein, and urine dipstick); structural, introduction
of PCT testing
Intervention Functions: enablement, environmental lab score derived from PCT, C-
reactive protein, and urine dipstick
DELIVERER: departmental physicians
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWERCALCULATION: yes, 140 participants taking into account dropouts. Details
in Appendix 3
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Lacroix 2014 (Continued)
Outcomes PRESCRIBING: Exposure:% patients receiving antibiotics
CLINICAL: re-admission and time to clinical resolution
Notes FINANCIAL SUPPORT: Funding: commercial, bioMérieux for data management, sta-
tistical analysis, and loan of the procalcitonin assay.Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Excel-generated random numbers table
Allocation concealment (selection bias) Low risk Sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
Low risk Outcome measured from routine data.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Incomplete outcome data on 3 of 134 con-
trol and 4 of 140 intervention children
Selective reporting (reporting bias) Low risk Outcomes reported on all remaining chil-
dren.
Other bias Low risk The trial ended after completion of a suf-
ficient number of children at the expected
timing
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk No lab score released for control children.
Baseline characteristics similar? Low risk Table 2
Lafaurie 2012
Methods STUDY DESIGN: CITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients receiving antibiotics
CLINICAL PROBLEM: use of fluoroquinolones
SETTING: 1 university hospital in France (intervention) with control data from 700
hospitals in the Coordinating Centres for Nosocomial Infection Control
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Lafaurie 2012 (Continued)
Interventions FORMAT: Interventions: audit and feedback; educational meeting with dissemination
of guideline; educational outreach by review and recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: fluoroquinolone use in DDD/1000 OBD
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: HIGH, case definition Low, planned intervention Low, other
infection control High, increase in use of alcohol-based handrub throughout study
period
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Low risk for prescribing outcome
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of anaysis.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy and microbiology
computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy and microbiology
computers
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy and microbiology
computers
Free of selected reporting (ITS) ? Low risk Data from pharmacy and microbiology
computers
Free of other bias (ITS) ? Low risk > 1 year of data pre- and postintervention
Landgren 1988
Methods STUDY DESIGN: CBA
Risk of Bias: HIGH
Participants PROVIDERS: all surgeons at the hospitals
PARTICIPANTS: all patients with clinical problem
CLINICAL PROBLEM: patients receiving surgical antibiotic prophylaxis
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Landgren 1988 (Continued)
SETTING: 12 hospitals in Australia
Interventions FORMAT: Interventions: audit and feedback; educational meetings with dissemination
of guidelines; educational outreach by academic detailing; reminders (physical, posters)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: pharmacist
COMPARISON: 6 hospitals were used as control in year 1, then intervention and
control hospitals were crossed over in year 2
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING:Choice and exposure: appropriate duration and timing of prophylaxis
FINANCIAL: drug cost savings in AUD
Notes FINANCIAL SUPPORT: Funding: Commonwealth Department of Health. Compet-
ing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk CBA; “hospitalswere paired beingmatched
as far as possible for type size and surgical
load”
Allocation concealment (selection bias) High risk Not done, CBA
Blinding (performance bias and detection
bias)
All outcomes
High risk Not stated; all hospitals in same Australian
state, CBA so not possible
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No statement
Selective reporting (reporting bias) Low risk Objective primary outcome measure on all
patients
Other bias Low risk No other apparent biases found.
Baseline Outcomes similar? Low risk Done, pre-intervention data for primary
outcome similar in intervention and con-
trol hospitals
Free of contamination? Low risk Intervention and control sites were differ-
ent hospitals.
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Landgren 1988 (Continued)
Baseline characteristics similar? Unclear risk Only information is about characteristics
of hospital (teaching, rural, etc.), no data
about case mix and unlikely to change over
study period
Landman 1999
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients requiring antibiotic treatment
SETTING: university hospital in the USA
Interventions FORMAT: no valid prescribing outcome data. Restriction.
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes MICROBIAL: Incidence (new cases per 1000 discharges per month) of ceftazidime-
resistant Klebsiella pneumoniae, MRSA, and cefotaxime-resistant Acinetobacter species
(ITS data)
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias MEDIUM: case definition: Low; planned intervention: Low;
infection control practices: High. At the start of the intervention, contact precautions
were changed to include patients with Clostridium difficile infection.
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Reliable primary outcome
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after) with t-test
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
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Landman 1999 (Continued)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Unclear risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Unclear risk Not clear, no information about protocols
for clinical sampling or testing
Free of other bias (ITS) ? High risk Change in infection control practices at
start of intervention
LaRosa 2007
Methods STUDY DESIGN: unintended consequences, cross-sectional and cohort study
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: 15,440 patients (cross-sectional) and 360 patients (cohort)
CLINICAL PROBLEM: receiving restricted antibiotics
SETTING: 1 hospital in the USA
Interventions FORMAT, Interventions: restrictive by prior approval
Intervention Functions: restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes UNINTENDED CONSEQUENCES: delay in ordering of restricted antibiotics
Notes ROBINS-I RISK OF BIAS CRITERIA:
1. Confounding: Low, confounding of the effect of intervention unlikely in this study
2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome
3. Measurement of interventions: Low, intervention status well defined, recorded at the time of intervention and
unaffected by knowledge of the outcome or risk of the outcome
4. Departures from intended interventions: Low, no switches to other interventions or evidence of intervention failure
5. Missing data: Low, outcome data and intervention status complete for both cross-sectional and cohort study
6. Measurement of outcome: Low, outcome measures objective and ascertained from patient administration system
7. Selection of the reported result: Low, single analysis of prespecified outcomes
FINANCIAL SUPPORT: Funding: Centers for Education and Research on Therapeutics grant (U18-HS10399)
from the Agency for Healthcare Research and Quality (AHRQ), the Mentored Patient-Oriented Research Career
Development Award (K23-AI-060887-01) of theNIH from theNational Institute of Allergy and Infectious Diseases,
Public Health Service grant (DK-02987-01) of the NIH, and an Improving Patient Safety Through Reduction in
Medication Errors grant (P01-HS11530-01) from the AHRQ
Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
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Lautenbach 2003
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians at the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: requiring antibiotic treatment
SETTING: 1 university hospital in the USA
Interventions FORMAT: Intervention: restrictive by expert approval, not clear if therewas also removal
Intervention Functions: restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: vancomycin use in DDD per 1000 patient days
MICROBIAL: proportion of enterococci resistant to vancomycin
Notes FINANCIAL SUPPORT: Funding: Public Health Service (grant DK-02987-01) of
the National Institutes of Health (to EL). This study was also supported in part by
an Agency for Healthcare Research and Quality Centers for Education and Research
on Therapeutics co-operative agreement (U18-HS10399). Competing Interests: no
information
ADDITIONAL DATA: authors provided additional prescribing data to enable seg-
mented regression analysis
Microbial Risk of Bias HIGH: Case definition: Low. Planned intervention: High:
unplanned intervention in response to emergence of VRE over the previous 3 years.
Other infection control measures: Low
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk
Shape of effect pre-specified (ITS) ? Low risk
Unlikely to affect data collection (ITS) ? Low risk
Knowledge of the allocation adequately
prevented(ITS)?
Low risk
Incomplete outcome data addressed (ITS)
?
Low risk
Free of selected reporting (ITS) ? Low risk
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Lautenbach 2003 (Continued)
Free of other bias (ITS) ? High risk Microbial outcome risk of bias: HIGH .
Lawes 2012
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: Staphylococcus aureus bacteraemia and use of antibiotics con-
sidered to be high risk for Clostridium difficile infection
SETTING: 1 university hospital in the UK
Interventions FORMAT: Interventions: dissemination of new antibiotic policy 3 months before the
structural intervention; restrictive: the new antibiotic policy included requirement for
expert approval; structural: introduction of universal screening for MRSA
Intervention Functions: education, environmental restructuring, restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: no valid data for re-analysis in the paper, but the authors’
ARIMA time series analysis includes the effect of the change in antibiotic policy on the
microbial outcomes
MICROBIAL: S aureus bacteraemias, MRSA, and MSSA
Notes FINANCIAL SUPPORT: Funding: Scottish government Health Directorate. Com-
peting Interests: IG has received personal and grant financial support from companies
manufacturing diagnostics and therapeutics for MRSA. BE has received grant financial
support from Novartis. Other authors: none
ADDITIONAL DATA: authors provided additional data
Microbial Risk of Bias MEDIUM: case definition High, MRSA screening introduced
at the same time as change in antibiotic policy, planned intervention Low, other infection
control Low for isolation and personal infection control
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk The change in antibiotic policy was 9
months after the introduction of MRSA
screening. The authors’ analysis suggests an
independent effect from the policy change
Analysed appropriately (ITS) ? Low risk ARIMA time series analysis
Shape of effect pre-specified (ITS) ? Low risk Point of analysis was point of intervention.
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Lawes 2012 (Continued)
Unlikely to affect data collection (ITS) ? Low risk Routine patient administration systems
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Routine patient administration systems
Incomplete outcome data addressed (ITS)
?
Low risk Routine patient administration systems
Free of selected reporting (ITS) ? Low risk Routine patient administration systems
Free of other bias (ITS) ? Low risk Other microbial ROB criteria low
Layios 2012
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the ICUs
PARTICIPANTS: 389 patients in the ICUs for > 48 h and with PCT measured (211
intervention, 178 control)
CLINICAL PROBLEM: duration of antibiotic treatment
SETTING: 5 ICUs in 1 university hospital in Belgium
Interventions FORMAT: Interventions: reminders (circumstantial and physical, decision support al-
gorithm triggered by PCT test result); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: specialist physician (ICU and respiratory)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 250 participants in each group. Details in Appendix 3
Outcomes PRESCRIBING: Exposure: antibiotic consumption as % ICU days and DDD/100
OBD
CLINICAL: mortality, length of ICU stay, days on ventilator
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “patients were prospectively randomized”,
but no information about how
Allocation concealment (selection bias) Unclear risk “patients were prospectively randomized”,
but no information about how
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Layios 2012 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Low risk Procalcitonin only reported for interven-
tion participants.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on all participants.
Selective reporting (reporting bias) Low risk Outcomes reported on all participants.
Other bias High risk Study did not achieve recruitment required
by power calculation
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk Procalcitonin only reported for interven-
tion participants.
Baseline characteristics similar? Low risk Table 1
Lee 1995
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: physicians
PATIENTS: a total of 480 patients reviewed during study period
CLINICAL PROBLEM: patients receiving ceftriaxone
SETTING: a hospital in the USA
Interventions FORMAT: Interventions: educational meetings with dissemination of guidelines; re-
minders (circumstantial and physical, letters sent to physicians when intervention needed
plus posters)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: grams of ceftriaxone and cefotaxime
FINANCIAL: cost of intervention (0.5 FTE ID physician and savings on drug costs)
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
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Lee 1995 (Continued)
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Data from pharmacy computer
Free of other bias (ITS) ? High risk > 1 year data pre- and postintervention, but
only 4 postintervention time points (quar-
terly data)
Lee 2007
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all staff in the hospital
PARTICIPANTS: all patients receiving cephalosporins
CLINICAL PROBLEM: high endemic rate of ESBL infections
SETTING: 1 university children’s hospital in Korea
Interventions FORMAT: Intervention: educational outreach by review and recommend change
Intervention Functions: enablement, persuasion
DELIVERER: specialist physicians (paediatric ID)
COMPARISON: pre-intervention
DESIRED CHANGE: decrease in use of extended-spectrum cephalosporins to reduce
ESBL infections
Outcomes PRESCRIBING: Choice: days on target antibiotics/1000 OBD
MICROBIAL: ESBL strains as % total isolates
Notes FINANCIAL SUPPORT: Funding: Wyeth Research. Competing Interests: none de-
clared.
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias LOW: case definition yes, planned intervention yes, stable ESBL
for 3 years pre-intervention, other infection control yes
Risk of bias
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Lee 2007 (Continued)
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Infection control policies unchanged
throughout (page 631).
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Decrease
Unlikely to affect data collection (ITS) ? Low risk Data about prescribing and microbial out-
comes were from routine, electronic data
systems
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data about prescribing and microbial out-
comes were from routine, electronic data
systems
Incomplete outcome data addressed (ITS)
?
Low risk Data about prescribing and microbial out-
comes were from routine, electronic data
systems
Free of selected reporting (ITS) ? Low risk Data about prescribing and microbial out-
comes were from routine, electronic data
systems
Free of other bias (ITS) ? Low risk 4 years’ data pre- and3 years’ data postinter-
vention, so can account for temporal trends
Lee 2014
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the units
PARTICIPANTS: all patients in the units
CLINICAL PROBLEM: requiring therapeutic antibiotics
SETTING: internal medicine (2 units) at 1 university hospital in Canada
Interventions FORMAT: Interventions: audit and feedback; educational meetings (monthly with
residents) with dissemination of educational materials
Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: DDD/1000 OBD of target antibiotics
FINANCIAL: intervention cost and savings (cost of all antibiotics)
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Lee 2014 (Continued)
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: authors provided additional data about the intervention and
for the meta-regression
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcomes were measured from electronic
pharmacy data.
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcomes were measured from electronic
pharmacy data.
Incomplete outcome data addressed (ITS)
?
Low risk Outcomes were measured from electronic
pharmacy data.
Free of selected reporting (ITS) ? Low risk Outcomes were measured from electronic
pharmacy data.
Free of other bias (ITS) ? Low risk > 12 months’ data pre- and postinterven-
tion
Lesprit 2013
Methods STUDY DESIGN: RCT
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in medical and surgical wards
PARTICIPANTS: 753 patients receiving antibiotics (376 intervention, 377 control)
CLINICAL PROBLEM: duration of treatment in patients receiving 1 of the targeted
antibiotics for at least 3 days
SETTING: 1 university hospital in France
Interventions FORMAT: Intervention: educational outreach by review and recommend change
Intervention Functions: enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 253 participants in each group. Details in Appendix 3
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Lesprit 2013 (Continued)
Outcomes PRESCRIBING: Exposure: duration of all antibiotic treatment
CLINICAL: Balancing: mortality, ICU admission, new course of antibiotic treatment,
length of stay
FINANCIAL: intervention cost and savings (supplementary file)
MICROBIAL: secondary infection and/or colonisationwithmultidrug-resistant bacteria
in the 6 months following randomisation
Notes FINANCIAL SUPPORT:Funding: none. Competing Interests: none declared
ADDITIONAL DATA: supplementary file online with data about financial and micro-
bial outcomes, no response from authors to request for additional data
Microbial Risk of Bias: case defintion low, planned intervention low, other infection
control unclear, no information
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Eligible patients were allocated to either
the intervention or the control group us-
ing a computer-generated randomisation
list, which was maintained independently
of the IDP
Allocation concealment (selection bias) Low risk Concealment of the allocation was main-
tained, as the physician in charge of the pa-
tient and the IDP were involved only after
randomisation
Blinding (performance bias and detection
bias)
All outcomes
High risk Blinding was not possible.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants were lost to follow-up.
Selective reporting (reporting bias) Low risk Outcomes reported on all participants.
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk IDP only visited intervention participants.
Baseline characteristics similar? Low risk Table 1
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Leverstein-van Hall 2001
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: Departments of Neurology and Neurosurgery
PARTICIPANTS: all patients in the departments
CLINICAL PROBLEM: colonisation with gentamicin-resistant Enterobacteriaceae
SETTING: 1 858-bed university hospital in the Netherlands
Interventions FORMAT: no valid prescribing data, restriction by expert approval and removal
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes MICROBIAL: prevalence of gentamicin-resistant Enterobacteriaceae in weekly screening
stool swabs
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk NOT DONE, major changes in infection
control 4 weeks before the antibiotic re-
striction. Separate effect cannot be esti-
mated because no screening before change
in infection control
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
no statistical analysis, time series data pre-
sented as run chart
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Screening protocol was the same pre- and
postintervention.
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Screening protocol was the same pre- and
postintervention.
Incomplete outcome data addressed (ITS)
?
Unclear risk NOTCLEAR, no explicit statement about
complete screening samples for all partici-
pants
Free of selected reporting (ITS) ? Unclear risk NOTCLEAR, no explicit statement about
complete screening samples for all partici-
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Leverstein-van Hall 2001 (Continued)
pants
Free of other bias (ITS) ? High risk Microbial Outcome Risk of Bias Cri-
teria: Case definition: DONE colonisa-
tion by screening; Planned intervention:
NOT DONE, in response to increase in
GRE; Other infection control practices:
NOT DONE changes 4 weeks before
antibiotic restriction; Isolation: isolation
of gentamicin-resistantEnterobacteriaceae-
positive patients in either side-rooms or
cohorted with other positive patients; IC
practices: increase in education plus several
new hygiene practices: disposable washing
gloves, elbow-directed soap dispensers; new
room-cleaning protocol. Hygiene was em-
phasised andmore stringent barrier precau-
tions
Liebowitz 2008
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: incidences of MRSA
SETTING: 1 general hospital in the UK
Interventions FORMAT: Intervention: educational meetings with dissemination of guideline; re-
minders, verbal on rounds
Intervention Function: education, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: reduce inappropriate
Outcomes PRESCRIBING: Choice: DDDs per 1000 OBD each month
MICROBIAL: Episodes of MRSA blood isolates per 1000 OBD each month
Notes FINANCIAL SUPPORT: Funding: unrestricted educational grant fromWyeth. Com-
peting Interests: LDL received honoraria for lectures from Bayer and Bard.
ADDITIONAL DATA: no response from authors to request for additional data
Microbial ROBHIGH; case definition Low, planned intervention Low, other infection
control High, no information about infection control other than screening for MRSA
Risk of bias
Bias Authors’ judgement Support for judgement
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Liebowitz 2008 (Continued)
Intervention independent (ITS) ? Low risk 18 months’ pre- and 15 months’ postinter-
vention data
Analysed appropriately (ITS) ? Low risk Segmented regresssion analysis
Shape of effect pre-specified (ITS) ? Low risk Point of analysis is point of intervention.
Unlikely to affect data collection (ITS) ? Low risk Pharmacy data used pre- and postinterven-
tion.
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Pharmacy data used pre- and postinterven-
tion.
Incomplete outcome data addressed (ITS)
?
Low risk Pharmacy data used pre- and postinterven-
tion.
Free of selected reporting (ITS) ? Low risk Pharmacy data used pre- and postinterven-
tion.
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
Linkin 2007
Methods STUDY DESIGN: unintended consequences, cohort study
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: 200 patients
CLINICAL PROBLEM: requests for restricted antibiotic to the Antimicrobial Stewardship Program
SETTING: 1 hospital in the USA
Interventions FORMAT: Interventions: restrictive
Intervention Functions: restriction
DELIVERER: AMT
COMPARISON: patients with appropriate vs inappropriate requests
DESIRED CHANGE: decrease excessive
Outcomes UNINTENDED CONSEQUENCES: accuracy of laboratory and clinical information provided in calls to the
Antimicrobial Stewardship Program
Notes ROBINS-I RISK OF BIAS CRITERIA:
1. Confounding: Low, the effects of inaccurate communication and each of the potential confounders on the risk of
inappropriate antimicrobial recommendations were evaluated in bivariable analyses
2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome
3. Measurement of interventions: Low, antimicrobial recommendations were evaluated for appropriateness by a
3-person panel of infectious diseases experts blinded to the accuracy of information communicated during the
Antimicrobial Stewardship Program call
4. Departures from intended interventions: Low, no switches to other interventions or evidence of intervention failure
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Linkin 2007 (Continued)
5. Missing data: High, panelists could not agree on appropriateness of treatment for 37 patients. Outcome data
complete for the 163 included patients
6. Measurement of outcome: Low, outcome measures objective and ascertained from patient administration system
7. Selection of the reported result: High, multiple secondary analyses were performed using the main study outcome
FINANCIAL SUPPORT: Funding:National Institutes of Health, Agency for Healthcare Research and Quality, and
University of Pennsylvania. Competing Interests: none declared.
ADDITIONAL DATA: no response from authors to request for additional data
Liu 2013
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: Department of Emergency Medicine, ICU staff
PARTICIPANTS: adults (age > 18) with sepsis
CLINICAL PROBLEM: sepsis without 7 exclusion criteria (cultures positive with Pseu-
domonas aeruginosa,Acinetobacter baumannii,Mycobacterium tuberculosis or any fungi, vi-
ral or parasitic infection, chronic localised inflammation, antibacterial therapy for > 48
h, immunosuppression, cancer, or refusal to consent)
SETTING: ICU in 1 university hospital in China
Interventions FORMAT: Interventions: reminders (circumstantial, decision support algorithm trig-
gered by measurement of PCT); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: no information
Outcomes PRESCRIBING: Exposure: duration of all antibiotic treatment
CLINICAL: Balancing: 28-day mortality, length of hospital stay, length of ICU stay,
recurrence within 28 days
Notes Translated from Chinese
FUNDING: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table method
Allocation concealment (selection bias) Unclear risk No information about concealment
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No information about blinding
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Liu 2013 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome reported on all participants.
Selective reporting (reporting bias) Low risk Outcome reported on all participants.
Other bias High risk The study had 7 exclusion criteria that are
not all clearly defined, so there is a high risk
of selection bias, especially as allocationwas
probably not concealed
Baseline Outcomes similar? Unclear risk No data about baseline outcomes
Free of contamination? Low risk PCT results only for intervention partici-
pants.
Baseline characteristics similar? Low risk Table 1, age, gender, APACHE score, co-
morbidities
Long 2014
Methods STUDY DESIGN: RCT
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians
PARTICIPANTS: 216 consecutive patients hospitalised with exacerbations of acute
asthma
CLINICAL PROBLEM: antibiotic treatment of acute asthma
SETTING: 1 university hospital in China
Interventions FORMAT: Interventions: reminders (circumstantial, decision support algorithm trig-
gered by measurement of PCT); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: departmental physicians (Internal and Geriatric Medicine)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 90 participants per group. Details in Appendix 3
Outcomes PRESCRIBING: Exposure:% treated with antibiotics
CLINICAL: Balancing: length of hospital stay; clinical, laboratory, and spirometry
outcomes at discharge; and results of spirometry at the 12-month follow-up examination,
as well as the results of the Asthma Control Test
Notes FINANCIAL SUPPORT: Funding: Shanghai Fifth People’s Hospital Science Founda-
tion and Minhang District Natural Science Foundation of Shanghai. Competing Inter-
ests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
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Long 2014 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Allocation to either intervention was con-
ducted according to computer-generated
random numbers produced by an indepen-
dent statistician.”
Allocation concealment (selection bias) Low risk “After randomization, an opaque, sealed,
sequentially numbered envelope contain-
ing the PCT or control protocol was pre-
pared for each subject according to group
assignment”
Blinding (performance bias and detection
bias)
All outcomes
High risk Blinding was not possible.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on all 180 randomised
participants.
Selective reporting (reporting bias) Low risk Antibiotic use reported for all 180 partici-
pants.
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk Procalcitonin only reported on interven-
tion participants.
Baseline characteristics similar? Low risk Tables 1 and 2
Madaras-Kelly 2006
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all prescribers and staff
PATIENTS: all inpatients
CLINICALPROBLEM:patients receiving antibiotic treatment andpatientswithMRSA
infections
SETTING: university-affiliated veterans hospital in the USA
Interventions FORMAT: Interventions: educational meetings, in-service training sessions with dis-
semination of guideline; reminders (circumstantial, electronic, triggered by prescribing
target drugs)
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Madaras-Kelly 2006 (Continued)
Intervention Functions: education, enablement, environmental restructuring
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: change in use of levofloxacin, ciprofloxacin, and other antibi-
otics
MICROBIAL: MRSA infection rate (number/1000 OBD)
Notes FINANCIAL SUPPORT: This article is the result of work supported with resources and
the use of facilities at the Boise Veterans Affairs Medical Center, and is partially funded
by an unrestricted educational grant fromWyeth Pharmaceuticals. Conflict of interest:
no information
ADDITIONAL DATA: email response from authors but no additional data
Microbial ROB: MEDIUM. Case definition Low, Planned intervention Low, Other
infection control High, prescribing intervention coincident with infection control inter-
ventions
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk Data collected for 11months postinterven-
tion. Season included as a variable in the
model, and summer found to be associated
with lower MRSA infection rate. Coinci-
dentwith infection control intervention for
norovirus outbreak, infection control vari-
ables included in the model and signifi-
cantly associated with lower MRSA rate
Analysed appropriately (ITS) ? Low risk Done in original paper: segmented regres-
sion analysis
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Unclear risk Not clear, no information about protocols
for sampling or testing for MRSA over the
study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Objective data about MRSA
Incomplete outcome data addressed (ITS)
?
Low risk Identification of cases was the same in the
pre- and postintervention phases
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Madaras-Kelly 2006 (Continued)
Free of selected reporting (ITS) ? Low risk In addition to the primary outcome of
MRSA infections, the figure shows percent-
age of MRSA for all Staphylococcus aureus
isolates with a reduction coincident with
the intervention.
Free of other bias (ITS) ? High risk NOT DONE data are MRSA infection
rates in 6-month time periods based on
very small numbers of cases (80 cases in 3½
years)
Microbial Outcome Risk of Bias: Case
definition: MRSA infection. Screening
for nosocomial infections was performed
through daily review of hospital admis-
sions and discharges, intravenous antibi-
otic use by patients admitted to the emer-
gency department, and laboratory reports
with case confirmation by review of med-
ical records. “An infection was assumed to
be caused by MRSA if cultures of blood,
intravenous line, sputum, urine, tissue, or
stool obtained at the time of symptom de-
velopment yielded MRSA.” Planned in-
tervention: YES. Intervention introduced
in July 2003 in response to May 2003
SHEA recommendations that institutions
where MRSA is endemic should consider
limiting the use of broad-spectrum antibi-
otics, especially fluoroquinolones. Other
infection control: NOT DONE. Antibi-
otic intervention coincident with environ-
mental decontamination and hand hygiene
campaign because of norovirus outbreak.
Data about some infection control variables
showed no change after start of interven-
tion
Magedanz 2012
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: physicians in the hospital
PARTICIPANTS: all patients in hospital
CLINICAL PROBLEM: antibiotic use in cardiology hospital, primary target fluo-
rquinolone use
SETTING: 1 cardiology hospital in Brazil
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Magedanz 2012 (Continued)
Interventions FORMAT: Interventions: educational outreach by review and recommend change
Intervention Functions: enablement, persuasion
DELIVERER: Intervention1 IDphysician (2 h per day), Intervention2AMT (physician
plus pharmacist, 4 h per day)
COMPARISON: usual care
DESIRED CHANGE: reduce inappropriate
Outcomes PRESCRIBING:Choice:monthly consumption (DDDs/100 OBD) of antibiotics, pri-
mary target fluoroquinolones
FINANCIAL: hours of time to implement the intervention
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk States in discussion that most changes not
related to any other external factor
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention is point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data from electronic pharmacy records
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from electronic pharmacy records
Incomplete outcome data addressed (ITS)
?
Low risk Data from electronic pharmacy records
Free of selected reporting (ITS) ? Low risk Data from electronic pharmacy records
Free of other bias (ITS) ? Low risk > 12 months’ data in each of the 3 study
phases
Maravic-Stojkovic 2011
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in cardiac surgery
PARTICIPANTS: 205 patients undergoing cardiac surgery
CLINICAL PROBLEM: antibiotic treatment after surgery
SETTING: 1 university hospital in Serbia
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Maravic-Stojkovic 2011 (Continued)
Interventions FORMAT: Interventions: reminders (circumstantial, decision support algorithm trig-
gered by measurement of PCT); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: departmental physicians (ICU and cardiology)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: unclear, target effect size decrease from 45% of antibiotic
use in the standard group to 22% in the procalcitonin group, but no data about sample
size
Outcomes PRESCRIBING: Exposure:% treated with antibiotics
CLINICAL: ICU stays, hospital stay, rehospitalisation, incidence of infections, severe
non-infection complications, and mortality rate with 1-year follow-up
FINANCIAL: cost of antibiotics and PCT tests
Notes FINANCIAL SUPPORT: no information provided
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation
scheme
Allocation concealment (selection bias) Unclear risk No information about concealment
Blinding (performance bias and detection
bias)
All outcomes
High risk Blinding not possible
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on all 205 participants.
Selective reporting (reporting bias) Low risk Antibiotic treatment reported on all partic-
ipants.
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk PCT only measured on intervention par-
ticipants.
Baseline characteristics similar? Low risk Tables 1 and 2
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Marwick 2013
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in medical and surgical wards
PARTICIPANTS: all patients in medical and surgical wards
CLINICAL PROBLEM: suspected sepsis (systemic inflammatory response and clinical
suspicion of infection)
SETTING: 1 university hospital in Scotland
Interventions FORMAT: Interventions: audit and feedback; educational meetings with dissemination
of guidelines; reminders (physical, posters in the wards and monthly email to doctors)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: increase effective
Outcomes PRESCRIBING: Choice: time to first antibiotic dose
Notes FINANCIAL SUPPORT: Funding: Scottish Government Chief Scientist Office (CSO)
Clinical Academic Training Fellowship (CAF/07/06). Competing Interests: salary costs
for 2 investigators from CSO, no others declared
ADDITIONAL DATA: email response from authors to request for additional data with
additional detail from a PhD thesis
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk There was a national intervention (Scottish
Patient Safety Program) that included re-
ducing time to rescue of deteriorating pa-
tients throughout the pre- and postinter-
vention phases
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Objective primary outcome measure (time
to first antibiotic dose) collected by single
person (CM)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Objective primary outcome measure (time
to first antibiotic dose) collected by single
person (CM)
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data collected on all participants.
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Marwick 2013 (Continued)
Free of selected reporting (ITS) ? Low risk Outcome data collected on all participants.
Free of other bias (ITS) ? Low risk Data collected over winter months in pre-
and postintervention period
Masia 2008
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: 278 patients receiving antibiotics, 146 intervention, 132 control
CLINICAL PROBLEM: prescription of target antibiotics
SETTING: 1 university hospital in Spain
Interventions FORMAT: Interventions: educational outreach by review and recommend change
Intervention Functions: education, enablement
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 140 participants in each group
Outcomes PRESCRIBING: Choice: use of target drugs in DDD
CLINICAL: length of stay, mortality, re-admissions
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Eligible prescriptions were allocated daily
to either the intervention or the control
group using a computer-generated ran-
domisation list
Allocation concealment (selection bias) Low risk Concealment of allocation was pharmacy
controlled. Instruction in allocation con-
cealment was provided
Blinding (performance bias and detection
bias)
All outcomes
High risk Blinding was not possible.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data reported on all randomised
participants.
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Masia 2008 (Continued)
Selective reporting (reporting bias) Low risk Outcome data reported on all randomised
participants.
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? High risk The authors say: “To minimize contamina-
tion bias, that is, any change in antibiotic
prescription practice in the control group,
only the infectious diseases physicians and
hospital pharmacists were informed about
the implementationof the program.”How-
ever, they were placing written recommen-
dations in case notes for intervention pa-
tients, and physicians caring for those pa-
tients would also be caring for control pa-
tients
Baseline characteristics similar? Low risk Table 1
May 2000
Methods STUDY DESIGN: Controlled ITS
Risk of bias: MEDIUM
Participants PROVIDERS: staff of Trauma & Burns ICU (TBICU), Medical ICU (MICU), and
Surgical ICU (SICU)
PATIENTS: all patients in these ICUs
CLINICAL PROBLEM: adults needing intensive care
SETTING: single > 500-bed university hospital in the USA
Interventions FORMAT: Intervention: dissemination of guideline
Intervention Function: education
DELIVERER: department physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of vancomycin, 3rd-generation cephalosporins, and
piperacillin tazobactam per 1000 patient days
MICROBIAL: MRSA infections and VRE infections per 1000 patient days
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Microbial ROB HIGH: Case definition: Low. Planned intervention: High for inter-
vention ward (response to increasing VRE in previous 2 years). However, steady increase
not an outbreak and VRE data presented for other wards with no intervention. Other
infection control: High, no information about isolation or infection control practices
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May 2000 (Continued)
before or after the intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Only 9 months’ data pre-intervention, so
secular/seasonal effects possible. No infor-
mation about infection control practices
before or after the intervention
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper: χ
2 test, uncontrolled before-after with Pois-
son regression analysis of VRE rates
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, objective outcome measure
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Objective outcome measure, VRE infec-
tions
Incomplete outcome data addressed (ITS)
?
Low risk Done, objective outcome measure
Free of selected reporting (ITS) ? Unclear risk Not clear, no information about protocol
for sampling or testing over study period
Free of other bias (ITS) ? Low risk >1 year of data pre- and post-intervention
McElnay 1995
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: all patients in hospital
CLINICAL PROBLEM: all patients receiving antibiotics
SETTING: 370-bed District General Hospital in the UK
Interventions FORMAT: Interventions: educational meetings and dissemination of new antibiotic
policy; educational outreach by academic detailing, “education of junior medical staff on
the rationale behind the antibiotic selection was also carried out by clinical pharmacists”
(p208); restrictive by compulsory order form and removal
Intervention Functions: education, persuasion, restriction
DELIVERER: department physician
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McElnay 1995 (Continued)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: dosage units of target antibiotic
FINANCIAL: expenditure on antibiotics
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk 12 months’ data pre- and postintervention
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after)
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk Antibiotic costs were adjusted to 1989
prices.
McGowan 1976
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients requiring antibiotic treatment
SETTING: single university hospital in USA
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McGowan 1976 (Continued)
Interventions FORMAT: Intervention: restrictive by expert approval and probably by review andmake
change
Intervention Function: restriction
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING:Choice: grams of chloramphenicol (thousands), data are also presented
for other drugs (ampicillin, nafcillin, and cloxacillin)
Notes FINANCIAL SUPPORT: Funding: grants 5R01-A1-23, 2T01-AJ-08, and IT01-Ai-
447 from theNational Institute of Allergy and InfectiousDiseases.Competing Interests:
no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Data over 8 years, 4 years pre- and 4 years
postintervention
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after)
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk No other apparent biases found.
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McLaughlin 2005
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: staff from 12 medical wards
PATIENTS: all patients in the wards
CLINICAL PROBLEM: adults requiring IV antibiotic therapy
SETTING: single university hospital in the UK
Interventions FORMAT: Interventions: educational meetings with dissemination of protocol for IV
to oral switch; educational outreach by academic detailing; reminders (circumstantial,
sticker in charts of patients receiving IV antibiotics and physical, posters in wards and
at nursing stations)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: modification of existing management (faster switch from IV to
oral administration of antibiotics)
Outcomes PRESCRIBING: Choice: appropriateness of timing of IV to oral switch
Notes FINANCIAL SUPPORT: Funding: Greater Glasgow Health Board. Competing In-
terests: no information
ADDITIONAL DATA: authors provided additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Not done, data were only collected for 4
weeks before and after the intervention, so
secular changes could have accounted for
any differences
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after) with χ2 test.
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Unclear risk Not stated
Knowledge of the allocation adequately
prevented(ITS)?
High risk
Incomplete outcome data addressed (ITS)
?
Unclear risk No information about reliability or com-
pleteness of primary outcome
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McLaughlin 2005 (Continued)
Free of selected reporting (ITS) ? Unclear risk No information about reliability or com-
pleteness of primary outcome
Free of other bias (ITS) ? High risk Only 4 weekly time points pre- and postin-
tervention
McNulty 1997
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the elderly care unit
PARTICIPANTS: all patients in the elderly care unit
CLINICAL PROBLEM: Clostridium difficile in the elderly care unit
SETTING: elderly care unit in 1 District General Hospital (non-teaching) in the UK
Interventions FORMAT: Interventions: dissemination of new antibiotic policy; restrictive by removal
and by review and make change
Intervention Functions: education, enablement, environmental restructuring, persua-
sion, restriction
DELIVERER: pharmacist
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: monthly cost of cefuroxime (ITS data)
MICROBIAL: cases of CDI per month (ITS data)
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Microbial ROB HIGH: Case definition: Low, CDI, definition unchanged during the
study periods. Unplanned intervention: High, antibiotic restriction was implemented in
response to increasing cases of CDI in the preceding 7months despite increased infection
control. Other infection control measures: High, changes to environmental cleaning and
reminders about hand hygiene implemented 3 months before the start of intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk
Analysed appropriately (ITS) ? Low risk
Shape of effect pre-specified (ITS) ? Low risk
Unlikely to affect data collection (ITS) ? Low risk
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McNulty 1997 (Continued)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk
Incomplete outcome data addressed (ITS)
?
Low risk
Free of selected reporting (ITS) ? Low risk
Free of other bias (ITS) ? Low risk
Mercer 1999
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: physicians
PARTICIPANTS: all patients with clinical problem
CLINICAL PROBLEM: patients receiving ceftriaxone
SETTING: a 360-bed community hospital in the USA
Interventions FORMAT: Interventions: dissemination of guidelines; educational outreach by aca-
demic detailing; educational outreach by review and recommend change; reminders
(physical, posters in clinical areas); restrictive by compulsory order form, expert approval
required, removal and review and make change
Intervention Functions: education, environmental restructuring, restriction
DELIVERER: specialist physician (ID)
COMPARISON: usual care
DESIRED CHANGE: reduction in established management (reduction in antibiotic
costs)
Outcomes PRESCRIBING: Choice: cost of antibiotics (USD) as an indicator of use
COSTS: cost of antibiotics
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Full year before and after
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after)
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Mercer 1999 (Continued)
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk Antibiotic costs were adjusted to 1995
prices and excluded ancillary or adminis-
trative charges
Meyer 1993
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients receiving antibiotics
SETTING: 1 university hospital in the USA
Interventions FORMAT: Interventions: restrictive by expert approval required
Intervention Functions: restriction
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of ceftazidime, imipenem, and ceftriaxone reported as
number of approvals for these drugs
MICROBIAL: incidence of ceftazidime-resistant Klebsiella pneumoniae as the rate per
1000 average daily census
Notes FINANCIAL SUPPORT: Funding: BMAMedical Foundation. Competing Interests:
no information
ADDITIONAL DATA: no response from authors to request for additional data
Microbial ROB: HIGH Case definition Low, Unplanned intervention High, Other
infection control High
Risk of bias
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Meyer 1993 (Continued)
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Infection control intervention simulta-
neous with antibiotic intervention. 14
months’ pre- and 11 months’ postinterven-
tion, so secular change unlikely
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
run chart with no statistical analysis
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
High risk Pre-intervention data were incomplete.
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period. Cri-
teria for sampling and testing were un-
changed over the study period
Free of other bias (ITS) ? High risk NOT DONE. Microbial Outcome Risk
of Bias Criteria: Planned intervention:
NOT DONE, unplanned intervention.
Case definition: DONE, microbial out-
come was colonisation by surveillance
screening. Clinical infection was diagnosed
by CDC definition but not used as an
outcome. Infection or colonisation by case
note review. Other infection control mea-
sures: NOT DONE, barrier precautions
were instituted on colonised and infected
patients at the same time that ceftazidime
restriction was implemented
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Meyer 2007
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: physicians in the neurosurgical ICU
PARTICIPANTS: patients with pneumonia
CLINICAL PROBLEM: antibiotic treatment for pneumonia in neurosurgical ICU
SETTING: neurosurgical ICU in 1 hospital in Germany
Interventions FORMAT: Interventions: educational meeting with neurosurgeons and dissemination
of guideline
Intervention Functions: education
DELIVERER: AMT
COMPARISON: usual care
DESIREDCHANGE: decrease excessive, in the new guideline the duration of antibiotic
therapy for nosocomial pneumoniawas reduced from14 to 7 days, while for community-
acquired pneumonia the period fell from 10 to 5 days
Outcomes PRESCRIBING: Exposure: total antibiotic use and cost/1000 OBD
FINANCIAL: changes in total antibiotic cost
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcome frompharmacy database pre- and
postintervention.
Knowledge of the allocation adequately
prevented(ITS)?
Unclear risk No mention of blinding
Incomplete outcome data addressed (ITS)
?
Low risk Outcome frompharmacy database pre- and
postintervention.
Free of selected reporting (ITS) ? Low risk Outcome frompharmacy database pre- and
postintervention.
Free of other bias (ITS) ? Low risk > 1 year of data pre- and postintervention
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Meyer 2009
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all patients in an adult surgical ICU
PARTICIPANTS: all staff in the ICU
CLINICAL PROBLEM: use of 3rd-generation cephalosporins for treatment and pro-
phylaxis of specific infections plus duration of prophylaxis for fractures
SETTING: 1 surgical ICU in a teaching hospital in Germany
Interventions FORMAT: Interventions: dissemination of guidelines and educational meetings in de-
partments of surgery and anaesthesiology
Intervention Functions: education
DELIVERER: multidisciplinary AMT
COMPARISON: pre-intervention outcomes
DESIRED CHANGE: reduction in use of cephalosporins and resistance in gram-nega-
tive bacteria
Outcomes PRESCRIBING: Choice: use of cephalosporins in DDD/1000 OBD
MICROBIAL: resistance to cephalosporins and piperacillin in gram-negative bacteria
isolated from clinical and surveillance cultures
Notes FINANCIAL SUPPORT: Funding: Federal Ministry of Education and Research (01Kl
9907). Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Microbial ROB: HIGH Case definition Low; Planned intervention Low; Other infec-
tion control Unclear, no clear information about isolation or personal-protection policies
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcome data from pharmacy and micro-
biology computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome data from pharmacy and micro-
biology computers
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data from pharmacy and micro-
biology computers
Free of selected reporting (ITS) ? Low risk Outcome data from pharmacy and micro-
biology computers
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Free of other bias (ITS) ? Low risk Data for > 2 years’ pre- and postinterven-
tion, so secular trends accounted for
Meyer 2010
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the ICU
PARTICIPANTS: all patients with clinical problem
CLINICAL PROBLEM: reducing length of antibiotic prophylaxis for cerebrospinal
shunts
SETTING: ICU department in 1 teaching hospital in Germany
Interventions FORMAT: Intervention: educational meeting and dissemination of new policy. In au-
tumn 2003, a comprehensive teaching session on antibiotic prophylaxis in cerebrospinal
shunts was organised by the infection control and neurosurgery teams. This resulted in a
revised recommendation of single-shot prophylaxis with cefuroxime for shunt catheters,
beginning in January 2004. Prior to implementation of this recommendation, cefurox-
ime was administered for the whole duration of external cerebrospinal fluid drainage,
which could be up to 2 to 3 weeks
Intervention Functions: education, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive, shorten duration of prophylaxis
Outcomes PRESCRIBING: Exposure: total antibiotic use in DDD/1000 OBD
Notes FINANCIAL SUPPORT: Funding: Federal Ministry of Education and Research (01Kl
9907). Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk Says they could not control for changes over
time and that an antimicrobial stewardship
programme was implemented
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data from pharamacy computers
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Meyer 2010 (Continued)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharamacy computers
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharamacy computers
Free of selected reporting (ITS) ? Low risk Data from pharamacy computers
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
Micek 2004
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: ICU physicians
PATIENTS: 302 adults in the ICU (154 intervention, 148 control)
CLINICAL PROBLEM: VAP requiring antibiotics
SETTING: single ICU in a teaching hospital in the USA
Interventions FORMAT: Interventions: educational outreach by review and recommend change
Intervention Functions: enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: no information
Outcomes PRESCRIBING: Exposure: duration of all antibiotic therapy
Notes FINANCIAL SUPPORT: Funding: part commercial, Barnes-Jewish Hospital Founda-
tion and an unrestricted grant from Elan Pharmaceuticals. Competing Interests: no
information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients were randomly assigned”, but no
details of how the sequence was generated
Allocation concealment (selection bias) Unclear risk Not stated
Blinding (performance bias and detection
bias)
All outcomes
High risk Not possible
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Micek 2004 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data were missing from 4 (2.6%)
patients in the intervention group and 8 (5.
4%) patients in the control group
Selective reporting (reporting bias) Low risk Done, outcomes were obtained from rou-
tine data systems.
Other bias High risk The policy was only implemented at week-
ends or on holidays when 1 of the 2 inves-
tigators was available in the hospital
Baseline Outcomes similar? Unclear risk No data about duration of therapy before
the intervention
Free of contamination? High risk Physiciansmanagingpatients in the control
group would have seen reminders for the
intervention group
Baseline characteristics similar? Low risk Table 1
Mittal 2014
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the Department of Paediatrics
PARTICIPANTS: all children < 2 years old with bronchiolitis
CLINICAL PROBLEM: antibiotic use as part of a new Clinical Practice Guideline to
improve management of bronchiolitis
SETTING: 1 university hospital in the USA
Interventions FORMAT: Interventions: audit and feedback, educational meeting with dissemination
of guideline; reminders (verbal (on rounds, somay have been circumstantial) and physical
(pocket-size guideline, screensavers))
Intervention Functions: education, enablement, persuasion
DELIVERER: departmental physicians (paediatrics and respiratory)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure:% treated with antibiotics
CLINICAL: length of stay, re-admission
Notes FINANCIAL SUPPORT: Funding: no external. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
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Mittal 2014 (Continued)
Intervention independent (ITS) ? High risk Antibiotic use was 1 of 10 recommenda-
tions in the guideline; the other 9 would
have impacted on clinical outcomes
Analysed appropriately (ITS) ? Low risk Statistical process control charts
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk All outcome data from hospital patient ad-
ministration system
Knowledge of the allocation adequately
prevented(ITS)?
Low risk All outcome data from hospital patient ad-
ministration system
Incomplete outcome data addressed (ITS)
?
Low risk All outcome data from hospital patient ad-
ministration system
Free of selected reporting (ITS) ? Low risk All outcome data from hospital patient ad-
ministration system
Free of other bias (ITS) ? Low risk Data collected over 3 winters, 1 pre- and 2
postintervention
Mol 2005
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: physicians in the Department of Internal Medicine
PATIENTS: all patients in the wards
CLINICAL PROBLEM: receiving antibiotic therapy
SETTING: 1 university hospital in the Netherlands
Interventions FORMAT: 1st Intervention: audit and feedback; educational meetings with dissemi-
nation of guideline
1st Intervention Functions: education, enablement
2nd Intervention: audit and feedback; educational meetings with dissemination of
guideline; educational outreach by academic detailing
2nd Intervention Functions: education, enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice:% compliance with guideline; antibiotic cost
FINANCIAL: antibiotic cost
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
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Mol 2005 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Done in original paper: segmented regres-
sion analysis
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was increase in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Data collection method was same through-
out study.
Knowledge of the allocation adequately
prevented(ITS)?
High risk Subjective outcomewithout blinded assess-
ment
Incomplete outcome data addressed (ITS)
?
Unclear risk Not stated whether compliance was as-
sessed in all patients.
Free of selected reporting (ITS) ? Unclear risk Not stated whether compliance was as-
sessed in all patients.
Free of other bias (ITS) ? Low risk The kappa value for the primary outcome
measure was 0.71, which is below the level
set by EPOC, but for the reasons given in
the text we feel is adequate for assessment
of compliance with an antibiotic guideline.
Drug costs were adjusted to April 2001
prices
Newland 2012
Methods STUDY DESIGN: CITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: all patients in children’s hospital
CLINICAL PROBLEM: inappropriate use of antimicrobials; a group of broad-spec-
trum, or “select”, antibiotics 2 calendar days after they were initiated by the clinician
SETTING: 1 children’s hospital in the USA (intervention) with data from 25 similar
hospitals of the Child Health Corporation of America as control
Interventions FORMAT: Interventions: educational outreach by review and recommend change.
NB the authors describe their intervention as “audit and feedback”, but there was no
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Newland 2012 (Continued)
feedback of data over time about progress to goal, just review with feedback about
individual patients
Intervention Functions: enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure: total antibiotic use (days of therapy/1000 patient days)
Notes FINANCIAL SUPPORT: Funding: Agency for Healtcare Quality and Reseach (grant
U18-HS10399). Competing Interests: none declared
ADDITIONAL DATA: authors provided additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk Unclear, there were some infection control
initiatives running
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Yes, point of analysis is point of interven-
tion.
Unlikely to affect data collection (ITS) ? Low risk Yes, data collection was the same pre- and
postintervention.
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Yes, objective outcomes
Incomplete outcome data addressed (ITS)
?
Low risk Routine data, so could assume complete.
Free of selected reporting (ITS) ? Low risk Yes, all relevant outcomes reported.
Free of other bias (ITS) ? Low risk Yes, all biases addressed.
Nobre 2008
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the ICU
PARTICIPANTS: 282 patients with suspected sepsis, 79 randomised (39 intervention,
40 control)
CLINICAL PROBLEM: duration of antibiotic treatment in patients with sepsis
SETTING: 1 ICU in 1 university hospital in Switzerland
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Nobre 2008 (Continued)
Interventions FORMAT: Interventions: reminders (circumstantial, decision support algorithm with
each PCT test); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: departmental physician (ICU)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, a total of at least 66 participants. Details in Appendix
3
Outcomes PRESCRIBING: Exposure: duration of treatment in days
CLINICAL: Balancing: mortality, relapse of infection, length of ICU stay, length of
hospital stay
Notes FINANCIAL SUPPORT: Funding: commercial B.R.A.H.M.S AG (USD 50,000).
Competing Interests: 2 authors received speaker honoraria from B.R.A.H.M.S AG.
ADDITIONAL DATA: online supplementary file with addtional infromation about
stopping rules in PCT group. No response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The randomisation was performed using a
computer-based random number genera-
tion
Allocation concealment (selection bias) Low risk Allocation was issued using opaque, sealed,
numbered envelopes
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk
Selective reporting (reporting bias) High risk 8/39 (20%) patients excluded from inter-
vention versus 3/40 (7%) from control;
4 patients excluded from intervention for
“complicated infections”, which is likely to
have biased the results on duration of an-
tibiotic treatment
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk PCT only measured for intervention
group.
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Nobre 2008 (Continued)
Baseline characteristics similar? Low risk Table 1
Nuila 2008
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in hospital
PARTICIPANTS: all patients receiving antibiotics
CLINICAL PROBLEM: reduce cases of Clostridium difficile-associated disease in hos-
pital by restricting use of parenteral antibiotics
SETTING: 1 teaching hospital in the USA
Interventions FORMAT: no valid prescribing data. Restriction and educational outreach - review and
recommend change
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: reduce inappropriate
Outcomes MICROBIAL: incidence of Clostridium difficile-associated disease
Notes FINANCIALSUPPORT:Funding:Merit ReviewFunding andDepartment of Veterans
Affairs. Competing Interests: none declared
ADDITIONAL DATA: email from authors but no additional data
Microbial ROB: MEDIUM: Case definition Low, Planned intervention Low, Other
infection control High
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk MRSA control programme introduced si-
multaneously.
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Routine data frommicrobiology computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Routine data frommicrobiology computer
Incomplete outcome data addressed (ITS)
?
Low risk Routine data frommicrobiology computer
Free of selected reporting (ITS) ? Low risk Routine data frommicrobiology computer
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Free of other bias (ITS) ? High risk Only 6 months’ data postintervention
Microbial Outcome Risk of Bias Crite-
ria: Case definition: DONE, CDC defi-
nition of C difficile. Planned intervention:
DONE. Other infection control measures:
NOT DONE, MRSA control programme
introduced simultaneously
Oliveira 2013
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians
PARTICIPANTS: 355 ICU patients assessed for inclusion, 94 patients randomised
CLINICAL PROBLEM: 94 patients with suspected sepsis randomised (49 intervention,
45 control)
SETTING: 1 university hospital ICU in Brazil
Interventions FORMAT: Interventions: reminders (circumstantial, decision support algorithm with
each PCT test); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: specialist physician (Infectious Diseases)
COMPARISON: usual care, patients monitored with C-reactive protein
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 58 participants per group. Details in Appendix 3
Outcomes PRESCRIBING: Exposure: duration of treatment in days
CLINICAL: mortality, recurrence of infection, ICU length of stay, hospital length of
stay, nosocomial infection
Notes FINANCIAL SUPPORT: Funding: Minas Gerais Research Foundation (Fundação de
Amparo à Pesquisa do Estado deMinas Gerais).Competing Interests: 1 author received
payment for lectures from bioMérieux. No others declared
ADDITIONAL DATA: online Microsoft Word document with additional information
about the criteria for stopping antibiotics, no response from authors to request for
additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation was performed using a ta-
ble of computer-generated random num-
bers
Allocation concealment (selection bias) Low risk Sealed, opaque envelopes were used for the
randomisation.
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Oliveira 2013 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 patient excluded from intervention and
2 from control. Outcomes measured on all
other randomised participants
Selective reporting (reporting bias) Low risk Duration of antibiotics measured from pa-
tient administration system
Other bias Unclear risk “Patients showing reduction in SOFA and
no sign of active infection were to receive
no more than 7 days of antibiotic therapy.
We used the
biomarker-guided protocols to further re-
duce this duration (i.e., to less than seven
days)”. This suggests that the ID physi-
cians imposed a ceiling of 7 days’ treatment
for these patients for both intervention and
control groups
Study did not achieve required recruit-
ment.
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk PCT only measured for intervention
group.
Baseline characteristics similar? Low risk Table 1
Oosterheert 2005
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: hospital physicians
PATIENTS: inpatients with LRTI, 107 randomised (55 intervention, 52 control)
CLINICAL PROBLEM: admitted to hospital for treatment of LRTI
SETTING: 2 Dutch hospitals
Interventions FORMAT: Interventions: educational meetings; dissemination of written information
about study procedures, test characteristics discussed and results from previous studies;
structural, rapid laboratory testing (PCR) for viral and atypical bacterial pathogens
Intervention Functions: education, environmental restructuring
DELIVERER: specialist physician (Medical Microbiology)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
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Oosterheert 2005 (Continued)
POWER CALCULATION: yes, a total of 100 patients. Details in Appendix 3
Outcomes PRESCRIBING: Exposure:% patients treated
CLINICAL: mortality, median duration of antibiotic treatment
FINANCIAL: cost of hospitalisation, all diagnostic and treatment costs
Notes FINANCIAL SUPPORT: Funding: Association of Academic Hospitals and the Dutch
Health Insurance Council (grant 01233). Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients were randomly allocated ... by
means of a computer generated table”
Allocation concealment (selection bias) High risk Allocation by investigators
Blinding (performance bias and detection
bias)
All outcomes
High risk Investigators were not blinded to patient
randomisation.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Reported on all 107 patients
Selective reporting (reporting bias) Low risk
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk Test data only reported for intervention pa-
tients.
Baseline characteristics similar? High risk “slightly more patients in the interven-
tion group had received previous antibiotic
treatment ”: 42% vs 23%, which is not
“slighly more”
Ostrowsky 2014
Methods STUDY DESIGN: CITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospitals
PARTICIPANTS: all patients in the hospitals
CLINICAL PROBLEM: reduce use of antibiotics considered high risk for Clostridium
213Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ostrowsky 2014 (Continued)
difficile infection
SETTING: 10 hospitals in the USA, 6 intervention and 4 control
Interventions FORMAT: Interventions: educational meetings (6 hospitals), dissemination of algo-
rithms (3 hospitals), educational outreach by review and recommend change (2 hospi-
tals), restrictive automatic stop order (1 hospital), unspecified “hospital wide restriction”
(3 hospitals)
NB the authors describe the intervention in 2 hospitals as “audit and feedback”, but
there was no feedback of data over time about progress to goal, just review with feedback
about individual patients
Intervention Functions: education, enablement, persuasion, restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive. Each intervention hospital did a case control
study to identify high-risk antibiotics; these were piperacillin tazobactam (6 hospitals),
fluoroquinolones (5 hospitals), or cefepime (2 hospitals)
Outcomes PRESCRIBING: Choice: use of target antibiotics in DDD/1000 OBD and in days of
therapy
MICROBIAL: C difficile infection (cases per 10,000 OBD)
Notes FINANCIAL SUPPORT: Funding: Agency for Healthcare Research and Quality; US
Department of Health and Human Services. Competing Interests: none declared
ADDITIONAL DATA: email response from authors with additional data about the
intervention used by each of the 6 intervention hospitals
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcome data from pharmacy and micro-
biology computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome data from pharmacy and micro-
biology computers
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data from pharmacy and micro-
biology computers
Free of selected reporting (ITS) ? Low risk Outcome data from pharmacy and micro-
biology computers
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Ostrowsky 2014 (Continued)
Free of other bias (ITS) ? High risk Intervention targets and intervention de-
sign were different in each of the 6 hospi-
tals.Microbial ROBMEDIUM: case defi-
nition low, planned intervention low, other
infection control UNCLEAR
Ozkaya 2009
Methods STUDY DESIGN: NRT
Risk of Bias: HIGH
Participants PROVIDERS: all staff in the ED
PARTICIPANTS: all children with influenza-like illness
CLINICAL PROBLEM: reduction in antibiotic prescribing for influenza
SETTING: 1 university hospital in Turkey
Interventions FORMAT: Intervention: structural, rapid laboratory test for influenza
Intervention Function: environmental restructuring
DELIVERER: specialist physicians, Department of Paediatrics
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure:% children prescribed antibiotics
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: email response from authors but no additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Does not say how groups were allocated
Allocation concealment (selection bias) Unclear risk Says there was blinding but unclear who
was blinded.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Says there was blinding but unclear who
was blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk All included
Selective reporting (reporting bias) Low risk Yes, all outcomes reported.
Other bias Low risk
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Baseline Outcomes similar? Unclear risk No baseline outcome data
Free of contamination? High risk Within same ward
Baseline characteristics similar? Low risk Yes, Table 1
Palmay 2014
Methods STUDY DESIGN: cluster RCT, stepped wedge, service level
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in 6 hospital services
PARTICIPANTS: all patients in 6 hospital services, 6 clusters (services)
CLINICAL PROBLEM: use of targeted antibiotics (carbapenems (ertapenem,
meropenem), piperacillin-tazobactam, 3rd-generation cephalosporins (ceftazidime, cef-
triaxone), fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin), and intravenous
vancomycin)
SETTING: 1 university hospital in Canada, 6 services: Neurosurgery, Orthopaedics,
Nephrology, General Internal Medicine, Cardiology, General Surgery/Trauma
Interventions FORMAT: Interventions: educational outreach by review and recommend change; re-
minders (circumstantial, physical, written recommendation on each patient reviewed)
NB the authors describe their intervention as “audit and feedback”, but there was no
feedback of data over time about progress to goal, just review with feedback about
individual patients.
Intervention Functions: enablement, environmental restructuring, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: no information
Outcomes PRESCRIBING: Choice: use of target antibiotics in days of therapy/1000 OBD
MICROBIAL: Clostridium difficile infection and infection with antibiotic-resistant or-
ganisms
FINANCIAL: time required to implement the intervention in critical-care wards is
described in Elligson 2012a.
Notes FINANCIALSUPPORT:Funding:OntarioMinistry ofHealth andCanadian Institutes
of Health Research. Competing Interests: none declared
ADDITIONAL DATA: email response with additional details about the intervention
from authors including Elligson 2012a describing the design and cost of implementing
the intervention in critical-care wards
Microbial Risk of Bias: MEDIUM: case definition low, unplanned intervention low,
other infection control UNCLEAR
Risk of bias
Bias Authors’ judgement Support for judgement
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Palmay 2014 (Continued)
Random sequence generation (selection
bias)
Low risk The order of implementation of the inter-
vention on the 6 clinical services was deter-
mined by random number generation per-
formed by a statistician uninvolved in daily
stewardship activities
Allocation concealment (selection bias) Low risk Following a 6-month control period dur-
ing which none of the services received an-
timicrobial stewardship (1May 2010 to 31
October 2011), the intervention was intro-
duced to each additional service at 1-month
intervals, beginning on 1 November 2010.
By 1 April 2011, clinical rollout was com-
plete
Blinding (performance bias and detection
bias)
All outcomes
High risk Blinding was not possible.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Prescribing outcome data were from phar-
macy computer.
Selective reporting (reporting bias) Low risk Prescribing outcome data were from phar-
macy computer.
Other bias Low risk Unit of analysis was service, and clustering
was included in themodel. “Negative bino-
mial regression, accounting for clustering
at the level of service using random effects
as well as for secular and seasonal trends,
was used to compare overall targeted an-
timicrobial utilization in the control and
intervention periods for the analysis involv-
ing patients qualifying for the stewardship
intervention as well as the analysis of all ad-
mitted patients. The unit of analysis was
each service’s mean monthly targeted days
of therapy count. The covariates included
in these multivariable models were study
period, study month (as a continuous vari-
able), and season”
Baseline Outcomes similar? Low risk Table 4
Free of contamination? High risk Contamination could have occurred dur-
ing the rollout of intervention over 6
months
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Palmay 2014 (Continued)
Baseline characteristics similar? Low risk
Parienti 2011
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients receiving antibiotics in the hospital
CLINICAL PROBLEM: use of fluoroquinolones; the aim of the study was to assess the
effect of removing restriction
SETTING: 1 university hospital in France
Interventions FORMAT: no reliable prescribing data. The intervention was removal of restriction, but
only 1 prescribing outcome data point during restriction and 3 after restriction lifted.
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes MICROBIAL: monthly MRSA rate (%)
Notes FINANCIAL SUPPORT:Funding: Centre Hospitalier Universitaire de Caen and the
French Health Ministry (Programme Hospitalier de Recherche Clinique National).
Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk MRSA data from microbiology computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk MRSA data from microbiology computer
Incomplete outcome data addressed (ITS)
?
Low risk MRSA data from microbiology computer
Free of selected reporting (ITS) ? Low risk MRSA data from microbiology computer
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Parienti 2011 (Continued)
Free of other bias (ITS) ? Low risk MICROBIAL RISK OF BIAS: case de-
fiinition Low, planned intervention Low,
other infection control Low, use of al-
chohol-based hand rub (ABHR) un-
changed during period of fluoroquinolone
restriction (2001-2) and for 3 years after re-
striction lifted (2003-5). Data are also pre-
sented for a further 6 years of increased use
of ABHR (2006-11)
Parikh 2014
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all paediatric physicians in the hospitals
PARTICIPANTS: children aged 28 days to 2 years
CLINICAL PROBLEM: antibiotic use in children with a primary diagnosis of acute
bronchiolitis
SETTING: 41 hospitals in the USA
Interventions FORMAT: Intervention: publication of American Academy of Pediatricians (AAP)
bronchiolitis guidelines
Intervention Functions: education but no information about how the guidelines were
disseminated
DELIVERER: departmental physicians (Pediatrics)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure:% children treated with antibiotics
Notes FINANCIAL SUPPORT: Funding: Academic Pediatric Association. Competing In-
terests: none declared
ADDITIONAL DATA: no response from authors to request for additional data. AAP
2006 Bronchiolitis Guidelines downloaded
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data from patient administration systems
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Parikh 2014 (Continued)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from patient administration systems
Incomplete outcome data addressed (ITS)
?
Low risk Data from patient administration systems
Free of selected reporting (ITS) ? Low risk Data from patient administration systems
Free of other bias (ITS) ? Low risk Monthly data points for 20 months’ pre-
and 60 months’ postintervention. “Guide-
line published in October 2006. Study
phases: preguideline (November 2004 to
March 2005), postguideline early (Novem-
ber 2007 to March 2008), and postguide-
line late (November 2011 to March 2012)
. These time periods were selected for the
unadjusted analysis because they represent
3 bronchiolitis seasons, before and after
guideline publication; the 2006 to 2007
season was not included because this is the
year the guideline was published and was
a period of distribution and assimilation.
For the adjusted segmented regression anal-
ysis, publication of the guidelines, October
2006, was considered the event point.”
Patel 1989
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients requiring antibiotic treatment
SETTING: single hospital in the UK
Interventions FORMAT: Interventions: educational meetings with dissemination of guidelines; ed-
ucational outreach by review and recommend change; reminders (physical and verbal,
posters and intervention promoted at weekly ward meetings)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: pharmacist
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: expenditure on oral co-amoxiclav
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Patel 1989 (Continued)
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Only 5 months’ pre-intervention data, so
secular changes possible
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after)
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk No other apparent biases found.
Paul 2006
Methods STUDY DESIGN: cluster RCT, service level
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PATIENTS: all patients in the 3 hospitals (intervention 8 wards with 1245 patients, 297
with microbiologically documented infections; control 7 wards with 1081 patients, 273
with microbiologically documented infections), 15 clusters (wards)
CLINICAL PROBLEM: antibiotic prescribing
SETTING: 3 hospitals in 3 countries: Israel, Germany, and Italy
Interventions FORMAT: Intervention: reminders (circumstantial, triggered by prescription of antibi-
otics); structural, computer decision support system
Intervention Functions: education, enablement, environmental restructuring, persua-
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Paul 2006 (Continued)
sion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 1500 patients with microbiologically documented in-
fections. Details in Appendix 3
Outcomes PRESCRIBING: Choice: appropriate antibiotic treatments
COST: Costs, which included the estimated ecological cost of inappropriate antibiotic
treatment
CLINICAL: Balancing: length of stay, 30-day mortality
Notes FINANCIAL SUPPORT: Funding: EU Fifth Framework, Information Society Tech-
nologies, IST-9999-11459. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Wards were randomly allocated ... by
drawing a random code from a closed
opaque box”
Allocation concealment (selection bias) High risk Allocation could not be concealed.
Blinding (performance bias and detection
bias)
All outcomes
Low risk Primary outcome was measured by the
CDSS.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on all patients.
Selective reporting (reporting bias) Low risk The primary outcome was objective, based
on whether or not the prescriber selected
one of the CDSS top 3 recommendations
Other bias High risk Trial was underpowered for the primary
outcome measure.
Adjustment of drug costs for changes in
prices not necessary because the interven-
tion lasted only 6 months
Baseline Outcomes similar? Low risk Table 1, cohort study before trial
Free of contamination? Low risk Only intervention wards had CDSS.
Baseline characteristics similar? Low risk
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Pear 1994
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients requiring antibiotic treatment
SETTING: single university hospital in the USA
Interventions FORMAT: restrictive, no valid prescribing data
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes MICROBIAL: cases of CDAD per month (ITS data). Prevalence of clindamycin-resis-
tant Clostridium difficile
Notes FINANCIAL SUPPORT: none
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Enough data to account for seasonal vari-
ation, and infection control measures did
not change over study period
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
run chart with no statistical analysis
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? High risk Not done, the method of detection of C
difficile toxin changed from cell culture as-
say in the first 4 years of the study to a la-
tex test in the final year (5 months after the
start of clindamycin restriction)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? High risk Not done, change in method of testing for
C difficile during the study period (see case
definition).
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Pear 1994 (Continued)
Free of other bias (ITS) ? High risk Microbial Outcome Risk of Bias Cri-
teria: Case definition: NOT DONE In-
fection: diarrhoea with positive assay for
C difficile cytotoxin and antibiotic ther-
apy within the previous 60 days. How-
ever, the method of detection of toxin
changed from cell culture assay in the first
4 years of the study to a latex test in
the final year (5 months after the start of
clindamycin restriction). Planned interven-
tion: NOT DONE Response to an out-
break of CDAD starting 12 months before
restriction. Other infection control, isola-
tion, and IC practices: DONE Infection
control measures were identical in the year
before and after the start of clindamycin re-
striction. Hospital staff education and in-
creased availability of gloves and improve-
ment of environmental hygiene were im-
plemented a year before restriction of clin-
damycin with no apparent impact on the
frequency of new cases
Perez 2003
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: physicians, surgeons, paediatricians, obstetricians-gynaecologists, and in-
tensivists
PARTICIPANTS: adults and children with normal renal function
CLINICAL PROBLEM: inappropriate prescribing of antibiotics (specifically in relation
to intervals betweendoses of aminoglycosides and1st- and3rd-generation cephalosporins
for Intervention 1 and timing of surgical prophylaxis for Intervention 2)
SETTING: university hospital in Colombia
Interventions FORMAT: Interventions: Intervention 1: reminders (posters, not circumstantial); ed-
ucational meetings and dissemination of guidelines; restrictive by expert approval. In-
tervention 2: reminder (circumstantial, on blood pressure cuffs in operating theatre);
educational meetings and dissemination of guidelines
Intervention Functions: Intervention 1: education, environmental restructuring, per-
suasion. Intervention 2: education, enablement, environmental restructuring, persuasion
DELIVERER: pharmacists
COMPARISON: usual care
DESIRED CHANGE: Intervention 1: increase effective; Intervention 2: decrease ex-
cessive
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Perez 2003 (Continued)
Outcomes PRESCRIBING: Choice: reduction in incidence of incorrect antibiotic prescriptions
(dosing intervals and timing of surgical prophylaxis)
Notes FINANCIAL SUPPORT: Funding: International Clinical Epidemiology Network (IN-
CLEN, grant #1004-97-6501) and by Pontificia Universidad Javeriana (grant #12-24-
01- 31). Competing Interests: no information
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk > 1 year data pre- and postintervention
Analysed appropriately (ITS) ? Low risk Done in original paper: ARIMA analysis,
selected in preference to segmented regres-
sion analysis because of nonlinear outcome
data
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk No other apparent biases found.
Peto 2008
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the surgical ICU
PARTICIPANTS: adult patients in surgical ICU (excluding general surgical andmedical)
CLINICAL PROBLEM: excessive antibiotic use
SETTING: surgical ICU in a university hospital in Hungary
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Peto 2008 (Continued)
Interventions FORMAT: Interventions: educational outreach by review and recommend change; re-
strictive by expert approval
Intervention Functions: enablement, persuasion, restriction
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure: total antibiotic consumption (DDD per 100 patient days)
Notes FINANCIAL SUPPORT: no information
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Routine data from pharmacy
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Routine data from pharmacy
Incomplete outcome data addressed (ITS)
?
Low risk Routine data from pharmacy
Free of selected reporting (ITS) ? Low risk Routine data from pharmacy
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
Petrikkos 2007
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients requiring antibiotics
CLINICAL PROBLEM: decrease use of cephalosporins
SETTING: 1 university hospital in Greece
Interventions FORMAT: Intervention: restrictive by expert approval
Intervention Function: restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
226Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Petrikkos 2007 (Continued)
Outcomes PRESCRIBING: Choice: use of cephalosporins in DDD/100 OBD
MICROBIAL: % ESBL-producing Klebsiella pneumoniae and Escherichia coli
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: HIGH case definition Low, planned intervention Low, other
infection control Unclear, no data about other infection control measures
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy and microbiology
computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy and microbiology
computers
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy and microbiology
computers
Free of selected reporting (ITS) ? Low risk Data from pharmacy and microbiology
computers
Free of other bias (ITS) ? Unclear risk 1 year (6 x 2-monthly time points) pre- and
postintervention
Pires 2011
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all prescribers in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients receiving carbapenems
SETTING: 1 teaching hospital in Brazil
Interventions FORMAT: Intervention: restriction by removal from availability in the hospital
Intervention Function: restriction
DELIVERER: Infection Control Committee
COMPARISON: pre-intervention
227Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pires 2011 (Continued)
DESIRED CHANGE: reduction in use of targeted carbapenems and in resistance
Outcomes PRESCRIBING: Choice: use of target antibiotics
MICROBIAL: carbapenem resistance in Pseudomonas aeruginosa
Notes FINANCIAL SUPPORT: Funding: Fundo de Incentivo a Pesquisa e Eventos, Hospital
de Clinicas de Port Alegre. Competing Interests: none declared
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk No outbreak or other changes coincident
with intervention
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy and microbiology
computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy and microbiology
computers
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy and microbiology
computers
Free of selected reporting (ITS) ? Low risk Data from pharmacy and microbiology
computers
Free of other bias (ITS) ? Low risk Data for 18 months’ pre- and 3 years’
postintervention
Po 2012
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: reduce linezolid use
SETTING: 1 hospital in the USA
Interventions FORMAT: Interventions: Intervention 1: educational mettings or dissemination of ed-
ucational materials. Intervention 2: reminders, structural, circumstantial - computerised
physician order entry system (CPOE) and educational meetings or dissemination of
educational materials
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Po 2012 (Continued)
Intervention Functions: Intervention 1: education. Intervention 2: education, enable-
ment, environmental restructuring
DELIVERER: specialist physician
COMPARISON: usual care
DESIRED CHANGE: reduce inappropriate
Outcomes PRESCRIBING: Choice: linezolid use (DDD per 1000 patient days)
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Yes, reports on all likely influencing inter-
ventions.
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Yes, the point of analysis is the point of the
intervention.
Unlikely to affect data collection (ITS) ? Low risk Yes, pharmacy data used both pre- and
postintervention.
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome is objective.
Incomplete outcome data addressed (ITS)
?
Low risk Yes, pharmacy data, so should be complete.
Free of selected reporting (ITS) ? Low risk Yes, all outcomes reported.
Free of other bias (ITS) ? High risk < 1 year data for phases 1 and 2
Poehling 2006
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: doctors in the ED
PARTICIPANTS: children with influenza-like illness
CLINICAL PROBLEM: decrease antibiotic prescribing for influenza
SETTING: 1 university hospital in the USA
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Poehling 2006 (Continued)
Interventions FORMAT: Interventions: structural, rapid influenza testing
Intervention Functions: environmental restructuring
DELIVERER: specialist physicians, Department of Pediatrics
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure:% children treated
Notes FINANCIAL SUPPORT: Funding: New Vaccine Surveillance Network and Robert
Wood Johnson Generalist Physicians Faculty Scholars Program. Competing Interests:
none declared
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number generator
Allocation concealment (selection bias) Unclear risk Does not say, but possibly not due to nature
of study
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk From records, outcomes on all included
children
Selective reporting (reporting bias) Low risk From records, outcomes on all included
children
Other bias Low risk
Baseline Outcomes similar? Unclear risk No baseline outcomes taken.
Free of contamination? Low risk Influenza testing only on children in inter-
vention group
Baseline characteristics similar? Low risk Table 1
Popovski 2015
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients with intra-abdominal infections
230Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Popovski 2015 (Continued)
CLINICAL PROBLEM: decrease use of ciprofloxacin for empirical treatment
SETTING: 1 university hospital in Canada
Interventions FORMAT: Interventions: educational meetings with dissemination of guidelines; re-
minders (physical, posters, and on intranet)
Intervention Functions: education, environmental restructuring
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of ciprofloxacin in DDD/1000 OBD
CLINICAL: mortality, re-admission (cohort data)
Notes FINANCIAL SUPPORT: Funding: commercial Merck, Pfizer, Astellas, and the Med-
buy Corporation. HamiltonHealth Sciences Foundation (JackHirsh Fellowship).Com-
peting Interests: 1 author received honoraria from Merck and Astellas for lectures. All
other authors: none to declare
ADDITIONALDATA: email response from authors with guideline and additional data
about the intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcome data from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Outcome data from pharmacy computer
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
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Price 2010
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: requiring antibiotic treatment or prophylaxis
SETTING: 1 university hospital in the UK
Interventions FORMAT: Interventions: dissemination of guidelines; restrictive by removal and expert
approval
Intervention Functions: education, restriction
Note that the published paper says: “The policy was widely disseminated in the hospital
but no specificmeasureswere put in place to enforce compliance”.However, the antibiotic
policy provided by the authors says: “Cephalosporins and fluoroquinolones. These agents
will NOT be ward stock on any general medical or surgical wards - continuation of
therapy beyond 24 hours (inMedicine) and single dose prophylaxis (in Surgery) requires
consultant review, prescription by consultant and discussion with Micro ID”
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of cephalosporins and quinolones (combined) in DDD/
1000 OBD
MICROBIAL: Clostridium difficile infection
Notes FINANCIAL SUPPORT: Funding: part commercial, Optimer Pharmaceuticals and
US Department of Veterans Affairs. Competing Interests: 1 author declared multiple
commercial sources of research funding and held patents relevant to C difficile infection
licensed to ViroPharma
ADDITIONAL INFORMATION: authors provided the 2008 version of the hospital
antibiotic policy, which included details about the restrictions on use of target drugs
Microbial Risk of Bias MEDIUM: case definition yes, planned intervention yes, in-
fection control no (a cohorting ward was introduced at the same time as the antibiotic
policy)
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk For prescrbiing outcome
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Pharmacy computer
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Price 2010 (Continued)
Incomplete outcome data addressed (ITS)
?
Low risk Pharmacy computer
Free of selected reporting (ITS) ? Low risk Pharmacy computer
Free of other bias (ITS) ? High risk 1 year data pre- and postintervention
Microbial Risk of Bias: cohorting intro-
duced at the same time as prescribing in-
tervention
Pulcini 2011
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the Medical ICU
PARTICIPANTS: all patients in the ICU
CLINICAL PROBLEM: receiving antibiotics for 24 h to 96 h
SETTING: 1 university hospital in France
Interventions FORMAT: Interventions: audit and feedback; educational outreach by academic de-
tailing; reminders (physical, circumstantial, stickers placed in notes of patients receiving
target antibiotics)
Intervention Functions: enablement, environmental restructuring, persuasion
DELIVERER: departmental physician (ICU consultant)
COMPARISON: usual care
DESIRED CHANGE: increase appropriate
Outcomes PRESCRIBING: Choice:% appropriate treatment
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL INFORMATION: email from authors with additional information
about intervention. The intervention design is described in more detail in Pulcini 2008.
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk
Unlikely to affect data collection (ITS) ? Low risk Primary outcome was appropriateness of
treatment at 24 to 96 hours, which was the
same in pre- and postintervention period
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Pulcini 2011 (Continued)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Dual data entry, the ICU consultant was
blinded to study period, although the ID
physician was not
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data on all participants
Free of selected reporting (ITS) ? Low risk No evidence of selective reporting
Free of other bias (ITS) ? High risk < 1 year of data (25 weeks) in the pre- and
postintervention phases
Qu 2012
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the ICU
PARTICIPANTS: 71 patients with with confirmed severe acute pancreatitis
CLINICAL PROBLEM: PCT for guiding duration of antibiotic therapy
SETTING: 1 hospital in China
Interventions FORMAT: Interventions: reminders (circumstantial, decision support algorithm with
each PCT test); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: department physician (ICU)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure: duration of all antibiotic treatment
CLINICAL: Balancing: mortality and length of stay
FINANCIAL: cost of hospitalisation, but no information about cost of intervention
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Says it was randomised, but no further in-
formation
Allocation concealment (selection bias) Unclear risk No information
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No mention of blinding
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Qu 2012 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes on all 71 participants
Selective reporting (reporting bias) Low risk
Other bias Low risk
Baseline Outcomes similar? Unclear risk No information
Free of contamination? Low risk PCT results only reported for intervention
participants.
Baseline characteristics similar? Low risk Yes, Table 1
Rattanaumpawan 2010
Methods STUDY DESIGN: NRT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: 953 hospitalised adults (1028 prescriptions)
CLINICAL PROBLEM: receiving treatment with piperacillin/tazobactam, imipenem,
and meropenem
SETTING: 1 hospital in Thailand
Interventions FORMAT: Interventions: educational outreach by review and recommend change
Intervention Functions: education, enablement, persuasion, restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: reduce excessive
Outcomes PRESCRIBING: Choice: use of target antibiotics
CLINICAL: Balancing: mortality, length of stay
FINANCIAL: cost of target antibiotics and all antibiotics. No information about cost
of intervention
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: email from authors but no additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk By hospital number, even number in last
digit received intervention
Allocation concealment (selection bias) High risk Not concealed
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Rattanaumpawan 2010 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Complete data reported.
Selective reporting (reporting bias) High risk Some outcomes (favourable clinical out-
come, death from infection) subject to se-
lective outcome reporting. No discussion
of why there was a significant difference for
death because of infection but no differ-
ence in the % of patients alive on discharge
from hospital
Other bias Low risk
Baseline Outcomes similar? Unclear risk Baseline frequency of inappropriate treat-
ment was 50% in January 2007, but no in-
formation about risk of inappropriate treat-
ment in the control group in August 2007
Free of contamination? High risk Invervention and control participants were
in the same hospital, and physicians were
likely to have patients in both groups
Baseline characteristics similar? Low risk Table 1
Rattanaumpawan 2011
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: adult patients receiving antibiotics
CLINICAL PROBLEM: unnecessary double coverage for infection with anaerobic bac-
teria
SETTING: 1 hospital in Thailand
Interventions FORMAT: Interventions: restrictive by prior approval, the intervention was removal of
this restriction
Intervention Functions: restriction
DELIVERER: AMT
COMPARISON: unnecessary treatment before and after removal of the restriction
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: cumulative incidence of unnecessary treatment in DDD/
admission
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Rattanaumpawan 2011 (Continued)
Notes FINANCIALSUPPORT:Funding:National Institutes ofHealth grant K24-AI080942.
Competing Interests: 1 author received research support from Merck, Ortho-McNeil,
Cubist, and AstraZeneca
ADDITIONAL DATA: email response from authors but no additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk 1 year of data pre- and postintervention
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? High risk Primary outcome (unnecessary DACT)
not objective.
Knowledge of the allocation adequately
prevented(ITS)?
High risk Primary outcome (unnecessary DACT)
not objective.
Incomplete outcome data addressed (ITS)
?
High risk Figure 1 includes 4 months with no unnec-
essary DACT, but it is not clear whether
this was because there was no DACT or
because all DACT was necessary. With the
exception of July 2008, these months had
relatively high use of ampicillin/sulbactam
and metronidazole, so suggests theymissed
some DACT patients
Free of selected reporting (ITS) ? Unclear risk Not clear if outcome was reported on all
patients.
Free of other bias (ITS) ? Low risk
Richards 2003
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients except ICU, ER, ID
CLINICAL PROBLEM: receiving treatment with target antibiotics
SETTING: 1 university hospital in Australia
Interventions FORMAT: Interventions: audit and feedback; educational meetings with dissemination
of guidelines; reminders (circumstantial and physical, on computer order form when
237Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Richards 2003 (Continued)
prescribing antibiotics); restrictive by compulsory order form, expert approval, and re-
moval
Intervention Functions: education, enablement, environmental restructuring, persua-
sion, restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: reduction in established management (reduction in use of target
drugs)
Outcomes PRESCRIBING: Choice: Primary: use of cefotaxime or ceftriaxone
Secondary: use of other antibiotics: gentamicin, benzyl penicillin, carbapenems,
piperacillin, ticarcillin, and ciprofloxacin
FINANCIAL: cost of intervention
Notes FINANCIAL SUPPORT: Funding: Royal Melbourne Hospital. Competing Interests:
none declared.
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk 8months data pre-intervention, 15months
postintervention, not enough to adjust for
seasonal variation
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after) with Kruskal-Wallis test
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk No other apparent biases found.
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Richardson 2000
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital. Number, age, and time since qualification
NOT CLEAR. 3 intensive care units, 3 general medical, and 1 general surgical
PARTICIPANTS: a total of 618 episodes of vancomycin use (220 pre- and 398 postin-
tervention). Number of patients, age, gender, and ethnicity NOT CLEAR.
CLINICAL PROBLEM: patients requiring antibiotic treatment
SETTING: single tertiary-care teaching hospital in the USA with 150 acute care and 90
long-term care beds
Interventions FORMAT: Interventions: educational outreach by review and recommend change
Intervention Functions: enablement, persuasion
COMPARISON: data for 3 months in the previous year (April, August, and January)
DESIREDCHANGE: decrease excessive (reduction in inappropriate use of vancomycin
with the aim of reducing prevalence of VRE infections)
Outcomes PRESCRIBING: Choice:% episodes of vancomycin use deemed inappropriate
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Data only collected for 3 months pre- and
6 months postintervention, so secular/sea-
sonal changes possible
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Unclear risk The reliability of the assessment of appro-
priate vancomycin use was not reported
Knowledge of the allocation adequately
prevented(ITS)?
High risk Retrospective assessment of appropriate-
ness without concealment of study phase
Incomplete outcome data addressed (ITS)
?
High risk Assessment of appropriateness from retro-
spective assessment of all patients treated in
1month but only done every 4 to 6months
Free of selected reporting (ITS) ? Unclear risk Not clear, data were only collected inter-
mittently.
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Free of other bias (ITS) ? Low risk No other apparent biases found.
Ross 2014
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all paediatricians in the hospitals
PARTICIPANTS: children with community-acquired pneumonia
CLINICAL PROBLEM: increase use of guideline-recommended antibiotics
SETTING: 38 hospitals in the USA
Interventions FORMAT: Intervention: dissemination of national guidelines
Intervention Function: education
DELIVERER: specialist physicians
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice:% patients treated with guideline-recommended antibiotics
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: 1 author has received
research funding fromMerck and Cubist and has served as a consultant forMerck, Pfizer,
Astellas Pharma, and Cubist, and 3 authors have received research funding from Pfizer
ADDITIONALDATA: email fromauthorswith no additional data. Paediatric infectious
diseases guidelines available online (cid.oxfordjournals.org/content/early/2011/08/30/
cid.cir531.full)
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcome data fromPediatricHealth Infor-
mation System
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome data fromPediatricHealth Infor-
mation System
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data fromPediatricHealth Infor-
mation System
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Ross 2014 (Continued)
Free of selected reporting (ITS) ? Low risk Outcome data fromPediatricHealth Infor-
mation System
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
Saizy-Callaert 2003
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients requiring antibiotic treatment
SETTING: single 600-bed university hospital in France
Interventions FORMAT: Interventions: educational meetings and dissemination of protocol; re-
minders (physical, pocket-size guideline); restrictive by compulsory order form and ex-
pert approval
Intervention Functions: education, environmental restructuring, restriction
COMPARISON: data for 3 years after implementation of the programme
DESIRED CHANGE: reduce excessive
Outcomes PRESCRIBING: Choice: anti-infective expenditure per hospital patient
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk 4 years’ data pre- and 3 years’ data postin-
tervention, so enough data to account for
seasonal change
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after) with Fisher’s exact test
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
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Saizy-Callaert 2003 (Continued)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
High risk There is no information about change in
price of antibiotics over the study period
Free of selected reporting (ITS) ? Unclear risk The intervention was targeted at specific
antibiotics, but no information is provided
about their use or cost
Free of other bias (ITS) ? Unclear risk No adjustment of antibiotic costs for
change in price, so change in price of an-
tibiotics (rather than change in use) over
the study period may have been responsi-
ble for reduction in cost per patient over
the study period. No data about number of
admissions pre-intervention
Salama 1996
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: requiring antibiotic therapy
SETTING: 1 university hospital in Canada
Interventions FORMAT: Interventions: audit and feedback; educational meetings with dissemination
of guidelines; educational outreach by academic detailing; reminders (circumstantial,
physical, and verbal: newsletters, posters, pocket charts, educational rounds, and triggered
by prescribing of target drugs); reminders (physical); restrictive by compulsory order
form plus automatic 3-day stop order for all antibiotics and review and make change
(therapeutic substitution of selected drugs)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion, restriction
DESIRED CHANGE: reduction in vancomycin and ceftazidime use
Outcomes PRESCRIBING: Choice: vancomycin and ceftazidime use in units, antibiotic cost as a
percentage of total drug cost
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
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Salama 1996 (Continued)
Intervention independent (ITS) ? Low risk > 12 months’ data pre- and postinterven-
tion, enough to account for seasonal change
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after)
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk No other apparent biases found.
Schnoor 2010
Methods STUDY DESIGN: cluster RCT, hospital level
Risk of Bias: HIGH
Participants PROVIDERS: doctors managing patients with community-acquired pneumonia
PARTICIPANTS: 623 patients with community-acquired pneumonia (275 interven-
tion, 348 control), 8 clusters (hospitals)
CLINICAL PROBLEM: community-acquired pneumonia
SETTING: 8 hospitals in Germany
Interventions FORMAT: Interventions: audit and feedback; educational meetings with dissemination
of guideline; reminders (physical, posters, electronic and pocket versions of guideline)
Intervention Functions: education, enablement, environmental restructuring
DESIRED CHANGE: increase in compliance of initial treatment with guideline rec-
ommendation and decrease in duration of treatment
POWER CALCULATION: no information
Outcomes PRESCRIBING: Choice:% guideline compliant for initial treatment
CLINICAL: Balancing: mortality, length of stay
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Schnoor 2010 (Continued)
Notes FINANCIAL SUPPORT: Funding: German Medical Assembly grant 06-69 and Ger-
man Federal Ministry of Education and Research grant 01K10103-105. Competing
Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer, by hospital
Allocation concealment (selection bias) Low risk
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not clear who collected outcome data or
whether they were blinded to allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk All outcome data given as %, so unclear if
some patients were missing
Selective reporting (reporting bias) Unclear risk No details of data collection
Other bias High risk Intervention period (1 April 2007 to 29
February 2008) was different than control
period (1 September 2006 to 28 February
2007)
Baseline Outcomes similar? High risk Duration of inpatient antibiotic at baseline
was appropriate in only 47% intervention
(versus 57% control)
Free of contamination? Low risk Randomised by site
Baseline characteristics similar? High risk 75% inpatients in control group versus
50% for intervention, also fewer CURB 0
and more CURB 3
Schouten 2007
Methods STUDY DESIGN: cluster RCT, hospital level
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians
PARTICIPANTS: 827 patients with lower respiratory tract infection (before interven-
tion, 212 intervention, 166 control; after intervention, 276 intervention, 166 control).
6 clusters (hospitals)
CLINICAL PROBLEM: patients with lower respiratory tract infection
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SETTING: 6 hospitals in the Netherlands
Interventions FORMAT: Interventions: audit and feedback; educational meetings with dissemination
of guideline; educational outreach by academic detailing; reminders (physical, desktop
on computers, and pocket card)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: AMT
COMPARISON: usual care
DESIREDCHANGE: decrease excessive (choice and streamlining) and increase effective
(timeliness)
POWER CALCULATION: no information
Outcomes PRESCRIBING:Choice:%patients compliant with guideline for selected drug, timing
(within 4 h of presentation), switching from IV to oral and streamlining
CLINICAL: Balancing: mortality, length of stay
Notes FINANCIAL SUPPORT: Funding:TheNetherlandsOrganisation for Health Research
and Development (Zon/Mw; 2300.0024). Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Blinded researcher coin flip, hospital level
Allocation concealment (selection bias) Low risk Allocation at hospital level
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data for all patients
Selective reporting (reporting bias) Unclear risk All relevant outcomes reported.
Other bias Low risk
Baseline Outcomes similar? Low risk Table 3, also pair-matched clusters for im-
portant variables
Free of contamination? Low risk Allocation at hospital level
Baseline characteristics similar? Low risk No clinically relevant differences
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Schroeder 2009
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the ICU
PARTICIPANTS: all patients with sepsis in the ICU
CLINICAL PROBLEM: receiving antibiotics for suspected intra-abdominal sepsis
SETTING: 1 university hospital in Germany
Interventions FORMAT: Interventions: reminders (circumstantial, decision support algorithm with
each PCT test); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: departmental physicians
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: no information
Outcomes PRESCRIBING: Exposure: duration of antibiotic treatment (days)
CLINICAL: Balancing: length of hospital stay
Notes FINANCIAL SUPPORT: Funding: none declared.Competing Interests: 1 author had
speaking engagements for B.R.A.H.M.S AG.
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information
Allocation concealment (selection bias) Unclear risk No information
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on all patients.
Selective reporting (reporting bias) Low risk Outcomes reported on all patients.
Other bias High risk Only 27 of 125 screened patients were ran-
domised.
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk PCT only measured for intervention pa-
tients.
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Baseline characteristics similar? Low risk Table 1
Schuetz 2009
Methods STUDY DESIGN: RCT
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians
PARTICIPANTS: 1381 patients with lower respiratory tract infection randomised (687
intervention, 694 control), 6 clusters (hospitals)
CLINICAL PROBLEM: lower respiratory tract infection
SETTING: 6 hospitals in Switzerland
Interventions FORMAT: Interventions: reminders (circumstantial, decision support algorithm with
each PCT test); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: departmental physician (respiratory)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 1002 participants total. Details in Appendix 3
Outcomes PRESCRIBING: Exposure:% patients treated
Notes FINANCIAL SUPPORT: Funding: grant SNF 3200BO-116177/1 from the Swiss Na-
tional Science Foundation and contributions from santésuisse and the Gottfried und
Julia Bangerter-Rhyner Foundation and participating hospitals. B.R.A.H.M.S Inc, the
major manufacturer of the procalcitonin assay, provided all assay-related material, Kryp-
tor machines if not already available on site, and kits and maintenance required for 10,
000 measurements related to the study
Competing Interests: 3 authors received support from B.R.A.H.M.S Inc to attend
meetings and fulfil speaking engagements, and 1 author served as a consultant and
received research support from B.R.A.H.M.S Inc
ADDITIONAL DATA: authors provided additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Prespecified, computer-generated
randomisation list
Allocation concealment (selection bias) Low risk Centralised, password-protected website
Blinding (performance bias and detection
bias)
All outcomes
Low risk Password-protected website with instruc-
tions for PCT and control groups
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Schuetz 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 1 of 1381 patients lost to follow-up;
16 (2%) patients in PCT group and 6 (1%)
patients in control group withdrew
Selective reporting (reporting bias) Low risk > 95% surviving patients completed 30-
day interview.
Other bias Low risk
Baseline Outcomes similar? Unclear risk No baseline outcome data
Free of contamination? High risk The study was conducted in 6 hospitals,
but patients in each hospital were in both
intervention and control groups
Baseline characteristics similar? Low risk Table 1
Schwann 2011
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians
PARTICIPANTS: all patients undergoing elective surgery requiring antibiotic prophy-
laxis
CLINICAL PROBLEM: timing of first dose of antibiotic
SETTING: 1 hospital network in the USA
Interventions FORMAT: Interventions: reminders (circumstantial and physical, point-of care elec-
tronic prompt (triggered by operating room admission)); reminders (physical); restric-
tive; structural
Intervention Functions: enablement, environmental restructuring
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: % patients with first dose administered within 1 hour of
incision
CLINICAL: Intended: surgical-site infection
Notes FINANCIAL SUPPORT: Funding: Lehigh Valley Hospital Network and Allentown
Anesthesia Associates. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
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Schwann 2011 (Continued)
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Statistical process control charts
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Electronic data for prescribing
Knowledge of the allocation adequately
prevented(ITS)?
Unclear risk Infection control personnel were blinded
for assessment of wound infection, unsure
about compliance data
Incomplete outcome data addressed (ITS)
?
Low risk Electronic data for prescribing
Free of selected reporting (ITS) ? Low risk Electronic data for prescribing
Free of other bias (ITS) ? Low risk 1 year data pre- and postintervention
Schwartz 2007
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the long-term care facility
PARTICIPANTS: all patients receiving antibiotics
CLINICAL PROBLEM: patients receiving antimicrobials
SETTING: 1 hospital
Interventions FORMAT: Interventions: educational meetings with dissemination of guidelines and
treatment algorithms; reminders (physical, pocket guidelines)
The guideline has 16 algorithms formanagement of clinical problems (fever, leukocytosis,
confusion, diarrhoea) and common infections in older people.
Intervention Functions: education, environmental restructuring
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure: antibiotic days/100 OBD
Notes FINANCIAL SUPPORT: Funding: Chicago Antimicrobial Resistance Project, Centers
for Disease Control and Prevention (U50/ CCU515853). Competing Interests: no
information
ADDITIONAL DATA: email response with the guideline. The guidelines are supposed
to be available online, but the link does not work
Risk of bias
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Schwartz 2007 (Continued)
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Days of antimicrobial use calculated auto-
matically by pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Days of antimicrobial use calculated auto-
matically by pharmacy computer
Incomplete outcome data addressed (ITS)
?
Unclear risk 1 and 2 January 2000 start data were cen-
sored, but thiswas reported andwould have
little impact on the other 48 data points
Free of selected reporting (ITS) ? Unclear risk Days of antimicrobial use calculated auto-
matically by pharmacy computer
Free of other bias (ITS) ? High risk Only 10 months’ pre-intervention data, so
secular trends could not be addressed
Senn 2004
Methods STUDY DESIGN: RCT
Risk of bias: MEDIUM
Participants PROVIDERS: residents on medical and surgical wards
PATIENTS: 251 patients were recruited, 126 intervention and 125 control
CLINICAL PROBLEM: adult patients receiving IV antibiotics for 3 to 4 days with no
modification since starting treatment
SETTING: single 800-bed university hospital in Switzerland. Data collected over 5
months
POWER CALCULATION: yes, 135 patients in each group, but the trial was under-
powered because the observed effect was lower than predicted. Details in Appendix 3
Interventions FORMAT: Interventions: dissemination of questionnaire about guidelines; reminders
(circumstantial and physical, questionnaire mailed to the resident in charge of patients
who were receiving IV antibiotic treatment. The questionnaire asked 3 questions regard-
ing possible adaptation of antibiotic therapy on day 3 or 4, and was collected 24 hours
later. If the resident had not yet completed it at that time, he/she was reminded once to
do so.)
Intervention Functions: education, enablement, environmental restructuring
DELIVERER: AMT
COMPARISON: control patients with no intervention
DESIRED CHANGE: reduction in established management (reduction in duration of
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Senn 2004 (Continued)
IV therapy)
TIMING: intervention at the point of decision making (potential modification 3 to 4
days after start of antibiotics)
Outcomes PRESCRIBING: Choice: % of patients discontinuing IV antibiotics and hazard ratio
adjusted for patients’ Karnofsky functional index
Notes FINANCIAL SUPPORT: Funding:Quality Improvement Committee of the Lausanne
University Hospital and grant 32-63128.00 of the Swiss National Science Foundation.
Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients allocated ... by using a computer
generated randomizations list”
Allocation concealment (selection bias) Low risk “Concealment of allocation was achieved
as the physician in charge of the patient was
involved after randomizations”
Blinding (performance bias and detection
bias)
All outcomes
High risk “This was a randomised, controlled, open
trial”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Primary outcome measure (duration of IV
antibiotics) collected on all patients. Only
70% of questionnaires returned for the in-
tervention group, which could account for
the intervention effect being lower than ex-
pected. However, this did not affect out-
come assessment
Selective reporting (reporting bias) Low risk Complete primary outcome data
Other bias High risk The study was underpowered.
Baseline Outcomes similar? Low risk Pre-study group, data collected for 2
months before intervention to estimate
the magnitude of possible observation bias
(Figure 2)
Free of contamination? Low risk The pre-intervention groupdatawere com-
parable to the control group, suggesting
minimal observation bias
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Senn 2004 (Continued)
Baseline characteristics similar? Low risk Presented in Table 1
Shehabi 2014
Methods STUDY DESIGN: RCT
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the ICU
PARTICIPANTS: 400 patients; 6 withdrew consent, leaving 196 in the intervention
and 198 in the control group
CLINICAL PROBLEM: patients with suspected sepsis and likely to receive antibiotics/
remain in the ICU for at least 24 h
SETTING: 11 university hospitals in Australia
Interventions Interventions: reminders (circumstantial, decision support algorithm with each PCT
test); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: departmental physicians (ICU)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, 165 participants per group. Details in Appendix 3
Outcomes PRESCRIBING: Exposure: duration of antibiotic treatment (days)
CLINICAL: mortality, re-admission, and length of hospital stay
Notes FINANCIAL SUPPORT: Funding: Intensive Care Foundation of Australia and New
Zealand.Material support was provided by RocheDiagnostics, Thermo Fisher Scientific,
and bioMérieux. Roche Diagnostics and Thermo Fisher Scientific provided additional
unrestricted grant funding. Competing Interests: none declared
ADDITIONAL DATA: email from authors with additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Patients were variable block randomised 1:
1 via a secured central study website into
either a PCT-guided (PCT) group or clin-
ician-guided (standard care) group. Ran-
domisation was stratified according to the
presence of septic shock (defined by the re-
ceipt of inotropes and/or any vasopressors
within the previous 24 hours)
Allocation concealment (selection bias) Low risk See above
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Shehabi 2014 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk Single-blind
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on 196/200 interven-
tion and 198/200 control participants
Selective reporting (reporting bias) Low risk
Other bias Low risk 1567 patients screened, but 1167 excluded;
full details of how many patients met each
of the exclusion criteria (Figure 1)
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk PCT only reported for intervention partic-
ipants.
Baseline characteristics similar? Low risk Table 1
Shen 2011
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians on 2 respiratory wards
PARTICIPANTS: all patients on the wards
CLINICAL PROBLEM: receiving antibiotics for respiratory infection
SETTING: 1 hospital
Interventions FORMAT: Interventions: educational outreach by review and recommend change
Intervention Functions: enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: no information
Outcomes PRESCRIBING: Choice: score on 6 indicators of inappropriate antibiotic use: indica-
tion, choice, dosage, dosing schedule, duration, conversion
CLINICAL: Balancing: length of stay
FINANCIAL: cost (mean, SD) of antibiotics and total patient costs
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
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Shen 2011 (Continued)
Random sequence generation (selection
bias)
Unclear risk Says it was randomised, no further infor-
mation.
Allocation concealment (selection bias) High risk Patients from 2 wards were randomised,
and there is no information about alloca-
tion concealment
Blinding (performance bias and detection
bias)
All outcomes
Low risk “At the end of the study, a blinded coor-
dinating investigator recorded the patients’
data”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes reported.
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk
Baseline Outcomes similar? Unclear risk No information
Free of contamination? High risk Intervention and control patients were on
both wards.
Baseline characteristics similar? Low risk Table 1
Shojania 1998
Methods STUDY DESIGN: RCT with nested ITS analysis (Figures 3 and 4)
Risk of Bias: HIGH
Participants PROVIDERS: unit of randomisation - 396 physicians in 7 specialties. Non-physicians
(nurses or pharmacists)whowere authorised to enter orders that required eventual signing
off by physicians were also randomised.
PARTICIPANTS: There were 5536 episodes of care in 1798 patients.
CLINICAL PROBLEM: receiving vancomycin treatment
SETTING: 1 university hospital in the USA
Interventions FORMAT: Interventions: dissemination of guideline; reminders (circumstantial, deliv-
ered through computer screen at the time of physician order entry and after 72 hours
of therapy). The reminder required prescribers to produce a response: when someone
would enter an order for intravenous vancomycin, a pop-up screen would appear and
display the appropriate indications for vancomycin use, which was a checkbox list of
indications based on CDC guidelines. Users had to pick a reason or enter free text under
’other’ in order to proceed
Intervention Functions: education, enablement, environmental restructuring
DELIVERER: AMT
COMPARISON: no reminder. ITS analysis used 9 months’ pre-intervention data.
DESIRED CHANGE: reduction of established management (reduction in use of van-
254Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Shojania 1998 (Continued)
comycin)
POWER CALCULATION: no information
Outcomes PRESCRIBING: Choice: initiation and renewal of vancomycin therapy. Duration of
vancomycin therapy on a per-prescriber basis. Total use of vancomycin in the hospital
FINANCIAL: estimated savings
Notes FINANCIAL SUPPORT: Funding: grant R01-HS08927 from the Agency for Health-
care Policy and Research. Competing Interests: no information
ADDITIONAL DATA: email from authors with additional details about the interven-
tion
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The study was a randomised controlled
trial”; no details on how randomisation se-
quence was generated
Allocation concealment (selection bias) High risk States “possible that physicians in the con-
trol group could learn of the intervention
from physicians in the study group”
Blinding (performance bias and detection
bias)
All outcomes
High risk Not done
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not clear for primary outcome
Selective reporting (reporting bias) Low risk Based on numbers of vancomycin orders
Other bias Low risk No issues noted.
Baseline Outcomes similar? Unclear risk No information about pre-intervention
vancomycin use
Free of contamination? High risk States “possible that physicians in the con-
trol group could learn of the intervention
from physicians in the study group”
Baseline characteristics similar? Low risk Table 1
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Singh 2000
Methods STUDY DESIGN: RCT, allocation by patient
Risk of Bias: HIGH
Participants PROVIDERS: all physicians on 1 ICU
PARTICIPANTS: 81 episodes of care (39 intervention, 42 control)
CLINICAL PROBLEM: suspected ventilator-associated pneumonia with low CPIS
SETTING: 1 hospital in the USA
Interventions FORMAT: Intervention: restrictive by expert approval and review and make change
Intervention Function: restriction
DELIVERER: ID physician
COMPARISON: choice, number, and duration of antibiotics at the discretion of the
care providers
DESIRED CHANGE: reduction of established management (reduction in duration of
antibiotic treatment)
POWER CALCULATION: yes, 88 patients per group. The study was terminated early.
Details in Appendix 3
Outcomes PRESCRIBING: Exposure: total duration of all antibiotic treatment
CLINICAL: Balancing: mortality, length of ICU stay
MICROBIAL: number of patientswith “antimicrobial resistance and/or superinfections”
from randomisation until hospital discharge
FINANCIAL: total costs of care for patients with CPIS < 6 at 3 days and no extrapul-
monary infections
Notes FINANCIAL SUPPORT: Funding: Bayer Corporation. Competing Interests: no in-
formation
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients were randomized to either the
control group or experimental group”; no
information about how randomisation se-
quence was generated
Allocation concealment (selection bias) Unclear risk Not stated
Blinding (performance bias and detection
bias)
All outcomes
High risk Page 509: “Because the study was not
blinded, physicians and care providers
could see the results”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Most outcomes are reported for 78 (96%)
episodes of care; antimicrobial resistance
and superinfection in 74 (91%) of episodes
Selective reporting (reporting bias) Low risk No problems found.
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Singh 2000 (Continued)
Other bias High risk Microbial Risk of Bias HIGH. Case
definition for microbial outcome NOT
CLEAR: “Follow-up respiratory cultures
or cultures from clinical specimens per-
formed 7 to 28 d after initiation of an-
tibiotics were evaluated to assess the emer-
gence of antimicrobial resistance or super-
infections. Emergence of resistance was de-
fined as the detection of new antimicrobial
resistance pattern in the old or previously
isolated organism. Superinfection was de-
fined as the detection of the following or-
ganisms not present at study entry: Acine-
tobacter species, Serratia marcescens, Pseu-
domonas aeruginosa, Stenotrophomonas mal-
tophilia, Enterobacter species, Citrobacter
species, methicillin-resistant Staphylococcus
aureus (MRSA), Enterococcus species, and
Candida species.” It is therefore impossible
to assess the impact of the intervention on
colonisation or infection with bacteria re-
sistant to specific antibiotics. Infection con-
trol NOT CLEAR. Planned intervention
YES
Baseline Outcomes similar? Unclear risk Not stated, no information about pre-in-
tervention duration of antibiotic treatment
Free of contamination? Unclear risk Not stated
Baseline characteristics similar? Low risk See Table 1 in study.
Sirinavin 1998
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients requiring treatment with imipenem vancomycin or
injectable ciprofloxacin
SETTING: 1 hospital in Thailand
Interventions FORMAT: Interventions: educational meetings with dissemination of antimicrobial
order form; educational outreach by review and recommend change of cases of inappro-
priate prescribing by ID consultant; restrictive by compulsory order form
Intervention Functions: education, enablement, persuasion, restriction
Figure 2 suggests that expenditure increased sharply in the final year of the study when
ID consultant review ceased
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Sirinavin 1998 (Continued)
DELIVERER: specialist physician (ID)
COMPARISON: data for 4 years’ pre-restriction
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: restricted drugs cost in million THB/200,000 OBD
Notes FINANCIAL SUPPORT: Funding: Ramathibodi Research Fund. Competing Inter-
ests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk 4 years’ data pre- and postintervention
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
run charts with no statistical analysis
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
High risk NOT DONE, there is no information
about change in price of antibiotics over
the study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Unclear risk NOTCLEAR, no adjustment of antibiotic
costs for change in price, so change in price
of antibiotics (rather than change in use)
over the study period may have been re-
sponsible for some of the change in cost.
Data were not adjusted for number of ad-
missions or occupied bed days
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Skaer 1993
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: physicians (numbers not clear)
PATIENTS: all patients in the hospital
CLINICAL PROBLEM: adult patients receiving imipenem treatment
SETTING: 1 hospital in the USA
Interventions FORMAT: Intervention: educational outreach by review and recommend change
Intervention Functions: enablement, persuasion
DELIVERER: pharmacist
COMPARISON: usual care in the pre-intervention phase
DESIRED CHANGE: reduce excessive
Outcomes PRESCRIBING: Choice:Monthly use (doses) of imipenem
CLINICAL: cohort data about length of stay and hospital charges for patients with a
primary diagnosis of infection
Notes FINANCIAL SUPPORT: Funding:Washington State University College of Pharmacy
and Pullman Memorial Hospital. Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after)
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk
Knowledge of the allocation adequately
prevented(ITS)?
Low risk
Incomplete outcome data addressed (ITS)
?
Low risk
Free of selected reporting (ITS) ? Low risk
Free of other bias (ITS) ? Low risk Yes for primary outcome but fatally flawed
(UBA) for secondary outcomes
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Skrlin 2011
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: use of ceftriaxone following removal of restriction
SETTING: 1 hospital in Croatia
Interventions FORMAT: Intervention: restrictive, removal of restriction by expert approval
Intervention Function: restriction
DELIVERER: AMT
COMPARISON: removal of restriction versus restriction
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of ceftriaxone in DDD/1000 OBD
MICROBIAL: number of ESBL-producing strains/1000 OBD
Notes FINANCIAL SUPPORT: Funding none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: LOW case definition Low, planned intervention Low, other
infection control Low
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy and microbiology
computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy and microbiology
computers
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy and microbiology
computers
Free of selected reporting (ITS) ? Low risk Data from pharmacy and microbiology
computers
Free of other bias (ITS) ? Low risk 24 months’ data pre- and postintervention
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Solomon 2001
Methods STUDY DESIGN: cluster RCT, service level
Risk of Bias: HIGH
Participants PROVIDERS: 17 Internal Medicine services randomly assigned to intervention (9 ser-
vices) or control (8 services)
PARTICIPANTS: a total of 4500 patients admitted during the baseline and study peri-
ods, of whom 260 patients received 278 unnecessary prescriptions for the target drugs;
17 clusters (services)
CLINICAL PROBLEM: patients receiving ceftazidime or levofloxacin.
SETTING: 1 hospital in the USA
POWERCALCULATION: no information. The methods say that the statistical model
adjusted for clustering, but no results are given (see risk of bias)
Interventions FORMAT: Interventions: educational meetings with dissemination of policy for neces-
sary use; educational outreach by review and recommend change, either verbal (face to
face or telephone) or by email
Intervention Functions: education, enablement, persuasion
COMPARISON: randomly assigned control services
DESIRED CHANGE: reduce excessive
POWER CALCULATION: no information. Note from Statistician: The study ad-
justed for some clustering, but possibly only in the repeated measures, not in the hospi-
tals. Just using the results from Table 2, I do not get the P value that they state in the
table using a unit of analysis error approach. This suggests to me that they are adjusting
for “things”. I therefore think on balance that it is probably OK to use the results
Outcomes PRESCRIBING: Choice: % patients with target antibiotics discontinued. Exposure:
% patients with all antibiotics discontinued
CLINICAL: inpatient mortality, transfer to ICU, length of stay, and re-admission within
30 days of discharge
FINANCIAL: estimated annual cost of the intervention
Notes FINANCIALSUPPORT:Funding:BrighamandWomen’sHospital andArthritis Foun-
dation Investigator Award. Competing Interests: no information
ADDITIONAL DATA: email from authors with information about the intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “We assigned services to intervention or
control status using a blocked randomiza-
tion design”
Allocation concealment (selection bias) Unclear risk Not concealed
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
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Solomon 2001 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Figure 2 and text give %, no denominator.
Selective reporting (reporting bias) Unclear risk Figure 2 and text give %, no denominator.
Other bias Unclear risk The methods say: “To estimate the relative
reduction in unnecessary use of target an-
tibiotics in the intervention group, we used
a fixedeffects model (PROC GENMOD
in SAS statistical software).20 This model
used a log-linear link function, assumed
a Poisson distribution, and accounted for
overdispersion. Experimental group assign-
ment (intervention or control) was the in-
dependent variable of interest, the indi-
vidual service was considered a class ef-
fect, and covariates included level of base-
line prescribing and time, modeled as both
a linear and categorical effect. The inter-
action between assignment and time was
also assessed.We further considered a linear
randomeffects model to account for varia-
tion between services (PROC MIXED in
SAS statistical software)20; the results of
this analysis were similar to those found
in the fixed-effects models with respect to
the level of statistical significance, and only
the fixedeffects model results are presented.
” However, no model outputs are given in
the results (only point estimates), and the
discussion says only: “This significant ef-
fect of the intervention remained after ad-
justing for baseline prescribing, clustering
of repeatedmeasures within a given service,
and duration of the intervention.”
Baseline Outcomes similar? Low risk Figures 1 and 2
Free of contamination? High risk The services were in the same hospital.
Baseline characteristics similar? Low risk Table 1
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Standiford 2012
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: cost of animicrobials
SETTING: 1 hospital in the USA
Interventions FORMAT: Interventions: educational outreach by review and recommend change
Intervention Functions: enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care pre-intervention and impact of removal of the intervention
(2 years)
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: quarterly cost of all antimicrobials
CLINICAL: Balancing: cohort data for mortality, length of stay, and unplanned re-
admission. The DRG case mix index was monitored to ensure that changes in outcomes
were not related to this index
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk No information is given about changes in
drug pricing over the 12 years of data col-
lection, which is likely to have changed the
outcome measure. In addition, there were
changes in pharmacy data systems after the
intervention, but the timing is clearly doc-
umented in Figure 1
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data were from the Pharmacy Administra-
tion and were independent from the AMT
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data were from the Pharmacy Administra-
tion and were independent from the AMT
Incomplete outcome data addressed (ITS)
?
Low risk Data were from the Pharmacy Administra-
tion and were independent from the AMT
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Standiford 2012 (Continued)
Free of selected reporting (ITS) ? Low risk Data were from the Pharmacy Administra-
tion and were independent from the AMT
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
Stevenson 1988
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: receiving antibiotics
SETTING: 1 hospital in the UK
Interventions FORMAT: Interventions: dissemination of antibiotic policy
Intervention Function: education
DELIVERER: pharmacist
COMPARISON: 10 quarters (30 months) pre-intervention
DESIRED CHANGE: reduce excessive
Outcomes PRESCRIBINGandFINANCIAL:Choice: average cost of antibiotics per patient. Prices
were indexed to 1980
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk 2 years’ data pre- and postintervention,
enough to account for seasonal effects
Analysed appropriately (ITS) ? Low risk Done in original paper: regression analysis
testing for structural break associated with
intervention
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
264Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Stevenson 1988 (Continued)
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, drug costs were adjusted to 1980
prices.
Free of other bias (ITS) ? Low risk Drug costs were adjusted to 1980 prices
and adjusted for number of discharges or
deaths
Stocker 2010
Methods STUDY DESIGN: RCT
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the neonatal ICU
PARTICIPANTS: 121 neonates (60 intervention, 61 control)
CLINICAL PROBLEM: suspected sepsis
SETTING: 1 hospital in Switzerland
Interventions FORMAT: Interventions: reminders (circumstantial, decision support algorithm with
each PCT test); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: departmental physician (Paediatrics)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: unclear. The trial was designed to obtain a power of 90%
to detect a 30% difference between the 2 groups in the duration of antibiotic therapy,
with an estimated standard deviation of 50%. Sample size: no information
Outcomes PRESCRIBING: Exposure: duration, % treated > 72 h
Notes FINANCIAL SUPPORT: Funding: commercial B.R.A.H.M.S Diagnostica (Berlin,
Germany) provided the testing kits for PCT. Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomised using assignment cards in en-
velopes
Allocation concealment (selection bias) Low risk Randomised using assignment cards in en-
velopes
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Stocker 2010 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes on all patients
Selective reporting (reporting bias) Low risk Outcomes on all patients
Other bias Low risk
Baseline Outcomes similar? Unclear risk No data
Free of contamination? Low risk PCT results only reported for intervention
patients.
Baseline characteristics similar? Low risk Table 1
Stolz 2007
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in Internal Medicine
PARTICIPANTS: all patients hospitalised with exacerbations of chronic obstructive
pulmonary disease; 288 screened, 226 randomised (113 intervention, 113 control)
CLINICAL PROBLEM: use of therapeutic antibiotics
SETTING: 1 hospital
Interventions FORMAT: Interventions: reminders (circumstantial, decision support algorithm with
each PCT test); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: departmental physician (Respiratory)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
POWER CALCULATION: yes, total 186 participants. Details in Appendix 3
Outcomes PRESCRIBING: Exposure:% antibiotic use for the exacerbation and in the subsequent
6 months
CLINICAL: Balancing: length of stay, death, symptom scores
Notes FINANCIAL SUPPORT: Funding: part commercial University Hospital Basel. B.R.
A.H.M.S provided procalcitonin assays for this investigator-driven study. Competing
Interests: 1 author served as consultant and received payments from B.R.A.H.M.S to
attend meetings and for travel expenses, speaking engagements, or research
ADDITIONALDATA: email response from authors with additional information about
intervention
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Stolz 2007 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details: “Patients satisfying the entry
criteria were randomly assigned to one of
two groups at the time of admission to the
emergency department ”
Allocation concealment (selection bias) Unclear risk No details
Blinding (performance bias and detection
bias)
All outcomes
High risk SIngle-blind
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data reported on all patients.
Selective reporting (reporting bias) High risk 11 (10%) patients excluded from interven-
tion and7 (6%) fromcontrol group for “ab-
sence of COPD according to GOLD”, but
this should have occurred pre-randomisa-
tion
Other bias Low risk
Baseline Outcomes similar? High risk No data
Free of contamination? Low risk PCT only reported for intervention pa-
tients.
Baseline characteristics similar? Low risk Table 1
Stolz 2009
Methods STUDY DESIGN: RCT
Risk of Bias: MEDIUM
Participants PROVIDERS: all staff in adult ICUs
PARTICIPANTS: 101 patients with VAP (51 intervention, 50 control)
CLINICAL PROBLEM: receiving antibiotics for VAP
SETTING: 3 university hospitals in Switzerland and the USA
Interventions FORMAT: Interventions: reminders (circumstantial, decision support algorithm with
each PCT test); structural, introduction of PCT testing
Intervention Functions: enablement, environmental restructuring
DELIVERER: respiratory physicians
COMPARISON: usual care
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Stolz 2009 (Continued)
DESIRED CHANGE: decrease excessive
POWER CALCULATION; yes, 84 participants total. Details in Appendix 3
Outcomes PRESCRIBING: Exposure: duration of antibiotic treatment
CLINICAL: Balancing: mortality, hospital length of stay
Notes FINANCIAL SUPPORT: Funding: Swiss National Foundation, Margarete und Wal-
ter Liechtenstein Foundation, Freiwillige Akademische Gesellschaft Basel, Will Rogers
Foundation, and participating hospitals. B.R.A.H.M.S AG funded assay material and
logistics. Competing Interests: not clear. The published paper says that a statement of
interest for the study itself is available but the web address provided online and in print
does not work
ADDITIONALDATA: email response from authors with additional information about
intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Block size 20 envelopes
Allocation concealment (selection bias) Low risk Sealed, opaque envelopes
Blinding (performance bias and detection
bias)
All outcomes
High risk Primary outcome measure required collec-
tion of data from case noes by investigators
Incomplete outcome data (attrition bias)
All outcomes
Low risk Text shows that primary outcome was re-
ported for all 101 randomised patients
Selective reporting (reporting bias) Low risk Text shows that primary outcome was re-
ported for all 101 randomised patients
Other bias Low risk Multivariate analysis to adjust primary out-
come for age, microbiology and centre ef-
fect
Baseline Outcomes similar? Unclear risk No data about baseline outcomes
Free of contamination? Low risk Procalcitonin only measured for interven-
tion patients.
Baseline characteristics similar? Low risk Table 1
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Strom 2010
Methods STUDY DESIGN: cluster RCT, professional level
Risk of Bias: MEDIUM
Participants PROVIDERS: A total of 1971 clinicians were assigned to either an intervention group
receiving a nearly hard-stop alert or a control group receiving the standard practice.
PARTICIPANTS: 342 patients receiving warfarin and trimethoprim-sulfamethoxazole
(194 intervention, 148 control), 1971 clusters (physicians)
CLINICAL PROBLEM: reduce risk of interaction between warfarin and trimethoprim-
sulfamethoxazole
SETTING: 2 hospitals in the USA
POWER CALCULATION: “It is generally accepted that randomization of at least 100
subjects will produce balance between the study groups and, of course, the present sample
size is much larger than this.”
Interventions FORMAT: Interventions: reminder (circumstantial) and restrictive by compulsory elec-
tronic order form that would not allow concomitant orders of warfarin and trimetho-
prim-sulfamethoxazole. The only exception allowed by the order formwas the indication
of Pneumocystis carinii pneumonia prophylaxis. Expert approval was allowed for other
patients when discussed with pharmacy
Intervention Functions: enablement, environmental restructuring, restriction
DELIVERER: pharmacist
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: the proportion of desired responses (i.e. not reordering the
alert-triggering drug within 10 minutes of firing)
CLINICAL: Balancing: 2 potential adverse outcomes of the computerised hard-stop
alert were monitored and reported to the Institutional Review Board. The first was a
delay in obtaining trimethoprim-sulfamethoxazole when the practitioner believed that an
infection was best treated with trimethoprim-sulfamethoxazole and when the potential
warfarin interaction was judged less important than the need for the antibiotic. The
secondwas unintentional warfarin cessation in a patient previously undergoing long-term
warfarin therapy. The study therefore also assessed the incidence of warfarin cessation
on the day when an order of trimethoprim-sulfamethoxazole was attempted in a patient
already receiving warfarin
Notes FINANCIAL SUPPORT: Funding: University of Pennsylvania Health System and
Agency for Healthcare Research and Quality. Competing Interests: none declared
ADDITIONAL DATA: email response from authors with additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Number randomisation
Allocation concealment (selection bias) Low risk “Each medical practitioner has a unique
access code to use the electronic ordering
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Strom 2010 (Continued)
system, and the order system menu can
be varied by individual user. In addition,
we wanted to keep each practitioner in the
same study group for the duration of the
study to minimize contamination between
the 2 groups. However, there is the possi-
bility”
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome reported on all patients, deter-
mined electronically.
Selective reporting (reporting bias) Low risk Outcome reported on all patients, deter-
mined electronically.
Other bias Low risk
Baseline Outcomes similar? Unclear risk No information
Free of contamination? Low risk “We attempted to reduce contamination by
trying to complete this study as rapidly as
possible. It was initially planned to last 7
months but had to be terminated early.”
Baseline characteristics similar? Low risk Table 1
Sun 2011
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all cardiac surgeons and other professionals
PARTICIPANTS: all patients undergoing coronary artery bypass surgery
CLINICAL PROBLEM: improve reliability of administration of prophylaxis (first dose
within 1 h of incision and duration not > 24 h)
SETTING: 1 hospital in Taiwan
Interventions FORMAT: Interventions: audit and feedback; educational meetings with dissemination
of guidelines and evidence base
Intervention Functions: education, enablement
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice and exposure: time to first antibiotic dose, % of prophylaxis
≤ 24 h
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Sun 2011 (Continued)
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk From Taiwan Quality Improvement
Project database
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome data from Taiwan Quality Im-
provement Project database
Incomplete outcome data addressed (ITS)
?
Low risk Outcome reported on all patients pre- and
postintervention.
Free of selected reporting (ITS) ? Low risk Objective outcomes from Taiwan Quality
Improvement Project database
Free of other bias (ITS) ? High risk < 1 year data pre- and postintervention
Suwangool 1991
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the Department of Medicine
PARTICIPANTS: all patients in the Department of Medicine
CLINICAL PROBLEM: inappropriate antibiotic prescribing
SETTING: single university hospital in Thailand
Interventions FORMAT: Interventions: dissemination of guidelines; restrictive by expert approval
Intervention Functions: education, restriction
DELIVERER: AMT
COMPARISON: 6 months’ data pre-intervention
DESIRED CHANGE: reduce excessive (cost)
Outcomes PRESRIBING: Choice: monthly cost of target antibiotics
CLINICAL: cohort data about mortality
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Suwangool 1991 (Continued)
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Data from pharmacy computer
Free of other bias (ITS) ? Unclear risk < 1 year data pre- and postintervention.
During the 18-month study period, no ad-
justment was made to antibiotic costs for
changes in prices, so changes in cost may
have been due to changes in price as well as
use
Talpaert 2011
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients receiving antibiotics for prophylaxis or treatment. The
intervention targeted fluoroquinolones, cephalosporins, clindamycin, amoxicillin, and
co-amoxiclav, as they were considered to be “high risk” for Clostridium difficile infection
SETTING: 1 hospital
Interventions FORMAT: Interventions: educational meetings with dissemination of guidelines; ed-
ucational outreach by review and recommend change; reminders (verbal (on rounds)
and physical (laminated pocket cards and posters)); restrictive by removal of target drugs
from clinical areas
Intervention Functions: education, enablement, environmental restructuring, persua-
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Talpaert 2011 (Continued)
sion restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of target antibiotics in DDD/1000 OBD
MICROBIAL: monthly cases of C difficile infection
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: 1 author was paid
lecture fees andprovided sponsorship to attend conferences by pharmaceutical companies
unrelated to this study
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias LOW: case definition Low (new cases), planned intervention
Low, other infection control Low, fully reported in ORION format
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk Change in site - moved to another building
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk From electronic records, so unlikely
Knowledge of the allocation adequately
prevented(ITS)?
Low risk From electronic records, so unlikely
Incomplete outcome data addressed (ITS)
?
Low risk From electronic records, so unlikely
Free of selected reporting (ITS) ? Low risk From electronic records, so unlikely
Free of other bias (ITS) ? Low risk 1 year data pre- and postintervention
Tangdén 2011
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients receiving therapeutic antibiotics
CLINICAL PROBLEM: aim (i) to reduce the consumption of 2nd- and 3rd-gener-
ation cephalosporins; and (ii) to avoid increased prescription of fluoroquinolones and
carbapenems.
SETTING: 1 hospital in Sweden
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Tangdén 2011 (Continued)
Interventions FORMAT: Interventions: educational meetings with dissemination of guidelines; edu-
cational outreach by academic detailing
Intervention Functions: education, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of target drugs in DDD/1000 OBD
Notes FINANCIAL SUPPORT: Funding: no external. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: HIGH, Case definition Low, Unplanned intervention High
(outbreak), Other infection control High. “In August 2006, the hospital director orga-
nized a steering group (SG) with the assignment to implement the necessary measures
to contain the outbreak, including reinforcement of hygienic measures, such as hand
disinfection, use of disposable gloves and aprons, and isolation of patients colonized or
infected with ESBL-KP.14 In addition to hygienic measures, the SG decided to perform
an antibiotic intervention.”
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk DDD from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk DDD from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk DDD from pharmacy computer
Free of selected reporting (ITS) ? Low risk DDD from pharmacy computer
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention
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Toltzis 1998
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the mixed medical and surgical paediatric ICU
PARTICIPANTS: all patients in the paediatric ICU
CLINICAL PROBLEM: patients requiring antibiotic treatment
SETTING: a paediatric ICU in 1 hospital in the USA
Interventions FORMAT: Intervention: restrictive, probably by expert approval (“Prohibition of cef-
tazidime use unless the patient’s microbiological results indicated that the drug was nec-
essary for cure.”)
Intervention Function: restriction
DELIVERER: specialist (ID) physician
COMPARISON: 7 months’ data before the start of the intervention
DESIRED CHANGE: reduce excessive
Outcomes PRESCRIBING: Choice: ceftazidime use in doses
Notes FINANCIAL SUPPORT: Funding: grant HD31323-02 from the National Institutes
of Health. Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk NOT CLEAR, data for 7 months pre- and
12 months postintervention, not enough
to adjust for seasonal variation
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after) with χ2 test.
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
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Toltzis 1998 (Continued)
Free of other bias (ITS) ? High risk < 1 year data pre-intervention
Toltzis 2002
Methods STUDY DESIGN: NRT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians (paediatricians) on the ICU
PARTICIPANTS: all neonates in the ICU
CLINICAL PROBLEM: neonates with proven or suspected infections caused by gram-
negative bacteria
SETTING: 1 neonatal ICU in 1 hospital in the USA
Interventions FORMAT: no valid prescribing data. Restrictive by removal, monthly rotation of the
antibiotic regimen used for empirical prescribing of patients with proven or suspected
gram-negative infections
DELIVERER: specialist physician (ICU)
COMPARISON: standard practice
DESIRED CHANGE: reduce excessive (colonisation with multiresistant bacteria)
Outcomes MICROBIAL: incidence of colonisation with multiantibiotic-resistant aerobic gram-
negative bacilli
Notes FINANCIAL SUPPORT: Funding: grant HD 31323-05 from the National Institutes
of Health Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: MEDIUM Case definition Low, Planned intervention Low,
Other infection control Unclear
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk NRT with monthly rotation of regimens
Allocation concealment (selection bias) High risk Not possible with this study design
Blinding (performance bias and detection
bias)
All outcomes
High risk Not possible with this study design
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not stated whether screening samples ob-
tained from all patients
Selective reporting (reporting bias) Unclear risk Not stated whether screening samples ob-
tained from all patients
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Toltzis 2002 (Continued)
Other bias Unclear risk NOT CLEAR Microbial Outcome Risk
of Bias Criteria Case definition: DONE
Colonisation by screening. “For the pur-
pose of this study, an ’antibiotic-resis-
tant Gram-negative organism’ was defined
as any Gram-negative bacillus resistant
to gentamicin, piperacillin-tazobactam, or
ceftazidime. Pharyngeal and rectal swab
specimens were obtained on all infants
every Monday, Wednesday, and Friday”.
Planned intervention: DONE; Other in-
fection control, Isolation: IC practices:
NOT CLEAR Not described, but it is rea-
sonable to assume that they were the same
for the intervention and control groups due
to the controlled clinical trial design
Baseline Outcomes similar? Unclear risk Not stated
Free of contamination? Unclear risk Not stated, but doctors likely to have been
managing patients in more than 1 study
phase
Baseline characteristics similar? Low risk Results, paragraph 1
Toltzis 2014
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all paediatric surgeons and anaesthetists
PARTICIPANTS: all children undergoing surgery
CLINICAL PROBLEM: increase % of patients receiving antibiotic prophylaxis within
1 hour of incision as 1 of 3 components of a bundle of care
SETTING: 8 paediatric hospitals in the USA
Interventions FORMAT: no valid prescribing data. Audit and feedback
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: increase effective
Outcomes CLINICAL: surgical-site infection rate per 100 procedures
Notes FINANCIAL SUPPORT: Funding: Ohio Business Roundtable, the Cardinal Health
Foundation, and the Ohio Children’s Hospital Association. Competing Interests: none
declared
ADDITIONAL DATA: no response from authors to request for additional data
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Toltzis 2014 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Administration of antibioticswithin 1 hour
was 1 component of the bundle; the other
2 were avoiding shaving and encouraging
use of clorhexidine for disinfection. In ad-
dition, 9 months after the intervention be-
gan an additional antibiotic element was
added to encourage administration of an
additional dose for operations lasting more
than 3 hours
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Patient administration systems and routine
collection of surgical-site infection data by
each hospital’s infection prevention teams
Knowledge of the allocation adequately
prevented(ITS)?
High risk Infection prevention teams were not pre-
vented from knowing about allocation
Incomplete outcome data addressed (ITS)
?
Low risk
Free of selected reporting (ITS) ? Low risk Data reported for all months when opera-
tions took place
Free of other bias (ITS) ? High risk Only 8 months’ pre-intervention data
Trenholme 1989
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: 226 patients (110 intervention, 116 control)
CLINICAL PROBLEM: patients with bacteraemia
SETTING: 1 hospital in the USA
Interventions FORMAT: Interventions: educational outreach by review and recommend change (in-
tervention and control); structural, rapid processing and reporting of antimicrobial sus-
ceptibility tests (intervention only)
Intervention Functions: enablement, environmental restructuring, persuasion
DESIRED CHANGE: reduce excessive
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Trenholme 1989 (Continued)
POWER CALCULATION: no information
Outcomes PRESCRIBING: Choice:% changes in therapy in response to recommendation
FINANCIAL: savings in drug costs
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated; “the organism from the patient
was randomly assigned”
Allocation concealment (selection bias) Unclear risk Not stated
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not stated as blind
Incomplete outcome data (attrition bias)
All outcomes
Low risk Table 2 reports primary outcome for all 226
randomised patients
Selective reporting (reporting bias) Low risk Table 2 reports primary outcome for all 226
randomised patients
Other bias Low risk No other apparent biases found.
Baseline Outcomes similar? Unclear risk No information about recommendations
for changes in therapy before the interven-
tion
Free of contamination? Unclear risk Likely to be contamination as doctorsman-
aging control patients would receive advice
on intervention patients
Baseline characteristics similar? Unclear risk No information
Uçkay 2009
Methods STUDY DESIGN: ITS
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in one orthopaedic unit
PARTICIPANTS: all patients in one orthopaedic unit
CLINICAL PROBLEM: suspected bone and joint infection
SETTING: 1 hospital in Switzerland
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Uçkay 2009 (Continued)
Interventions FORMAT: Interventions: educational outreach by review and recommend change. The
intervention is reported in 2 phases, the 1st delivered by “Dedicated ID specialist and one
internist” and the 2nd delivered by “ID specialist with experience in Infection Control”.
Intervention Functions: enablement, persuasion
DELIVERER: specialist (ID) physician
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of IV and oral antibiotics in DDD/1000 OBD
Notes FINANCIAL SUPPORT: Funding: none.Competing Interests: none declared.
ADDITIONAL DATA: email response from authors with additional data about the
intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk Insufficient information to assess
Analysed appropriately (ITS) ? Low risk Time series analysis with ARIMA mod-
elling
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Unclear risk Outcomedatawere from routine pharmacy
systems.
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcomedatawere from routine pharmacy
systems.
Incomplete outcome data addressed (ITS)
?
Low risk Outcomedatawere from routine pharmacy
systems.
Free of selected reporting (ITS) ? High risk The information in Table 1 does not in-
clude total antibiotic use or cost, so cannot
be used to support the claims made in the
paper
Free of other bias (ITS) ? High risk < 1 year pre-intervention data
Insufficient information to assess. In partic-
ular, it is not clear what difference the “ID
specialist with experience in InfectionCon-
trol” would make compared with “Dedi-
cated ID specialist and one internist”
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Valiquette 2007
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: receiving therapeutic or prophylactic antibiotics
SETTING: 1 hospital in Canada
Interventions FORMAT: Interventions: educational meetings with dissemination of guideline and
letter; educational outreach by review and recommend change; reminders (physical,
pocket-size guideline)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING:Choice and exposure: use of individual targeted drugs in DDD/1000
OBD; use of all antibiotics in DDD/1000 OBD
MICROBIAL: Clostridium difficile infections/1000 OBD
Notes FINANCIALSUPPORT:Funding:National Foundation for InfectiousDiseases.Com-
peting Interests: 1 author has been on the speakers’ bureau for Wyeth; served on ad-
visory boards for Wyeth and Cubist; and received grants from Wyeth, Genzyme, and
Arpida. 1 author has been on the speakers’ bureau for Wyeth Canada; served on advisory
boards for Bayer, Wyeth, ViroPharma, and Acambis; and received grants from Genzyme
ADDITIONAL DATA: email from authors but no additional data
Microbial Risk of Bias: HIGH Case definition Low. Planned intervention High, re-
sponse to epidemic of infection caused by high-virulence strain. Other infection control
High, the rate of CDI was already declining in response to infection control intervention
when antimicrobial intervention began
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Antimicrobial intervention followed an in-
fection control intervention, so it is not
possible to assess the independent impact
onCdifficile infection.Moreover, the infec-
tion control intervention could have been
responsible for some or all of the reduction
in total antibiotic use
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
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Valiquette 2007 (Continued)
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy and microbiology
computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy and microbiology
computers
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy and microbiology
computers
Free of selected reporting (ITS) ? Low risk Data from pharmacy and microbiology
computers
Free of other bias (ITS) ? High risk Microbial Risk of Bias HIGH
> 1 year of data pre-intervention
van Hees 2008
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in theDepartments of InternalMedicine,Gastroenterology,
Surgery, Urology, and Pulmonary Diseases
PARTICIPANTS: all patients in the same departments
CLINICAL PROBLEM: patients receiving ciprofloxacin
SETTING: 1 university hospital in the Netherlands
Interventions FORMAT: Interventions: educational meetings; educational outreach by review and
recommend change
Intervention Functions: education, enablement, persuasion
DELIVERER: specialist physicians (microbiologists)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive (reduce unnecessary ciprofloxacin)
Outcomes PRESCRIBING: Choice: use of ciprofloxacin in prescriptions/1000 OBD
Notes FINANCIAL SUPPORT:Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
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van Hees 2008 (Continued)
Unlikely to affect data collection (ITS) ? Low risk Data for primary outcome measure were
from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data for primary outcome measure were
from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Data for primary outcome measure were
from pharmacy computer
Free of selected reporting (ITS) ? Low risk Data for primary outcome measure were
from pharmacy computer
Free of other bias (ITS) ? High risk Only 3months’ pre- and 6months’ postin-
tervention data, so cannot be adjusted for
seasonal trends
Van Kasteren 2005
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospitals
PATIENTS: all patients undergoing elective surgery
CLINICAL PROBLEM: surgical prophylaxis across 4 surgical disciplines
SETTING: 14 hospitals in the Netherlands
Interventions FORMAT, Interventions: audit and feedback; educational meetings with dissemination
of guidelines
Intervention Functions: education, enablement
DELIVERER: AMT
COMPARISON: pre-intervention periods
DESIRED CHANGE: reduce excessive duration of surgical prophylaxis
Outcomes PRESCRIBING: Exposure: total antibiotic use in DDD/100 procedures
CLINICAL: Balancing: cohort data on surgical-site infections
Notes FINANCIAL SUPPORT: Funding:Netherlands Organisation for Health Research and
Development (ZonMw). Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Only 6 months’ pre- and postintervention
data, and the model was not adjusted for
seasonal trends
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Van Kasteren 2005 (Continued)
Analysed appropriately (ITS) ? Low risk Done in original paper: segmented regres-
sion analysis
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk Done, data were from routine systems
and unlikely to change over study period.
Change in price unlikely to be a prob-
lem because only 6 months’ data pre- and
postintervention
Volpe 2012
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the ED
PARTICIPANTS: all patients with fever and suspected neutropenia
CLINICAL PROBLEM: fever and suspected neutropenia
SETTING: 1 university paediatric hospital in the USA
Interventions FORMAT: Interventions: audit and feedback with action planning; educational meet-
ings with dissemination of care algorithm and forms to facilitate care; educational out-
reach by academic detailing; reminders (circumstantial, root-cause analysis of individual
cases not meeting goal); reminders (physical, posters, email, and verbal, during rounds)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: increase effective, reduce time to first antibiotic dose
Outcomes PRESCRIBING: Choice: time (minutes) to first antbiotic dose
BALANCINGMEASURE OF UNINTENDED CONSEQUENCES: “For balancing
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measures during the improvement period, we chose to follow the timeliness of first b-
agonist treatment of patients with asthma and the left without being seen (LWBS) rate.”
Notes FINANCIAL SUPPORT:Funding: no external funding. Competing Interests: none
declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Statistical process control chart
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcome data from patient administration
system
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome data from patient administration
system
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data from patient administration
system
Free of selected reporting (ITS) ? Low risk Outcome data from patient administration
system
Free of other bias (ITS) ? Low risk > 12 months’ data pre- and postinterven-
tion
Walker 1998
Methods STUDY DESIGN: RCT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: 50 patients (25 intervention, 25 control)
CLINICAL PROBLEM: duration of IV antibiotics for patients with community-ac-
quired pneumonia
SETTING: 1 hospital in the USA
Interventions FORMAT: Interventions: educational outreach by review and recommend change
Intervention Functions: enablement, persuasion
A written recommendation to change from IV ceftriaxone to an oral regimen was placed
in each patient’s prescription chart by the pharmacist. Direct contact with prescribers
was not possible “because the medical staff in community hospitals have a large variation
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in the hours in which they make rounds” and “the physician is frequently busy, phone
calls usually involve multiple pharmacists”.
DELIVERER: pharmacist
COMPARISON: standard practice (no intervention)
DESIRED CHANGE: reduce excessive
POWER CALCULATION: no information
Outcomes PRESCRIBING: Choice: number of patients changed to oral antibiotic therapy
CLINICAL: Balancing: re-admissions (total and for pneumonia)
Notes FINANCIAL SUPPORT: Funding: commercial, Pharmacia and Upjohn. Competing
Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A list of random numbers was generated
from Sigmastat version 1.0 statistical soft-
ware”
Allocation concealment (selection bias) Unclear risk Not stated, but open label, so unlikely to
be concealed
Blinding (performance bias and detection
bias)
All outcomes
High risk “Open label”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No problems found.
Selective reporting (reporting bias) Low risk No problems found.
Other bias Low risk No other apparent biases found.
Baseline Outcomes similar? Unclear risk Not stated
Free of contamination? Unclear risk Not stated
Baseline characteristics similar? Low risk See Table 1 in paper
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Wang 2014
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in 16 adult ICUs
PARTICIPANTS: all patients in the ICUs
CLINICAL PROBLEM: use of target antibiotics in patients with positive blood cultures
SETTING: 1 University hospital in Taiwan
Interventions FORMAT: Intervention: educational outreach by review and recommned change; re-
strictive by expert approval
Intervention Functions: education, enablement, persuasion, restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive, reduce cost of antimicrobials by reducing
unnecessary use
Outcomes PRESCRIBING: Choice: primary outcome is cost of all antimicrobials (Figure 4G).
Also reports impact on use of 7 target antibacterials and use of antifungals in DDD/
1000 OBD
CLINICAL: Balancing: mortality, ICU re-admission (segmented regression analysis)
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcome data from pharmacy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome data from pharmacy computer
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data from pharmacy computer
Free of selected reporting (ITS) ? Low risk Outcome data from pharmacy computer
Free of other bias (ITS) ? High risk > 12 months’ data pre- and postinterven-
tion. However, no adjustment of primary
outcome for changes in drug pricing over
the 5 years of the study
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Wax 2007
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all anaesthetists in the hospital
PARTICIPANTS: all patients undergoing elective surgery
CLINICAL PROBLEM: time to first dose for antibiotic prophylaxis
SETTING: 1 hospital in the USA
Interventions FORMAT: Interventions: reminders (physical, electronic on screen during all surgical
procedures, not just those requiring prophylaxis)
Intervention Functions: education, environmental restructuring, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: increase effective
Outcomes PRESCRIBING: Choice:% patients with first dose within 1 hour of incision
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcome data from electronic patient
record, Anaesthesia Information Manage-
ment System (AIMS)
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcome data from electronic patient
record (AIMS)
Incomplete outcome data addressed (ITS)
?
Low risk Outcome data from electronic patient
record (AIMS)
Free of selected reporting (ITS) ? Low risk Outcome data from electronic patient
record (AIMS)
Free of other bias (ITS) ? High risk Only 6 months’ data pre-intervention
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Weinberg 2001
Methods STUDY DESIGN: controlled ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: operating theatre teams at participating hospitals
PARTICIPANGS: low-income women needing C-section
CLINICAL PROBLEM: infection after C-section
SETTING: 2 hospitals in Colombia
Interventions FORMAT: Interventions: audit and feedback in the form of run charts for the 2 key
process measures (secondary outcomes) with data collected and displayed by the clinical
teams; disseminationof flowchartswith revised system for administration of prophylactic
antibiotics
Intervention Functions: education, enablement
DELIVERER: obstetric teams, doctors and nurses
COMPARISON: physician choice about antibiotic and timing
DESIRED CHANGE: reduce infection after C-section
TIMING: before clinical decision making; the intervention was continued for 2 years
Outcomes PRESCRIBING: Choice: percentage of women who received prophylaxis; percentage
who received prophylaxis within 1 hour
CLINICAL: Intended: SSI rate per 100 C-sections
Notes INSTRUCTIONS: action plan provided, specific target but no specified time for target
to be achieved
FINANCIAL SUPPORT: Funding: International Society for Infectious Diseases, Paul
Schliesman Memorial Traveling Fellowship, and the Von L. Meyer Award. Competing
Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk Data collection method was the same pre-
and postintervention
Analysed appropriately (ITS) ? Low risk Done in original paper: segmented regres-
sion analysis
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Data collection method was the same pre-
and postintervention
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Prescribing outcome data were from elec-
tronic systems.
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Weinberg 2001 (Continued)
Incomplete outcome data addressed (ITS)
?
Low risk For prescribing outcome. Not stated
whether SSI was evaluated in all patients
Free of selected reporting (ITS) ? Low risk For prescribing outcome. Not stated
whether SSI was evaluated in all patients
Free of other bias (ITS) ? High risk < 1 year of data in each of the 3 study phases
Weiner 2009
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all attending emergency physicans, physician assistants, and emergency
nurses
PARTICIPANTS: all patients with community-acquired pneumonia
CLINICAL PROBLEM: time to first antibiotic dose
SETTING: 1 university hospital in the USA
Interventions FORMAT: Interventions: audit and feedback; reminders (physical, electronic - weekly
emails)
Intervention Functions: enablement, environmental restructuring, persuasion
DELIVERER: departmental nurse administrator
COMPARISON: usual care
DESIRED CHANGE: increase effective
Outcomes PRESCRIBING: Choice: mean time to first antibiotic dose (minutes)
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed; our analysis questions the au-
thors’ conclusion that the intervention was
effective
Shape of effect pre-specified (ITS) ? Low risk Point of analysis was point of intervention.
Unlikely to affect data collection (ITS) ? Low risk TFAD from patient administration system
Knowledge of the allocation adequately
prevented(ITS)?
Low risk TFAD from patient administration system
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Incomplete outcome data addressed (ITS)
?
Low risk TFAD frompatient administration system,
outcome reported on all included patients
Free of selected reporting (ITS) ? Low risk “Patients were excluded if the time of
antibiotic administration was not docu-
mented in the electronic medical record, if
the patient was documented as having re-
ceived antibiotics within 48 hours prior to
arrival, or if the patient was referred from
another facility or clinic with a knowndiag-
nosis of pneumonia.” Exclusion rate in pre-
intervention period (37/281, 13%) similar
to intervention period (40/342, 12%)
Free of other bias (ITS) ? High risk Only 11 months’ data pre- and postinter-
vention
Weiss 2013
Methods STUDY DESIGN: cluster NRT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the ICU
PARTICIPANTS: all patients in the ICU
CLINICAL PROBLEM: receiving antibiotic treatment
SETTING: 1 University hospital in the USA
Interventions FORMAT: Intervention: reminder, verbal (on rounds) based on a scripted electronic
checklist of issues to discuss about antibiotics
Intervention Functions: environmental restructuring, persuasion
DELIVERER: departmental physicians
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: duration of empiric antibiotic treatment before narrowing
choice, % patient days on which empiric antibiotics were used. Exposure: duration of
all antibiotic treatment
CLINICAL:Balancing:mortality (total, standardised mortality ratio, and adjusted odds
of death), length of hospital stay, length of ICU stay
Notes FINANCIAL SUPPORT: National Heart, Lung, and Blood Institute (T32HL076139-
07) and Parker B. Francis Fellowship to CHW. Dr Weiss has received funding from the
National Institutes of Health. Drs Sung and Rho received a travel award to present a
research abstract at American Thoracic Society conference in May 2012 from North-
western University. Dr Wunderink is a board member for Pfizer and has consulted for
Crucell (now Johnson & Johnson), Trius, AstraZeneca, and GlaxoSmithKline. He has
received grant support from bioMérieux and payment for lectures from the American
Thoracic Society. The remaining authors have not disclosed any potential conflicts of
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interest
ADDITIONAL DATA: online supplementary data for this article and further details of
intervention in Weiss 2011. No response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Coin toss to allocate 1 medical team to in-
tervention and 1 to control
Allocation concealment (selection bias) High risk No concealment
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported on all patients.
Selective reporting (reporting bias) High risk No information about inter-rater reliabil-
ity of primary outcomemeasure, whichwas
not objective: “empirical antibiotics were
defined as any antimicrobial agent admin-
istered without culture-documented infec-
tion”
Other bias High risk Unit of analysis error, no adjustment for
clustering
Baseline Outcomes similar? Unclear risk No data
Free of contamination? High risk Intervention and control teams worked on
the same ICU.
Baseline characteristics similar? Low risk Table 1
Welker 2008
Methods STUDY DESIGN: unintended consequences, cohort study
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the ED
PARTICIPANTS: 548 patients with an admission diagnosis of community-acquired pneumonia
CLINICAL PROBLEM: hospital admission diagnosis of community-acquired pneumonia
SETTING: 1 hospital in the USA
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Welker 2008 (Continued)
Interventions FORMAT: Interventions: audit and feedback; financial, institution incentive
Intervention Functions: enablement, incentive
DELIVERER: departmental physicians (ED)
COMPARISON: usual care (before introduction of core quality measure of 4 hours’ time to first antibiotic dose)
DESIRED CHANGE: increase effective
Outcomes UNINTENDED CONSEQUENCES: accuracy of admission diagnosis, antibiotic-associated adverse drug events
Notes ROBINS-I RISK OF BIAS CRITERIA:
1. Confounding: Low, confounding of the effect of intervention unlikely in this study
2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome
3. Measurement of interventions: Low, intervention status well defined, recorded at the time of intervention and
unaffected by knowledge of the outcome or risk of the outcome
4. Departures from intended interventions: Low, no switches to other interventions or evidence of intervention failure
5. Missing data: Low, outcome data and intervention status complete in all 548 patients
6. Measurement of outcome: High, outcome measures not objective, and investigators were not blinded to interven-
tion status
7. Selection of the reported result: Low, single analysis of prespecified outcomes
FINANCIAL SUPPORT: Funding: commercial: Pfizer, US Pharmaceutical Corporation. Competing Interests:
none declared.
ADDITIONAL DATA: no response from authors to request for additional data
Wenisch 2014
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients receiving moxifloxacin
SETTING: 1 university hospital in Austria
Interventions FORMAT: Intervention: educational meetings; restrictive by compulsory order form
Intervention Functions: education, restriction
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of moxifloxacin in DDD
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: Low for case definition, planned intervention, and other infec-
tion control
Risk of bias
Bias Authors’ judgement Support for judgement
293Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Wenisch 2014 (Continued)
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Re-analysed
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy and microbiology
computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy and microbiology
computers
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy and microbiology
computers
Free of selected reporting (ITS) ? Low risk Data from pharmacy and microbiology
computers
Free of other bias (ITS) ? High risk < 12 months’ data in the pre-interven-
tion (5 months) and postintervention (7
months) phases
Microbial Risk of Bias LOW: case defini-
tion Low, planned intervention Low, other
infection control Low
Willemsen 2010
Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients receiving therapeutic antibiotics
CLINICAL PROBLEM: decrease use of ciprofloxacin
SETTING: 1 hospital in the Netherlands
Interventions FORMAT: Interventions: educational meetings with dissemination of guidelines; ed-
ucational outreach by review and recommend change; reminders (physical, newsletter
and on all microbiology reports saying that ciprofloxacin should be prescribed on strict
indications only)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: prescribed daily doses of ciprofloxacin (IV and oral)
MICROBIAL: % quionolone-resistant gram-negative clinical isolates
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Willemsen 2010 (Continued)
Notes FINANCIAL SUPPORT: Funding: AmphiaHospital, Breda/Oosterhout, Netherlands.
Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: LOWCase definition infectionwith quionolone-resistant gram-
negative bacteria, Planned intervention Low, Other infection control Low, no changes
(information in Discussion)
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcomes from pharmacy and microbiol-
ogy computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Outcomes from pharmacy and microbiol-
ogy computers
Incomplete outcome data addressed (ITS)
?
Low risk Outcomes from pharmacy and microbiol-
ogy computers
Free of selected reporting (ITS) ? Low risk Outcomes from pharmacy and microbiol-
ogy computers
Free of other bias (ITS) ? Low risk 1 year data pre- and postintervention
Wilson 1991
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients receiving amoxicillin or pivampicillin
SETTING: 3 hospitals in the UK
Interventions FORMAT: Intervention: dissemination of newsletter to all prescribers
Intervention Function: education
DELIVERER: pharmacists
COMPARISON: 5 months before introduction of the newsletter
DESIRED CHANGE: reduce excessive
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Wilson 1991 (Continued)
Outcomes PRESCRIBING: Choice: use of amoxicillin and pivampicillin
Notes FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk Only 5 months’ pre-intervention data.
Even with 26 months’ postintervention
data, could still be secular changes
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
run chart with no statistical analysis
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk No other apparent biases found.
Winters 2010
Methods STUDY DESIGN: unintended consequences, cohort study
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: 3251 patients receiving antibiotics
CLINICAL PROBLEM: time to first antibiotic dose
SETTING: 1 hospital in the USA
Interventions FORMAT: Interventions: restrictive by prior approval
Intervention Functions: restriction
DELIVERER: AMT
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Winters 2010 (Continued)
COMPARISON: usual care, 10 restricted vs 15 unrestricted antibiotics; daytime (8 am to 10 pm)when prior approval
is required vs nighttime (10 pm to 8 am) when the first dose of all antimicrobials was exempted
DESIRED CHANGE: decrease excessive
Outcomes UNINTENDED CONSEQUENCES: delays of > 1 hour or > 2 hours in TFAD
Notes ROBINS-I RISK OF BIAS CRITERIA:
1. Confounding: Low, confounding of the effect of intervention unlikely in this study
2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome
3. Measurement of interventions: Low, intervention status well defined, recorded at the time of intervention and
unaffected by knowledge of the outcome or risk of the outcome
4. Departures from intended interventions: Low, no switches to other interventions or evidence of intervention failure
5. Missing data: Low, outcome data and intervention status complete in all 3251 patients
6. Measurement of outcome: Low, outcome measures objective and ascertained from patient administration system
7. Selection of the reported result: Low, single analysis of prespecified outcomes
FINANCIAL SUPPORT: no information
ADDITIONAL DATA: no response from authors to request for additional data
Wishaupt 2011
Methods STUDY DESIGN: NRT
Risk of Bias: HIGH
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: 614 children < 12 years old (309 intervention, 305 control)
CLINICAL PROBLEM: acute respiratory infections (NB only 2/3 of randomised pa-
tients admitted to hospital)
SETTING: 1 hospital in the Netherlands
Interventions FORMAT: Intervention: structural, rapid reporting of microbiology results
Intervention Function: environmental restructuring
DELIVERER: specialist physician (Microbiology)
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Exposure:% treated with antibiotics and duration if treated
CLINICAL: Intended: length of stay
Notes FINANCIAL SUPPORT:Funding: Research Activity Committee of the Reinier de
Graaf Hospital (project 620604). Competing Interests: no information
ADDITIONAL DATA: email response and additional files (protocol) from authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk By lab number
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Allocation concealment (selection bias) High risk Not concealed
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk States missing information was retrieved
from records
Selective reporting (reporting bias) Low risk Outcomes on all patients
Other bias Low risk
Baseline Outcomes similar? Unclear risk No information
Free of contamination? Low risk Rapid reporting for intervention only
Baseline characteristics similar? Low risk Table 1
Woodward 1987
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: inpatient prescribing of all antibiotics
SETTING: 1 hospital in the USA
Interventions FORMAT: Interventions: educational meetings; restrictive by expert approval, auto-
matic stop order after 72 hours’ treatment, and by removal from formulary
Intervention Functions: education, restriction
DELIVERER: specialist physician (ID)
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING and FINANCIAL: total antibiotic costs and average antibiotic cost per
day
Notes FINANCIAL SUPPORT: Funding: administration of Barnes Hospital. Competing
Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk 25 months’ pre- and 17 months’ postinter-
vention data
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Woodward 1987 (Continued)
Analysed appropriately (ITS) ? Low risk Done in original paper: ordinary least
squares regression analysis adjusting for
pre-existing time trends, re-analysis with
segmented regression performed for the
purposes of comparison of effect size with
other studies in the review
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Unclear risk The abstract states: “Even after some cost
increases (not significant) in new and other
antibiotics, the program saved $1.33 per
antibiotic day”, but it is not clear whether
the analysis was adjusted for changes in
the price of antibiotics during the 3½-year
study period
Wyatt 1998
Methods STUDY DESIGN: cluster RCT, hospital level
Risk of Bias: MEDIUM
Participants PROVIDERS: a total of 25 hospitals, 13 control and 12 intervention, targeting 2
providers (lead obstetrician and senior midwife manager) in each hospital
PARTICIPANTS: 1318 episodes of care in 1318 patients, 25 clusters (hospitals)
CLINICAL PROBLEM: administration of prophylactic antibiotics to women under-
going Caesarean section. The intervention also targeted 3 other care processes.
SETTING: 25 district general (non-teaching) hospitals
POWERCALCULATION: As only 25 obstetric units were available for randomisation,
and accurate baseline figures for the rates and variability of the 4 marker clinical practices
were not available, sample size calculation was not carried out
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Wyatt 1998 (Continued)
Interventions FORMAT: educational meeting with dissemination of guideline and slides
COMPARISON: 13 control hospitals with no intervention
DESIRED CHANGE: increase effective
Outcomes PRESCRIBING: Exposure:% women that received antibiotic prophylaxis
Notes FINANCIAL SUPPORT: Funding: regional research implementation initiatives of the
North Thames and South Thames regional health authorities; the Imperial Cancer Re-
search Fund; and North Staffordshire Hospital Trust. Competing Interests: none de-
clared
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Obstetric units were allocated to interven-
tion or control group by the toss of a coin
Allocation concealment (selection bias) Low risk To eliminate bias during data collection at
follow-up by a second research midwife,
and to allow blinded assessment of guide-
line quality, the allocation was concealed
from everyone except JCW, DGA, RJ, and
the first research midwife
Blinding (performance bias and detection
bias)
All outcomes
Low risk To eliminate bias during data collection at
follow-up by a second research midwife,
and to allow blinded assessment of guide-
line quality, the allocation was concealed
from everyone except JCW, DGA, RJ, and
the first research midwife
Incomplete outcome data (attrition bias)
All outcomes
Low risk “No unit was excluded after randomisa-
tion, all intervention units participated in
the visits, and data on clinical practices
were available for all units, although smaller
numbers of case notes were obtainable than
planned for steroid usage”
Selective reporting (reporting bias) Low risk See above
Other bias Low risk “To reduce the impact of ceiling effects,
the proportion of cases in which clinicians
failed to carry out each clinical practice was
recorded for each obstetric unit at baseline
and follow up, and then baseline to follow
up ratios were computed to yield the risk
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ratio for failure to implement each practice
in each unit.”
Baseline Outcomes similar? Unclear risk “Accurate baseline figures for the rates and
variability of the four marker clinical prac-
tices were not available”
Free of contamination? Low risk Randomisation by units that were located
in different hospitals
Baseline characteristics similar? Low risk “Despite randomisation therewere baseline
differences in two of the four clinical prac-
tices” (use of ventouse and use of polygly-
colic acid sutures). “There were no other
baseline differences.” (includes antibiotic
prophylaxis)
Yealy 2005
Methods STUDY DESIGN: cluster RCT, hospital level
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the ED
PARTICIPANTS: 2075 patients admitted from ED (849 intervention, 1227 control),
32 clusters (EDs)
CLINICAL PROBLEM: community-acquired pneumonia
SETTING: 32 EDs in the USA
Interventions FORMAT: low-intensity (control, 8 hospitals); moderate-intensity (12 hospitals); and
high-intensity (12 hospitals) interventions
Low-intensity intervention: audit and feedback of baseline data; disseminationof guide-
lines
Low-intensity invervention functions: education, enablement
Moderate-intensity intervention: same as low intensity, but with additional on-site
educational meeting before patient enrolment
Moderate-intensity intervention additional function: education
High-intensity intervention: same as moderate with additional audit and feedback
of data about management of individual patients within a week of enrolment plus 2
monthly feedback of group performance data; educational outreach through academic
detailing with Plan Do Study Act cycles to discuss actions to be taken in response to
group performance data
High-intensity intervention additional functions: education, enablement, persuasion
DELIVERER: departmental physicians
COMPARISON: usual care
DESIRED CHANGE: increase effective: 4 process measures including time to first
antibiotic dose
POWER CALCULATION: Primary outcome was site of treatment rather than the
antibiotic process measures. “We estimated that we would need 96 eligible patients per
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Yealy 2005 (Continued)
hospital (3072 in total) to achieve 80% power to detect a 12% difference across the
intervention groups for the site-of-treatment decision among low-risk patients.”
“For the site-of-treatment decision, this study achieved greater than 80% power to detect
differences of 10%betweenhigh-intensity andmoderate-intensity groups anddifferences
of 12% between high-intensity and low-intensity groups according to separate 1-tailed
tests in which the level was 0.025.”
Outcomes PRESCRIBING: Choice: time to first antibiotic dose and choice compliant with guide-
line
CLINICAL: Intended: mortality and medical complications
Notes INSTRUCTIONS: action plan provided, no explicit target
FINANCIAL SUPPORT: Funding: Agency for Healthcare Research andQuality (grant
number R01 HS10049). National Institute of Allergy and Infectious Diseases (grant
number K24 AI001769). Competing Interests: 1 author received consultancies, hon-
oraria or grants from Genesoft Pharmaceuticals, Zynx Health Corporation, Healthcare
Communications Inc., Stephen Lynn Klein, Kellogg Grants, and Pfizer Inc
ADDITIONAL DATA: email response from authors to request for additional data with
care pathway, slide sets, order sheets, and protocol (Yealy 2004)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “After stratifying emergency departments
by state, teaching status, and annual vol-
ume, our statistician randomly assigned
these departments to low-intensity, moder-
ate-intensity, and high-intensity guideline
implementation strategies in the ratio of 2:
3:3, respectively”
Allocation concealment (selection bias) Low risk
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Incomplete chart review on only 19 (0.6%)
of 3219 patients
Selective reporting (reporting bias) Low risk
Other bias Low risk “The target sample size included an adjust-
ment of 30% to account for the clustering
of patients within providers.”
Baseline Outcomes similar? Unclear risk No data
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Free of contamination? Low risk Cluster RCT
Baseline characteristics similar? Low risk Demographic characteristics differed be-
tween eligible patients who were and were
not enrolled. Moreover, authors observed
some imbalances in levels of illness sever-
ity across the intervention groups; how-
ever, their analyses of the site of treatment
were performed separately for low-risk and
higher-risk patients, and their multivari-
able analyses were not sensitive to the few
imbalances that were observed at baseline
Yeo 2012
Methods STUDY DESIGN: CITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians
PARTICIPANTS: all patients receiving therapeutic antibiotics
CLINICAL PROBLEM: use of all carbapenems (ertapenem, imipenem, and
meropenem), 3rd- and 4th-generation cephalosporins (ceftriaxone, ceftazidime, and ce-
fepime), piperacillin/tazobactam, and vancomycin
SETTING: 1 cancer hospital in Singapore
Interventions FORMAT: Interventions: audit and feedback; educational outreach by review and rec-
ommend change
Intervention Functions: enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of target antibiotics in DDD/1000 OBD
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: 1 author received
research funding and speaker’s honoraria from Pfizer, AstraZeneca, Janssen-Cilag, and
Merck Sharp & Dohme
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Low risk
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
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Unlikely to affect data collection (ITS) ? Low risk Prescribing outcome in DDD from phar-
macy computer
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Prescribing outcome in DDD from phar-
macy computer
Incomplete outcome data addressed (ITS)
?
Low risk Prescribing outcome in DDD from phar-
macy computer
Free of selected reporting (ITS) ? Low risk Prescribing outcome in DDD from phar-
macy computer
Free of other bias (ITS) ? Low risk Same 11 months of data (Aug-Jun) in con-
secutive years pre- and postintervention
Yong 2010
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients receiving therapeutic antibiotics
CLINICAL PROBLEM: use of broad-spectrum antibiotics (3rd- and 4th-generation
cephalosporins, aminoglycosides, antipseudomonal penicillins, carbapenems, fluoro-
quinolones)
SETTING: 1 hospital in Australia
Interventions FORMAT: Interventions: structural, computerised decision support system
Intervention Functions: enablement, environmental restructuring, persuasion
DELIVERER: AMT
COMPARISON: usual care
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of broad-spectrum antibiotics in DDD/1000 OBD
Notes FINANCIAL SUPPORT: Funding: Victorian Department of Human Services Quality
Branch and AustralianCommonwealth Biotechnology Information Fund, which funded
the development of Guidance DS. Competing Interests: none declared
ADDITIONAL DATA: email from authors with additional data about intervention
(Richards 2003; Thursky 2006)
Microbial Risk of Bias: MEDIUM (Other infection control High)
Risk of bias
Bias Authors’ judgement Support for judgement
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Intervention independent (ITS) ? High risk Acinetobacter outbreak during interven-
tion period resulting in hand hygiene and
staff education interventions. Also see Ta-
ble 4
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of analysis was point of intervention.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy and microbiology
computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy and microbiology
computers
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy and microbiology
computers
Free of selected reporting (ITS) ? Low risk Data from pharmacy and microbiology
computers
Free of other bias (ITS) ? Low risk > 1 year data pre- and postintervention, so
low risk for prescribing outcome
Microbial Risk of Bias: MEDIUM Case
definition Low, % susceptibility of Pseu-
domonas isolates, Planned intervention
Low for outcome (outbreakwas of Acineto-
bacter), Other infection control High, en-
hanced during prescribing intervention
Yoon 2014
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: requiring therapeutic antibiotics and receiving carbapenems
SETTING: 1 university hospital in Korea, same hospital as Kim 2008
Interventions FORMAT: Intervention 1: restrictive by expert approval (same intervention format as
Kim 2008)
Intervention 1 functions: restriction
Intervention 2: addition of reminders (circumstantial, electronic triggered by comput-
erised antibiotic order, the system is described in more detail in Kim 2008)
Intervention 2 functions: enablement, environmental restructuring, persuasion
DELIVERER: AMT
COMPARISON: usual care
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Yoon 2014 (Continued)
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of carbapenems in DDD/1000 OBD
MICROBIAL: infections with CRAB (carbapenem-resistant Acinetobacter baumanii)/
1000 OBD
CLINICAL: Balancing measures of adverse effects, all-cause mortality
Notes FINANCIAL SUPPORT: Funding: commercial, Merck Sharp & Dohme. Competing
Interests: supported by Merck Sharp & Dohme Corp.
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: HIGH case definition Low, planned intervention Low, other
infection control High, ICU cleaning intervention during Phase 3
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? High risk Intensive environmental cleaning imple-
mented in 2012 in ICU, which was in-
tended to reduce infections with CRAB
(microbial outcome)
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre-specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Data from pharmacy and microbiology
computers
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Data from pharmacy and microbiology
computers
Incomplete outcome data addressed (ITS)
?
Low risk Data from pharmacy and microbiology
computers
Free of selected reporting (ITS) ? Low risk Data from pharmacy and microbiology
computers
Free of other bias (ITS) ? Low risk > 1 year data in each study phase
Young 1985
Methods STUDY DESIGN: ITS
Risk of Bias: MEDIUM
Participants PROVIDERS: all physicians in the hospital
PARTICIPANTS: all patients in the hospital
CLINICAL PROBLEM: patients requiring aminoglycoside antibiotic treatment
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Young 1985 (Continued)
SETTING: 1 hospital in the USA
Interventions FORMAT: Interventions: restrictive by review and make change (substitution of
amikacin for gentamicin) and expert approval from the Infectious Diseases Division
Intervention Function: restriction
DELIVERER: pharmacist
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING:Choice: gentamicin usage as a percentage of total aminoglycoside usage
Notes FINANCIAL SUPPORT: Funding: Veterans Adminstration and Bristol-Myers Squibb.
Competing Interests: none declared, but Bristol-Myers Squibb was the manufacturer
of amikacin
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Intervention independent (ITS) ? Unclear risk 3 months’ data before, 15 months’ during,
and 22 months’ after the restriction. Not
enough data to adjust for seasonal variation
Analysed appropriately (ITS) ? Low risk Re-analysed. Not done in original paper:
comparisonofmeans (uncontrolled before-
after)
Shape of effect pre-specified (ITS) ? Low risk Done, intended effect was decrease in pri-
mary outcome, and point of analysis was
point of intervention
Unlikely to affect data collection (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Knowledge of the allocation adequately
prevented(ITS)?
Low risk Done, data were from routine systems and
unlikely to change over study period
Incomplete outcome data addressed (ITS)
?
Low risk Done, data were from routine systems and
unlikely to change over study period
Free of selected reporting (ITS) ? Low risk Done, data were from routine systems and
unlikely to change over study period
Free of other bias (ITS) ? Low risk No other apparent biases found.
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Yu 2014
Methods STUDY DESIGN: CBA
Risk of Bias: HIGH
Participants PROVIDERS: all physicians
PARTICIPANTS: all patients
CLINICAL PROBLEM: patients receiving therapeutic antibiotics
SETTING: 5 hospitals in an integrated healthcare system in the USA
Interventions FORMAT: Intervention: educational outreach through review and recommend change
in 2 hospitals
Intervention Functions: enablement, persuasion
DELIVERER: AMT
COMPARISON: usual care in 3 hospitals
DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: use of target antibiotics in DDD/1000 OBD
CLINICAL: hospital standardised mortality ratio
MICROBIAL: Clostridium difficile infection rates
FINANCIAL: total and direct acquisitional cost of targeted antimicrobials
Notes FINANCIAL SUPPORT: Funding: none. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: HIGH case definition Not Clear, planned intervention Low,
other infection control measures Not Clear
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Study sites selected from baseline antimi-
crobial use.
Allocation concealment (selection bias) High risk No concealment
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data from pharmacy computer
Selective reporting (reporting bias) Low risk Data from pharmacy computer
Other bias Low risk
Baseline Outcomes similar? High risk Table 2
Free of contamination? Low risk Intervention and control sites different hos-
pitals
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Yu 2014 (Continued)
Baseline characteristics similar? High risk Several potentially important differences
between intervention and control sites
Zanetti 2003
Methods STUDY DESIGN: NRT
Risk of Bias: HIGH
Participants PROVIDERS: all surgeons in the hospital
PARTICIPANTS: 331 patients undergoing cardiac surgery
CLINICAL PROBLEM: additional dose of antibiotic prophylaxis for operations that
lasted more than 4 hours
SETTING: 1 hospital in the USA
Interventions FORMAT: Intervention: dissemination of guideline; reminder (circumstantial, elec-
tronic, automated intra-operative alert)
Intervention Functions: education, enablement, environmental restructuring, persua-
sion
COMPARISON: control group plus 480 patients from the 6 months before the study
period
DESIRED CHANGE: increase effective
Outcomes PRESCRIBING: Exposure:% patients who received additional intra-operative antibi-
otics
CLINICAL: Intended: wound infection rate
Notes FINANCIALSUPPORT:Funding:Centers forDiseaseControl andPrevention cooper-
ative agreement, UR8/CCU115079,UniversityHospital of Lausanne, and the Leenaards
Foundation. Competing Interests: no information
ADDITIONAL DATA: no response from authors to request for additional data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Based on a case number assigned to every
surgical procedure performed in the hospi-
tal, independent of the study itself
Allocation concealment (selection bias) High risk No concealment
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome on all 273 patients
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Zanetti 2003 (Continued)
Selective reporting (reporting bias) Low risk Outcome on all 273 patients
Other bias Low risk Outcome on all 273 patients
Baseline Outcomes similar? Low risk Cohort data before start of trial
Free of contamination? High risk Control patients were operated on by the
same surgeons, and the reminder for inter-
vention patients is likely to have increased
awareness of the need for additional doses
Baseline characteristics similar? Low risk Table 1
AB: antibiotic
AKI: acute kidney injury
AMT: multidisciplinary antibiotic management team
APACHE: Acute Physiology and Chronic Health Evaluation
ARGNB: antibiotic-resistant gram-negative bacilli
ARGPB: antibiotic-resistant gram-positive bacilli
ARIMA: autoregressive integrated moving average
ASP: Antimicrobial Stewardship Program
BCT: behaviour change technique
CAP: community-acquired pneumonia
CBA: controlled before-after study
CBC: complete blood count
CDAD: Clostridium difficile-associated diarrhoea
CDC: Centers for Disease Control and Prevention
CDI: Clostridium difficile infection
CDSS: clinical decision support system
CI: confidence interval
CITS: comparative interrupted time series
CPIS: clinical pulmonary infection score
CRP: C-reactive protein
C-section: Caesarean section
DACT: double anaerobic coverage therapy
DDD: defined daily dose
DRG: diagnosis-related group
ED: emergency department
EPOC: Effective Practice and Organisation of Care
ER: emergency room
ESBL-EB: extended-spectrum beta-lactamase-producing Enterobacteriaceae
FTE: full-time equivalent
GRE: glycopeptide-resistant enterococci
IC: infectious control
ICD: International Classification of Diseases
ICU: intensive care unit
ID: infectious diseases
IDP: infectious diseases physician
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IHC: Intermountain Healthcare
IL-8: interleukin-8
ITS: interrupted time series
IQR: interquartile range
IV: intravenous
LOS: length of stay
MRSA: methicillin-resistant Staphylococcus aureus
MSSA: methicillin-sensitive Staphylococcus aureus
LRTI: lower respiratory tract infection
MICU: medical intensive care unit
NHAP: nursing home-acquired pneumonia
NIH: National Institutes of Health
NRT: non-randomised (controlled) trial
NRSI: non-randomised studies of interventions
OBD: occupied bed day
OR: odds ratio
PA: parenteral antibiotics
PCR: polymerase chain reaction
PCT: procalcitonin
RCT: randomised controlled trial
RCOG: Royal College of Obstetricians and Gynaecologists
RDD: recommended daily doses
ROB: risk of bias
ROBINS-I: risk of bias in non-randomised studies of interventions
RR: risk ratio
SCIP: Surgical Care Improvement Project
SD: standard deviation
SE: standard error
SHEA: Society for Healthcare Epidemiology of America
SICU: surgical intensive care unit
SNF: skilled nursing facilities
SSI: surgical-site infection
TFAD: time to first antibiotic dose
TREAT: computerised decision support system for antibiotic treatment
UBA: uncontrolled before-after study
VAP: ventilator-associated pneumonia
VRE: vancomycin-resistant enterococci
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ahronheim 2000 RCT with no relevant data. Antibiotics were only part of a complex care plan for 6% of participants in the
intervention group, and the outcome data do not include information about the effect of the intervention
on antibiotic prescribing
Bruno-Murtha 2005 ITS of antibiotic cycling with no interpretable data because there are no pre-cycling data. Only provides
data for 4 phases of cycling
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(Continued)
Burke 1997 ITS with no interpretable data. 2 different interventions (education, then restriction via order form) with
3 points before the education intervention and 3 after, but the restriction intervention started after the
4th point
Cook 2006 ITS with no interpretable data because no clearly defined point in time at which the intervention started
Crist 1987 NRT with no interpretable data. Unacceptable allocation bias (“the allocation of a patient to a particular
group was determined by the attending physician”)
Cunningham 2008 ITS with no relevant data. The only valid outcome data are about compliance with a guideline about
generic documentation of prescription rather than any specific antibiotic prescribing outcome. The data
about time to first antibiotic dose are UBA
Dellinger 2005 ITS with no interpretable data because no clearly defined point in time at which the intervention started.
Only 4 data points for antibiotic use, and the intervention included multiple components in addition to
antibiotic use, so even if an intervention effect could be calculated reliably it could not be attributed to
change in antibiotic prescribing
Destache 1990 RCT with no interpretable data because of incomplete and selective reporting of outcome data. The
primary outcome measure was length of stay, but 32% of participants in the intervention group were
excluded because they had prolonged length of stay
Ehrenkranz 1992 RCT with no interpretable data. Only report data for participants whose physicians followed recommen-
dations
Ehrenkranz 1993 RCT with no interpretable data. Only report data for participants whose physicians followed recommen-
dations
Evans 1994 NRT with no interpretable data. The first part compared the drugs that the Antibiotic Consultant
programme recommended, with the drugs actually prescribed by physicians. Data from the second part are
presented in an uninterpretable format, with the denominator as cultures, not participants or physicians
Foy 2004 Cluster RCT with no relevant data. Intervention targeted 5 care processes for women having an abortion.
Only 1 included antibiotic prescribing within a composite (antibiotic prophylaxis or screening for lower
genital tract organisms). Effect of intervention on prescribing cannot be estimated
Garcia-San Miguel 2014 Cluster RCT with no interpretable data. The study included 9 hospitals with 32 hospitalisation units
(wards). Patients were included if they had drugs dispensed from an electronic system
Baseline: Jan-June 2003 baseline, no intervention
1. Jan-June 2004, intervention in half of the wards that were randomised in each hospital
2. Jan-June 2005, cross-over, intervention in wards that were randomised to control in Period 2
There is no description of the randomisation process. The primary outcome measure was adherence to
recommendations; text on page 658 says they do not present data about mortality or re-admission, but
that appears to be what is in Figure 4. Figure 4: legend (and text) says it is about DDD and cost of drugs,
but labelling says it is mortality and re-admission. We asked authors to clarify and provide valid outcome
data but received no reply
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(Continued)
Gerding 1991 ITS with no interpretable data. Describes 10 years of experience with aminoglycoside cycling, but the
intervention periods cannot be mapped onto the outcome data about prescribing or resistance
Kolar 1999 ITS with no interpretable data due to inadequate control for the effect of other interventions (infection
control measures; see detailed critique by Monnet 2000).
Lan 2003 ITS with unacceptable missing data and inappropriate statistical analysis. There are 3 monthly data points
pre-intervention, then a gap in colonisation data for 3 months at the start of the intervention period
followed by 3 monthly data points from months 4 to 6 of the intervention phase
Lee 2004 ITS with no interpretable data. There were no isolates of ESBL-Klebsiella pneumoniae in the last 3 months
of the intervention phase, but no data are provided about the number of specimens screened. Appropriate
statistical analysis in original paper not done (averages pre- and postintervention with χ2 and Fisher’s
exact test). Re-analysis not possible because there are only 2 reliable data points in the postintervention
phase
MacCosbe 1985 RCT with no interpretable data. Only 29% of randomised doctors were followed up, and recommenda-
tions were only made in 6% of the intervention group
Marrie 2000 Cluster RCT with no relevant data. Antibiotic prescribing was only 1 component of a care pathway, results
for impact on antibiotic prescribing and its contribution to outcome not reported separately
Martin 2005 ITS with no interpretable data. No antibiotic data pre-intervention, only data about MRSA; this infor-
mation is uninterpretable without information about pre-intervention antibiotic prescribing
McGregor 2006 RCT with no interpretable data. Statistical analysis of primary outcome measure (antibiotic costs) not
done, and re-analysis not possible from the data presented
Nagao 2010 ITS with no interpretable data. Figure 1 reports the number of participants with inappropriate antibiotic
use, consultations, significant laboratory test results, and total number of blood cultures obtained. How-
ever, the number of participants in each category is not clear in the figure. We asked the authors for raw
data but they were unable to provide this information
Naughton 2001 Cluster RCT in 10 skilled nursing facilities. The intention was to increase use of IV antibiotics for severe
pneumonia. The comparison was between the same intervention delivered by a multidisciplinary team
(intervention) versus a physician (control). There was no difference in the intervention effect, but the
study provides no reliable evidence of intervention effect (UBA data in all 10 skilled nursing facilities)
Pastel 1992 NRT in 1 hospital, no interpretable data because no protection against contamination and unreliable
primary outcome measure
Ronning 1998 RCT with no relevant data. Not primarily an intervention on antibiotic therapy, compared stroke unit
versus general medical ward
Sanazaro 1978 NRT with no relevant data. Antibiotic prescribing was only 1 of 3 components of a care pathway, results
for impact on antibiotic prescribing and its contribution to outcome not reported separately
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Takahashi 2010 ITS with no interpretable data. The only time series data (Figures 2 and 3) are MRSA and Pseudomonas
aeruginosa infections. The paper claims that a prophylaxis intervention in early 2007 was responsible for
reduction in P aeruginosa and MRSA infections, whereas the figures clearly show the reduction happened
between July and December 2006. The paper does not include valid data about prescribing outcomes,
and the authors were unable to provide these data
Thomas 2002 CBA in 64 hospitals, no interpretable data because no clear point in time for the intervention
Tiley 2003 ITS with no interpretable data. Multiple interventions are described without clear definition of interven-
tion points
Tsiata 2001 RCT with no interpretable data. These are provider interventions, but allocation was by patient randomi-
sation. The unequal numbers of patients in each group (134 Group A, 141 Group B, and 105 Group C)
and the differences in baseline characteristics indicate unacceptable allocation bias
Van Loon 2005 ITS with no interpretable data about the impact of antibiotic cycling on resistance because there are no
pre-cycling data
Wahlstrom 2003 RCT with no relevant data. Antibiotics included in the indicators for treatment of hospitalised cases of
pneumonia (compliance with policy, dose and duration) and diarrhoea (no use of antibiotics without
bacterial identification), but no separate data are presented for these outcomes. The only data provided
are mean scores on a single composite indicator for each condition
CBA: controlled before-after study
DDD: defined daily dose
ESBL: extended-spectrum beta-lactamase
ITS: interrupted time series
MRSA: methicillin-resistant Staphylococcus aureus
NRT: non-randomised trial
RCT: randomised controlled trial
UBA: uncontrolled before-after study
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D A T A A N D A N A L Y S E S
Comparison 1. Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic
use
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Dichotomous outcomes, increase
in desired practice
29 23394 Risk Difference (M-H, Random, 95% CI) 0.19 [0.15, 0.23]
2 Dichotomous outcomes, all
RCTs with results of cluster
RCTs adjusted by inflation
factor
29 5802 Risk Difference (M-H, Fixed, 95% CI) 0.17 [0.15, 0.19]
3 Dichotomous outcomes, low or
medium ’Risk of bias’ studies
only
15 13086 Risk Difference (M-H, Fixed, 95% CI) 0.11 [0.10, 0.12]
4 Continuous outcomes, duration
of all antibiotic treatment
(days)
14 3318 Mean Difference (IV, Fixed, 95% CI) -1.95 [-2.22, -1.67]
5 Continuous outcomes, duration
of all antibiotic treatment with
results of cluster RCTs adjusted
by inflation factor
14 3318 Mean Difference (IV, Fixed, 95% CI) -1.95 [-2.23, -1.67]
6 Continuous outcomes, low or
medium ’Risk of bias’ studies
only
3 755 Mean Difference (IV, Fixed, 95% CI) -3.06 [-3.76, -2.37]
7 Continuous outcome,
consumption of targeted
antibiotic only, standardised
mean reduction (original
outcome cost, days or DDD)
4 1053 Std. Mean Difference (IV, Fixed, 95% CI) -0.25 [-0.37, -0.13]
Comparison 2. Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic
use
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality, all RCTs 28 15827 Risk Difference (M-H, Fixed, 95% CI) -0.00 [-0.01, 0.00]
2 Mortality, all RCTs with results
of cluster RCTs adjusted by
inflation factor
28 8332 Risk Difference (M-H, Fixed, 95% CI) -0.01 [-0.02, 0.01]
3 Mortality, low or medium ’Risk
of bias’ RCTs
8 6249 Risk Difference (M-H, Fixed, 95% CI) -0.00 [-0.02, 0.01]
4 Length of stay, all RCTs 15 3834 Mean Difference (IV, Fixed, 95% CI) -1.12 [-1.54, -0.70]
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5 Length of stay, all RCTs with
results of cluster RCTs adjusted
by inflation factor
15 3834 Mean Difference (IV, Fixed, 95% CI) -1.22 [-1.68, -0.76]
6 Length of stay, low or medium
’Risk of bias’ RCTs only
6 1731 Mean Difference (IV, Fixed, 95% CI) -0.85 [-1.38, -0.32]
Comparison 3. Adverse effects: Clinical outcomes of interventions targeting antibiotic choice
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality for trial patients 11 7658 Risk Difference (M-H, Fixed, 95% CI) -0.00 [-0.02, 0.01]
2 Length of stay for trial patients 7 2276 Mean Difference (IV, Fixed, 95% CI) -1.50 [-2.16, -0.83]
Comparison 4. Adverse effects: Clinical outcomes of interventions targeting antibiotic exposure
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality for trial patients 18 9173 Risk Difference (M-H, Fixed, 95% CI) -0.00 [-0.01, 0.01]
2 Length of stay for trial patients 8 1558 Mean Difference (IV, Fixed, 95% CI) -0.87 [-1.42, -0.33]
Comparison 5. Modifiers of intended effect: Comparison of enabling interventions with and without feedback
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Enablement with feedback 4 3747 Risk Difference (M-H, Fixed, 95% CI) 0.19 [0.16, 0.22]
2 Enablement without feedback 7 1827 Risk Difference (M-H, Fixed, 95% CI) 0.13 [0.09, 0.17]
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Analysis 1.1. Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 1 Dichotomous outcomes, increase in desired practice.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 1 Dichotomous outcomes, increase in desired practice
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Annane 2013 9/30 5/28 2.0 % 0.12 [ -0.10, 0.34 ]
Burton 1991 58/70 44/73 2.9 % 0.23 [ 0.08, 0.37 ]
Camins 2009 92/112 60/138 3.4 % 0.39 [ 0.28, 0.50 ]
Christ-Crain 2004 69/124 20/119 3.4 % 0.39 [ 0.28, 0.50 ]
Christ-Crain 2006 23/151 2/151 4.0 % 0.14 [ 0.08, 0.20 ]
Ding 2013 7/33 0/35 2.9 % 0.21 [ 0.07, 0.36 ]
Dranitsaris 2001 122/162 102/147 3.5 % 0.06 [ -0.04, 0.16 ]
Esposito 2011 24/155 0/155 4.1 % 0.15 [ 0.10, 0.21 ]
Franz 2004 419/656 320/635 4.1 % 0.13 [ 0.08, 0.19 ]
Gulmezoglu 2007 895/3891 135/3613 4.4 % 0.19 [ 0.18, 0.21 ]
Kritchevsky 2008 374/2225 331/2238 4.3 % 0.02 [ 0.00, 0.04 ]
Lacroix 2014 77/131 81/140 3.3 % 0.01 [ -0.11, 0.13 ]
Long 2014 46/90 11/90 3.2 % 0.39 [ 0.27, 0.51 ]
Maravic-Stojkovic 2011 83/102 55/103 3.2 % 0.28 [ 0.16, 0.40 ]
Paul 2006 216/297 176/273 3.8 % 0.08 [ 0.01, 0.16 ]
Poehling 2006 92/135 121/170 3.5 % -0.03 [ -0.13, 0.07 ]
Schnoor 2010 182/275 186/348 3.8 % 0.13 [ 0.05, 0.20 ]
Schouten 2007 296/460 154/338 3.9 % 0.19 [ 0.12, 0.26 ]
Schuetz 2009 136/628 61/629 4.2 % 0.12 [ 0.08, 0.16 ]
Senn 2004 80/126 73/125 3.2 % 0.05 [ -0.07, 0.17 ]
Singh 2000 28/39 8/42 2.4 % 0.53 [ 0.34, 0.71 ]
Solomon 2001 88/125 69/153 3.3 % 0.25 [ 0.14, 0.37 ]
Stocker 2010 27/60 11/61 2.7 % 0.27 [ 0.11, 0.43 ]
Stolz 2009 61/102 32/106 3.1 % 0.30 [ 0.17, 0.43 ]
-0.5 -0.25 0 0.25 0.5
Favours control Favours intervention
(Continued . . . )
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(. . . Continued)
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Strom 2010 111/194 20/148 3.7 % 0.44 [ 0.35, 0.53 ]
Trenholme 1989 102/110 90/116 3.7 % 0.15 [ 0.06, 0.24 ]
Walker 1998 22/25 9/25 1.9 % 0.52 [ 0.29, 0.75 ]
Wyatt 1998 224/314 222/297 3.9 % -0.03 [ -0.10, 0.04 ]
Yealy 2005 631/849 677/1227 4.2 % 0.19 [ 0.15, 0.23 ]
Total (95% CI) 11671 11723 100.0 % 0.19 [ 0.15, 0.23 ]
Total events: 4594 (Intervention), 3075 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 367.98, df = 28 (P<0.00001); I2 =92%
Test for overall effect: Z = 8.81 (P < 0.00001)
Test for subgroup differences: Not applicable
-0.5 -0.25 0 0.25 0.5
Favours control Favours intervention
318Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.2. Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 2 Dichotomous outcomes, all RCTs with results of cluster RCTs adjusted
by inflation factor.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 2 Dichotomous outcomes, all RCTs with results of cluster RCTs adjusted by inflation factor
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Annane 2013 9/30 5/28 1.0 % 0.12 [ -0.10, 0.34 ]
Burton 1991 58/70 44/73 2.5 % 0.23 [ 0.08, 0.37 ]
Camins 2009 19/23 12/28 0.9 % 0.40 [ 0.16, 0.64 ]
Christ-Crain 2004 18/32 5/31 1.1 % 0.40 [ 0.19, 0.62 ]
Christ-Crain 2006 23/151 2/151 5.2 % 0.14 [ 0.08, 0.20 ]
Ding 2013 7/33 0/35 1.2 % 0.21 [ 0.07, 0.36 ]
Dranitsaris 2001 122/162 102/147 5.3 % 0.06 [ -0.04, 0.16 ]
Esposito 2011 24/155 0/155 5.4 % 0.15 [ 0.10, 0.21 ]
Franz 2004 419/656 320/635 22.3 % 0.13 [ 0.08, 0.19 ]
Gulmezoglu 2007 23/102 4/94 3.4 % 0.18 [ 0.09, 0.27 ]
Kritchevsky 2008 18/106 16/106 3.7 % 0.02 [ -0.08, 0.12 ]
Lacroix 2014 77/131 81/140 4.7 % 0.01 [ -0.11, 0.13 ]
Long 2014 46/90 11/90 3.1 % 0.39 [ 0.27, 0.51 ]
Maravic-Stojkovic 2011 83/102 55/103 3.5 % 0.28 [ 0.16, 0.40 ]
Paul 2006 26/35 21/33 1.2 % 0.11 [ -0.11, 0.33 ]
Poehling 2006 92/135 121/170 5.2 % -0.03 [ -0.13, 0.07 ]
Schnoor 2010 11/17 11/21 0.7 % 0.12 [ -0.19, 0.44 ]
Schouten 2007 11/17 6/12 0.5 % 0.15 [ -0.22, 0.51 ]
Schuetz 2009 3/15 1/15 0.5 % 0.13 [ -0.11, 0.37 ]
Senn 2004 80/126 73/125 4.3 % 0.05 [ -0.07, 0.17 ]
Singh 2000 28/39 8/42 1.4 % 0.53 [ 0.34, 0.71 ]
Solomon 2001 22/31 17/38 1.2 % 0.26 [ 0.04, 0.49 ]
Stocker 2010 27/60 11/61 2.1 % 0.27 [ 0.11, 0.43 ]
Stolz 2009 61/102 32/106 3.6 % 0.30 [ 0.17, 0.43 ]
-1 -0.5 0 0.5 1
Favours control Favours intervention
(Continued . . . )
319Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Strom 2010 133/232 24/177 6.9 % 0.44 [ 0.36, 0.52 ]
Trenholme 1989 102/110 90/116 3.9 % 0.15 [ 0.06, 0.24 ]
Walker 1998 22/25 9/25 0.9 % 0.52 [ 0.29, 0.75 ]
Wyatt 1998 39/55 39/52 1.8 % -0.04 [ -0.21, 0.13 ]
Yealy 2005 46/62 49/89 2.5 % 0.19 [ 0.04, 0.34 ]
Total (95% CI) 2904 2898 100.0 % 0.17 [ 0.15, 0.19 ]
Total events: 1649 (Intervention), 1169 (Control)
Heterogeneity: Chi2 = 143.98, df = 28 (P<0.00001); I2 =81%
Test for overall effect: Z = 15.03 (P < 0.00001)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours control Favours intervention
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Analysis 1.3. Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 3 Dichotomous outcomes, low or medium ’Risk of bias’ studies only.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 3 Dichotomous outcomes, low or medium ’Risk of bias’ studies only
Study or subgroup Experimental Control
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Christ-Crain 2004 69/124 20/119 1.9 % 0.39 [ 0.28, 0.50 ]
Christ-Crain 2006 23/151 2/151 2.3 % 0.14 [ 0.08, 0.20 ]
Esposito 2011 24/155 0/155 2.4 % 0.15 [ 0.10, 0.21 ]
Franz 2004 419/656 320/635 9.9 % 0.13 [ 0.08, 0.19 ]
Kritchevsky 2008 374/2225 331/2238 34.4 % 0.02 [ 0.00, 0.04 ]
Lacroix 2014 77/131 81/140 2.1 % 0.01 [ -0.11, 0.13 ]
Long 2014 46/90 11/90 1.4 % 0.39 [ 0.27, 0.51 ]
Paul 2006 216/297 176/273 4.4 % 0.08 [ 0.01, 0.16 ]
Schouten 2007 296/460 154/338 6.0 % 0.19 [ 0.12, 0.26 ]
Schuetz 2009 136/628 61/629 9.7 % 0.12 [ 0.08, 0.16 ]
Senn 2004 80/126 73/125 1.9 % 0.05 [ -0.07, 0.17 ]
Stocker 2010 27/60 11/61 0.9 % 0.27 [ 0.11, 0.43 ]
Strom 2010 111/194 20/148 2.6 % 0.44 [ 0.35, 0.53 ]
Wyatt 1998 224/314 222/297 4.7 % -0.03 [ -0.10, 0.04 ]
Yealy 2005 631/849 677/1227 15.5 % 0.19 [ 0.15, 0.23 ]
Total (95% CI) 6460 6626 100.0 % 0.11 [ 0.10, 0.12 ]
Total events: 2753 (Experimental), 2159 (Control)
Heterogeneity: Chi2 = 212.69, df = 14 (P<0.00001); I2 =93%
Test for overall effect: Z = 14.96 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 4 Continuous outcomes, duration of all antibiotic treatment (days).
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 4 Continuous outcomes, duration of all antibiotic treatment (days)
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bouza 2004 167 15.72 (9.47) 83 18.92 (10.92) 1.0 % -3.20 [ -5.95, -0.45 ]
Christ-Crain 2004 119 10.9 (3.6) 124 12.8 (5.5) 5.6 % -1.90 [ -3.06, -0.74 ]
Christ-Crain 2006 151 6.8 (5.1) 151 13.1 (6.4) 4.4 % -6.30 [ -7.61, -4.99 ]
Danaher 2009 14 4.5 (3) 38 6.6 (4.6) 1.6 % -2.10 [ -4.25, 0.05 ]
Ding 2013 33 8.7 (6.6) 35 14.5 (5.2) 0.9 % -5.80 [ -8.64, -2.96 ]
Hochreiter 2009 63 5.9 (1.7) 57 7.9 (0.5) 39.0 % -2.00 [ -2.44, -1.56 ]
Kerremans 2008 497 26.6 (24.5) 503 32.9 (31.9) 0.6 % -6.30 [ -9.82, -2.78 ]
Kristoffersen 2009 103 5.1 (3.64) 107 6.8 (4.77) 5.7 % -1.70 [ -2.84, -0.56 ]
Layios 2012 258 14.73 (20.6) 251 14.11 (13.69) 0.8 % 0.62 [ -2.41, 3.65 ]
Liu 2013 42 8.1 (1.94) 40 9.3 (1.9) 10.9 % -1.20 [ -2.03, -0.37 ]
Micek 2004 150 6 (4.9) 140 8 (5.6) 5.1 % -2.00 [ -3.21, -0.79 ]
Oliveira 2013 49 8.1 (3.7) 45 7.2 (3.5) 3.6 % 0.90 [ -0.56, 2.36 ]
Qu 2012 35 10.89 (2.85) 36 16.06 (2.48) 4.9 % -5.17 [ -6.41, -3.93 ]
Schroeder 2009 14 6.6 (1.1) 13 7.1 (0.7) 15.8 % -0.50 [ -1.19, 0.19 ]
Total (95% CI) 1695 1623 100.0 % -1.95 [ -2.22, -1.67 ]
Heterogeneity: Chi2 = 119.95, df = 13 (P<0.00001); I2 =89%
Test for overall effect: Z = 13.91 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 5 Continuous outcomes, duration of all antibiotic treatment with results
of cluster RCTs adjusted by inflation factor.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 5 Continuous outcomes, duration of all antibiotic treatment with results of cluster RCTs adjusted by inflation factor
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bouza 2007 167 15.72 (9.47) 83 18.92 (10.92) 1.1 % -3.20 [ -5.95, -0.45 ]
Christ-Crain 2004 119 10.9 (13.82) 124 12.8 (49.12) 0.1 % -1.90 [ -10.90, 7.10 ]
Christ-Crain 2006 151 6.8 (5.1) 151 13.1 (6.4) 4.7 % -6.30 [ -7.61, -4.99 ]
Danaher 2009 14 4.5 (3) 38 6.6 (4.6) 1.7 % -2.10 [ -4.25, 0.05 ]
Ding 2013 33 8.7 (6.6) 35 14.5 (5.2) 1.0 % -5.80 [ -8.64, -2.96 ]
Hochreiter 2009 63 5.9 (1.7) 57 7.9 (0.5) 41.3 % -2.00 [ -2.44, -1.56 ]
Kerremans 2008 497 26.6 (24.5) 503 32.9 (31.9) 0.6 % -6.30 [ -9.82, -2.78 ]
Kristoffersen 2009 103 5.1 (3.64) 107 6.8 (4.77) 6.1 % -1.70 [ -2.84, -0.56 ]
Layios 2012 258 14.73 (20.6) 251 14.11 (13.69) 0.9 % 0.62 [ -2.41, 3.65 ]
Liu 2013 42 8.1 (1.94) 40 9.3 (1.9) 11.5 % -1.20 [ -2.03, -0.37 ]
Micek 2004 150 6 (4.9) 140 8 (5.6) 5.4 % -2.00 [ -3.21, -0.79 ]
Oliveira 2013 49 8.1 (3.7) 45 7.2 (3.5) 3.8 % 0.90 [ -0.56, 2.36 ]
Qu 2012 35 10.89 (2.85) 36 16.06 (2.48) 5.2 % -5.17 [ -6.41, -3.93 ]
Schroeder 2009 14 6.6 (1.1) 13 7.1 (0.7) 16.7 % -0.50 [ -1.19, 0.19 ]
Total (95% CI) 1695 1623 100.0 % -1.95 [ -2.23, -1.67 ]
Heterogeneity: Chi2 = 119.94, df = 13 (P<0.00001); I2 =89%
Test for overall effect: Z = 13.54 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 6 Continuous outcomes, low or medium ’Risk of bias’ studies only.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 6 Continuous outcomes, low or medium ’Risk of bias’ studies only
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Christ-Crain 2004 119 10.9 (3.6) 124 12.8 (5.5) 35.3 % -1.90 [ -3.06, -0.74 ]
Christ-Crain 2006 151 6.8 (5.1) 151 13.1 (6.4) 28.1 % -6.30 [ -7.61, -4.99 ]
Kristoffersen 2009 103 5.1 (3.64) 107 6.8 (4.77) 36.5 % -1.70 [ -2.84, -0.56 ]
Total (95% CI) 373 382 100.0 % -3.06 [ -3.76, -2.37 ]
Heterogeneity: Chi2 = 32.90, df = 2 (P<0.00001); I2 =94%
Test for overall effect: Z = 8.68 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 7 Continuous outcome, consumption of targeted antibiotic only,
standardised mean reduction (original outcome cost, days or DDD).
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 7 Continuous outcome, consumption of targeted antibiotic only, standardised mean reduction (original outcome cost, days or DDD)
Study or subgroup Intervention Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bailey 1997 51 19.8 (36.5) 51 35.8 (45.48541) 9.6 % -0.39 [ -0.78, 0.01 ]
Gums 1999 127 2078 (2208.9) 125 2663 (2873.4) 24.0 % -0.23 [ -0.48, 0.02 ]
Shen 2011 176 832 (373) 178 943.9 (412) 33.6 % -0.28 [ -0.49, -0.07 ]
Shojania 1998 174 1.8 (1.1) 171 2 (1.1) 32.9 % -0.18 [ -0.39, 0.03 ]
Total (95% CI) 528 525 100.0 % -0.25 [ -0.37, -0.13 ]
Heterogeneity: Chi2 = 0.99, df = 3 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 3.98 (P = 0.000068)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 1 Mortality, all RCTs.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 1 Mortality, all RCTs
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Annane 2013 7/31 10/30 0.4 % -0.11 [ -0.33, 0.12 ]
Bailey 1997 3/51 3/51 0.6 % 0.0 [ -0.09, 0.09 ]
Bouza 2007 92/167 43/83 1.4 % 0.03 [ -0.10, 0.16 ]
Camins 2009 11/390 18/394 5.0 % -0.02 [ -0.04, 0.01 ]
Christ-Crain 2004 4/124 4/119 1.5 % 0.00 [ -0.05, 0.04 ]
Christ-Crain 2006 18/151 20/151 1.9 % -0.01 [ -0.09, 0.06 ]
Ding 2013 21/33 20/35 0.4 % 0.06 [ -0.17, 0.30 ]
Fine 2003 22/283 29/325 3.8 % -0.01 [ -0.06, 0.03 ]
Fraser 1997 19/141 12/111 1.6 % 0.03 [ -0.05, 0.11 ]
Gums 1999 8/127 15/125 1.6 % -0.06 [ -0.13, 0.01 ]
Hochreiter 2009 15/57 14/53 0.7 % 0.00 [ -0.17, 0.16 ]
Kristoffersen 2009 2/103 1/107 1.3 % 0.01 [ -0.02, 0.04 ]
Liu 2013 6/42 5/40 0.5 % 0.02 [ -0.13, 0.17 ]
Maravic-Stojkovic 2011 7/102 8/103 1.3 % -0.01 [ -0.08, 0.06 ]
Masia 2008 40/140 33/132 1.7 % 0.04 [ -0.07, 0.14 ]
Micek 2004 48/150 52/140 1.8 % -0.05 [ -0.16, 0.06 ]
Oliveira 2013 21/49 21/45 0.6 % -0.04 [ -0.24, 0.16 ]
Paul 2006 149/1153 145/1012 13.7 % -0.01 [ -0.04, 0.01 ]
Qu 2012 7/35 8/36 0.5 % -0.02 [ -0.21, 0.17 ]
Schnoor 2010 10/302 13/348 4.1 % 0.00 [ -0.03, 0.02 ]
Schouten 2007 15/207 15/194 2.5 % 0.00 [ -0.06, 0.05 ]
Schroeder 2009 3/14 3/11 0.2 % -0.06 [ -0.40, 0.28 ]
Schuetz 2009 34/671 33/688 8.6 % 0.00 [ -0.02, 0.03 ]
Senn 2004 8/126 5/125 1.6 % 0.02 [ -0.03, 0.08 ]
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(. . . Continued)
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Singh 2000 5/39 13/42 0.5 % -0.18 [ -0.36, -0.01 ]
Solomon 2001 60/2624 55/2489 32.4 % 0.00 [ -0.01, 0.01 ]
Stolz 2007 5/102 9/106 1.3 % -0.04 [ -0.10, 0.03 ]
Yealy 2005 57/617 61/701 8.3 % 0.01 [ -0.03, 0.04 ]
Total (95% CI) 8031 7796 100.0 % 0.00 [ -0.01, 0.00 ]
Total events: 697 (Intervention), 668 (Control)
Heterogeneity: Chi2 = 16.34, df = 27 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 1.13 (P = 0.26)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 2 Mortality, all RCTs with results of cluster RCTs adjusted by inflation
factor.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 2 Mortality, all RCTs with results of cluster RCTs adjusted by inflation factor
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Annane 2013 7/31 10/30 0.7 % -0.11 [ -0.33, 0.12 ]
Bailey 1997 3/51 3/51 1.2 % 0.0 [ -0.09, 0.09 ]
Bouza 2007 92/167 43/83 2.7 % 0.03 [ -0.10, 0.16 ]
Camins 2009 7/237 11/240 5.8 % -0.02 [ -0.05, 0.02 ]
Christ-Crain 2004 4/109 4/104 2.6 % 0.00 [ -0.05, 0.05 ]
Christ-Crain 2006 18/151 20/151 3.6 % -0.01 [ -0.09, 0.06 ]
Ding 2013 21/33 20/35 0.8 % 0.06 [ -0.17, 0.30 ]
Fine 2003 12/152 16/175 3.9 % -0.01 [ -0.07, 0.05 ]
Fraser 1997 19/141 12/111 3.0 % 0.03 [ -0.05, 0.11 ]
Gums 1999 8/127 15/125 3.0 % -0.06 [ -0.13, 0.01 ]
Hochreiter 2009 15/57 14/53 1.3 % 0.00 [ -0.17, 0.16 ]
Kristoffersen 2009 2/103 1/107 2.5 % 0.01 [ -0.02, 0.04 ]
Liu 2013 6/42 5/40 1.0 % 0.02 [ -0.13, 0.17 ]
Maravic-Stojkovic 2011 7/102 8/103 2.5 % -0.01 [ -0.08, 0.06 ]
Masia 2008 40/140 33/132 3.3 % 0.04 [ -0.07, 0.14 ]
Micek 2004 48/150 52/140 3.5 % -0.05 [ -0.16, 0.06 ]
Oliveira 2013 21/49 21/45 1.1 % -0.04 [ -0.24, 0.16 ]
Paul 2006 61/474 60/416 10.7 % -0.02 [ -0.06, 0.03 ]
Qu 2012 7/35 8/36 0.9 % -0.02 [ -0.21, 0.17 ]
Schnoor 2010 6/168 7/193 4.3 % 0.00 [ -0.04, 0.04 ]
Schouten 2007 9/125 9/117 2.9 % 0.00 [ -0.07, 0.06 ]
Schroeder 2009 3/14 3/11 0.3 % -0.06 [ -0.40, 0.28 ]
Schuetz 2009 10/206 10/211 5.0 % 0.00 [ -0.04, 0.04 ]
Senn 2004 8/126 5/125 3.0 % 0.02 [ -0.03, 0.08 ]
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(. . . Continued)
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Singh 2000 5/39 13/42 1.0 % -0.18 [ -0.36, -0.01 ]
Solomon 2001 15/656 14/623 15.4 % 0.00 [ -0.02, 0.02 ]
Stolz 2007 5/102 9/106 2.5 % -0.04 [ -0.10, 0.03 ]
Yealy 2005 41/440 44/500 11.3 % 0.01 [ -0.03, 0.04 ]
Total (95% CI) 4227 4105 100.0 % -0.01 [ -0.02, 0.01 ]
Total events: 500 (Intervention), 470 (Control)
Heterogeneity: Chi2 = 14.33, df = 27 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 1.02 (P = 0.31)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 3 Mortality, low or medium ’Risk of bias’ RCTs.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 3 Mortality, low or medium ’Risk of bias’ RCTs
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Christ-Crain 2004 4/124 4/119 3.9 % 0.00 [ -0.05, 0.04 ]
Christ-Crain 2006 18/151 20/151 4.8 % -0.01 [ -0.09, 0.06 ]
Kristoffersen 2009 2/103 1/107 3.4 % 0.01 [ -0.02, 0.04 ]
Paul 2006 149/1153 145/1012 34.6 % -0.01 [ -0.04, 0.01 ]
Schouten 2007 15/207 15/194 6.4 % 0.00 [ -0.06, 0.05 ]
Schuetz 2009 34/671 33/688 21.8 % 0.00 [ -0.02, 0.03 ]
Senn 2004 8/126 5/125 4.0 % 0.02 [ -0.03, 0.08 ]
Yealy 2005 57/617 61/701 21.1 % 0.01 [ -0.03, 0.04 ]
Total (95% CI) 3152 3097 100.0 % 0.00 [ -0.02, 0.01 ]
Total events: 287 (Intervention), 284 (Control)
Heterogeneity: Chi2 = 2.66, df = 7 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 0.40 (P = 0.69)
Test for subgroup differences: Not applicable
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Analysis 2.4. Comparison 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 4 Length of stay, all RCTs.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 4 Length of stay, all RCTs
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bailey 1997 41 4.9 (5.25) 38 4.4 (4.74) 3.6 % 0.50 [ -1.70, 2.70 ]
Burton 1991 72 16 (11.03) 75 20.3 (14.72) 1.0 % -4.30 [ -8.49, -0.11 ]
Christ-Crain 2004 124 10.7 (8.9) 119 11.2 (10.6) 2.9 % -0.50 [ -2.97, 1.97 ]
Christ-Crain 2006 151 12 (9.1) 151 13 (9) 4.2 % -1.00 [ -3.04, 1.04 ]
Esposito 2011 79 5.01 (2.43) 76 5.93 (1.7) 40.6 % -0.92 [ -1.58, -0.26 ]
Gums 1999 127 5.7 (5.64) 125 9 (5.59) 9.1 % -3.30 [ -4.69, -1.91 ]
Kristoffersen 2009 103 5.9 (5.17) 107 6.7 (5.15) 9.0 % -0.80 [ -2.20, 0.60 ]
Liu 2013 42 27 (31.7) 40 32 (34.1) 0.1 % -5.00 [ -19.27, 9.27 ]
Maravic-Stojkovic 2011 102 12.08 (11.28) 103 12.93 (10.73) 1.9 % -0.85 [ -3.86, 2.16 ]
Micek 2004 150 15.7 (18.2) 140 15.41 (15.9) 1.1 % 0.29 [ -3.64, 4.22 ]
Paul 2006 297 8.83 (11.29) 273 9.45 (11.52) 5.0 % -0.62 [ -2.50, 1.26 ]
Qu 2012 35 16.66 (23.7) 36 23.81 (45.3) 0.1 % -7.15 [ -23.90, 9.60 ]
Schnoor 2010 275 10 (7.6) 348 10.7 (9.5) 9.8 % -0.70 [ -2.04, 0.64 ]
Senn 2004 126 19.4 (24.51) 125 19.3 (16.22) 0.7 % 0.10 [ -5.04, 5.24 ]
Shen 2011 176 14.2 (6.2) 178 15.8 (6) 10.9 % -1.60 [ -2.87, -0.33 ]
Total (95% CI) 1900 1934 100.0 % -1.12 [ -1.54, -0.70 ]
Heterogeneity: Chi2 = 17.32, df = 14 (P = 0.24); I2 =19%
Test for overall effect: Z = 5.25 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 2.5. Comparison 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 5 Length of stay, all RCTs with results of cluster RCTs adjusted by
inflation factor.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 5 Length of stay, all RCTs with results of cluster RCTs adjusted by inflation factor
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bailey 1997 41 4.9 (5.25) 38 4.4 (4.74) 4.4 % 0.50 [ -1.70, 2.70 ]
Burton 1991 72 16 (11.03) 75 20.3 (14.72) 1.2 % -4.30 [ -8.49, -0.11 ]
Christ-Crain 2004 124 10.7 (34.15) 119 11.2 (42.98) 0.2 % -0.50 [ -10.29, 9.29 ]
Christ-Crain 2006 151 12 (9.1) 151 13 (9) 5.1 % -1.00 [ -3.04, 1.04 ]
Esposito 2011 79 5.01 (2.43) 76 5.93 (1.7) 49.1 % -0.92 [ -1.58, -0.26 ]
Gums 1999 127 5.7 (5.64) 125 9 (5.59) 11.1 % -3.30 [ -4.69, -1.91 ]
Kristoffersen 2009 103 5.9 (5.17) 107 6.7 (5.15) 10.9 % -0.80 [ -2.20, 0.60 ]
Liu 2013 42 27 (31.7) 40 32 (34.1) 0.1 % -5.00 [ -19.27, 9.27 ]
Maravic-Stojkovic 2011 102 12.08 (11.28) 103 12.93 (10.73) 2.3 % -0.85 [ -3.86, 2.16 ]
Micek 2004 150 15.7 (18.2) 140 15.41 (15.9) 1.4 % 0.29 [ -3.64, 4.22 ]
Paul 2006 297 8.83 (94.84) 273 9.45 (96.77) 0.1 % -0.62 [ -16.37, 15.13 ]
Qu 2012 35 16.66 (23.7) 36 23.81 (45.3) 0.1 % -7.15 [ -23.90, 9.60 ]
Schnoor 2010 275 10 (124.45) 348 10.7 (155.56) 0.0 % -0.70 [ -22.69, 21.29 ]
Senn 2004 126 19.4 (24.51) 125 19.3 (16.22) 0.8 % 0.10 [ -5.04, 5.24 ]
Shen 2011 176 14.2 (6.2) 178 15.8 (6) 13.2 % -1.60 [ -2.87, -0.33 ]
Total (95% CI) 1900 1934 100.0 % -1.22 [ -1.68, -0.76 ]
Heterogeneity: Chi2 = 16.25, df = 14 (P = 0.30); I2 =14%
Test for overall effect: Z = 5.20 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 2.6. Comparison 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce
unnecessary antibiotic use, Outcome 6 Length of stay, low or medium ’Risk of bias’ RCTs only.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use
Outcome: 6 Length of stay, low or medium ’Risk of bias’ RCTs only
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Christ-Crain 2004 124 10.7 (8.9) 119 11.2 (10.6) 4.6 % -0.50 [ -2.97, 1.97 ]
Christ-Crain 2006 151 12 (9.1) 151 13 (9) 6.8 % -1.00 [ -3.04, 1.04 ]
Esposito 2011 79 5.01 (2.43) 76 5.93 (1.7) 65.1 % -0.92 [ -1.58, -0.26 ]
Kristoffersen 2009 103 5.9 (5.17) 107 6.7 (5.15) 14.5 % -0.80 [ -2.20, 0.60 ]
Paul 2006 297 8.83 (11.29) 273 9.45 (11.52) 8.0 % -0.62 [ -2.50, 1.26 ]
Senn 2004 126 19.4 (24.51) 125 19.3 (16.22) 1.1 % 0.10 [ -5.04, 5.24 ]
Total (95% CI) 880 851 100.0 % -0.85 [ -1.38, -0.32 ]
Heterogeneity: Chi2 = 0.34, df = 5 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 3.15 (P = 0.0016)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Adverse effects: Clinical outcomes of interventions targeting antibiotic choice,
Outcome 1 Mortality for trial patients.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 3 Adverse effects: Clinical outcomes of interventions targeting antibiotic choice
Outcome: 1 Mortality for trial patients
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bailey 1997 3/51 3/51 1.3 % 0.0 [ -0.09, 0.09 ]
Camins 2009 11/390 18/394 10.3 % -0.02 [ -0.04, 0.01 ]
Fine 2003 22/283 29/325 8.0 % -0.01 [ -0.06, 0.03 ]
Fraser 1997 19/141 12/111 3.3 % 0.03 [ -0.05, 0.11 ]
Gums 1999 8/127 15/125 3.3 % -0.06 [ -0.13, 0.01 ]
Masia 2008 40/140 33/132 3.6 % 0.04 [ -0.07, 0.14 ]
Paul 2006 149/1153 145/1012 28.3 % -0.01 [ -0.04, 0.01 ]
Schnoor 2010 10/275 13/348 8.1 % 0.00 [ -0.03, 0.03 ]
Schouten 2007 16/587 7/444 13.3 % 0.01 [ -0.01, 0.03 ]
Senn 2004 8/126 5/125 3.3 % 0.02 [ -0.03, 0.08 ]
Yealy 2005 57/617 61/701 17.3 % 0.01 [ -0.03, 0.04 ]
Total (95% CI) 3890 3768 100.0 % 0.00 [ -0.02, 0.01 ]
Total events: 343 (Intervention), 341 (Control)
Heterogeneity: Chi2 = 9.01, df = 10 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 0.51 (P = 0.61)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Adverse effects: Clinical outcomes of interventions targeting antibiotic choice,
Outcome 2 Length of stay for trial patients.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 3 Adverse effects: Clinical outcomes of interventions targeting antibiotic choice
Outcome: 2 Length of stay for trial patients
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bailey 1997 41 4.9 (5.25) 38 4.4 (4.74) 9.0 % 0.50 [ -1.70, 2.70 ]
Burton 1991 72 16 (11.03) 75 20.3 (14.72) 2.5 % -4.30 [ -8.49, -0.11 ]
Gums 1999 127 5.7 (5.64) 125 9 (5.59) 22.8 % -3.30 [ -4.69, -1.91 ]
Paul 2006 297 8.83 (11.29) 273 9.45 (11.52) 12.5 % -0.62 [ -2.50, 1.26 ]
Schnoor 2010 275 10 (7.6) 348 10.7 (9.5) 24.3 % -0.70 [ -2.04, 0.64 ]
Senn 2004 126 19.4 (24.51) 125 19.3 (16.22) 1.7 % 0.10 [ -5.04, 5.24 ]
Shen 2011 176 14.2 (6.2) 178 15.8 (6) 27.2 % -1.60 [ -2.87, -0.33 ]
Total (95% CI) 1114 1162 100.0 % -1.50 [ -2.16, -0.83 ]
Heterogeneity: Chi2 = 13.96, df = 6 (P = 0.03); I2 =57%
Test for overall effect: Z = 4.43 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 4.1. Comparison 4 Adverse effects: Clinical outcomes of interventions targeting antibiotic
exposure, Outcome 1 Mortality for trial patients.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 4 Adverse effects: Clinical outcomes of interventions targeting antibiotic exposure
Outcome: 1 Mortality for trial patients
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Annane 2013 7/31 10/30 0.7 % -0.11 [ -0.33, 0.12 ]
Bouza 2007 92/167 43/83 2.4 % 0.03 [ -0.10, 0.16 ]
Christ-Crain 2004 4/124 4/119 2.7 % 0.00 [ -0.05, 0.04 ]
Christ-Crain 2006 18/151 20/151 3.3 % -0.01 [ -0.09, 0.06 ]
Ding 2013 21/33 20/35 0.7 % 0.06 [ -0.17, 0.30 ]
Hochreiter 2009 15/57 14/53 1.2 % 0.00 [ -0.17, 0.16 ]
Kristoffersen 2009 2/103 1/107 2.3 % 0.01 [ -0.02, 0.04 ]
Liu 2013 6/42 5/40 0.9 % 0.02 [ -0.13, 0.17 ]
Maravic-Stojkovic 2011 7/102 8/103 2.2 % -0.01 [ -0.08, 0.06 ]
Micek 2004 48/150 52/140 3.2 % -0.05 [ -0.16, 0.06 ]
Oliveira 2013 21/49 21/45 1.0 % -0.04 [ -0.24, 0.16 ]
Qu 2012 7/35 8/36 0.8 % -0.02 [ -0.21, 0.17 ]
Schouten 2007 15/207 15/194 4.4 % 0.00 [ -0.06, 0.05 ]
Schroeder 2009 3/14 3/11 0.3 % -0.06 [ -0.40, 0.28 ]
Schuetz 2009 34/671 33/688 14.9 % 0.00 [ -0.02, 0.03 ]
Singh 2000 5/39 13/42 0.9 % -0.18 [ -0.36, -0.01 ]
Solomon 2001 60/2624 55/2489 55.9 % 0.00 [ -0.01, 0.01 ]
Stolz 2007 5/102 9/106 2.3 % -0.04 [ -0.10, 0.03 ]
Total (95% CI) 4701 4472 100.0 % 0.00 [ -0.01, 0.01 ]
Total events: 370 (Intervention), 334 (Control)
Heterogeneity: Chi2 = 9.72, df = 17 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Not applicable
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Analysis 4.2. Comparison 4 Adverse effects: Clinical outcomes of interventions targeting antibiotic
exposure, Outcome 2 Length of stay for trial patients.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 4 Adverse effects: Clinical outcomes of interventions targeting antibiotic exposure
Outcome: 2 Length of stay for trial patients
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Christ-Crain 2004 124 10.7 (8.9) 119 11.2 (10.6) 4.8 % -0.50 [ -2.97, 1.97 ]
Christ-Crain 2006 151 12 (9.1) 151 13 (9) 7.0 % -1.00 [ -3.04, 1.04 ]
Esposito 2011 79 5.01 (2.43) 76 5.93 (1.7) 67.7 % -0.92 [ -1.58, -0.26 ]
Kristoffersen 2009 103 5.9 (5.17) 107 6.7 (5.15) 15.0 % -0.80 [ -2.20, 0.60 ]
Liu 2013 42 27 (31.7) 40 32 (34.1) 0.1 % -5.00 [ -19.27, 9.27 ]
Maravic-Stojkovic 2011 102 12.08 (11.28) 103 12.93 (10.73) 3.2 % -0.85 [ -3.86, 2.16 ]
Micek 2004 150 15.7 (18.2) 140 15.41 (15.9) 1.9 % 0.29 [ -3.64, 4.22 ]
Qu 2012 35 16.66 (23.7) 36 23.81 (45.3) 0.1 % -7.15 [ -23.90, 9.60 ]
Total (95% CI) 786 772 100.0 % -0.87 [ -1.42, -0.33 ]
Heterogeneity: Chi2 = 1.33, df = 7 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 3.16 (P = 0.0016)
Test for subgroup differences: Not applicable
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Analysis 5.1. Comparison 5 Modifiers of intended effect: Comparison of enabling interventions with and
without feedback, Outcome 1 Enablement with feedback.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 5 Modifiers of intended effect: Comparison of enabling interventions with and without feedback
Outcome: 1 Enablement with feedback
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Camins 2009 92/112 60/138 6.8 % 0.39 [ 0.28, 0.50 ]
Schnoor 2010 182/275 186/348 16.8 % 0.13 [ 0.05, 0.20 ]
Schouten 2007 296/460 154/338 21.4 % 0.19 [ 0.12, 0.26 ]
Yealy 2005 631/849 677/1227 55.0 % 0.19 [ 0.15, 0.23 ]
Total (95% CI) 1696 2051 100.0 % 0.19 [ 0.16, 0.22 ]
Total events: 1201 (Intervention), 1077 (Control)
Heterogeneity: Chi2 = 14.98, df = 3 (P = 0.002); I2 =80%
Test for overall effect: Z = 12.39 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 5.2. Comparison 5 Modifiers of intended effect: Comparison of enabling interventions with and
without feedback, Outcome 2 Enablement without feedback.
Review: Interventions to improve antibiotic prescribing practices for hospital inpatients
Comparison: 5 Modifiers of intended effect: Comparison of enabling interventions with and without feedback
Outcome: 2 Enablement without feedback
Study or subgroup Intervention Control
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Burton 1991 58/70 44/73 7.8 % 0.23 [ 0.08, 0.37 ]
Dranitsaris 2001 122/162 102/147 16.9 % 0.06 [ -0.04, 0.16 ]
Paul 2006 216/297 176/273 31.2 % 0.08 [ 0.01, 0.16 ]
Senn 2004 80/126 73/125 13.8 % 0.05 [ -0.07, 0.17 ]
Solomon 2001 88/125 69/153 15.1 % 0.25 [ 0.14, 0.37 ]
Trenholme 1989 102/110 90/116 12.4 % 0.15 [ 0.06, 0.24 ]
Walker 1998 22/25 9/25 2.7 % 0.52 [ 0.29, 0.75 ]
Total (95% CI) 915 912 100.0 % 0.13 [ 0.09, 0.17 ]
Total events: 688 (Intervention), 563 (Control)
Heterogeneity: Chi2 = 22.90, df = 6 (P = 0.00083); I2 =74%
Test for overall effect: Z = 6.26 (P < 0.00001)
Test for subgroup differences: Not applicable
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A D D I T I O N A L T A B L E S
Table 1. Definition of behaviour change techniques and intervention functions
Intervention Function Definition Intervention components
Education Increasing knowledge or understanding Educational meetings;
Dissemination of educational materials;
Educational outreach
Persuasion Using communication to induce positive or neg-
ative feelings or to stimulate action
Educational outreach by academic detailing or re-
view and recommend change
Restriction Using rules to reduce the opportunity to engage
in the target behaviour (or increase the target be-
haviour by reducing the opportunity to engage in
competing behaviours)
Restrictive
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Table 1. Definition of behaviour change techniques and intervention functions (Continued)
Environmental restructuring Changing the physical context Reminders (physical) such as posters, pocket-size
or credit card-size summaries or on laboratory test
reports;
Structural (e.g. new laboratory tests or rapid re-
porting of results)
Enablement Increasing means/reducing barriers to increase ca-
pability or opportunity
Audit and feedback;
Decision support through computerised systems
or through circumstantial reminders that were
triggered by actions or events related to the tar-
geted behaviour;
Educational outreach by review and recommend
change
Table 2. Unintended consequences of ITS studies: mortality*
Study Prescribing target Restriction Design of analysis Effect estimate 95% CI
Lee 2014 Choice of drug No Cohort Incidence rate ratio 1.1 0.9 to 1.5
Popovski 2015 Choice of drug No Cohort Increase by 1.4% -1.2% to 4.1%
Wang 2014 Choice of drug Yes ITS, segmented regres-
sion
Change in slope -0.0172 No data
Yoon 2014 Choice of drug Yes Cohort +0.43 per 1000 OBD No data
*Mortality was measured in all patients in the hospital rather than just those patients who were the targets of the interventions.
CI: confidence interval
ITS: interrupted time series
OBD: occupied bed day
Table 3. Unintended consequences of ITS studies: length of stay*
Study Prescribing target Restrictive Design of analysis Effect estimate 95% CI
Mittal 2014 Exposure, % treated No Cohort -0.5 days No data
Skaer 1993 Choice of drug No Cohort -0.1 days -0.49 to +0.29
*Length of stay was measured in all patients in the hospital rather than just those patients who were the targets of the interventions.
CI: confidence interval
ITS: interrupted time series
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Table 4. Unintended consequences of ITS studies: other
Study Prescribing target Design of analysis Effect measure Effect estimate 95% CI
Bell 2014 Antibiotic choice ITS, segmented re-
gression
Risk of postopera-
tive acute kidney in-
jury
Increase 98% 93.8% to 94.2%
Van Kasteren 2005 Exposure, duration Cohort Surgical-site infec-
tion
Decrease 0.8% -2.2% to 0.6%
Volpe 2012 Time to first antibi-
otic dose
Cohort Left without being
seen rate
Decrease 0.4% No data
CI: confidence interval
ITS: interrupted time series
Table 5. Unintended consequences studies (case control, cohort, or qualitative)
Study Design Patients Intended target Unintended con-
sequence
Effect estimate 95% CI
Interventions with a restrictive component
Baysari 2013 Qualitative 36 physicians Re-
duce unnecessary
use of restricted
antibiotics
Inaccurate
feedback
Not quantified; qualitative study
Calfee 2003 Case control Not clear Increase in physi-
cian-based diag-
nosis of nosoco-
mial infection
No denominator data
Connor 2007 Cohort 120 Failure to warn
prescribers about
discontinuation
- -
Duvoisin 2014 Cohort 222 Reduce
unnecessary labo-
ratory tests
Delay in TFAD
(HR>1 shows de-
lay less likely in
intervention pe-
riod)
Multivariate HR
1.56
1.17 to 2.07
LaRosa 2007 Cross-sectional 15,440 Re-
duce unnecessary
use of restricted
antibiotics
Or-
ders for restricted
antibiotics (% all
orders) from 10 to
11 pm vs all other
hours
- -
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Table 5. Unintended consequences studies (case control, cohort, or qualitative) (Continued)
Cohort 360 % appropriate or-
ders 10 to 11 pm
vs 9 to 10 pm
-23.7% -31.8% to -15.5%
Linkin 2007 Cohort 200 Risk of inaccurate
information in or-
ders judged inap-
propriate vs ap-
propriate
OR 2.2 1.0 to 4.4
Winters 2010 Cohort 3251 Risk of 1-hour de-
lay in TFAD
OR 1.5 1.2 to 1.8
Risk of 2-hour de-
lay in TFAD
OR 1.8 1.4 to 2.2
Interventions with no restrictive component
Friedberg 2009 Cohort 13,042 Reduce time
to first antibiotic
dose for patients
with community-
acquired
pneumonia
% CAP diagnoses 1% increase No denominator
data
Kanwar 2007 Cohort 518 %correct CAPdi-
agnoses
-7.9% decrease -15.4% to -0.4%
Welker 2008 Cohort 548 %correct CAPdi-
agnoses
-16.0% decrease -7.6% to -24.4%
CAP: community-acquired pneumonia
CI: confidence interval
HR: hazard ratio
OR: odds ratio
TFAD: time to the first antibiotic dose
Table 6. Summary of intervention components for 29 RCTs (Analysis 1.1; Figures 3 and 12) and 91 ITS studies (Figure 15)
Intervention function and components RCT ITS
Enablement 24
studies
59
studies
Number of enabling or restrictive interven-
tion components
27 76
Studies with > 1 Enabling intervention
component
2
8%*
19
32%*
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Table 6. Summary of intervention components for 29 RCTs (Analysis 1.1; Figures 3 and 12) and 91 ITS studies (Figure 15)
(Continued)
Audit and feedback 4
17%
24
41%
Computerised decision support 1
4%
3
5%
Circumstantial reminders 16
67%
18
31%
Review and recommend change 6
25%
31
53%
Restriction 2
studies
29
studies
Number of Restrictive intervention com-
ponents
3 41
Studies with > 1 Restrictive intervention
component
1
50%
10
34%
Expert approval 1
50%
18
62%
Compulsory order form 1
50%
7
24%
Removal 0 10
34%
Review and make change 1
50%
6
21%
No Enablement or Restriction 4
studies
18
studies
Number of intervention components 6 25
Studies with > 1 intervention component 2
50%
6
33%
Educational materials or meetings 3
75%
16
89%
Educational outreach (academic detailing) 1
25%
6
33%
Physical reminders 1
25%
2
11%
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Table 6. Summary of intervention components for 29 RCTs (Analysis 1.1; Figures 3 and 12) and 91 ITS studies (Figure 15)
(Continued)
Structural intervention 1
25%
1
6%
*The denominator for all percentages is the number of studies for each intervention function. One RCT, Strom 2010, and 16 ITS
studies (Figure 11) included both enabling and restrictive intervention components.
ITS: interrupted time series
RCT: randomised controlled trial
Table 7. Data from 5 studies about the effect of removal of interventions. The intended effect of all interventions was reduction
in unnecessary antibiotic use
Study Intervention function Intervention effect (95%
CI)
Time intervention was in
place
Effect of removal (95%
CI)
Kallen 2009 Restriction -87.5%
-115.4 to -59.7
6 months 398.9%
238.2 to 559.5
Kim 2008 Restriction -23.1%
-53.7 to +7.4
9 months 6.0%
-23.4 to 35.4
Standiford 2012 Enablement -28.6%
-46.5 to -10.6
7 years 31.0%
6.8 to 55.3
Himmelberg 1991 Restriction No data “long-standing” 301.2%
230.9 to 371.5
Skrlin 2011 Restriction 2 years 255.8%
194.7 to 316.9
CI: confidence interval
Table 8. Randomised controlled trials with microbial outcomes
Study Design Microbial outcome Reason not in meta-analysis
Annane 2013 RCT Colonisation with MRSA (nasal swab) and GNRB
(rectal swabs)
Not comparable with any other RCT
Bouza 2007 RCT Number of cases of Clostridium difficile Not in prescribing meta-analysis
Lesprit 2013 RCT Secondary infection and/or colonisation with mul-
tidrug-resistant bacteria in the 6 months following
randomisation
Not in prescribing meta-analysis. It is impossible to
assess the impact of the intervention on colonisation
or infection with bacteria resistant to specific antibi-
otics
Palmay 2014 RCT CDI and infection with antibiotic resistant organ-
isms cases/1000 OBD
Not in prescribing meta-analysis
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Table 8. Randomised controlled trials with microbial outcomes (Continued)
Singh 2000 RCT Number of participants with “antimicrobial resis-
tance and/or superinfections” from randomisation
until discharge from hospital
It is impossible to assess the impact of the interven-
tion on colonisation or infection with bacteria resis-
tant to specific antibiotics
CDI: Clostridium difficile infection
GNRB: gram-negative resistant bacteria
MRSA: methicillin-resistant Staphylococcus aureus
OBD: occupied bed day
RCT: randomised controlled trial
Table 9. Microbial outcomes from26 ITS studies from the prescribingmeta-analysis that include reliable data about prescribing
outcomes at 6 months and microbial outcomes at 12 months postintervention
Prescribing target Microbial outcome N Study ID
Cephalosporins GNRB 8 Grohs 2014; Kim 2008; Knudsen 2014; Lee 2007; McNulty 1997; Meyer
2009; Petrikkos 2007; Tangdén 2011
MRSA 1 May 2000
Carbapenems GNRB 1 Goldstein 2009
Fluoroquinolones GNRB 3 Cook 2011b; Lafaurie 2012; Willemsen 2010
MRSA 1 Lafaurie 2012
High-risk antibiotics CDI 6 Aldeyab 2012; Chan 2011; Dancer 2013; Fowler 2007; Talpaert 2011;
Valiquette 2007
GNRB 4 Buising 2008a; Chan 2011; Dancer 2013; Liebowitz 2008
MRSA 6 Aldeyab 2014; Ananda-Rajah 2010; Chan 2011; Dancer 2013; Fowler 2007;
Liebowitz 2008
Total antibiotic use CDI 2 Cook 2011a; Jump 2012
MRSA 1 Cook 2011a
Vancomycin VRE 1 Lautenbach 2003
Total microbial 34*
*Some studies had more than one microbial outcome, so the total is 34 microbial outcomes from 26 studies.
CDI: Clostridium difficile infection
GNRB: gram-negative resistant bacteria
ITS: interrupted time series
MRSA: methicillin-resistant Staphylococcus aureus
VRE: vancomycin-resistant enterococci
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A P P E N D I C E S
Appendix 1. Search strategies
MEDLINE <1946 to Present> andMEDLINE In-Process&Other Non-Indexed Citations (Searched 19 January 2015) (OvidSP)
1 (hospital$ and antibiotic?).ti.
2 ((antibiotic? or alamethicin? or amdinocillin? or amdinocillin pivoxil? or amikacin? or amoxicillin? or amoxicillin-potassiumclavulanate
combination? or amphotericin? or ampicillin? or anisomycin? or antimycin? or aurodox? or azithromycin? or azlocillin? or aztreonam?
or bacitracin? or bacteriocin? or bambermycin? or bongkrekic acid? or brefeldin? or butirosin sulfate? or calcimycin? or candicidin?
or capreomycin? or carbenicillin? or carfecillin? or cefaclor? or cefadroxil? or cefamandole? or cefatrizine? or cefazolin? or cefixime?
or cefmenoxime? or cefmetazole? or cefonicid? or cefoperazone? or cefotaxime? or cefotetan? or cefotiam? or cefoxitin? or cefsulodin?
or ceftazidime? or ceftizoxime? or ceftriaxone? or cefuroxime? or cephacetrile? or cephalexin? or cephaloglycin? or cephaloridine? or
cephalosporin? or cephalothin? or cephamycin? or cephapirin? or cephradine? or chloramphenicol? or chlortetracycline? or citrinin? or
clarithromycin? or clavulanic acid? or clavulanic acid? or clindamycin? or cloxacillin? or colistin? or cyclacillin? or dactinomycin? or
daptomycin? or demeclocycline? or dibekacin? or dicloxacillin? or dihydrostreptomycin sulfate? or diketopiperazine? or distamycin? or
doxycycline? or echinomycin? or edeine? or enviomycin? or erythromycin? or erythromycin estolate? or erythromycin ethylsuccinate? or
filipin? or floxacillin? or fluoroquinolone? or fosfomycin? or framycetin? or fusidic acid? or gentamicin? or gramicidin? or hygromycin?
or imipenem? or josamycin? or kanamycin? or kitasamycin? or lactam? or lasalocid? or leucomycin? or lincomycin? or lincosamide?
or lucensomycin? or lymecycline? or mepartricin? or methacycline? or methicillin? or mezlocillin? or mikamycin? or minocycline? or
miocamycin? or moxalactam? or mupirocin? or mycobacillin? or nafcillin? or natamycin? or nebramycin? or neomycin? or netilmicin? or
netropsin? or nigericin? or nisin? or norfloxacin? or novobiocin? or nystatin? or ofloxacin? or oleandomycin? or oligomycin? or oxacillin?
or oxytetracycline? or paromomycin? or penicillanic acid? or penicillic acid? or penicillin?? or piperacillin? or pivampicillin? or polymyxin
b? or polymyxin? or pristinamycin? or prodigiosin? or ribostamycin? or rifabutin? or rifamycin? or ristocetin? or rolitetracycline?
or roxarsone? or roxithromycin? or rutamycin? or sirolimu? or sisomicin? or spectinomycin? or spiramycin? or streptogramin?? or
streptomycin? or streptovaricin? or sulbactam? or sulbenicillin? or sulfamerazine? or sulfamethoxypyridazine? or talampicillin? or
teicoplanin? or tetracycline? or thiamphenicol? or thienamycin? or thiostrepton? or ticarcillin? or tobramycin? or troleandomycin? or
tunicamycin? or tylosin? or tyrocidine? or tyrothricin? or valinomycin? or vancomycin? or vernamycin? or viomycin? or virginiamycin? or
beta-lactams) adj2 (resistant or resistance)).ti,ab. and (pc.fs. or (preventi$ or best practice? or evidence$ or policy or policies or pathway?
).ti,ab,hw. or (guidance or guiding or guide? or guideline? or algorithm? or collaborat$ or computer$ or decision$ or emergency or
formulary or guidance or guideline? or icu or impact or initiat$ or intensive care interdisciplin$ or interprofession$ or multidisciplin$
or multi-disciplin$ or notification? or order entry or pharmacist? or pharmacy or pharmacies or policy or policies or prescrib$ or
(quality adj2 (manag$ or improv$ or circle?)) or ((patient? or hospital?) adj2 record?) or reminder? or rotating or rotation or support
or team$).ti,ab.)
3 (antibiotic? and (education$ or continuing-education$ or cme or decision-making or evidence-based or ebm or guidance or guideline?
or habit? or impact or improper$ or inappropriat$ or influenc$ or intervention? ormanagement or overprescrib$ or overuse or overusing
or pattern? or policy or policies or prescribing or prudent$ or stewardship? or rational or unnecessary or “use” or “usage”)).ti.
4 (antibiotic? adj4 (education$ or continuing-education$ or cme or decision-making or evidence-based or ebm or guidance or guideline?
or habit? or impact or improper$ or inappropriat$ or influenc$ or intervention? ormanagement or overprescrib$ or overuse or overusing
or pattern? or policy or policies or prescribing or prudent$ or rational or stewardship or unnecessary or “use” or “usage”)).ab.
5 antibiotic?.ti. and evidence-based.hw.
6 ((antimicrobial? or anti-microbial? or penicillin?) and (stewardship or guidance or guideline? or policy or policies)).ti.
7 ((antimicrobial? or anti-microbial? or penicillin?) adj3 (stewardship or guidance or guideline? or policy or policies)).ab.
8 (antibiotic? adj5 (hour? or immediat$ or emergency)).ab. or (antibiotic? and (hour? or immediat$ or emergency)).ti. or (antibiotic?
adj3 (rotat$ or timing or time or decision$ or notification or appropriat$)).ab. or (antibiotic? and (rotat$ or timing or time or decision$
or notification or appropriat$)).ti.
9 or/1-8
10 exp anti-bacterial agents/
11 antibiotic?.ti,ab.
12 (alamethicin or amdinocillin or amdinocillin pivoxil or amikacin or amoxicillin or amoxicillin-potassium clavulanate combination
or amphotericin or ampicillin or anisomycin or antimycin or aurodox or azithromycin or azlocillin or aztreonam or bacitracin or
bacteriocins or bambermycins or bongkrekic acid or brefeldin or butirosin sulfate or calcimycin or candicidin or capreomycin or
carbenicillin or carfecillin or cefaclor or cefadroxil or cefamandole or cefatrizine or cefazolin or cefixime or cefmenoxime or cefmetazole
or cefonicid or cefoperazone or cefotaxime or cefotetan or cefotiam or cefoxitin or cefsulodin or ceftazidime or ceftizoxime or ceftriaxone
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or cefuroxime or cephacetrile or cephalexin or cephaloglycin or cephaloridine or cephalosporins or cephalothin or cephamycins or
cephapirin or cephradine or chloramphenicol or chlortetracycline or citrinin or clarithromycin or clavulanic acid or clavulanic acids or
clindamycin or cloxacillin or colistin or cyclacillin or dactinomycin or daptomycin or demeclocycline or dibekacin or dicloxacillin or
dihydrostreptomycin sulfate or diketopiperazines or distamycins or doxycycline or echinomycin or edeine or enviomycin or erythromycin
or erythromycin estolate or erythromycin ethylsuccinate or filipin or floxacillin or fluoroquinolones or fosfomycin or framycetin or
fusidic acid or gentamicins or gramicidin or hygromycin or imipenemor josamycin or kanamycin or kitasamycin or lactams or lasalocid or
leucomycins or lincomycin or lincosamides or lucensomycin or lymecycline or mepartricin or methacycline or methicillin or mezlocillin
or mikamycin or minocycline or miocamycin or moxalactam or mupirocin or mycobacillin or nafcillin or natamycin or nebramycin
or neomycin or netilmicin or netropsin or nigericin or nisin or norfloxacin or novobiocin or nystatin or ofloxacin or oleandomycin
or oligomycins or oxacillin or oxytetracycline or paromomycin or penicillanic acid or penicillic acid or penicillin? or piperacillin or
pivampicillin or polymyxin b or polymyxins or pristinamycin or prodigiosin or ribostamycin or rifabutin or rifamycins or ristocetin or
rolitetracycline or roxarsone or roxithromycin or rutamycin or sirolimus or sisomicin or spectinomycin or spiramycin or streptogramin?
or streptomycin or streptovaricin or sulbactamor sulbenicillin or sulfamerazine or sulfamethoxypyridazine or talampicillin or teicoplanin
or tetracycline or thiamphenicol or thienamycins or thiostrepton or ticarcillin or tobramycin or troleandomycin or tunicamycin or
tylosin or tyrocidine or tyrothricin or valinomycin or vancomycin or vernamycin or viomycin or virginiamycin or beta-lactams).ti,ab.
13 (infection control$ or nosocomial$ or cross infection? or hospital acquired infection? or mrsa).ti,ab.
14 methicillin resistan$.ti,ab.
15 aminoglycosides/ or metronidazole/ or anti-infective agents/ or anti-infective agents, urinary/
16 or/10-15
17 (programs or programmes).ti.
18 empiric.ti.
19 (quality adj3 improvement?).ti.
20 (adherence or alert? or benchmark$ or (change adj3 treatment) or computer assist$ or computer support or computeri?ed or clinical
decision$ or dosing or education$ or formulary or guidance or guideline? or impact or intervention or justification or methicillan-
resistant or overuse or over-prescrib$ or overprescrib$ or pathway? or pharmacist? or policy or policies or program or programme or
(quality adj3 improv$) or reminder? or resistance or restriction? or rotation? or timing or turnaround or unnecessary).ti.
21 or/17-20
22 16 and 21
23 22 not 9
24 (randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or ran-
domly.ab. or trial.ti.
25 exp animals/ not humans.sh.
26 43 not 45
27 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or design$ or doctor? or educational or
family doctor? or family physician? or family practitioner? or financial or gp or general practice? or hospital? or impact? or improv$ or
individuali?e? or individuali?ing or interdisciplin$ or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or
multifacet$ or multi-facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or pharmacy
or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or provider? or regulatory or regulatory or
tailor$ or target$ or team$ or usual care)).ab.
28 (pre-intervention? or preintervention? or “pre intervention?” or post-intervention? or postintervention? or “post intervention?”).ti,ab.
29 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing
or doctor?).ti,hw.
30 demonstration project?.ti,ab.
31 (pre-post or “pre test$” or pretest$ or posttest$ or “post test$” or (pre adj5 post)).ti,ab.
32 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab.
33 trial.ti. or ((study adj3 aim?) or “our study”).ab.
34 (before adj10 (after or during)).ti,ab.
35 (“quasi-experiment$” or quasiexperiment$ or “quasi random$” or quasirandom$ or “quasi control$” or quasicontrol$ or ((quasi$
or experimental) adj3 (method$ or study or trial or design$))).ti,ab,hw.
36 (“time series” adj2 interrupt$).ti,ab,hw.
37 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or
hour? or day? or “more than”)).ab.
38 pilot.ti.
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39 pilot projects/ [ml]
40 (clinical trial or controlled clinical trial or multicenter study).pt. [ml]
41 (multicentre or multicenter or multi-centre or multi-center).ti.
42 andom$.ti,ab. or controlled.ti.
43 (control adj3 (area or cohort? or compare? or condition or design or group? or intervention? or participant? or study)).ab. not
(controlled clinical trial or randomized controlled trial).pt. [ml]
44 “comment on”.cm. or review.ti,pt. or randomized controlled trial.pt. [ml]
45 review.ti.
46 (rat or rats or cow or cows or chicken? or horse or horses or mice or mouse or bovine or animal?).ti.
47 exp animals/ not humans.sh.
48 (animal$ not human$).sh,hw.
49 *experimental design/ or *pilot study/ or quasi experimental study/ [em]
50 (“quasi-experiment$” or quasiexperiment$ or “quasi random$” or quasirandom$ or “quasi control$” or quasicontrol$ or ((quasi$
or experimental) adj3 (method$ or study or trial or design$))).ti,ab.
51 (“time series” adj2 interrupt$).ti,ab.
52 or/26-43
53 or/44-48
54 52 not 53
55 9 or 23
56 54 and 55
EMBASE <1996 to 2015 Week 03> (Searched 22 January 2015) (OvidSP)
1 exp *antibiotic agent/
2 (bundle or bundles or education$ or continuing-education$ or cme or decision-making or guidance or (guideline? adj2 (adherence
or implement$ or complian$ or comply$)) or improper$ or inappropriat$ or incorrect$ or nurse led or overprescrib$ or overuse or
overusing or pharmacist initiated or physician? practice? or policy or policies or practice pattern? or (prescribing adj2 (ebm or evidence-
based or habit? or pattern? or practice or practices)) or prudent$ or rational or stewardship or unnecessary or underprescrib$).ti.
3 (“antibiotic use” or “antibiotic usage”).ti.
4 (hospital$ and antibiotic?).ti.
5 ((antibiotic? or alamethicin? or amdinocillin? or amdinocillin pivoxil? or amikacin? or amoxicillin? or amoxicillin-potassiumclavulanate
combination? or amphotericin? or ampicillin? or anisomycin? or antimycin? or aurodox? or azithromycin? or azlocillin? or aztreonam?
or bacitracin? or bacteriocin? or bambermycin? or bongkrekic acid? or brefeldin? or butirosin sulfate? or calcimycin? or candicidin?
or capreomycin? or carbenicillin? or carfecillin? or cefaclor? or cefadroxil? or cefamandole? or cefatrizine? or cefazolin? or cefixime?
or cefmenoxime? or cefmetazole? or cefonicid? or cefoperazone? or cefotaxime? or cefotetan? or cefotiam? or cefoxitin? or cefsulodin?
or ceftazidime? or ceftizoxime? or ceftriaxone? or cefuroxime? or cephacetrile? or cephalexin? or cephaloglycin? or cephaloridine? or
cephalosporin? or cephalothin? or cephamycin? or cephapirin? or cephradine? or chloramphenicol? or chlortetracycline? or citrinin? or
clarithromycin? or clavulanic acid? or clavulanic acid? or clindamycin? or cloxacillin? or colistin? or cyclacillin? or dactinomycin? or
daptomycin? or demeclocycline? or dibekacin? or dicloxacillin? or dihydrostreptomycin sulfate? or diketopiperazine? or distamycin? or
doxycycline? or echinomycin? or edeine? or enviomycin? or erythromycin? or erythromycin estolate? or erythromycin ethylsuccinate? or
filipin? or floxacillin? or fluoroquinolone? or fosfomycin? or framycetin? or fusidic acid? or gentamicin? or gramicidin? or hygromycin?
or imipenem? or josamycin? or kanamycin? or kitasamycin? or lactam? or lasalocid? or leucomycin? or lincomycin? or lincosamide?
or lucensomycin? or lymecycline? or mepartricin? or methacycline? or methicillin? or mezlocillin? or mikamycin? or minocycline? or
miocamycin? or moxalactam? or mupirocin? or mycobacillin? or nafcillin? or natamycin? or nebramycin? or neomycin? or netilmicin? or
netropsin? or nigericin? or nisin? or norfloxacin? or novobiocin? or nystatin? or ofloxacin? or oleandomycin? or oligomycin? or oxacillin?
or oxytetracycline? or paromomycin? or penicillanic acid? or penicillic acid? or penicillin?? or piperacillin? or pivampicillin? or polymyxin
b? or polymyxin? or pristinamycin? or prodigiosin? or ribostamycin? or rifabutin? or rifamycin? or ristocetin? or rolitetracycline?
or roxarsone? or roxithromycin? or rutamycin? or sirolimu? or sisomicin? or spectinomycin? or spiramycin? or streptogramin?? or
streptomycin? or streptovaricin? or sulbactam? or sulbenicillin? or sulfamerazine? or sulfamethoxypyridazine? or talampicillin? or
teicoplanin? or tetracycline? or thiamphenicol? or thienamycin? or thiostrepton? or ticarcillin? or tobramycin? or troleandomycin? or
tunicamycin? or tylosin? or tyrocidine? or tyrothricin? or valinomycin? or vancomycin? or vernamycin? or viomycin? or virginiamycin?
or beta-lactams) adj2 (resistant or resistance) adj10 (best practice? or (chang$ adj (practice or clinical practice)) or evidence-base? or
policy or policies or pathway? or ((treatment or care) adj (algorithm? or pathway? or protocol)) or collaborat$ or computeri?ed or
computer-supported or decision-mak$ or (support adj decision?) or formulary or guidance or (guideline? adj (adher$ or implement$
or concord$ or comply or complian$)) or interdisciplin$ or interprofession$ or multidisciplin$ or multi-disciplin$ or notification? or
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order entry or (pharmacist? adj2 (led or initiat$ or intervention? or participat$)) or policy or policies or (prescrib$ adj (practice? or
method? or algorithm? or protocol? or habit?)) or (quality adj (manag$ or improv$ or circle?)) or ((patient? or medical or electronic)
adj2 record?) or reminder? or rotating or rotation or team$)).ti,ab.
6 (antibiotic? and (bundle or bundles or education$ or continuing-education$ or cme or decision-making or guidance or (guideline?
adj2 (adherence or implement$ or complian$ or comply$)) or improper$ or inappropriat$ or incorrect$ or nurse led or overprescrib$
or overuse or overusing or pharmacist initiated or physician? practice? or policy or policies or practice pattern? or (prescribing adj2
(ebm or evidence-based or habit? or pattern? or practice or practices)) or prudent$ or rational or stewardship or unnecessary or
underprescrib$)).ti.
7 (antibiotic? adj3 (bundle or bundles or education$ or continuing-education$ or cme or decision-making or guidance or (guideline?
adj2 (adherence or implement$ or complian$ or comply$)) or improper$ or inappropriat$ or incorrect$ or nurse led or overprescrib$
or overuse or overusing or pharmacist initiated or physician? practice? or policy or policies or practice pattern? or (prescribing adj2
(ebm or evidence-based or habit? or pattern? or practice or practices)) or prudent$ or rational or stewardship or unnecessary or
underprescrib$)).ab.
8 ((antimicrobial? or anti-microbial? or penicillin?) and (bundle or bundles or education$ or continuing-education$ or cme or decision-
making or guidance or (guideline? adj2 (adherence or implement$ or complian$ or comply$)) or improper$ or inappropriat$ or
incorrect$ or nurse led or overprescrib$ or overuse or overusing or pharmacist initiated or physician? practice? or policy or policies or
practice pattern? or (prescribing adj2 (ebm or evidence-based or habit? or pattern? or practice or practices)) or prudent$ or rational
or stewardship or unnecessary or underprescrib$)).ab. or ((antimicrobial? or anti-microbial? or penicillin?) and (bundle or bundles
or education$ or continuing-education$ or cme or decision-making or guidance or (guideline? adj2 (adherence or implement$ or
complian$ or comply$)) or improper$ or inappropriat$ or incorrect$ or nurse led or overprescrib$ or overuse or overusing or pharmacist
initiated or physician? practice? or policy or policies or practice pattern? or (prescribing adj2 (ebm or evidence-based or habit? or
pattern? or practice or practices)) or prudent$ or rational or stewardship or unnecessary or underprescrib$)).ti.
9 1 and 2
10 or/3-8
11 9 or 10
12 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or design$ or doctor? or educational or
family doctor? or family physician? or family practitioner? or financial or gp or general practice? or hospital? or impact? or improv$ or
individuali?e? or individuali?ing or interdisciplin$ or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or
multifacet$ or multi-facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or pharmacy
or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or provider? or regulatory or regulatory or
tailor$ or target$ or team$ or usual care)).ab.
13 (pre-intervention? or preintervention? or “pre intervention?” or post-intervention? or postintervention? or “post intervention?”).ti,ab.
14 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing
or doctor?).ti,hw.
15 demonstration project?.ti,ab.
16 (pre-post or “pre test$” or pretest$ or posttest$ or “post test$” or (pre adj5 post)).ti,ab.
17 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab.
18 trial.ti. or ((study adj3 aim?) or “our study”).ab.
19 (before adj10 (after or during)).ti,ab.
20 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or
hour? or day? or “more than”)).ab.
21 pilot.ti.
22 (multicentre or multicenter or multi-centre or multi-center).ti.
23 random$.ti,ab. or controlled.ti.
24 review.ti.
25 or/12-23
26 25 not 24
27 11 and 26
Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library Issue 1 2015 (Searched 22 January 2015)
#1 antibiotic?:ti,ab,kw
#2 ((antibacterial or anti-bacterial or antiinfective or anti-infective) and (agent? or drug?)):ti,ab,kw
#3 ((alamethicin? or amdinocillin? or amdinocillin pivoxil? or amikacin? or amoxicillin? or amoxicillin-potassium clavulanate com-
bination? or amphotericin? or ampicillin? or anisomycin? or antimycin? or aurodox? or azithromycin? or azlocillin? or aztreonam? or
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bacitracin? or bacteriocin? or bambermycin? or bongkrekic acid? or brefeldin? or butirosin sulfate? or calcimycin? or candicidin? or
capreomycin? or carbenicillin? or carfecillin? or cefaclor? or cefadroxil? or cefamandole? or cefatrizine? or cefazolin? or cefixime? or
cefmenoxime? or cefmetazole? or cefonicid? or cefoperazone? or cefotaxime? or cefotetan? or cefotiam? or cefoxitin? or cefsulodin?
or ceftazidime? or ceftizoxime? or ceftriaxone? or cefuroxime? or cephacetrile? or cephalexin? or cephaloglycin? or cephaloridine? or
cephalosporin? or cephalothin? or cephamycin? or cephapirin? or cephradine? or chloramphenicol? or chlortetracycline? or citrinin? or
clarithromycin? or clavulanic acid? or clavulanic acid? or clindamycin? or cloxacillin? or colistin? or cyclacillin? or dactinomycin? or
daptomycin? or demeclocycline? or dibekacin? or dicloxacillin? or dihydrostreptomycin sulfate? or diketopiperazine? or distamycin? or
doxycycline? or echinomycin? or edeine? or enviomycin? or erythromycin? or erythromycin estolate? or erythromycin ethylsuccinate? or
filipin? or floxacillin? or fluoroquinolone? or fosfomycin? or framycetin? or fusidic acid? or gentamicin? or gramicidin? or hygromycin?
or imipenem? or josamycin? or kanamycin? or kitasamycin? or lactam? or lasalocid? or leucomycin? or lincomycin? or lincosamide?
or lucensomycin? or lymecycline? or mepartricin? or methacycline? or methicillin? or mezlocillin? or mikamycin? or minocycline? or
miocamycin? or moxalactam? or mupirocin? or mycobacillin? or nafcillin? or natamycin? or nebramycin? or neomycin? or netilmicin?
or netropsin? or nigericin? or nisin? or norfloxacin? or novobiocin? or nystatin? or ofloxacin? or oleandomycin? or oligomycin? or
oxacillin? or oxytetracycline? or paromomycin? or penicillanic acid? or penicillic acid? or penicillin?? or piperacillin? or pivampicillin?
or polymyxin b? or polymyxin? or pristinamycin? or prodigiosin? or ribostamycin? or rifabutin? or rifamycin? or ristocetin? or rolitetra-
cycline? or roxarsone? or roxithromycin? or rutamycin? or sirolimu? or sisomicin? or spectinomycin? or spiramycin? or streptogramin?
? or streptomycin? or streptovaricin? or sulbactam? or sulbenicillin? or sulfamerazine? or sulfamethoxypyridazine? or talampicillin? or
teicoplanin? or tetracycline? or thiamphenicol? or thienamycin? or thiostrepton? or ticarcillin? or tobramycin? or troleandomycin? or
tunicamycin? or tylosin? or tyrocidine? or tyrothricin? or valinomycin? or vancomycin? or vernamycin? or viomycin? or virginiamycin?
or beta-lactams) and (prescrib$ or resistance or “use” or “usage” or utlii?ation)):ti,ab,kw
#4 ((antibacterial agent? or anti-bacterial agent?) and (prescrib$ or resistance or “use” or “usage” or utili?ation)):ti,ab,kw
#5 “stewardship”:ti,ab,kw
#6 (antibiotic* or antimicrobial*) and (prescrib* or prescrip*):ti,ab,kw
#7 #1 or #2 or #3 or #4 or #5 or #6
Appendix 2. Decisions based on 5 GRADE criteria about quality of evidence from RCTs in
’Summary of findings’ table
Outcome prescribing, % compliance with guideline
Criterion Evidence Decision
Risk of bias Effect estimate lower for 15 studies with low/medium
risk of bias
Not serious, 95% confidence interval for effect estimate
10% to 12% in studies at low or medium risk of bias
Imprecision1 23,394 patients and 3660 events Not serious
Inconsistency Chi2 = 367.98, df = 28 (P < 0.00001); I2 = 92% Not serious, effect size rather than direction (Figure 3)
. Variation partially explained by prespecified subgroup
analysis by intervention function (Figure 7). Direction
of effect consistent despite high levels of statistical het-
erogeneity
Indirectness Only 2 RCTs of restrictive interventions (Singh 2000;
Strom 2010)
Not serious because this is a concern for safety rather
than effectiveness
Publication bias Large trials, few commercially sponsored Not serious
1Imprecision, optimal information size threshold 862 patients for 1 10%, control compliance 43%, α 0.05, β 0.2, dropout 10%.
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Outcome prescribing, reduction in duration of all antibiotic treatment
Criterion Evidence Decision
Risk of bias Effect estimate greater for 3 studies with low/medium
risk of bias (Analysis 1.6).
Not serious
Imprecision1 3318 patients Not serious, number of patients is > OIS to detect 1 1
day (3018 patients)
Inconsistency2 All trials: Chi2 = 119.95, df = 13 (P < 0.00001); I2 =
89%
Not serious, most variation is effect size rather than di-
rection (Figure 4).
Indirectness Not serious for effectiveness Not serious
Publication bias Large trials, few commercially sponsored Not serious
1Imprecision, OIS is 754 patients for 1 2 days, standard deviation 9.3 days (highest of the 3 studies contributing > 10% of weight),
α 0.05, β 0.8, dropout 10%, and 3018 patients for 1 1 day.
OIS: optimal information size
Outcome mortality
Criterion Evidence Decision
Risk of bias Effect estimate and confidence interval similar for 8 stud-
ies with low/medium risk of bias
Not serious
Imprecision1 17,697 patients and 1587 events
This is > OIS for 2% difference in mortality (6726 pa-
tients)
Not serious
Inconsistency Heterogeneity: Chi2 = 16.55, df = 28 (P = 0.96); I2 =
0%
Not serious (Figure 5)
Indirectness No trials of restrictive interventions.
Mortality lower in trials at low/medium risk of bias.
Serious
Publication bias Large trials, few commercially sponsored Not serious
1Imprecision, OIS threshold for patients for non-inferiority is 6726 patients for a 2% difference in mortality.
OIS: optimal information size
All trials:
Mortality, control 11%, power 80%, dropout 10%
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Non-inferiority criteria Total number of patients to be recruited
1% 26,900
2% 6726
3% 2988
4% 1682
Outcome length of hospital stay
Criterion Evidence Decision
Risk of bias Effect size only slightly smaller for 6 RCTs at low or
medium risk of bias, and the 95% CI did not include
increase in length of stay
Not serious
Imprecision1 3834 patients (> OIS for1 1 day but not 0.5 day). The
lower bound of CI is reduction by 0.7 days for all RCTs
and 0.3 days for RCTs at low or medium risk of bias
Not serious
Inconsistency Heterogeneity: Chi2 = 17.32, df = 14 (P = 0.24); I2 =
19%
Not serious, effect size rather than direction (Figure 6)
Indirectness No trials of restrictive interventions Serious
Publication bias Large trials, few commercially sponsored Not serious
1Imprecision, OIS is 2014 patients for 1 1 day and 7640 patients for 1 0.5 day, standard deviation 7.6 (highest of the 3 studies
contributing > 20% of weight), α 0.05, β 0.2, dropout 10%.
CI: confidence interval
OIS: optimal information size
RCT: randomised controlled trial
Appendix 3. Details of power calculations for RCTs
Annane 2013
Based on a previous study, the authors estimated that on day 5, 85% of control patients would be on antibiotics. They thus calculated
that 57 patients in each arm would be needed to detect in a two-sided test with an 80% probability and a 0.05 type I error, a 25%
absolute reduction in the proportion of antibiotic-treated patients on day 5. They also estimated that 20% of patients would eventually
be withdrawn from the study after showing indisputable infection. One hundred and forty patients in total (70 in each arm) would
thus be needed.
Bouadma 2010
Power: Assuming a mean of 12 days without antibiotics for the control group, 133 patients per study group would provide 90% power
to detect a 3-day increase in number of days without antibiotics.
Bruins 2005
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The sample calculation was based on the difference in mortality of 6.5% as detected by Doern 1994. With 296 patients in each study
group in each study period, the study would have power of 80.1% to yield a statistically significant result (α = 0.05, two-tailed, specific
proportions 0.120 vs 0.055).
Christ-Crain 2004
We designed the trial to enrol 105 patients with completed follow-up in each group. This number gave the study 95% power to detect a
30% reduction in antibiotic exposure. Assumptions included use of a two-tailed test, a 5% level of significance, and a standard deviation
(SD) of 6 days in both groups.
Christ-Crain 2006
A study sample of 150 patients in each group gave the study a power of 95% to detect a 30% reduction in antibiotic exposure from 10
to 7 days per patient assuming a two-tailed test, a 1% level of significance, and a SD of 6 days in both groups. This sample size gave
the study a power of 74% to detect a 10% increase in the combined treatment failure and complication rate (from 10% to 20%), using
the procalcitonin algorithm with a one-sided value of 0.05.
Dranitsaris 2001
This study was designed to compare the two cefotaxime groups with the hypothesis that a higher proportion of cefotaxime orders would
be within hospital guidelines in the intervention group. Inappropriate antibiotic prescribing has been shown to be as high as 40% (17).
By assuming an alpha of 5% (two-tailed), power of 80%, probability of appropriate prescribing with and without the intervention at
75% and 60% (absolute difference = 15%), respectively, the case sample size for the uncorrected Chi2 test in this randomised study
was 300, which was then increased by 10% to account for patient dropouts.
Esposito 2011
Pre-study power calculations (with 90% power) showed that 76 patients in each group were necessary to detect a 15% lower antibiotic
use, considering that 100% of children hospitalised for community-acquired pneumonia were treated with antibiotics and assuming
a two-tailed test and a 5% level of significance. Since we planned to analyse the data in subgroups of mild and severe community-
acquired pneumonia, we doubled the number of patients per group (n = 152). We thus decided to enrol 160 patients in each group to
allow for a 5% dropout participant.
Fine 2003
This study was designed with 80% power to detect a 1-day decrease in length of stay from an assumed baseline of 7.2 days. The sample
size was adjusted for the clustering on physician group assuming an average of 3.5 patients per group and an intraclass correlation
coefficient of 0.1.
Franz 2004
The sample size calculation was based on the following assumptions: a significance level .05, a power .80, a proportion of initially
missed infections of 4% in the interleukin-8 group and 9% in the standard group, and an equivalence limit of 3%. On the basis of
these assumptions, a sample size of 207 patients with infection in each group was required to demonstrate 1-sided equivalence of the
proportions of initially missed infections. Assuming a rate of bacterial infection of 18% in the study population, a total of 1150 patients
needed to be enrolled into the study.
Gulmezoglu 2007
We calculated the power using standard formulae for comparison of proportions in a completely randomised design and estimated that
with 40 hospitals, we would have 90% power to detect a decrease or an increase in a practice equal to the SD between hospitals, in a
one-sided significance test at 5% level of significance. For example, if the SD of use of episiotomy is 20%, we would be able to detect
a decrease in the end-of-study rate of use of episiotomy from 70% to 50%. We used a one-sided significance test because we believed
the intervention could only improve the use of evidence-based practices.
Jensen 2011
The final (adjusted) sample size of 1200 patients was based on an estimated mortality in the standard-of-care-only group of 31.0% and a
proposed absolute risk reduction of 7.5%. Detailed sample size considerations are available in the supplemental data (see Supplemental
Digital Content 2, links.lww.com/CCM/A257).
Kerremans 2008
It was calculated that 1500 patients were needed to demonstrate a 6% absolute reduction in mortality (power of 80% and a two-sided
alpha of 0.05) from 25% in the control group to 18% in the rapid group (Sample Power, SPSS, Chicago, USA).
Kristoffersen 2009
Pre-study power calculations (with 90% power) showed that 107 patients in each group were necessary to detect a 20% reduction in
antibiotic use (from 10 to 8 days), assuming a two-tailed test and a 5% level of significance.
Kritchevsky 2008
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A priori power calculations determined that 40 hospitals sampling 100 cases per measurement period would give 80% power to detect
a 15% difference in the pre-post change between groups in the timing of prophylaxis based on an intraclass correlation coefficient of
0.15, estimated from an earlier study of intensive care unit process improvement (0.05, 2-tailed test).
Lacroix 2014
Power calculation suggested that 97 patients should be enrolled in each group to give 80% power at the 5% level of significance to
detect a 20% difference in antibiotic prescription rate. Taking into account the possibility for lost to follow-up patients or missing or
incomplete results, we considered including 140 patients in each group.
Layios 2012
Assuming a mean stay of 7 days with 50% antibiotic exposure, a study sample of at least 250 patients in each group was deemed
necessary to detect a 20% reduction in antibiotic consumption with 95% power at the 5% significance level.
Lesprit 2013
We hypothesized that the intervention might result in a 20% reduction of the duration of hospitalisation. The sample size was estimated
based on the results of previous observations performed in our hospital showing that themean length of hospital stay for patients treated
with one of the targeted antibiotics was 15 ± 7 days. To detect a 20% reduction in the length of hospital stay in the intervention group
with a type I error of 5% and a type II error of 80%, it was necessary to enrol a total of 506 patients (253 patients in each group).
Long 2014
“Assuming 90% of the patients in the control group would use antibiotics, and anticipating a 15% decrease in antibiotic usage in the
procalcitonin (PCT) group, a sample size of 158 patients (79 patients per group) was necessary to detect a significant difference in
antibiotic prescription rate between the groups with 80% power and an α error of 0.05. To account for possible loss of patients to
follow-up, we planned to enrol 180 patients.” One hundred and eighty eligible patients were randomised to intervention (n = 90) or
control (n = 90).
Masia 2008
We hypothesised a difference of at least 15% in defined daily doses of the targeted antibiotics between intervention and control groups
based on the results of previous reports. One hundred and forty-four patients were required in each group to reach 80% power, alpha
0.05, and, within awaited group, standard deviation of 5 days.
Nobre 2008
The trial was designed to enrol at least 66 patients to obtain a power of 90% to detect a 33% (4-day) difference in the duration of
antibiotic therapy for the initial infection between the two groups based on an estimated baseline duration of 12 days.
Oliveira 2013
Sample size calculation was based on data from a previous study, in which themean duration of antibiotic therapy for the index infection
was 8.6 ± 5.0 days among patients treated according to a PCT-guided protocol, as compared with 10.7 (± 4.0) days in the control
group (V. Nobre, unpublished observation, 2008). We thus hypothesised that the duration of the antibiotic therapy in patients treated
with a PCT-guided protocol would be at least 25% shorter than the duration observed in patients treated according to a protocol
based on the serum C-reactive protein levels. We found that 58 patients per group (a total of 116 individuals) would be necessary to
demonstrate this difference, with a power of 80% and an alpha error of 5%.
Oosterheert 2005
In the control group, all patients were expected to receive a complete course of antibiotic treatment. On the basis of an expected
detection rate of 20% for atypical and viral pathogens in the intervention group and an estimate of the number of possible dropouts,
100 patients would be required to demonstrate a reduction in the use of antibiotic treatment from 100% to 80%.
Paul 2006
The primary outcome measure was % inappropriate treatment, which could only be assessed in patients with microbiologically
documented infections. The planned sample of 1500 patients in 15 wards had a power of greater than 99% to detect a 15% reduction
in inappropriate antibiotic treatment (from 35% to 20%), for a two-tailed test, assuming cluster randomisation of wards stratified
within three hospitals by a two-way analysis of variance and a between-ward variance of 0.0005. We chose a sample size that would
allow us to detect a difference even if two wards defaulted. The authors say that “Owing to the grant time limits the trial was stopped
before attaining the planned sample size”; they recruited 570 patients for the primary outcome measure instead of the planned 1500.
Schuetz 2009
To define non-inferiority with regard to the primary combined endpoint, the planning committee agreed on a 7.5% absolute difference
as the clinically tolerable upper limit (i.e. at worst the risk of an overall adverse outcome in the PCT group was increased by 7.5%). Based
on this non-inferiority boundary, a minimal sample size of 1002 patients was determined, allowing for an overall adverse outcome rate
in the control group of at most 20% and aiming for a power of 90%. Instead of a fixed sample size, we predefined a fixed recruitment
period of 18 months with the goal to randomise all eligible patients from the 6 participating hospitals during that period and an
354Interventions to improve antibiotic prescribing practices for hospital inpatients (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
extension if fewer than 1002 patients had been recruited. This prospective rule allows for the possibility of a higher number of patients
and thus better power for subgroup analyses, while maintaining the integrity of the trial.
Senn 2004
The sample size was estimated according to the Freedman method of sample size estimation under the proportional-hazards model,
on the basis of pre-study observation. One hundred and thirty-five patients were required in each group to reach 80% power of
demonstrating a 40% increase in the hazard ratio (a difference that would correspond approximately to a 25% reduction in the expected
number of antibiotic-days until modification). For practical reasons, study duration was determined before the beginning of prospective
data collection: we chose a five-month period, which was the estimated time necessary to achieve the calculated sample size. However,
the observed effect (14% reduction) was lower than predicted, so the trial was underpowered.
Shehabi 2014
Sample size calculations were derived from the findings of Schuetz in which patients with lower respiratory tract infections treated with
a PCT-based algorithm showed a 35% (29% to 40%) reduction in antibiotic exposure. Assuming a median baseline exposure level of
9 days and a standard deviation of 6 days, with 165 patients per group this study had greater than 90% power to detect a clinically
relevant reduction in duration of antibiotic usage of 25% (9.0 versus 6.7 days). As duration of antibiotic usage is unlikely to follow a
normal distribution, in accordance with Lehmann this figure was inflated by 15%. To further account for potential dropout or loss to
follow-up (anticipated to be less than 5%), a total of 400 participants were recruited.
Singh 2000
Assuming that the patients in the experimental therapy group would have 10% worse outcome than patients in the standard therapy
arm, a sample size of 200 patients (100 in each arm) would detect a difference at 0.05 and power 0.5. Assuming a 20% incidence of
development of resistance in the standard therapy group and 5% in the experimental therapy group, a sample size of 176 patients (88
in each group) would be needed for significance at 0.05 and power 0.8.
NB: The study was terminated prematurely because providers caring for patients in the control group were influenced by the favourable
results in the intervention group.
Stolz 2007
The trial was designed to demonstrate the persistent superiority of procalcitonin guidance in decreasing antibiotic use up to six months
after the index exacerbation. The sample size was calculated from the following assumptions: a 75% use of antibiotics to treat the index
exacerbation and an expected absolute reduction of this frequency from 75% to 45% with procalcitonin guidance. Considering an
exacerbation rate of 70% within 6 months and 75% antibiotic use in the following exacerbations, a sample size of 186 patients (93
patients per group) was necessary to detect a significant difference in antibiotic use between both groups with a power of 85% and an
error of 0.05. Considering a 20% dropout rate after assignment to the study, 223 inclusions were planned.
Stolz 2009
Considering 13 antibiotic-free days in the control group and 18 antibiotic-free days in the procalcitonin group, a sample size of 84
patients (42 per group) was necessary to detect a significant difference in antibiotic-free days alive between both groups with a power
of 90% and an error of 0.05 using a two-tailed test. Assuming 8% lost to follow-up, we planned the inclusion of 100 participants.
Yealy 2005
The primary outcome was site of treatment rather than the antibiotic process measures. “We estimated that we would need 96 eligible
patients per hospital (3072 in total) to achieve 80% power to detect a 12% difference across the intervention groups for the site-of-
treatment decision among low-risk patients.”
“For the site-of-treatment decision, this study achieved greater than 80% power to detect differences of 10% between high-intensity
and moderate-intensity groups and differences of 12% between high-intensity and low-intensity groups according to separate 1-tailed
tests in which the level was 0.025.”
Appendix 4. Contribution of 49 RCTs to meta-analyses and to meta-regression
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Study MA MR Analysis 1.1 Analysis 1.4 Analysis 1.5 Analysis 2.1 Analysis 2.4
Annane 2013 1 1 1 0 0 1 0
Bailey 1997 1 0 0 0 1 1 1
Bouza 2004 1 0 0 1 0 0 0
Bouza 2007 1 0 0 0 0 1 0
Burton 1991 1 1 1 0 0 0 1
Camins 2009 1 1 1 0 0 1 0
Christ-Crain
2004
1 1 1 1 0 1 1
Christ-Crain
2006
1 1 1 1 0 1 1
Danaher 2009 1 0 0 1 0 0 0
Ding 2013 1 1 1 1 0 1 0
Dranitsaris
2001
1 1 1 0 0 0 0
Esposito 2011 1 1 1 0 0 0 1
Fine 2003 1 0 0 0 0 1 0
Franz 2004 1 1 1 0 0 0 0
Fraser 1997 1 0 0 0 0 1 0
Gulmezoglu
2007
1 1 1 0 0 0 0
Gums 1999 1 0 0 0 1 1 1
Hochreiter
2009
1 0 0 1 0 1 0
Kerremans
2008
1 0 0 1 0 0 0
Kristofferson
2009
1 0 0 1 0 1 1
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(Continued)
Kritchevsky
2008
1 1 1 0 0 0 0
Lacroix 2014 1 1 1 0 0 0 0
Layios 2012 1 0 0 1 0 0 0
Liu 2013 1 0 0 1 0 1 1
Long 2014 1 1 1 0 0 0 0
Maravic-Sto-
jkovic 2011
1 1 1 0 0 1 1
Masia 2008 1 0 0 0 0 1 0
Micek 2004 1 0 0 1 0 1 1
Oliveira 2013 1 0 0 1 0 1 0
Paul 2006 1 1 1 0 0 1 1
Poehling 2006 1 1 1 0 0 0 0
Qu 2012 1 0 0 1 0 1 1
Schnoor 2010 1 1 1 0 0 1 1
Schouten
2007
1 1 1 0 0 1 0
Schroeder
2009
1 0 0 1 0 1 0
Schuetz 2009 1 1 1 0 0 1 0
Senn 2004 1 1 1 0 0 1 1
Shen 2011 1 0 0 0 1 0 1
Shojania 1998 1 0 0 0 1 0 0
Singh 2000 1 1 1 0 0 1 0
Solomon
2001
1 1 1 0 0 1 0
Stocker 2010 1 1 1 0 0 0 0
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(Continued)
Stolz 2007 1 0 0 0 0 1 0
Stolz 2009 1 1 1 0 0 0 0
Strom 2010 1 1 1 0 0 0 0
Trehnholme
1989
1 1 1 0 0 0 0
Walker 1998 1 1 1 0 0 0 0
Wyatt 1998 1 1 1 0 0 0 0
Yealy 2005 1 1 1 0 0 1 0
Totals 49 29 29 14 4 28 15
Appendix 5. Contribution of 109 ITS studies to meta-regression of prescribing outcomes for
intervention effect (n = 107) or removal (n = 5, 2 studies only had data about intervention removal)
Intervention effect Intervention
removal Table 7
Figure 10 Figure 11 Figure 12
TOTALS 107 5 91 29 43
Study
Abramowitz 1982 1 0 1 0 1
Adachi 1997 1 0 1 0 1
Akenroye 2014 1 0 1 0 1
Aldeyab 2012 1 0 1 1 0
Ananda Rajah 2010 1 0 0 0 0
Ansari 2003 1 0 1 0 1
Avorn 1988 1 0 1 0 1
Bantar 2006 1 0 1 1 0
Barlow 2007 1 0 1 0 1
Bassetti 2009 1 0 1 1 0
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(Continued)
Belliveau 1996 1 0 1 1 0
Benson 2014 1 0 1 0 1
Berild 2002 1 0 0 0 0
Borde 2014a 1 0 1 0 1
Borde 2015a 1 0 1 0 1
Borde 2015b 1 0 1 0 1
Bradley 1999 1 0 1 1 0
Buising 2008a 1 0 1 1 0
Buising 2008b 1 0 1 0 1
Bunz 1990 1 0 1 1 0
Buyle 2010 1 0 1 0 1
Chan 2011 1 0 1 1 0
Chan 2014 1 0 1 1 0
Chandy 2014 1 0 1 0 0
Cheng 2009 1 0 1 0 1
Cook 2011 1 0 1 0 1
Cook 2011a 1 0 1 1 0
Cortoos 2011 1 0 1 0 0
Dancer 2013 1 0 1 1 0
Dull 2008 1 0 1 0 1
Elligsen 2012a 1 0 1 0 1
Everitt 1990 1 0 1 1 0
Fitzpatrick 2008 1 0 0 0 0
Fowler 2007 1 0 1 0 1
Fukuda 2014 1 0 1 0 1
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(Continued)
Grohs 2014 1 0 0 0 0
Gupta 1989 1 0 1 1 0
Hadi 2008 1 0 1 0 0
Halm 2004 1 0 0 0 0
Hess 1990 1 0 1 0 1
Hitti 2012 1 0 1 0 0
Huber 1982 1 0 0 0 0
Hulgan 2004 1 0 1 0 1
Inaraja 1986 1 0 0 0 0
Jobson 2015 1 0 1 0 1
Jump 2012 1 0 1 0 1
Kallen 2009 1 1 0 0 0
Kim 2008 1 1 1 1 0
Knudsen 2014 1 0 1 0 1
Kumana 2001 1 0 1 0 1
Lafuarie 2012 1 0 1 0 1
Lautenbach 2003 1 0 0 0 0
Lee 1995 1 0 1 0 1
Lee 2007 1 0 0 0 0
Lee 2014 1 0 1 0 1
Liebowitz 2008 1 0 1 0 0
Magedanz 2012 1 0 1 0 1
Marwick 2013 1 0 1 0 1
May 2000 1 0 1 0 0
McElnay 1995 1 0 1 1 0
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(Continued)
McGowan 1976 1 0 0 0 0
McNulty 1997 1 0 1 1 0
Mercer 1999 1 0 1 1 0
Meyer 2007 1 0 1 0 0
Meyer 2009 1 0 1 0 0
Meyer 2010 1 0 1 0 0
Mittal 2014 1 0 1 0 1
Mol 2005 1 0 0 0 0
Newland 2012 1 0 1 0 1
Parikh 2014 1 0 1 0 0
Patel 1989 1 0 0 0 0
Perez 2003, Inter-
vention 2
1 0 1 0 1
Peto 2008 1 0 1 1 0
Petrikkos 2007 1 0 1 0 0
Po 2012, Interven-
tion 1
1 0 1 0 0
Popovski 2014 1 0 1 0 0
Price 2010 1 0 1 1 0
Richards 2003 1 0 1 1 0
Ross 2014 1 0 1 0 0
Saizy-Callaert 2003 1 0 0 0 0
Salama 1996 1 0 1 1 0
Schwann 2011 1 0 1 0 1
Schwartz 2007 1 0 1 0 0
Sirinavin 1998 1 0 0 0 0
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(Continued)
Skaer 1993 1 0 1 0 1
Standiford 2012 1 1 1 0 1
Stevenson 1988 1 0 1 0 0
Sun 2011 1 0 1 0 1
Suwangool 1991 1 0 1 1 0
Talpaert 2011 1 0 1 1 0
Tangden 2011 1 0 1 0 0
Toltzis 1998 1 0 1 1 0
Valiquette 2009 1 0 1 0 1
van Kasteren 2005 1 0 1 0 1
Volpe 2012 1 0 1 0 1
Wang 2014 1 0 1 1 0
Wax 2007 1 0 1 0 0
Weinberg 2001 1 0 0 0 0
Weiner 2009 1 0 1 0 1
Wenisch 2014 1 0 1 1 0
Willemsen 2010 1 0 1 0 1
Wilson 1991 1 0 1 0 0
Woodward 1987 1 0 1 1 0
Yeo 2012 1 0 1 0 1
Yong 2010 1 0 1 0 1
Yoon 2014 1 0 1 1 0
Young 1985 1 0 1 1 0
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Appendix 6. RCTs and ITS studies not included in any evidence synthesis
Reasons for exclusion of 9 RCTs from prescribing meta-analysis. Note that these studies had no valid clinical outcome data and so were
not included in any meta-analysis:
Reason Number Studies
Prescribing outcome continuous variable
with no standard deviation
5 Lesprit 2013; Nobre 2008; Oosterheert 2005; Palmay 2014; Shehabi 2014
Insufficient detail to quantify impact on
prescribing outcomes used in the meta-
analyses
4 Bouadma 2010; Farinas 2012; Jensen 2011; Kerremans 2009
Reasons for exclusion of 28 ITS studies from meta-regression:
16 ITS studies did not include time series data about prescribing outcomes: Aldeyab 2014;Calil 2001;Carling 2003;Charbonneau 2006;
Climo 1998; de Champs 1994; Dempsey 1995; Dua 2014; Gerding 1985; Khan 2003; Landman 1999; Lawes 2012; Leverstein-van
Hall 2001; Nuila 2008; Pear 1994; Toltzis 2014. Note that Bell 2014 did not include data about prescribing outcomes but did include
valid clinical outcome data (Table 4).
13 ITS studies included time series data about prescribing outcomes but were excluded from meta-regression for the following reasons:
Study Reason
Borde 2014b Only 3 postintervention points and compound outcome (choice and dose) not comparable with other
studies
Goldstein 2009 Intervention was substitution of ertapenem for ampicillin-sulbactam, but there are no ampicillin-sulbactam
data
Madaras-Kelly 2006 Effect size reported for segmented regression analysis but no variance
McLaughlin 2005 Large, unjustified gap between pre- and postintervention data
Meyer 1993 Restriction of cephalosporins was in place throughout the study period. The paper reports an outbreak of
cephalosporin-resistant Klebsiella pneumoniae. Following the outbreak “approvals were reduced by 80%”,
but unclear whether this was because of change in restriction or reduction in requests
Parienti 2011 Removal of restriction of fluoroquinolone and effect on MRSA, BUT only one data point prior to removal
so cannot be re-analysed
Ostrowsky 2014 Non-standardised intervention and prescribing outcomes across multiple hospitals
Pires 2011 “Intervention” was introduction of ertapenem into the formulary with no instruction to use less of anything
else
Pulcini 2011 4 months’ pre- and postintervention data in 2 weekly time points. Data format not compatible with other
studies
Rattanaumpawan 2011 Removal of restriction only, and there is not enough unnecessary use before de-restriction to detect change
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(Continued)
Richardson 2000 Not truly 3 pre-intervention time points, and time intervals irregular
Uçkay 2009 Comparison is between the deliverer of the same intervention (infectious disease physicians with and
without infection control training). No pre-intervention data
van Hees 2008 Large, unjustified gap between pre- and postintervention data
Appendix 7. Details of disagreements with other reviews
A systematic review on current evidence about antimicrobial stewardship objectives reported that “guideline-adherent empirical therapy
was associated with a relative risk reduction for mortality of 35% (odds ratio 0.65, 95% CI 0.54-0.80)” (Schuts 2016). This analysis
was based on 39 studies, of which 19 were identified by our literature search. We have reviewed the 20 studies that were not identified
by our literature search. Only two of the 39 studies in this review reported an intervention, and both were identified by our literature
review: one was invalid because it was an uncontrolled before-after study (Garcia 2007), and one controlled before-after study (CBA) is
in our ’Characteristics of included studies’ table (Dean 2006). The remaining 27 studies used case control or cohort designs to compare
the outcomes of patients with and without guideline-adherent antibiotic treatment, and did not include an intervention to change
professional practice. The results of this review are in marked contrast to our analysis of mortality in 11 randomised controlled trials
targeting antibiotic choice (Analysis 3.1). The aim of these interventions was to increase adherence with antibiotic guidelines for the
antibiotic or route of administration. We have presented results as risk differences (Figure 8), but the odds ratio for mortality in these
11 randomised controlled trials is 0.96 (95% confidence interval (CI) 0.82 to 1.13). The most likely explanation for the discrepancy
between our results and those of Schuts 2016 is confounding by indication. It is likely that patients with less complex or severe illness
weremore likely to receive guideline-adherent antibiotic treatment and that there was residual confounding after adjustment for available
clinical information. The only valid intervention study in the analysis by Schuts 2016 was a CBA. This study compared outcomes for
community-acquired pneumonia (CAP) for patients in 16 hospitals that had implemented a policy based on national guidelines with
19 control hospitals from the same state (Dean 2006). The CAP policy included several important elements in addition to antibiotic
choice, such as antibiotic administration in the outpatient or emergency department before admission to hospital; administration of
enoxaparin; and early ambulation of hospital inpatients. This study did not include any measures of process compliance, so it is unclear
whether there is any relationship between mortality and adherence with the antibiotics recommended in the CAP policy.
A systematic review on the effect of antibiotic stewardship programmes on Clostridium difficile infection (CDI) reported that inter-
ventions were associated with a consistent, significant protective effect (pooled risk ratio for CDI 0.48, 95% CI 0.38 to 0.62) (Feazel
2014). This analysis was based on 16 studies, of which 10 were identified by our literature search. We have reviewed the six studies
that were not identified by our literature search. Of the 16 studies included in this systematic review, four were interrupted time series
(ITS) studies that we have included in our review (Elligsen 2012; Fowler 2007; Price 2010; Talpaert 2011); the remaining 12 studies
were either uncontrolled before-after or inadequate ITS studies. Elligsen 2012 only has reliable data about prescribing outcomes; CDI
data are in the form of an inadequate CBA with aggregated before and after data from one intervention and one control site. The
statistical analysis in this review, Feazel 2014, was not appropriate for the three ITS studies included in our review (Fowler 2007; Price
2010; Talpaert 2011). Calculation of risk ratios for the post- versus pre-intervention periods is an uncontrolled before-after analysis,
which does not provide a reliable estimate of intervention effect. This is most clearly demonstrated by the results of one study (Price
2010), in which CDIs were declining pre-intervention by -0.04 cases per 1000 occupied bed days per month (95% CI -0.08 to -0.01;
P = 0.03). Postintervention CDI continued to decline at a slightly greater rate, but our estimate of the intervention effect was only a
10% reduction at 12 months (95% CI 85% reduction to 65% increase). In the systematic review (Feazel 2014), the reported risk ratio
in the post- versus pre-intervention phase was 0.52 (95% CI 0.44 to 0.61), but this result is mainly attributable to a steady decline in
CDI over the entire study period rather than to any intervention effect.
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WH A T ’ S N E W
Last assessed as up-to-date: 19 January 2015.
Date Event Description
19 January 2015 New search has been performed New searches performed to January 2015 and 132 new
studies have been included in the review
New authors: Charis Marwick, Kirsty McNeil, Claire
Scott, replacingLyndaFenelon, AlisonHolmes, PhilWif-
fen, and Mark Wilcox
Important changes to the methods are inclusion of case
control, cohort, or qualitative studies of unintended con-
sequences, new data extraction forms to identify be-
haviour change techniques in the interventions, and a
prespecified subgroup analysis andmeta-regression by be-
haviour change technique
Cluster non-randomised controlled trials and ran-
domised controlled trials (RCTs) with fewer than 2 in-
tervention or control sites have been excluded, including
1 non-randomised controlled trial from the previous ver-
sion of the review
Results updated, ’Characteristics of included studies’ and
’Characteristics of excluded studies’ tables re-written and
updated to end of December 2014. Meta-analysis of
RCTs completed prior to meta-regression of RCTs and
interrupted time series studies
19 January 2015 New citation required and conclusions have changed The addition of new data to the review has strengthened
the conclusions regarding the effect on antibiotic pre-
scribing and mortality. The review shows that there is a
reduction in length of hospital stay
The review now has identified that interventions are con-
sistently more effective if they contain enabling compo-
nents, which provide advice or feedback to help physi-
cians makemore informed decisions about their prescrib-
ing. However only 10% of interventions used the most
effective enabling techniques: goal setting, feedback and
action planning
Given the high certainty of evidence for our primary
outcome we believe that additional trials comparing an-
tibiotic stewardship with no intervention are unlikely to
change our conclusions or build on our understanding of
the current evidence
This review includes 221 studies.
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H I S T O R Y
Protocol first published: Issue 1, 2002
Review first published: Issue 3, 2005
Date Event Description
22 November 2014 Amended Major edits in preparation for next update, ’Charac-
teristics of included studies’ table re-written and up-
dated to end of December 2012
1 May 2014 Amended Protocol completely revised.
26 February 2013 New search has been performed New search, 89 studies found.
26 February 2013 New citation required and conclusions have changed New search, 89 new studies found.
12 February 2009 Amended Minor edits, tables modified.
29 July 2008 Amended Converted to new review format.
28 July 2005 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
Peter Davey (Clinical Pharmacologist) wrote the protocol; assisted with the literature search; reviewed all intervention studies for risk
of bias using Cochrane Effective Practice and Organisation of Care (EPOC) Group methodology; contributed to re-analysis of data
from interrupted time series (ITS) studies and meta-regression of ITS studies and randomised controlled trials (RCTs); wrote the first
draft of the review and was responsible for final decisions about included studies; contributed to EPOC check sheets, data extraction,
and GRADE assessment of certainty of evidence.
Charis Marwick (Infectious Diseases Physician) re-analysed all of the ITS studies and performed meta-regression of ITS studies and
RCTs with an analysis plan written by Craig Ramsay (Statistician); was a member of the review writing group; and contributed to
EPOC check sheets, data extraction, and GRADE assessment of certainty of evidence.
Claire Scott (Psychologist) managed the review; set up the database; was a member of the review writing group; and contributed to
EPOC check sheets, data extraction, and GRADE assessment of certainty of evidence.
Esmita Charani (Pharmacist) and Kirsty McNeil (Medical Student) were members of the review writing group and contributed to
EPOC check sheets, data extraction, and GRADE assessment of certainty of evidence.
Erwin Brown (Medical Microbiologist) initiated the review in 2000 and for this update handsearched bibliographies of individual
papers for additional references; screened titles and abstracts; and reviewed all papers to identify those that reported the results of an
intervention to change antibiotic prescribing.
Ian Gould (Medical Microbiologist) reviewed papers for microbial risk of bias and was a member of the review writing group.
Craig Ramsay (Statistician) wrote the analysis plan for re-analysis of ITS studies and meta-regression of ITS studies and RCTs.
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Susan Michie (Psychologist) advised on the design of data extraction for behaviour change techniques and the analysis of intervention
functions; was a member of the review writing group; and contributed to GRADE assessment of certainty of evidence.
D E C L A R A T I O N S O F I N T E R E S T
Peter Davey is an author of four of the included studies. Charis Marwick is an author of two of the included studies. Ian Gould is an
author of one of the included studies. Craig Ramsay is an author of one of the included studies. Other review authors completed data
extractions for these studies. The institutions of the following authors received funding from the Chief Scientist Office that helped to
support the conduct of this review: Peter Davey, Charis Marwick, Esmita Charani.
Peter Davey, none other than as indicated above.
Charis Marwick, none other than as indicated above.
Claire Scott, none other than as indicated above.
Esmita Charani, none other than as indicated above.
Kirsty McNeil, none other than as indicated above.
Susan Michie, none other than as indicated above.
Erwin Brown, none other than as indicated above.
Ian Gould, none other than as indicated above.
Craig Ramsay, none other than as indicated above.
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Internal sources
• Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.
• Imperial College, London, England, UK.
• University of Dundee, Dundee, Scotland, UK.
• University of Aberdeen, UK.
• UK Cochrane Centre, UK.
• University College London, UK.
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• British Society for Antimicrobial Chemotherapy, UK.
• Chief Scientist Office for Scotland, UK.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The protocol was completely revised for this update of the review. The most notable changes to the original protocol used for the first
version of the review are as follows.
1. We amended the main outcome of interest to reflect desired change in practice. This fits better with the overall objective of the
review relating to appropriate prescription in order to provide evidence of better targeting of antibiotic prescribing.
2. We changed the measure of effect from risk ratios to risk differences to better convey the intervention effect in absolute terms.
3. We adjusted for the effect of clustering in sensitivity analyses, as we had not considered this aspect of trial design in the previous
version of the review.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Drug Resistance, Bacterial; ∗Practice Patterns, Physicians’; Anti-Bacterial Agents [adverse effects; ∗therapeutic use]; Bacterial Infections
[∗drug therapy; prevention & control]; Cross Infection [∗drug therapy; prevention & control]; Inpatients; Randomized Controlled
Trials as Topic
MeSH check words
Humans
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